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What Is a TIP?
 
Treatment Improvement Protocols (TIPs) are developed by the Center 
for Substance Abuse Treatment (CSAT), part of the Substance Abuse 
and Mental Health Services Administration (SAMHSA) within the U.S. 
Department of Health and Human Services (HHS). TIPs are best-practice 
guidelines for the treatment of substance use disorders. TIPs draw on 
the experience and knowledge of clinical, research, and administrative 
experts to evaluate the quality and appropriateness of various forms 
of treatment. TIPs are distributed to facilities and individuals across 
the country. Published TIPs can be accessed via the Internet at 
http://www.kap.samhsa.gov. 
While each TIP strives to include an evidence base for the practices it 
recommends, SAMHSA/CSAT recognizes that the field of substance abuse 
treatment is continually evolving, and research frequently lags behind the 
innovations pioneered in the field. A major goal of each TIP is to convey 
“front-line” information quickly but responsibly. If research supports a 
particular approach, citations are provided. 
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Foreword

 The Treatment Improvement Protocol (TIP) 
series supports SAMHSA’s mission of building 
resilience and facilitating recovery for people 
with or at risk for mental or substance use 
disorders by providing best practices guidance 
to clinicians, program administrators, and pay­
ers to improve the quality and effectiveness of 
service delivery, and, thereby promote recovery. 
TIPs are the result of careful consideration of 
all relevant clinical and health services research 
findings, demonstration experience, and imple­
mentation requirements. A panel of clinical 
researchers, clinicians, program administrators, 
and client advocates debates and discusses its 
particular areas of expertise until it reaches a 
consensus on best practices. This panel’s work is 
then reviewed and critiqued by fi eld reviewers. 
The talent, dedication, and hard work that 
TIPs Panelists and reviewers bring to this highly 
participatory process have helped to bridge the 
gap between the promise of research and the 
needs of practicing clinicians and administrators 
to serve people who abuse substances in the 
most scientifically sound and effective ways. We
are grateful to all who have joined with us to 
contribute to advances in the substance abuse 
treatment fi eld. 
Eric Broderick, D.D.S., M.P.H. 
Acting Administrator 
Substance Abuse and Mental Health Services 
Administration 
H. Westley Clark, M.D., J.D., M.P.H., CAS, 
FASAM 
Director 
Center for Substance Abuse Treatment 
Substance Abuse and Mental Health Services 
Administration 
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Executive Summary
 
Clinicians and program administrators are increasingly aware of 
the important differences between men and women with regard to 
the physical effects of substance use and the specific issues related 
to substance use disorders. They are also recognizing that these 
differences have an impact on treatment—that gender does make 
a difference. When women’s specific needs are addressed from the 
outset, improved treatment engagement, retention, and outcomes are 
the result. 
This TIP endorses a biopsychosociocultural framework based 
on clinical practice and research centered on women. By placing 
emphasis on the importance of context, many topics examine the 
role of factors that influence women’s substance use from initiation 
of use to engagement of continuing care treatment services, i.e., 
relationships, gender socialization, and culture. The knowledge and 
models presented here are grounded in women’s experiences, built on 
women’s strengths, and based on best, promising, or research-based 
practices. The primary goal of this TIP is to assist substance abuse 
treatment providers in offering effective, up-to-date treatment to 
adult women with substance use disorders. 
The TIP is organized into eight chapters. The following section 
summarizes the content of each chapter to present an overview of this 
publication. 
Creating the Context 
The consensus panel for this TIP proposes that substance abuse 
treatment for women be approached from a perspective that 
encompasses the contexts of women’s lives. These contexts include 
a woman’s social and economic environment; her relationships with 
family, extended family, and support systems; and the impact of 
gender and culture. As a framework to explore women’s substance 
use disorders, treatment needs, and treatment approaches, this TIP 
adopted two systemic models: Bronfenbrenner’s ecological model 
and CSAT’s Comprehensive Substance Abuse Treatment Model for 
Women and Their Children. Both models endorse the relevance 
and influence of multisystems and their bidirectional infl uence upon 
women’s lives. 
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What makes gender an important clinical issue 
in substance abuse treatment? Are there gender 
differences in the development and pattern of 
substance use disorders? Do these differences 
warrant specific treatment approaches? To
date, there is considerable evidence denoting 
that gender differences do exist, and these 
differences begin with early risk factors for 
substance use and extend throughout the 
course of treatment and recovery. Grounded 
in research, this TIP begins with unique 
biopsychosocial and developmental issues 
of women that create or intensify gender 
differences across the continuum of care. 
Knowledge of these unique factors is essential 
for treatment providers to fully understand the 
contexts of women’s lives and their needs. 
Based on the premise and knowledge that 
women are biopsychosocially unique in ways 
that are relevant to substance use, substance 
use disorders, and substance abuse treatment, 
this consensus panel endorses core principles for 
gender responsive treatment for women, such 
as–– 
• 	 Acknowledging the importance as well as 
the role of the socioeconomic issues and 
differences among women. 
• 	 Promoting cultural competence specifi c to 
women. 
• 	 Recognizing the role as well as the 
significance of relationships in women’s lives. 
• 	 Addressing women’s unique health concerns. 
• 	 Endorsing a developmental perspective. 
• 	 Attending to the relevance and infl uence of 
various caregiver roles that women often 
assume throughout the course of their lives. 
• 	 Recognizing that ascribed roles and 
gender expectations across cultures affect 
societal attitudes toward women who abuse 
substances. 
• 	 Adopting a trauma-informed perspective. 
• 	 Using a strengths-based model for women’s 
treatment. 
• 	 Incorporating an integrated and 
multidisciplinary approach to women’s 
treatment. 
• 	 Maintaining a gender responsive treatment 
environment across settings. 
• 	 Supporting the development of gender 
competency specific to women’s issues. 
Patterns of Use: From 

Initiation to Treatment
 
Numerous factors influence the reasons for 
initiation of substance use among women, and 
a number of these factors are more prevalent 
among women than men. Women often report 
that stress, negative affect, and relationships 
precipitate initial use. In fact, women are often 
introduced to substance use by a signifi cant 
relationship such as boyfriend, family member, 
or close friend. Though genetics also may be a 
significant risk factor for women, more research 
supports familial influence—a combination of 
genetic and environment effects. Less is known 
about familial influence of illicit drugs, but 
parental alcohol use increases the prevalence of 
alcohol use disorders among women by at least 
50 percent. Family of origin characteristics play 
a role too. Exposure to chaotic, argumentative, 
and violent households, or being expected to 
take on adult responsibilities as a child, are 
other factors associated with initiation and 
prevalence of substance use disorders among the 
female population. 
Women are signifi cantly infl uenced by 
relationships, relationship status, and the 
effects of a partner’s substance abuse. Women 
dependent on substances are more likely to have 
partners who have substance use disorders. 
At times, women perceive shared drug use 
with their partner as a means of connection 
or of maintaining the relationship. Often, 
rituals surrounding drug use are initiated by 
a male partner, and women bear more risk in 
contracting HIV/AIDS and hepatitis by sharing 
needles or having sexual relationships with men 
who inject drugs. Relationship status similarly 
influences use and potential development of 
substance use disorders. Marriage appears 
protective, whereas separated, never married, 
or divorced women are at greater risk for use 
and the development of substance use disorders. 
Relationship influence does not stop at the 
point of treatment entry; relationships also 
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signifi cantly influence treatment engagement, 
retention, and outcome among women. 
Other risk factors associated with initiation 
of use and the prevalence of substance use 
disorders include sensation-seeking, symptoms 
of depression and anxiety, posttraumatic stress 
and eating disorders, and difficulty in regulating 
affect. Women with a history of trauma, 
including interpersonal and childhood sexual 
abuse, are highly represented in substance abuse 
samples. In addition, sociocultural issues play a 
significant role across the continuum beginning 
with enhanced risk for substance use. Degree 
of acculturation, experiences of discrimination, 
and socioeconomic status are prominent risk 
factors from the outset but continue to infl uence 
women’s substance use, health status, treatment 
access, and help-seeking behavior. 
Among women, six patterns of substance use 
clearly emerge from empirical data. First, 
the gender gap is narrowing for substance use 
across ethnicities, particularly among young 
women. Second, women are more likely to be 
introduced to and initiate substance use through 
significant relationships, while marital status 
appears to play a protective role. Third, women 
accelerate to injecting drugs at a faster rate 
than men, and rituals and high-risk behaviors 
surrounding drug injection are directly 
influenced by significant relationships. Fourth, 
women’s earlier patterns of use (including age of 
initiation, amount, and frequency) are positively 
associated with higher risks for dependency. 
Next, women are more likely to temporarily 
alter their pattern of use in response to caregiver 
responsibilities. And last, women progress faster 
from initiation of use to the development of 
substance-related adverse consequences. 
Substance use is not as prevalent among women 
as it is among men, but women are as likely as 
men to develop substance use disorders after 
initiation. Women who are pregnant are likely to 
reduce or remain abstinent during pregnancy; 
however, continued use is associated with a wide 
range of issues and effects—from less prenatal 
care to potential irreparable harm to the child 
from fetal exposure. Among those entering treat­
ment, women are more likely to report drug use 
as the main reason for admission. 
Physiological Effects of Alcohol, 
Drugs, and Tobacco on Women 
Women develop substance use disorders in 
less time than men. Some factors that either 
influence or compound the physiological effects 
of drugs and alcohol include ethnicity, health 
disparity, socioeconomic status, developmental 
issues, aging, and co-occurring conditions. 
Although research on the physiological 
effects of alcohol and illicit drugs on women 
is limited and often inconclusive, signifi cant 
differences have been found in the way 
women and men metabolize alcohol. Women 
have more complications and more severe 
problems from alcohol use than do men, and 
these complications and problems develop 
more rapidly. This phenomenon is known as 
“telescoping.” Complications include liver 
disease and other organ damage; cardiac-related 
conditions such as hypertension; reproductive 
consequences; osteoporosis; cognitive and other 
neurological effects; breast and other cancers; 
and greater susceptibility and progression of 
infections and infectious diseases, including 
HIV/AIDS and hepatitis C virus (HCV). 
Although many physiological effects of licit and 
illicit drugs have not been well studied, research 
has shown that abuse of substances such as 
stimulants, opioids, and some prescription 
(e.g., anxiolytics, narcotic analgesics) and 
over-the-counter (e.g., laxatives, diuretics, 
diet pills) drugs causes adverse effects on 
women’s menstrual cycles and gastrointestinal, 
neuromuscular, and cardiac systems, among 
others. With regard to nicotine use, women 
who smoke increase their risk of lung cancer. 
Currently, cancer is the second leading cause 
of death among women, with mortality rates 
higher for lung cancer than breast cancer. 
Other physiological consequences of tobacco 
use include, but are not limited to, increased 
risks for peptic ulcers, Crohn’s disease, estrogen 
deficiencies, strokes, and atherosclerosis. 
Women who smoke are more likely to have 
chronic obstructive pulmonary disease and 
coronary heart disease. 
Women who use alcohol, drugs, or tobacco 
while pregnant or nursing expose their fetuses 
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 or infants to these substances as well. The most 
thoroughly examined effect of alcohol on birth 
outcomes is fetal alcohol syndrome, which 
involves growth retardation, central nervous 
system and neurodevelopmental abnormalities, 
and craniofacial abnormalities. Alcohol and 
drug use by pregnant women is associated with 
many complications, including spontaneous 
abortion, prematurity, low birth weight, 
premature separation of the placenta from the 
uterine wall, neonatal abstinence syndrome, 
and fetal abnormalities. Likewise, women who 
are pregnant and use tobacco are more likely to 
deliver premature and low birth weight infants. 
Screening and Assessment
 
Understanding the extent and nature of 
a woman’s substance use disorder and its 
interaction with other areas of her life is 
essential for accurate diagnosis and successful 
treatment. This understanding can be acquired 
through screening and assessment. Screening is 
typically a brief process for identifying whether 
certain conditions may exist and usually involves 
a limited set of questions to establish whether 
a more thorough evaluation and referral(s) 
are needed. Sociocultural factors—ethnicity, 
culture, acculturation level, language, and 
socioeconomic status—are particularly 
relevant in screening and assessment selection, 
in determining the appropriateness of the 
instruments, and in interpreting the subsequent 
results. Sociocultural and socioeconomic 
characteristics of the client can affect testing 
expectations and behavior of both the 
counselor and client during the screening and 
assessment process; e.g., the client’s distrust and 
subsequent reluctance in the testing process or 
the counselor’s expectation that a woman with 
lower socioeconomic status will have a positive 
screening for alcohol or drug use. 
For women, general alcohol and drug screening 
that determines current or at-risk status for 
drug and alcohol use during pregnancy is 
essential. However, healthcare professionals 
sometimes overlook the necessity of drug 
and alcohol screening for older, Asian, and/ 
or middle- and upper-class women who are 
pregnant. Screening is more likely based 
on preconceived beliefs concerning greater 
prevalence of substance abuse among women 
from diverse ethnic groups. Counselors and 
intake personnel may also alter their behavior 
when working with diverse populations, such as 
eye contact, body language, and communication 
styles, that ultimately affect clients’ responses 
and trust in the screening process. 
Other screenings involve the determination of 
co-occurring risks, conditions, or disorders, 
including general mental disorders, mood 
and anxiety disorders, risk of harm to self 
or others, history of childhood trauma and 
interpersonal violence, and eating disorders. 
Considering women’s likely involvement with 
health care providers, screening for substance 
use and abuse should be a standard practice. 
Yet, the implementation of screening, regardless 
of setting, is only as good as the protocol in 
providing feedback, referral, and follow-
up. Screening is not an intervention. What 
makes the difference is how a woman’s positive 
endorsement of screening questions leads to 
feedback, referral, further assessment, and 
intervention, if warranted. 
The difference between screening and 
assessment is that assessment examines 
several domains in a client’s life in detail so 
that diagnoses can be made for substance use 
disorders and possible co-occurring mental 
disorders. Assessment is an ongoing process 
in which the counselor forms an increasingly 
clearer picture of the client’s issues, how they 
can best be addressed, and how the client is 
changing over time. An assessment interview, 
such as a structured psychosocial interview, 
an unstructured psychosocial and cultural 
history, and/or the Addiction Severity Index, 
needs sufficient time to complete. The degree 
to which it is possible or advisable to probe in 
depth in different areas of functioning depends 
on the individual issues, the needs of the woman, 
the complexity of her issues, and the level 
of rapport between the client and clinician. 
Equally important, assessment processes should 
explore coping styles, strengths, and available 
support systems. An assessment process would 
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not be complete without a health assessment and 
medical examination. 
In sum, screening and assessment for women 
must be approached from a perspective that 
allows for and affirms cultural relevance and 
strengths. Whenever possible, instruments that 
have norms established for specifi c population 
groups should be used. Counselors’ sensitivity to 
the clients’ cultural values and beliefs, language, 
acculturation level, literacy level, and emotional 
ability to respond facilitates the assessment 
process and helps women engage in treatment. 
Treatment Engagement, 

Placement, and Planning
 
Women face many obstacles and challenges 
in engaging in treatment services: lack of 
collaboration among social service systems, 
limited options for women who are pregnant, 
lack of culturally congruent programming, 
few resources for women with children, fear 
of loss of child custody, and the stigma of 
substance abuse. On one hand, intake personnel 
and counselors can help women tackle and 
overcome personal barriers to treatment (such 
as issues of motivation and shame); yet, on the 
other hand, programming and administrative 
policies must address obstacles surrounding 
program structure, interagency coordination, 
and service delivery to improve treatment 
engagement. In recent years, more effective 
engagement strategies have been implemented. 
Outreach services, pretreatment intervention 
groups, and comprehensive and coordinated 
case management can effectively address the 
numerous barriers and the array of complex 
problems that women often express in their role 
as caregivers. 
Treatment placement decisions are based not 
only on the woman’s individual needs and 
the severity of her substance use disorder but 
also on the treatment options available in the 
community, her financial circumstances, and 
available healthcare coverage. To determine 
treatment placement, the American Society 
of Addiction Medicine’s Patient Placement 
Criteria, Second Edition Revised (ASAM’s PPC­
2R), are used widely, and the levels determined 
by these criteria are useful to standardize 
treatment placement. To date, empirical 
literature supporting specific placement criteria 
for women is limited. The treatment levels 
suggested by the consensus panel and supported 
by ASAM criteria include pretreatment or 
early intervention; detoxifi cation; outpatient 
treatment; intensive outpatient treatment 
(IOT); residential and inpatient treatment; 
and medically managed, intensive inpatient 
treatment. Specific placement criteria must also 
account for pregnancy, child placement, and 
children services. Treatment services for women 
must extend beyond standard care to address 
specific needs for women, pregnant women, and 
women with children such as medical services, 
health promotion, life skills, family- and child-
related treatment services, comprehensive and 
coordinated case management, and mental 
health services. 
When clients participate fully in decisions 
related to treatment, they are more likely to 
understand the process and develop realistic 
expectations of treatment. Active involvement 
of clients in all aspects of treatment planning 
and placement significantly contributes to both 
recovery and empowerment and is essential to 
the development of meaningful, effective services 
for women. 
Substance Abuse Among 
Specific Population Groups 
and Settings 
Women who are of different racial and ethnic 
groups, different sexual orientations, in the 
criminal justice system, living in rural areas, 
older, and who speak languages other than 
English are among the population groups that 
may experience unique challenges that affect 
their substance use or abuse and its treatment. 
The risk for substance abuse and its 
consequences and optimal processes for 
treatment and recovery differ by gender, 
race, ethnicity, sexual orientation, and other 
factors. The complex interplay of culture and 
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health—as well as the influence of differing 
attitudes toward, definitions of, and beliefs 
about health and substance use among cultural 
groups—affects the psychosocial development of 
women and their alcohol, drug, and tobacco use 
and abuse. Women’s risks for substance abuse 
are understood best in the social and historical 
context in which the influences of gender, race 
and ethnicity, education, economic status, age, 
geographic location, sexual orientation, and 
other factors converge. Understanding group 
differences across segments of the population of 
women is critical to designing and implementing 
effective substance abuse treatment programs 
for women. 
Training helps staff members recognize the 
individual and group strengths and resiliency 
factors that can assist women from diverse 
identity groups in recovery. These include 
beliefs regarding health care and substance 
abuse; the value the individual or identity group 
places on family and spirituality; the effects of 
group history on current behaviors; how women 
are socialized in a particular culture; and the 
flexibility of gender norms, communication 
styles, rituals, the status of women, the stigma 
the group or individual faces, and attitudes 
toward self-disclosure and help-seeking 
behavior. 
Substance Abuse 
Treatment for Women 
Gender does not appear to predict retention 
in substance abuse treatment. Women are 
as likely as men to stay in treatment once 
treatment is initiated. Factors that encourage a 
woman to stay in treatment include supportive 
therapy, a collaborative therapeutic alliance, 
onsite child care and children services, and 
other integrated and comprehensive treatment 
services. Sociodemographics also play a role 
in treatment retention. Studies suggest that 
support and participation of signifi cant others, 
being older, and having at least a high school 
education are important factors that improve 
retention. Criminal justice system or child 
protective service involvement also is associated 
with longer lengths of treatment. Women are 
more likely to stay in treatment if they have had 
prior successful experiences in other life areas 
and possess confidence in the treatment process 
and outcome. Although pregnancy may motivate 
women in initiating treatment, studies suggest 
that pregnant women do not stay in treatment 
as long and that retention may be signifi cantly 
affected by stage of pregnancy and the presence 
of co-occurring psychiatric disorders. 
Limited research is available highlighting 
specific therapeutic approaches for women 
outside of trauma-informed services. In recent 
years, more attention has been given to effective 
women’s treatment programming across systems 
with considerable emphasis on integrated care 
and the identification of specifi c treatment 
issues and needs for women. Gender specifi c 
factors that influence the treatment process 
and recovery evolve around the importance of 
relationships, the influence of family, the role of 
substance use in sexuality, the prevalence and 
history of trauma and violence, and common 
patterns of co-occurring disorders. Among 
women with substance use and co-occurring 
mental disorders, diagnoses of posttraumatic 
stress and other anxiety disorders, postpartum 
depression and other mood disorders, and 
eating disorders are more prevalent than among 
men who are in treatment for substance use 
disorders. Consequently, clinical strategies, 
treatment programming, and administrative 
treatment policies must address these issues to 
adequately treat women. Likewise, women often 
need clinical and treatment services tailored 
to effectively address pregnancy, child care, 
children services, and parenting skills. 
Recovery Management 
and Administrative 
Considerations 
Empirical data suggest that women are as likely 
as men to attend continuing care services. 
Transition from a more intensive level of care 
to less intensive services has proven to be 
challenging for all clients, but evidence suggests 
that women will continue with services if they 
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stay within the same agency and/or effort 
is made to connect them to the new service 
provider prior to transition. 
Gender does not consistently predict treatment 
outcome. For example, women have comparable 
abstinent rates with men and are as likely to 
complete treatment. Even so, women are more 
likely to have positive treatment outcomes in the 
following ways: less incarceration, higher rates 
of employment, and more established recovery-
oriented social support systems. Women and 
men do not differ in relapse rates. It is more 
likely that individual characteristics hold the 
key in determining who may be a greater risk 
for relapse. However, there is a delineation 
of the types of risks and triggers that make 
women versus men more vulnerable to relapse, 
and women exhibit different emotional and 
behavioral responses during and after relapse. 
Women report more interpersonal problems and 
strong negative affect, including symptoms of 
depression, severe traumatic stress reactions to 
early childhood trauma, and low self-worth, as 
precipitants of relapse. They also display a lack 
of coping skills, greater difficulty in severing 
their connections with individuals who use, and 
a failure in establishing new recovery-oriented 
friends. Conversely, women who relapse are 
more likely to seek help and have shorter 
relapse episodes. 
Other considerations in providing treatment 
to women involve programmatic and 
administrative issues. First, full participation 
of clients as partners in treatment is important, 
and both the program and client will benefi t 
if they are involved in program development 
and serve in an advisory capacity. Programs 
will likely improve the quality of services and 
clients will benefit from an increase in self-
efficacy, the attainment of specific skills, and a 
reduced stigma from substance abuse treatment. 
Gender-responsive treatment involves a safe 
and non-punitive atmosphere, where staff hold 
a hopeful and positive attitude toward women 
and show investment in learning about women’s 
experiences, treatment needs, and appropriate 
interventions. Administrators need to invest 
in staff training and supervision and show a 
commitment to training beyond immediate 
services. Training should include other social 
and healthcare facilities and personnel within 
the community to enhance awareness, identify 
women with substance use disorders, and 
increase appropriate referrals. As research, 
programming, and clinical experience expand 
along gender lines in substance abuse treatment, 
clinicians and administrators alike will have 
considerable opportunities in adapting new 
standards of care for women. 
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1 Creating the Context
 
Overview 
Women with substance use disorders have unique biopsychosocial 
needs that should be addressed if their treatment is to be successful. 
This TIP examines the current state of women’s substance abuse 
treatment needs, approaches, and experience; highlights promising 
strategies and best practices for treatment counselors working with 
female clients; and explores evidence-based research and clinical 
issues that affect treatment for women. The primary goals of this TIP 
are to help substance abuse treatment counselors and administrators 
provide effective treatment for women and to assist clinicians in 
equipping their female clients with the tools they need to maintain 
recovery. 
Following is an introduction to many of the themes and issues 
discussed in greater depth in later chapters. This chapter presents a 
guiding framework for treatment of women who have substance use 
disorders. It highlights the multiple contexts of women’s lives and 
treatment issues, provides gender responsive principles of treatment, 
and presents the unique biopsychosocial needs that characterize 
the issues women face in treatment. The chapter concludes with a 
discussion on guidelines for readers and definitions of terms and 
concepts used in this TIP. 
Creating the Context 
According to the Substance Abuse and Mental Health Services 
Administration’s (SAMHSA’s) National Survey on Drug Use and 
Health (NSDUH), 6.2 percent of females ages 12 and older were 
classified with substance dependence or abuse in 2004, but only 
0.9 percent of females received treatment in 2004 (SAMHSA 2005). 
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The medical, social, emotional, and fi nancial 
consequences and costs of these disorders to 
women’s families and society are enormous. 
By and large, women with substance use 
disorders must find a way to support themselves 
and their children, often with little experience 
or education and few job skills. They frequently 
have to overcome feelings of guilt and shame 
for how they treated their children while 
abusing substances. When a woman becomes 
pregnant, her motivation to seek treatment 
may rise greatly. However, pregnancy itself can 
be a barrier to treatment because substance 
abuse treatment programs are not always able 
to admit pregnant women or to provide the 
services required, such as medically indicated 
bed rest, transportation to prenatal care, and 
nutritious meals (Jessup et al. 2003). Some 
women fear the negative consequences that will 
result if their substance abuse becomes known. 
In many States, pregnant and parenting women 
can be reported to child protective services, lose 
custody of their children, or be prosecuted for 
using drugs. On top of additional healthcare 
needs, substance use during pregnancy confers 
stigma and shame, which may create another 
challenge in treatment. 
A high proportion of women with substance 
use disorders have histories of trauma, often 
perpetrated by persons they both knew and 
trusted. A woman might have experienced 
sexual or physical abuse or witnessed violence 
as a child. She may be experiencing domestic 
violence such as battering by a partner or 
rape as an adult (Finkelstein 1994; Young and 
Gardner 1997). These traumas contribute to the 
treatment needs for women. 
The societal stigma toward women who abuse 
substances tends to be greater than that toward 
men, and this stigma can prevent women from 
seeking or admitting they need help. Women 
who use alcohol and illicit drugs often have 
great feelings of shame and guilt, have low levels 
of self-esteem and self-efficacy, and often are 
devalued or disliked by other women. These 
feelings make it difficult for women to seek 
help or feel that they deserve to be helped— 
creating yet more treatment needs that must be 
addressed. Gender role expectations in many 
cultures result in further stigmatization of 
substance use; additional challenges face women 
who are of color, disabled, lesbians, older, and 
poor. 
Over the last decade, women with substance use 
disorders have increasingly been the subject of 
scientific study. Studies have explored the effects 
of alcohol and illicit drugs on pregnancy in 
greater detail, best practices in substance abuse 
treatment for women, the impact of trauma 
and the need for trauma-informed services, 
and the importance of incorporating a gender 
responsive framework. More recently, research 
is burgeoning in the area of outcome variables, 
relapse prevention, women and child services, 
and specific treatment approaches. This TIP 
seeks to help the substance abuse treatment 
system lower barriers, improve treatment, and 
assist clinicians in providing their female clients 
with the tools needed to maintain recovery. 
Improved collaboration within the current 
system of health care and social services will 
result in more comprehensive and responsive 
care for women in recovery. 
Sociocultural Context 
The consensus panel for this TIP approached 
substance abuse treatment for women from 
a perspective that encompasses the multiple 
contexts of women’s lives. This TIP provides 
a systemic framework for looking at women 
with substance use disorders, and uses 
Bronfenbrenner’s ecological model (1989), 
where women are engaged in multisystems and 
relationships that maintain a bidirectional 
influence—the systems and relationships 
influence the woman with a substance use 
disorder and the woman, along with the 
impact of her substance use, infl uences her 
relationships and the systems that interact with 
her. Figure 1-1 depicts a woman as the center of 
a circle, surrounded by other concentric rings. 
Each ring represents a different system with 
the closest adjacent ring representing her most 
immediate relationships––the microsystem. 
The following ring, the mesosystem, represents 
the interrelationships between her immediate 
relationships and systems; e.g. the interaction 
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between her family and school, the potential 
influence or conflict between her substance using 
peer group and her family. Next, the exosystem 
represents larger systems that directly infl uence 
the woman but where the woman has no direct 
active role; e.g., county funding for treatment or 
State and Federal laws pertaining to sentencing 
or child protective services. The macrosystem 
is the largest system that involves cultural 
values and beliefs, gender socialization, political 
ideologies, etc. Each system is infl uenced by 
chronology, or life events. These events, either 
normative or non-normative individual events 
at specific developmental periods or historical 
events, can have significant impact and infl uence 
on further development, treatment needs and 
recovery, and ultimately interactions among all 
systems. 
Using a systems approach is appropriate 
regardless of gender, yet it is a vital framework 
for understanding women’s treatment needs 
and the impact of substance use on their 
relationships and caregiving roles. Consistent 
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Figure 1-1 
A Woman’s Life in Context 
Source: Bronfenbrenner 1989
 
 with Bronfenbrenner’s model, this TIP uses 
SAMHSA’s Center for Substance Abuse 
Treatment’s (CSAT’s) Comprehensive Substance 
Abuse Treatment Model for Women and 
Their Children as the keystone in addressing 
women’s treatment needs and services. Figure 
1-2 highlights the four broad interrelated 
elements of CSAT’s comprehensive model of 
care including clinical treatment services, 
clinical support services, community support 
services, and cultural competence. For more 
in-depth information about this model, refer to 
Appendix B. This model is an update of a model 
published in 1994 in Practical Approaches in 
the Treatment of Women Who Abuse Alcohol and 
Other Drugs (CSAT 1994a). 
Gender Responsive 

Treatment Principles
 
The principles articulated by the consensus 
panel, which serve as the TIP’s conceptual 
framework, are explained below. Each principle 
is derived from research that highlights the 
distinctive characteristics and biopsychosocial 
issues associated with women in general and 
specific to women with substance use disorders. 
• 	Acknowledge the importance and role 
of socioeconomic issues and differences 
among women. Biological, cognitive– 
behavioral, and psychological dimensions 
of women’s substance use and abuse should 
be framed in their socioeconomic contexts 
Figure 1-2 
Interrelated Elements in the Comprehensive Treatment Model 
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including, but not limited to, employment, 
educational status, transportation, housing, 
literacy levels, and income. 
• 	Promote cultural competence specifi c 
to women. Treatment professionals and 
staff must understand the worldviews and 
experiences of women from different ethnic 
and cultural backgrounds, as well as the 
interaction among gender, culture, and 
substance use to provide effective substance 
abuse treatment. In addition, effective 
treatment will depend equally on attention 
and sensitivity to the vast diversity among 
the female population, including overlapping 
identities of race, class, sexual orientation, 
age, national origin, marital status, disability, 
and religion. 
• 	Recognize the role and signifi cance 
of relationships in women’s lives. The 
relational model recognizes the centrality of 
relationships or connections in women’s lives 
and the importance of those relationships 
with respect to alcohol, tobacco, and drug 
use. While substance use may initially play 
an integral role in making or maintaining 
connections in relationships, the relational 
approach views the development of substance 
use disorders as a “disconnection” and 
stresses the development and repair of 
connections to others, oneself, one’s beliefs, 
and one’s culture as critical for recovery. 
The relational model takes a family-focused 
perspective, using a broad defi nition of 
family as those individuals a woman views 
as her significant support system. In this 
model, a woman’s children are included in 
her treatment, and prevention and treatment 
services must be provided directly to her 
children and family. 
• 	Address women’s unique health concerns. 
Women possess distinctive risk factors 
associated with onset of use, have greater 
propensity for health-related consequences 
from drug and alcohol consumption, exhibit 
higher risks for infectious diseases associated 
with drug use, and display greater frequency 
of various co-occurring disorders. Moreover, 
women who abuse substances are more 
likely to encounter problems associated with 
reproduction, including fetal effects from 
substance use during pregnancy, spontaneous 
abortion, infertility, and early onset of 
menopause. Substance abuse treatment needs 
to address women’s unique health concerns 
throughout the course of treatment. 
• 	Endorse a developmental perspective. 
In general, women experience unique life 
course issues. Specific to women who abuse 
substances, these life course issues, along 
with developmental milestones, impact their 
patterns of use, engagement in treatment, 
and recovery. Substance use and abuse affect 
women differently at different times in their 
lives. It is important to consider age-specifi c 
and other developmental concerns starting 
with the assessment process and continuing 
through continuing care and long-term 
recovery. 
• 	Attend to the relevance and infl uence 
of various caregiver roles that women 
often assume throughout the course 
of their lives. Regardless of substance 
abuse, women are more likely to assume 
primary caregiving responsibilities for 
their children, grandchildren, parents, and 
other dependents. These roles may heavily 
influence a woman’s willingness to seek help 
for substance abuse, and also may interfere 
with her ability to fully engage in the 
treatment process or to adhere to treatment 
recommendations. 
• 	Recognize that ascribed roles and gender 
expectations across cultures affect societal 
attitudes toward women who abuse 
substances. Whether or not a woman neglects 
her roles as a caregiver, engages in alcohol 
or drug-induced sexual activity, continues 
to use despite pregnancy, or uses sex to 
secure her next supply of drugs or alcohol, 
women with substance use disorders are 
significantly stigmatized by societal attitudes 
and stereotypes of women who drink and use 
drugs. As a result, women may experience 
feelings of shame associated with their use 
and the consequences of their use. 
• 	Adopt a trauma-informed perspective. 
Current and past violence, victimization, 
and abuse greatly affect many women 
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who abuse alcohol and drugs. Substance 
abuse treatment approaches need to help 
women find safety, develop effective coping 
strategies, and recover from the effects of 
trauma and violence. 
• 	Utilize a strengths-based model for 
women’s treatment. A strengths-based 
approach builds on the woman’s strengths 
and uses available resources to develop 
and enhance resiliency and recovery skills, 
deepen a sense of competency, and improve 
the quality of her life. These strengths 
may include personality traits, abilities, 
knowledge, cultural values, spirituality, and 
other assets; while resources may involve 
supportive relationships, environments, and 
professional support. 
• 	Incorporate an integrated and 
multidisciplinary approach to women’s 
treatment. Treatment needs to integrate 
current knowledge, research, theory, 
experience, and treatment models from 
diverse disciplines critical to understanding 
women and substance abuse treatment. 
In addition to incorporating and blending 
information from the mental health, women’s 
health, and social and behavioral sciences 
fields, treatment providers must network 
and collaborate with other agencies to 
provide comprehensive case management and 
treatment planning to address the complexity 
of biopsychosocial and cultural issues that 
women may exhibit throughout treatment. 
• 	Maintain a gender-responsive treatment 
environment across settings. Effective 
treatment for women begins with a 
collaborative environment that is nurturing, 
supportive, and empowering. Women with 
substance use disorders are more likely 
to remain in a treatment setting that feels 
familiar and safe, includes their children, 
utilizes proactive case management, and 
fosters the development of supportive 
relationships across the continuum of care. 
• 	Support the development of gender-
competency specific to women’s issues.
Administrative commitment and vigilance 
is needed to ensure that staff members 
are provided gender-specific training and 
supervision to promote the development of 
gender competency for women. 
Women’s Biopsychosocial 
Uniqueness 
There is notable evidence to suggest that gender 
does make a difference. Whether examining risk 
factors to relapse potential, biological aspects to 
psychological issues, or treatment engagement 
to attrition rates, empirical evidence suggests 
that gender differences do exist in substance use 
disorders. For women, unique biopsychosocial 
and developmental issues create or intensify 
these differences, which require specifi c 
treatment needs across the continuum of care of 
substance use disorders. 
This TIP is based on the premise that women 
are biopsychosocially unique in ways relevant 
to substance use, substance use disorders, and 
the treatment of these disorders. Specifi cally, 
this TIP takes the following position: There 
are biopsychosocial factors that may affect 
a significant proportion of women across 
the continuum of substance abuse services. 
The knowledge of these factors will likely 
assist the substance abuse counselor in better 
understanding and responding to the treatment 
needs of female clients. 
Not only do women face numerous obstacles to 
entering and remaining in treatment, they also 
have specific needs while in treatment. Some 
obstacles stem from the frequently low economic 
status of women, the likelihood that they are 
custodial parents, the greater incidence of 
trauma and violence in female clients, and the 
societal stigma of substance abuse. 
Additional treatment needs stem from a 
greater incidence of co-occurring mental 
disorders among female clients, and the 
growing realization that women respond better 
to treatment approaches that are supportive 
rather than confrontational and that promote 
relationships and positive connections among 
other clients in recovery and treatment 
providers. 
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Supported by research, this section highlights 
the biopsychosocial uniqueness of women 
and the impact that these characteristics may 
have on the onset of use, the development and 
progression of substance abuse and dependence, 
and the treatment of substance use disorders. 
The unique biopsychosocial characteristics 
are divided into three segments: biological and 
psychological, social, and developmental. This 
section does not focus on specific populations or 
on biopsychosocial, cultural, or developmental 
issues that are common in both men and women. 
Biological and Psychological 
Differences between women and men in 
genetics, physiology, anatomy, and sociocultural 
expectations and experiences lay the 
foundation—that women have unique health 
concerns related to substance use disorders as 
well as elevated risk for certain co-occurring 
physical and mental issues or disorders. This 
segment highlights and outlines the unique 
physiological and psychological issues that need 
attention across the continuum of care. 
1. Women have different physical responses 
to substances. 
Women have different physical responses to 
substances and typically display a quicker 
progression from initial use to the development 
of health-related problems (Antai-Otong 2006; 
Mann et al. 2005). Women become intoxicated 
after drinking smaller quantities of alcohol than 
men. For women who drink, they are affected 
more by alcohol consumption due to higher 
blood alcohol concentrations, proportionately 
more body fat, and a lower volume of body 
water to dilute alcohol. 
Women develop substance use disorders and 
health-related problems in less time than do 
men, and this effect is known as telescoping. 
While research has studied the differences 
in metabolism with alcohol intake, studies 
highlighting gender differences with illicit drugs 
is limited (Brady and Ashley 2005; Greenfi eld 
and O’Leary 2002; Sherman 2006). A few 
preliminary studies (Katz et al. 2004) have 
identified perceptual differences between men 
and women asserting that women report more 
intense or positive effects; yet fi ndings across 
studies are inconclusive. Chapter 3 of this 
TIP provides a review of physical responses to 
substance use, beginning with the factors that 
influence these reactions including, but not 
limited to, ethnicity, acculturation, and aging. 
2. Women with substance use disorder have 
greater susceptibility to as well as earlier 
onset of serious medical problems and 
disorders. 
In general, women develop alcohol-related 
physical health problems at lower doses and 
over shorter periods of time than do men. Less 
evidence is available on gender differences 
regarding the effects and health consequences of 
other illicit drug use, but women also appear to 
have higher rates of health problems resulting 
from other substances (Sherman 2006). From 
moderate to heavy use, drugs and alcohol 
consumption increase specific health risks and 
physical disorders among women. 
Alcohol consumption signifi cantly increases 
risk for breast and other cancers (Bagnardi 
et al. 2001; Key et al. 2006; Tiemersma et al. 
2003), osteoporosis in premenopausal women 
(Sampson 2002), peripheral neuropathy, 
and cognitive impairments (Flannery et 
al. 2007; Sohrabji 2002). Overall, women 
develop cirrhosis and heart muscle and nerve 
damage with fewer years of heavy drinking in 
comparison to men. Likewise, illicit drug use is 
associated with greater risk for liver and kidney 
diseases, bacterial infections, and opportunistic 
diseases. Chapter 3 presents an overview of the 
physiological effects and consequences of alcohol 
and drug use, including nicotine, among women. 
3. Women who abuse substances have specifi c 
health issues and medical needs related to 
gynecology. 
Routine gynecological care is fundamental to 
the prevention or early detection of a variety 
of serious health problems among women with 
substance use disorders, including cervical, 
breast, and other cancers; HIV/AIDS; and 
other infectious diseases. Evidence supports 
the havoc substances play on reproductive 
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processes, such as the role of heavy alcohol use 
on infertility and drug use on menstrual cycles 
(Lynch et al. 2002; Reynolds and Bada 2003; 
Tolstrup et al. 2003). Even though gynecological 
concerns are frequently one of the main health 
concerns identified by women in substance abuse 
treatment, many young and low-income women 
have never had a gynecological examination. 
Moreover, women over 40 with substance use 
disorders are less likely to have received a 
mammogram than other women of similar age 
(Carney and Jones 2006). Refer to chapter 3 for 
more information on gynecological consequences 
related to substance use disorders. 
4. In treating women of childbearing age who 
have a substance use disorder, pregnancy is 
a signifi cant concern. 
Women who are abusing or are dependent on 
alcohol or other drugs may not realize they are 
pregnant. At times, women may mistakenly 
associate early signs of pregnancy as symptoms 
related to use or withdrawal from substances. 
Often, women who are pregnant and using 
alcohol and illicit drugs do not begin prenatal 
care until well into their pregnancies. Some of 
the most negative effects of substance use on the 
developing embryo can occur in the fi rst weeks 
of pregnancy. 
Adequate prenatal care often defi nes the 
difference between routine and high-risk 
pregnancy and between good and bad pregnancy 
outcomes. Timely initiation of prenatal care 
remains a problem nationwide, and it is 
overrepresented among women with substance 
use disorders. In part, the threat of legal 
consequences for using during pregnancy and 
limited substance abuse treatment facilities 
(only 14 percent) that offer special programs 
for pregnant women (SAMHSA 2007) are key 
obstacles to care. 
Numerous medical concerns can result from 
substance use during pregnancy as well as from 
detoxification and the medications used to treat 
substance use disorders. Thus, identifi cation, 
comprehensive case management, and integrated 
services are essential in addressing these 
significant threats. The following chapters 
provide information on negative consequences 
of alcohol and drug use during pregnancy 
(chapter 3), specific screening questions and 
tools (chapter 4), engagement strategies and 
programming for pregnant women (chapter 5), 
and retention and review of treatment issues 
and needs for pregnant women with substance 
use disorders, including co-occurring disorders 
(chapter 7). 
5. Women who abuse substances are more 
likely than other women to have co­
occurring disorders. 
In general, women with substance use disorders 
are more likely to meet diagnostic criteria for 
mood disorders specific to depressive symptoms, 
agoraphobia with or without panic attacks, 
posttraumatic stress, and eating disorders 
(Hudson et al. 2007; Piran and Robinson 2006; 
Tolin and Foa 2006). For women, literature 
suggests that the onset of psychiatric disorders 
is apt to precede substance use disorders. For 
instance, women who experience depression 
are more prone to develop alcohol problems 
after their first depressive episode (Caldwell et 
al. 2002; Wang and Patten 2002). Chapter 2 of 
this TIP addresses risk factors for substance 
use disorders, including the role of other 
psychological disorders. Chapter 4 offers 
screening tools to help counselors identify the 
need for further assessment due to presenting 
psychological symptoms. Chapter 7 identifi es 
treatment needs and strategies for the more 
prevalent psychological symptoms and disorders 
among women with substance use disorders, 
including trauma, posttraumatic stress and 
other anxiety disorders, and mood and eating 
disorders. 
6. Women who have substance use disorders 
are more likely to have been physically 
or sexually traumatized and subjected to 
interpersonal violence. 
A high proportion of women with substance 
use disorders have histories of trauma, often 
perpetrated by persons they both knew and 
trusted. These women may have experienced 
sexual or physical abuse, domestic violence, 
or witnessed violence as a child. Studies have 
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consistently found that rates of sexual abuse 
in both childhood and adulthood are higher 
for women than for men, and that a lifetime 
history of sexual abuse ranges from 15 to 25 
percent (Leserman 2005; Tjaden and Thoennes 
1998). Similarly, prevalence of lifetime domestic 
violence among women in the United States 
ranges from 9 to 44 percent, depending on the 
employed definition of domestic violence in each 
study (for review, see Thompson et al. 2006; 
Wilt and Olson 1996). While race/ethnicity is 
not generally associated with interpersonal 
violence, lower socioeconomic status appears to 
be associated with greater prevalence. 
Women who have been abused as children are 
more likely to report substance use disorders 
as adults (Kendler et al. 2000). In a large study 
of female twins (n=3,536), childhood sexual 
abuse was associated with a greater likelihood 
of lifetime alcohol use, having the first drink at 
an early age, and alcohol dependence (Sartor 
et al. 2007). Likewise, physical and sexual 
dating violence were found to be “signifi cant 
independent predictors of substance use” in 
other research (Silverman et al. 2001). Among 
women seeking treatment for crack/cocaine 
abuse/dependence, a history of sexual trauma 
was associated with a greater number of health 
issues related to substance use, dependence on 
a greater number of substances, and a greater 
number of substance abuse treatment episodes 
(Young and Boyd 2000). In a study focused on 
the severity of childhood trauma among men 
and women who were dependent on cocaine, 
only a history of childhood trauma among 
women created a greater susceptibility to relapse 
and escalation in use after relapse (Hyman et al. 
2008). 
Numerous studies on interpersonal violence 
have found a similar reciprocal relationship 
between substance abuse and domestic violence 
(Kilpatrick et al. 1997; Swan et al. 2000; 
Tjaden and Thoennes 1998, 2000, 2006). Rates 
of partner abuse appear highest for women 
who use cocaine/crack (Swan et al. 2000) or 
methamphetamine (Cohen et al. 2003). However, 
women with substance use disorders and a 
history of physical abuse (from a known person, 
not necessarily a partner) are more likely to 
enter substance abuse treatment than women 
with substance use disorders who don’t have 
such a history (Walton-Moss and McCaul 2006). 
Clinical issues related to childhood sexual and 
physical abuse, interpersonal violence, and 
trauma are addressed throughout this TIP. More 
specific information is covered in the following 
chapters: 
 Chapter 2 addresses risk factors (including 
interpersonal violence, sexual abuse, 
and other traumas) associated with the 
development of substance use disorders. 
 Chapter 4 provides general screening and 
assessment guidelines, including tools for 
sexual victimization, childhood abuse, and 
interpersonal violence. 
 Chapter 7 highlights the treatment needs and 
interventions for these specifi c populations. 
For more comprehensive reviews of domestic 
violence and child abuse, refer to TIP 25 
Substance Abuse Treatment and Domestic 
Violence (CSAT 1997b); TIP 36 Substance Abuse 
Treatment for Persons with Child Abuse and 
Neglect Issues (CSAT 2000b); and the planned 
TIP Substance Abuse and Trauma (CSAT in 
development h). 
Social 
1. Significant relationships and family history 
play an integral role in the initiation, 
pattern of use, and continuation of 
substance abuse for women. 
From a sociocultural perspective, women (more
than men) tend to define themselves in terms of
their webs of social relationships and obligations.
Relationships with others have special
significance for many women. Hence, family
history may have a more profound effect on
initiation of use among women than men. Women
with alcohol use disorders are also more likely
than men to report having had alcohol dependent
parents, other alcohol dependent relatives, and
dysfunctional family patterns (Jennison and
Johnson 2001; Nelson-Zlupko et al. 1995).
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Women are more likely to be introduced to and 
initiate alcohol and drug use through signifi cant 
relationships including boyfriends, spouses, 
partners, and family members. This infl uence 
does not stop with initiation; it extends to 
greater use and higher incidence of substance 
use disorders when they have partners who 
abuse substances (Klein et al. 2003). In 
comparison to men, women with substance 
use disorders are more likely to have intimate 
partners who also have substance use disorders 
(Brady and Ashley 2005; Lex 1991; Riehman 
et al. 2003; Wright et al. 2007). In this TIP, 
chapter 2 addresses initiation, risk factors, and 
patterns of substance use and substance use 
disorders among women across the lifespan. 
2. Significant relationships and other adult 
family members may substantially infl uence 
and impact women’s behavior associated 
with treatment seeking, support for 
recovery, and relapse. 
Women may have less support from family/ 
partners than do men for seeking treatment. 
Women with alcohol problems are more likely 
to be left by their partners at the time of entry 
into treatment (Lex 1991), and their partners 
are less likely to stay with them after completion 
of treatment. Unless they themselves are 
involved in treatment or recovery, partners with 
substance use disorders may be unsupportive of 
women’s treatment seeking (Brady and Ashley 
2005). Couples in which both partners have 
substance use disorders and in those in which 
only the woman has a substance use disorder 
are more likely to spend time separated after 
treatment than are couples where only the man 
has a substance use disorder (Fals-Stewart et al. 
1999). At the same time, husbands who do not 
themselves have substance use disorders expect 
greater change from wives with substance use 
disorders in treatment than if the circumstances 
were reversed (Fals-Stewart et al. 1999). 
At times, substance use and the rituals 
associated with use may be a signifi cant 
ingredient and symbol of intimacy and closeness 
in relationships. This history and relational 
pattern may make recovery more challenging 
during and after treatment. Especially in the 
early phase of recovery, women may believe that 
their decision to not use is or will be perceived 
as a direct threat against their signifi cant 
relationship or family. Hence, women are more 
likely to relapse due to interpersonal problems 
and conflicts, and relapse is more likely to occur 
in the presence of a significant other (McKay et 
al. 1996; Rubin et al. 1996; Sun 2007). To obtain 
more information on relational factors that 
influence women across the continuum from risk 
factors to relapse, see chapters 2, 5, 6, 7, and 8. 
3. For women, pregnancy, parenting, and 
childcare influence alcohol and drug 
consumption and increase the likelihood of 
entering and completing substance abuse 
treatment. 
For many women, including those with 
substance use disorders, use of alcohol, tobacco, 
and/or illicit drugs significantly decreases after 
becoming aware of their pregnancy (Tough et 
al. 2006). It is also not uncommon for women 
who abstained from alcohol, drugs, and 
tobacco during pregnancy to return to use after 
childbirth. So, the impact of pregnancy on 
patterns of consumption can present a double-
edged sword in treatment planning. On the one 
hand, pregnancy may represent a “teachable 
moment” where motivation to protect the fetus 
can be expanded to help motivate the mother to 
make more permanent changes in her substance 
use behavior. On the other hand, progress 
toward recovery made by pregnant women 
may be transient if this progress is primarily in 
response to the pregnancy itself. 
Women are much more likely than men to 
enter treatment because it affects child custody 
(Grella and Joshi 1999). If they are able to have 
their children in treatment, women are more 
likely to enter treatment, participate and stay in 
the program, and maintain abstinence (Brady 
and Ashley 2005; Lungren et al. 2003; Szuster 
et al. 1996). Likewise, women with children 
in treatment have better treatment outcomes 
in major life areas in comparison to women 
who are without their children in treatment 
(Stevens and Patton 1998). Women in recovery 
see the support of their children as an essential 
ingredient for their recovery (Tracy and 
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Martin 2007). Every chapter of this TIP covers 
issues pertaining to pregnancy, parenting, or 
child care, with specific attention to treatment 
modalities and treatment issues highlighted in 
chapters 5 and 7. 
4. Women are more likely to encounter 
obstacles across the continuum of care 
as a result of caregiver roles, gender 
expectations, and socioeconomic 
hardships. 
• 	Women with substance use disorders 
have enhanced treatment needs related 
to pregnancy, care of children, and other 
caregiver roles. Familiarity with these 
gender-based experiences can contribute 
to effective treatment programming and 
successful treatment outcomes. To begin 
with, pregnancy itself can be an obstacle 
to treatment because substance abuse 
treatment programs are not always able 
to admit pregnant women or to provide 
the services required. Beyond pregnancy, 
women often assume many other caregiver 
roles, and these roles can signifi cantly 
interfere with treatment engagement and 
regular attendance at treatment services. 
Brady and Ashley (2005) reported that 
women are more likely to encounter 
difficulties surrounding treatment 
attendance due to family responsibilities. 
Often family expectations regarding 
responsibilities involve care for other 
family members and the need to attend to 
their signifi cant relationship. 
• 	Most women with substance use disorders 
have to contend with economic and 
social factors as well as individual and 
family issues to negotiate their recoveries 
successfully. Because women frequently 
earn less than men for doing the same 
job, they face more economic barriers 
to entering and staying in treatment 
than do men. Women are less likely 
than men to be able to pay out-of­
pocket for treatment, have less access 
to private health insurance, are less 
likely to have savings or other fi nancial 
resources to support themselves while 
in treatment, and often cannot afford a 
car to take them to treatment. According 
to NSDUH (SAMHSA 2003), 34 percent 
of women who reported they did receive 
substance use treatment indicated that 
they could not cover treatment costs 
due to inadequate or nonexistent health 
insurance. As important, women with 
co-occurring serious mental illness and 
substance use disorders were less likely to 
be employed full-time than women with 
only a substance use disorder (SAMHSA 
2003). Many female clients need assistance 
with transportation; affordable, safe 
housing; and onsite child care and other 
services for their children. To obtain more 
specific information on obstacles pertinent 
to women in treatment, refer to chapter 5. 
5. Despite the unique challenges, women 
are more likely to engage in help-seeking 
behavior and in attending treatment after 
admission. 
Women are more likely to seek health and 
mental health services than are men. Studies 
have found that women with alcohol use 
disorders as well as drug use disorders marked 
with severity are either as likely as or more 
prone to initiate treatment than men (Moos et 
al. 2006; Weisner et al. 2001). Once women are 
admitted to substance abuse treatment, they 
are at least as likely as men to participate and 
stay in treatment. Help-seeking behavior among 
women with substance use disorders appears 
to remain consistent across time. In one study, 
Chatham et al. (1999) found that women, in 
comparison to men, were more likely to seek 
further help for both psychological issues and 
drug use 1 year postdischarge from a methadone 
maintenance program. Another study found that 
women were also more apt to seek help after a 
relapse (McKay et al. 1996). Refer to chapter 5 
of this TIP for treatment engagement strategies 
that help reinforce help-seeking behavior. 
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6. Women report more interpersonal stressful 
life events. 
Overall, women report more interpersonal 
related stress in relation to negative affect 
whereas men report more legal and work-
related stressful life events (Kendler et al. 
2001). This difference is likely a refl ection of 
gender role expectations and socialization, and 
is evident among men and women in substance 
abuse treatment. Specifically, women entering 
treatment report a greater level of family and 
social problems as measured by the Addiction 
Severity Index (Green et al. 2002; Weiss et al. 
1997). During the week prior to relapse and 
on the initial day of relapse, women report 
interpersonal problems and negative affect as 
key stressors (McKay et al. 1996). For more 
information regarding interpersonal risk factors 
of use, relational treatment needs, and relapse 
risk factors associated with interpersonal stress 
among women, refer to chapters 2, 7, and 8, 
respectively. 
7. Women often take different paths in 
accessing treatment for substance use 
disorders. 
Women are more likely than men to seek 
out physical and mental health treatment, 
including substance abuse treatment. They 
are also more likely to make use of a variety of 
healthcare options including primary care and 
psychological counseling (Cherry and Woodwell 
2002). Among women with substance use 
disorders, the most frequent source of referral 
to treatment was made by self-referral followed 
by the criminal justice system and other 
community referrals, including child protective 
services (Brady and Ashley 2005). Refer to 
chapter 2 of this TIP to review more information 
regarding treatment admission characteristics 
among women. 
8. Women have unique client–counselor 
expectations and relational needs related to 
treatment. 
Women’s sociocultural role as caregivers 
predisposes them to define themselves in 
terms of social relationships and obligations. 
Through this lens, women are more likely 
to view relationship building as an essential 
treatment ingredient. If attention is given to 
establishing and maintaining relationships 
across the continuum of care, women are more 
likely to initiate, engage, and successfully 
complete treatment. Women have identifi ed 
several counselor characteristics that they 
believe contribute to treatment success—a 
projection of acceptance and care, trust and 
warmth, a non-authoritarian attitude, and a 
sense of confidence in their abilities (Fiorentine 
and Anglin 1997; Sun 2006). Likewise, women 
are more likely to stay in treatment longer if 
they receive more intensive and individual care, 
are able to maintain their parenting role while 
in treatment, and either stay within the same 
treatment services or maintain a connection with 
treatment providers throughout the continuum 
of services, including continuing care. In this 
TIP, chapter 7 covers the main factors that 
influence retention; particular attention is given 
to women’s treatment expectations surrounding 
environment, theoretical approach, therapeutic 
alliance, and counselor characteristics. 
9. Women are uniquely stigmatized in 
relationship to substance abuse. 
• 	 Stigma is a significant barrier to treatment 
and recovery. Ascribed roles and gender 
expectations across cultures affect societal 
attitudes toward women with substance 
abuse. The societal stigma toward women 
who abuse substances tends to be greater 
than that toward men, which can prevent 
women from seeking or admitting they need 
help. According to NSDUH (SAMHSA 2003), 
women who reported not receiving or not 
perceiving a need for treatment attributed 
social stigma as the primary reason. 
Women who use alcohol and illicit drugs often 
have great feelings of shame and guilt, have 
low levels of self-esteem and self-effi cacy, and 
often are devalued by other women and men. 
These feelings make it difficult for women to 
seek help or feel that they deserve to be helped. 
Additionally, women may carry internalized 
feelings of guilt and shame concerning their 
failure in maternal roles (Ehrmin 2001). Some 
women fear negative consequences, including 
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mandatory involvement with child protective 
services, loss of child custody, or other 
legal consequences, if their substance abuse 
becomes known. Gender role expectations in 
many cultures result in further stigmatization 
of substance use, and additional challenges 
face women who are of color, disabled, older, 
lesbians, and poor. For additional information 
on gender socialization and the role of stigma 
associated with substance abuse across specifi c 
populations, review chapter 6. For additional 
discussion and material on stigmatization, 
review risk factors in chapter 2 and 
sociocultural obstacles in chapter 5. 
Developmental 
1. Women have unique life-course issues and 
events. 
Over the past two decades, the substance 
abuse field has increasingly recognized the 
importance of developmental issues over the 
entire lifespan (Klitzner 1992; White 2006). 
Changes in physiology, emotional and social 
development, and cognitive capacity as well as 
changes in social roles and expectations have 
all been associated with substance abuse and 
its treatment. Many of these life course issues 
are different or more salient for women than 
for men. The following segment covers the 
main developmental milestones for women, and 
additional information is interwoven throughout 
this TIP. 
Identity and gender expectations—the 
younger years: During adolescence and young 
adulthood, young women are likely to face 
greater gender-based sociocultural expectations 
(Gilligan et al. 1990). Consistent with this notion 
is the finding that girls and young women may 
be more susceptible to substance use-related 
social influences than are boys (Dick et al. 
2007). Substance use may play an essential role 
in exploring new experiences while forming 
identity, but it is as likely that substance use 
helps provide relief when identity formation and 
the negotiation of new gender role expectations 
becomes confusing or difficult (Arnett 2005). 
Educational, employment, and career 
issues: In a recent summary of women’s 
career development, Fitzgerald and Harmon 
(2001; p. 226) concluded that “life is, in many 
ways, less gendered than it was in the 1970s”; 
however, “there are still ways in which life and 
its opportunities are partially controlled by 
gender stereotypes” and roles. Several writers 
have argued that “women’s work lives are 
more complex than men’s” (Fitzgerald et al. 
1995; p. 76). For example, the need to balance 
career endeavors—education, training, and 
employment—with caregiver responsibilities is a 
major developmental task that more often than 
not is unique to women. 
While younger women are more likely and 
able to invest in earlier career development 
than the women of 50 years ago (Arnett 2005), 
they still do not characteristically encounter 
the same career opportunities, and for many 
women, early career aspirations may be placed 
on hold or pared down until years later due 
to pregnancy and childcare responsibilities. 
Disparity in employment opportunities, income, 
healthcare insurance, and/or childcare support 
presents unique challenges for all women, but 
significantly impacts women with substance use 
disorders and women seeking substance abuse 
treatment. Overall, women with substance use 
disorders have more pronounced employment 
barriers than men with substance use disorders 
and women without substance use problems, 
including women who are recipients of the 
Temporary Assistance to Needy Families 
program (TANF; McCoy et al. 2007; Meara 
2006). 
Pregnancy, parenting, and childcare issues:
This developmental milestone and the issues 
involving substance use disorders and treatment 
are covered in the above social section, item 3. 
Menopause: Menopause is a complex 
biopsychosocial transition for women. Rather 
than an event, menopause is a process that 
unfolds over many years as estrogen levels 
decrease. These decreases, in turn, may lead 
to a variety of physical and psychological 
symptoms, the onset of which may precede the 
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cessation of fertility by as much as a decade 
(Stewart 2005). For some women, cessation of 
fertility occasions a re-examination of social 
roles, which may lead to depression or anxiety 
in some and a new sense of freedom in others. 
Studies evaluating the impact of hormonal 
changes on alcohol and drug metabolism 
and the consequences of substance use on 
the development of menopause are limited. 
Yet, preliminary studies refl ect potential 
effects even though research remains mixed 
and methodological issues are evident. Most 
noteworthy, substance abuse and dependence 
may exacerbate postmenopausal risks for 
coronary heart disease, osteoporosis, and breast 
cancer in this population (Register et al. 2003). 
Caring for parents and partners: Many more 
people than ever before are having to cope 
with caring for elderly parents in addition to 
the usual demands of work and family. The 
typical pattern is that sons offer fi nancial 
assistance, and daughters and daughters-in-law 
provide the time-consuming, hands-on care. 
More than 60 percent of caregivers are female 
(National Alliance for Caregiving and American 
Association of Retired Persons [AARP] 2004). 
An estimated 80 percent of informal care 
for elders is imparted on family caregivers 
(International Longevity Center 2006), and these 
caretaking responsibilities can last 10 years or 
more. 
Women may be caught between the 
responsibilities of providing care to their 
parents or parents-in-law while simultaneously 
taking care of their own dependent children. 
Time and energy spent caring for elderly parents 
often come at the expense of other family or 
occupational roles as well as self-care. Although 
unpaid family leave is now available to many 
workers, the demands of caring for an elderly 
parent force some women to make hard choices. 
They either have to reduce or stop work or have 
to find professional and institutional care. Some 
have had to switch to part-time work, pass up 
promotions, or quit their jobs altogether. This 
decision can lead to greater risk for living in 
poverty in the later years due to terminating 
or decreasing hours of employment to care for 
aging parents (Wakabayashi and Donato 2006). 
For women with substance use disorders, the 
emotional, physical, and financial stressors are 
likely to exacerbate substance use. Moreover, 
unique obstacles exist for women with substance 
use disorders—balancing the need to care 
for their parents and the need for their own 
substance abuse treatment. 
Longer life than male partners: Women are 
more likely than men to outlive their partners. 
According to the Centers for Disease Control 
and Prevention, the general life expectancy 
for women and men is 80.4 and 75.2 years, 
respectively. Data from the Census Bureau 
indicate that almost one-half of American 
women over the age of 65 are widowed (Fields 
and Casper 2001). A recent cross-sectional 
and longitudinal study of more than 70,000 
American women ages 50 –79 (Wilcox et al. 2003) 
found that widowed women were signifi cantly 
more physically impaired than married women 
on a variety of measures, including general 
health and physical functioning, obesity, 
hypertension, and pain. Widowed women were 
also significantly lower in overall mental health 
and social functioning and significantly higher in 
depressed mood. 
The later years: Various sources of data 
suggest that alcohol problems are ordinary 
events among the elderly, and estimates of the 
prevalence of heavy drinking or alcohol abuse 
range from 2 to 20 percent for this population 
(Benshoff and Harrawood 2003). There is also 
some suggestion that the baby-boom generation 
is more likely than earlier generations to have 
been exposed to drug and alcohol use and may 
drink or consume drugs at greater rates after 
age 65. The literature on the etiology of elder 
substance use disorders is limited, but spousal 
loss is one commonly cited factor (Benshoff and 
Harrawood 2003). 
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Organization of this TIP 
Scope 
This TIP discusses treatment for women 
from diverse cultures, ethnicities, and sexual 
orientations; women living in urban and rural 
areas; women who are pregnant, parenting, 
or without children; and women of all ages, 
socioeconomic classes, and histories. Although 
alcohol and drug effects on fetuses and neonates 
are mentioned, the details and implications 
for fetuses and neonates are not discussed in 
detail. Female adolescents are not addressed in 
this TIP. Whereas some adolescents’ needs may 
parallel those of women, their developmental 
stage requires specialized treatment. 
Information on treating adolescents can be 
found in TIP 32 Treatment of Adolescents 
with Substance Use Disorders (CSAT 1999d). 
Substance abuse treatment issues specifi c to 
male clients are addressed in the planned TIP 
Substance Abuse Treatment and Men’s Issues
(CSAT in development f). 
Whenever possible, TIPs include empirical 
findings in support of practices they 
recommend. However, the field of substance 
abuse treatment is evolving and research can lag 
behind the innovations being pioneered in the 
field. Treatment recommendations included in 
this TIP are based on both consensus panelists’ 
clinical experience and scientifi c literature. 
When the research supports a particular 
approach, citations are provided. 
Audience 
The primary audience for this TIP is substance 
abuse treatment clinicians and counselors 
who work with women. Secondary audiences 
include administrators, educators, researchers, 
policymakers for substance abuse treatment 
and related services, consumers, and other 
healthcare and social service personnel who 
work with women with substance use disorders. 
Approach: Gender Responsive 
Treatment 
This TIP draws on the systemic framework 
of Bronfenbrenner’s ecological theory and 
CSAT’s Comprehensive Substance Abuse 
Treatment Model for Women and Children (see 
Appendix B). It is based on clinical practice and 
research centered on women. It is not derived 
primarily by comparing women with men. The 
knowledge, models, and strategies presented 
are grounded in women’s experiences and their 
unique biopsychosocial and cultural needs. 
The basic elements and principles of gender-
responsive treatment are presented throughout 
this TIP, with suggestions and resources on 
how to implement such a system of care. Also 
presented are approaches to treating substance 
use disorders among women; these employ model 
treatment programs, evidence-based and best 
practices, and other research on women’s issues 
along with knowledge from related fi elds. 
Guidelines for Readers 
The consensus panel recognizes the realities 
of substance abuse treatment sometimes 
precludes implementing the wide array of 
services and programs recommended in this 
volume. Nevertheless, by presenting a variety 
of techniques for addressing the specifi c 
treatment needs of women, the panel hopes to 
increase sensitivity to these needs and options 
for improving treatment. A special feature 
throughout the TIP, “Advice to the Clinician,” 
imparts the TIP’s most direct and accessible 
guidance for the counselor. Readers with basic 
backgrounds (such as addiction counselors or 
other practitioners) can study the Advice to the 
Clinician boxes for the most immediate practical 
guidance. Brief “Note(s) to the Clinician” and 
“Note(s) to the Clinician and Administrator” are 
offered to highlight specific issues in treatment 
services. The TIP also includes “Clinical 
Activity” inserts that provide counselors 
examples of practical individual or group 
activities that support specific treatment issues 
for women. 
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Terminology 
African American: The term is used to identify 
women who live in the United States and whose 
ancestors at some point arrived from Africa. 
Although it blurs the distinction between women 
whose families came to this country from 
Caribbean nations and other countries and 
those who came directly from Africa, it is the 
term used by the U.S. Census Bureau and by 
SAMHSA and CSAT. 
Co-occurring disorders: The term “co-occurring 
disorders” refers to a diagnosis of substance use 
disorder and one or more mental disorders. 
Gender: This term is used not just as a biological 
category, but also as a social category meaning 
society or culture shapes the definition of gender 
and shapes the socialization of each woman. 
Gender affects how women live their lives, see 
their roles and their expectations of themselves 
and others, view and interpret the world, and 
handle the opportunities open to them and the 
constraints placed on them. People enact their 
gender in the world through transactions with 
others and are guided by social and cultural 
values and conceptions (West and Zimmerman 
1987). 
Gender responsive: “Being gender-responsive 
(or woman-centered) refers to the creation 
of an environment––through site selection, 
staff selection, program development, and 
program content and materials—that refl ects an 
understanding of the realities of women’s and 
girls’ lives and that addresses and responds to 
their challenges and strengths” (Covington 2007, 
p. 1). 
Hispanic/Latina: The use of the Spanish 
feminine term “Hispanic/Latina” indicates 
a woman of Hispanic heritage. The phrase 
“Hispanic/Latino” refers to men only or a group 
of men and women. The phrase “women of 
color” refers in this document to women of racial 
and cultural groups other than Caucasian, as 
well as women who consider themselves biracial 
or multiracial. 
Substance abuse: The term “substance abuse” 
refers to both substance abuse and substance 
dependence (as defined by the Diagnostic 
and Statistical Manual of Mental Disorders, 
Fourth Edition, Text Revision [DSM-IV-TR] 
[American Psychiatric Association {APA} 
2000a]) because substance abuse treatment 
professionals commonly use the term “substance 
abuse” to describe any excessive use of addictive 
substances. In this TIP, the term refers to the 
use of alcohol as well as other substances of 
abuse. Readers should attend to the context 
in which the term occurs to determine the 
possible range of meanings it covers; in most 
cases, however, the term refers to all varieties of 
substance use disorders described by DSM-IV­
TR. 
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2 Patterns of Use: 
From Initiation to 
Treatment 
Overview 
This chapter addresses patterns of substance use, abuse, and 
dependence using a continuum beginning with initial risk factors and 
concluding with common attributes associated with women entering 
treatment for substance use disorders. Information pertaining to risk 
factors linked to initiation of use, abuse of alcohol and other drugs, 
and/or the development of substance dependence is explored. Also 
examined are the potential reasons for initiation of use, means of 
introduction, and other characteristics of drug and alcohol patterns 
of use among women. In addition, to shed light on common patterns, 
this chapter provides prevalence rates of substance use, abuse, and 
dependence, including specific populations of women and substances 
as well as psychosocial characteristics of women who enter treatment. 
While this section provides a wealth of information on the unique 
psychosocial issues and patterns of use among women to aid in 
program development, the essential value for clinicians is recognizing 
that substance use disorders do not occur in a vacuum. By gathering 
information on the specific risk factors associated with initiation of 
use, people of introduction, and other individual characteristics, 
clinicians can identify clients’ potential barriers to treatment 
engagement and retention along with high-risk relapse triggers. For 
example, women who identify that their initial use was infl uenced by 
a sexual relationship and that their present use involves a signifi cant 
relationship will be more likely threatened by the potential loss of a 
relationship if they continue in treatment and recovery. In addition, 
the client may be greatly influenced by phone calls from boyfriends, 
spouses, or significant others that lead to premature termination of 
treatment. Thus, risk factors associated with either the initiation 
or continuation of use can assist clinicians in identifying specifi c 
problem areas, in anticipating intervention strategies for these 
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specific risks, and in developing a compatible 
treatment plan and an individually tailored 
continuing care plan. 
Initiation of Use Among 
Women 
The reasons for initiation of substance use 
and the subsequent development of substance 
use disorders involve a network of factors 
among women (Maharj et al. 2005). No 
one biopsychosocial characteristic is solely 
responsible for substance initiation, abuse, or 
dependence. For women, initiation of substance 
use typically begins after an introduction of the 
substance by a significant relationship such as 
a boyfriend, partner, or spouse. Reasons for 
initiation of substance use vary among women; 
they frequently report that stress, negative 
affect, and relationships are very infl uential in 
first use. Depending on the physiological effects 
of the substance, some women report they 
initiate use due to a desire to lose weight or to 
have more energy; e.g., methamphetamine use 
(Brecht et al. 2004). 
Women initiate substance use at an older 
age than do males. According to SAMHSA’s
Treatment Episode Data Set (TEDS; SAMHSA 
2004), the average age of first use of drugs or 
alcohol for females is almost 20 years old. In 
reviewing gender differences in initiation of use 
between males and females, a key ingredient that 
appears paramount is the opportunity to use. 
While females currently have fewer restrictions 
than in the past, they generally encounter more 
parent-imposed restrictions and constraints 
on activities, greater parental monitoring, and 
higher expectations surrounding responsibilities 
in the home. These restrictions often limit 
drug and alcohol exposure and opportunity to 
use (van Etten and Anthony 2001). Yet, when 
women across ethnically diverse groups have the 
same opportunity as men, they are just as likely 
to initiate use. In recent years, women have had 
more opportunities and greater availability in 
accessing drugs and alcohol (van Etten et al. 
1999). 
Risk Factors Associated 
with Initiation of 
Substance Use and the 
Development of Substance 
Use Disorders Among 
Women 
Why one woman uses a substance without 
becoming dependent while another progresses 
to abuse and dependence is not entirely clear. 
Substance use disorders have complex and 
interrelated causes. For women, some factors 
are associated only with initiation of use, while 
other factors are associated with progression 
from initial use to substance dependence; e.g., 
co-occurring disorders (Agrawal et al. 2005). 
Just as some factors increase the likelihood of 
women developing substance abuse problems, 
others decrease those chances. For example, 
having a partner can be a risk factor if that 
person abuses alcohol or drugs, but having a 
supportive, caring partner who does not use 
alcohol or drugs can be a protective factor. 
In this section, risk factors associated with 
initiation of use, ongoing alcohol and drug 
involvement, and alcohol and drug abuse and 
dependence are explored. 
Familial Substance Abuse 
Substance use disorders aggregate in families: 
relatives of people with substance use disorders 
are more likely to have a disorder. In all 
likelihood, both genetic and environmental 
factors play important and interconnected 
roles. Most research on familial aggregation has 
been done on alcohol use disorders and on male 
subjects. Reviews of several studies indicate 
that parental substance abuse can infl uence 
the development of substance use disorders in 
their children (Finkelstein et al. 1997; Heath et 
al. 1997). Jennison and Johnson (2001) cite a 
growing body of research on the risk for adult 
children of parents who abuse alcohol. The 
literature indicates that women are affected by 
familial substance abuse as much as men, with 
Patterns of Use: From Initiation to Treatment 18 
  
 
 
 
a prevalence of alcohol dependence from 10 to 
50 times higher than women who do not have a 
parent who abuses substances. 
Twin and adoption studies have established 
an important role for genetic influences in the 
etiology of alcohol use disorders in men. Some 
studies show that genetic factors appear to be 
important in women as well, making women 
similarly vulnerable to substance abuse from 
a genetic standpoint (Johnson and Leff 1999; 
Merikangas and Stevens 1998; Pickens et al. 
1991). A study of 1,030 female twins found that 
alcohol use disorders were consistently higher 
in identical twins than in non-identical twins 
and suggested that women’s genetic likelihood 
of developing an alcohol use disorder is in the 
range of 50 to 60 percent (Kendler et al. 1992). 
Kendler and Prescott (1998) found that among 
women, genetic risk factors have a moderate 
effect on the probability of ever using cannabis 
and a strong effect on the likelihood of heavy 
use, abuse, and, probably, dependence. 
However, on the whole, the evidence for genetic 
influence on the development of alcohol use 
disorders in women is less consistent than 
for men. Interpretation of the literature is 
complicated by methodological issues, such as 
small sample sizes. Some research suggests that 
differences between men and women exist in the 
sets of genes that influence alcohol use disorder 
risk or perhaps in the interactions of genes 
contributing to alcohol use disorder risk with 
other genetic or cultural factors (Prescott 2002). 
A study of women who were adopted found that 
early-life family conflict and psychopathology 
in the adoptive family interacted with a 
biological background of alcohol use disorders. 
Among women with at least one biological 
parent with an alcohol use disorder, confl ict 
or psychopathology in the adoptive family 
increased the probability of alcohol abuse or 
dependence (Cutrona et al. 1994). 
A number of possible explanations could 
account for this genetic and behavioral parental 
impact (Heath et al. 1997; Johnson and Leff 
1999). Parents who use alcohol and illicit drugs 
sometimes are unable to supervise their children 
and protect them from physical or sexual 
abuse by other family members or strangers 
(Moncrieff and Farmer 1998). They more often 
are emotionally unavailable to nurture and help 
their children. According to Johnson and Leff’s
(1999) review of the literature, alcohol use by 
parents is both directly linked to alcohol use 
by children and indirectly linked to stress, less 
parental supervision, and greater emotional 
volatility. Jessup’s (1997) review indicates that 
when parents have substance use disorders, 
it signals to a child that coping with problems 
by using alcohol and illicit drugs is acceptable 
behavior. 
Family of Origin Characteristics 
Across ethnic and cultural population groups, 
major risk factors for substance initiation and 
dependence among women include chaotic, 
argumentative, blame-oriented, and violent 
households. As a general tenet, women who 
grew up in families where they take on adult 
responsibilities as a child, including household 
duties, parenting of younger children, and 
emotional support of parents, are more likely 
to initiate drug and alcohol use. Women who 
are dependent on substances are more likely 
to have a history of over-responsibility with 
their family of origin (Nelson-Zlupko et al. 
1995). While prevalence of alcohol dependence 
appears consistently higher among women who 
report parental alcohol abuse regardless of the 
number of adverse childhood experiences (Anda 
et al. 2002), these experiences, characterized 
by childhood abuse and various forms of 
dysfunctional households, signifi cantly increase 
early initiation of use on or before the age of 14 
(Dube et al. 2006). 
Marital Status 
Women (18 to 49 years of age) who are married 
have a lower rate of alcohol or illicit drug abuse 
or dependence than women of any other marital 
status (SAMHSA 2003). History of divorce is 
positively associated with illicit drug use, not 
drug dependence, among women (Agrawal et al. 
2005). Approximately 11 percent of divorced 
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or separated women and 16 percent of women 
who have never married (in age range of 18 to 
49 years) abuse or are dependent on alcohol 
or an illicit drug compared to only 4 percent of 
married women (SAMHSA 2004). 
Effect of Partner Substance Abuse 
The “interaction, assistance, and encouragement 
of other people” are major factors in women’s 
substance use and abuse (Finkelstein 1996, 
p. 30). One study found that to some degree 
partners influence each other’s drinking 
patterns (Wilsnack et al.1998b). Men who drink 
alcohol more frequently than their partners 
influence them to drink more often, and women 
who drink lightly influence their partners to 
drink less (Wilsnack et al. 1998b). 
Women dependent on illicit drugs are more 
likely than males dependent on illicit drugs to 
have partners who use illicit drugs (Lex 1995). 
Although alcohol and marijuana use often begins 
with peer pressure during adolescence, women 
are likely to be introduced to cocaine and 
heroin by men (Amaro and Hardy-Fanta 1995; 
Henderson et al. 1994). Some women continue 
using alcohol and illicit drugs to have an activity 
in common with their partners or to maintain 
the relationships. The man often supplies drugs, 
and the woman becomes dependent on him for 
drugs. Among women with partners who have 
alcohol-related problems, they are more likely to 
report mental health problems including mood, 
anxiety, and quality-of-life problems as well as 
substance use disorders (Dawson et al. 2007). 
The dynamic of one partner being the supplier 
and the other using the drug to maintain the 
relationship is present also in some same-sex 
relationships. A few studies have examined the 
effects of partner substance abuse in lesbian 
relationships, especially the association between 
substance use and violence, but little is actually 
known (Hughes and Norris 1995; Schilit et al. 
1990). 
Women are at risk of contracting HIV/AIDS 
and hepatitis from sharing needles or having 
sexual relations with men who inject drugs or 
have sex with men. Some women may have 
unrealistic notions about intimacy, assume their 
partners are monogamous, or fear alienating 
their partners by demanding safe sex practices. 
Women with a history of abuse may have 
particular problems negotiating the use of these 
practices. 
Although ending a bad relationship can lessen 
stress, it also causes psychological distress (Hope 
et al. 1999; Horwitz et al. 1996) and can increase 
alcohol use and related problems (Chilcoat and 
Breslau 1996; Neff and Mantz 1998; Power et 
al. 1999), especially among women (Fillmore et 
al. 1997; Horwitz et al. 1996). The situation is 
more complicated when a couple has a child and 
the woman may feel unable to leave the child’s 
father for emotional or financial reasons (Amaro 
and Hardy-Fanta 1995). 
Partners may prevent women from entering or 
staying in treatment (Tuten and Jones 2003). A 
study of male partners of women in treatment 
for crack/cocaine found that most of the men 
accepted their partners’ drug use as long as 
the women managed to care for the home and 
children (Laudet et al. 1999). This study notes 
the difficulty of involving male partners in 
women’s treatment. Despite the fact that nearly 
two-thirds of the men said they supported their 
partners in treatment, they found this support 
to be passive and inconsistent. Laudet and 
colleagues (1999) suggest a number of possible 
reasons for the male partners’ detachment: 
the males’ own alcohol and drug use, desire to 
maintain the status quo, different treatment 
goals, preoccupation with their own treatment, 
and fear of stigma. 
Personality Measures 
Novelty-seeking was positively associated more 
with initiation of illicit drug use than with 
Protective Factor—Parental Warmth: If a woman comes from a family of origin that has high 
parental warmth, she is less likely to initiate use, abuse substances, or become dependent on 
alcohol or other substances (Agrawal et al. 2005) 
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Protective Factor—Partner Support: In their study of nearly 4,500 women, Jennison and 
Johnson (2001) found that a good marriage was protective against the development of alcohol 
abuse in women with a familial history of alcohol abuse. Partners can be the key motivators in 
successful interventions that bring a woman to treatment. Treatment readiness and willingness to 
accept help are higher in women whose partners have been in treatment (Riehman et al. 2000). 
 
 
 
progression from use to abuse/dependence 
(Agrawal et al. 2005). Among women, sensation-
seeking (risk-taking personality) has signifi cant 
effects on substance use. One study (VanZile-
Tamsen et al. 2006) that examined the impact of
personality constructs on health risk behavior 
among women showed that sensation-seeking ha
large indirect effects on risky sexual behavior, 
affiliation with risky partners, and drinking an 
illicit drug use behavior, and that sensation-
seeking is more strongly associated with 
substance use than with sexual risk behavior. 
Premorbid personality risk factors that lay 
the foundation for substance abuse (besides 
depressive features) include obsessiveness 
and anxiety, difficulty in regulating affect  
and behavior (such as temper tantrums and 
frequent tearfulness), and low self-worth and 
ego integration (Brook et al. 1998). According 
to Page (1993), a negative self-perception 
of physical attractiveness is associated with 
 
s 
d 
increased illicit drug use. 
Sexual Orientation 
Studies show higher rates of substance use 
and dependence in women who have sex with 
women compared with heterosexual women 
(Bickelhaupt 1995; Cochran et al. 2000; 
Diamant et al. 2000; UCLA Center for Health 
Policy Research 2005). Hughes and Wilsnack 
(1997) conclude that lesbians differ from 
heterosexual women in that they are less likely 
to abstain from alcohol, have higher rates of 
alcohol problems, and do not decrease alcohol 
intake as much with age. Conversely, Drabble 
and Underhill (2002) note that two studies found 
no significant differences in levels of drinking 
between lesbians and heterosexual women and 
that lesbians who did not drink were more likely 
to report being in recovery. Heffernan (1998) 
suggests these comparable rates of drinking 
among lesbian and heterosexual women are 
perhaps the result of a greater emphasis on 
sobriety in the lesbian community over the past 
decade. 
Studies have reported greater prevalence of 
marijuana use in comparison to other illicit 
drugs among lesbians (Cochran et al. 2004). In a 
study reporting elevated rates of illicit drug use 
among lesbian and bisexual women, marijuana 
was the most prevalent (33 percent), followed 
by opioids other than heroin (15.1 percent), 
and tranquilizers (11.6 percent; Corliss et al. 
2006). Lesbians who have moderate or high-
risk levels of use, measured by patterns of 
drug use and severity, were also more likely to 
report depressive symptoms, and this pattern 
of depressive symptoms is reflected in Hispanic/ 
Latina and Asian populations (Cochran et al. 
2007). Among younger lesbians and bisexual 
women, they appear to be most likely to abuse 
prescription drugs (Kelly and Parson 2007). 
Empirical studies reveal that lesbians are 
more likely to smoke than heterosexual women 
(Hughes and Jacobson 2003). 
Protective Factor—Religious and Spiritual Practices: Numerous studies (for review, see 
Matthews et al. 1998) highlight that higher levels of personal devotion, religious affi liation, and 
religious beliefs (defined as religiosity) reduce the risk for substance use and dependence. A female 
twin study found a negative association between religious beliefs and illicit drug use (Agrawal et al. 
2005)—that religiosity is associated with a reduced risk for substance abuse. Consistent with other 
studies (Kendler et al. 1997; Kendler et al. 2003), this study suggests that religiosity is a protective 
factor in substance use and abuse, and that faith-based approaches may serve as a potential 
relapse prevention strategy. 
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Lesbians who have a history of child sexual 
abuse possess a heightened risk for lifetime 
alcohol abuse in comparison to lesbians 
without a similar abuse history (Hughes et al. 
2007). Adolescent females and women who 
are either struggling with issues or prejudice 
surrounding sexual orientation also have greater 
risks in initiating and maintaining drug and 
alcohol use (McKirnan and Peterson 1992). 
More information on treating lesbian clients 
is available in A Provider’s Introduction to 
Substance Abuse Treatment for Lesbian, Gay, 
Bisexual, and Transgender Individuals (CSAT 
2001b). 
History of Interpersonal Violence, 
Childhood Sexual Abuse, and 
Other Traumas 
A history of traumatic events including, but 
not limited to, sexual and physical assaults, 
childhood sexual and physical abuse, and 
domestic violence, are signifi cantly associated 
with initiation of substance use and the 
development of substance use disorders among 
women (Agrawal et al. 2005; Brady and Ashley 
2005; Hawke et al. 2000; Pettinati et al. 2000). 
One review found a lifetime history of trauma 
in 55 to 99 percent of women who abused 
substances, compared with rates of 36 to 51 
percent in the general population (Najavits et 
al. 1997). Although not every woman who has 
a history of trauma develops posttraumatic 
stress disorder (PTSD), it is important to note 
that traumatic experiences are associated with 
substance use and subsequent substance use 
disorders. Several interpretations have been 
offered to explain why substance abuse often 
accompanies trauma. Studies (Grayson and 
Noelen-Hoeksema 2005; Jarvis et al.1998; 
Schuck and Wisdom 2001; Testa et al. 2003; 
Ullman et al. 2005) suggest that some survivors 
of sexual and/or physical abuse may use 
substances to self-medicate their depression 
or the anxiety that results from the abuse. 
Some survivors who use primarily cocaine and 
amphetamines may be trying to increase their 
vigilance against further victimization. Others 
with low self-esteem may use alcohol to increase 
their sociability. Conversely, substance use 
disorders increase a woman’s vulnerability 
to additional trauma, decrease her ability to 
Note to Clinicians 
For those women who are more likely to seek out novel events and thrive on risk-taking behavior 
or those women who are accustomed to living in high stress or in crisis, one of the challenges in 
maintaining recovery is learning to engage in day-to-day activities without seeking out or creating 
these situations. Some women may be so used to higher levels of stress that when life becomes a 
little more settled without the use of alcohol and drugs, they may experience a sense of boredom, 
uncomfortable feelings, or a sense of being down or depressed. In recovery, women may place 
themselves in circumstances that are high risk for relapse by returning to old risk-taking 
behaviors or by creating stressful situations to offset these feelings. 
As a clinician, it is important to anticipate these behaviors and reactions and to begin teaching 
strategies to manage these experiences. Using anxiety management strategies can be invaluable, 
but it is important to teach these techniques as early as possible to help build an arsenal of coping 
skills. Women need to learn about their accustomed risk-taking levels and premorbid levels 
of stress and the subsequent consequences if they engage in sensation-seeking behaviors. By 
developing alternative, healthy behaviors, some women will discover they don’t need to maintain 
the same level of stress to function as in the past, while other women will learn they can exchange 
their destructive desire for excitement with other recovery-oriented activities; e.g., enrolling in 
an exercise class (with medical clearance) or telling their recovery story at a 12-Step speakers 
meeting. 
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defend herself, alter her judgment, and draw 
her into unsafe environments. 
Kilpatrick and colleagues (1997) speak of 
the “vicious cycle” of substance abuse and 
violence, in which violence is both a risk factor 
and a consequence of substance abuse. TIP 
25, Substance Abuse Treatment and Domestic 
Violence (CSAT 1997b), defi nes domestic 
violence as “the use of intentional emotional, 
psychological, sexual, or physical force by one 
family member or intimate partner to control 
another” and provides an array of means 
of abuse: “verbal, emotional, and physical 
intimidation; destruction of the victim’s 
possessions; maiming or killing pets; threats; 
forced sex; and slapping, punching, kicking, 
choking, burning, stabbing, shooting, and killing 
victims” (p. 1). 
The actual introduction to substances by a 
significant other can be a way of increasing 
control and establishing power over some 
women. While rates of domestic violence vary 
across studies, it is evident that there is a 
significant relationship between violence and 
substance initiation, abuse, and dependence. 
In one survey study assessing the prevalence of 
domestic violence among women in substance 
abuse treatment, 60 percent of women reported 
either current or past domestic violence, 47 
percent reported current domestic violence 
at treatment intake, and 39 percent reported 
either physical or emotional abuse in the past 
year leading up to treatment (Swan et al. 2000). 
Moreover, the prevalence of interpersonal 
violence and substance use extends to pregnant 
women who are drug dependent. In another 
study on prevalence of violence and pregnant 
women, 73 percent reported a lifetime history 
of physical abuse. Approximately 33 percent of 
women in substance abuse treatment who were 
pregnant reported having physical fi ghts with 
their current partner in the past year (Velez et 
al. 2006). In the first analysis of evaluating the 
role of substance use as a means of coping among 
women who have experienced domestic violence 
(Kaysen et al. 2007), the results support the self-
medication hypothesis in that women use alcohol 
as a means of managing painful affect.
Co-Occurring Substance Use and 
Mental Disorders 
Women are more likely than men to have co­
occurring mental and substance use disorders 
(see chapter 8 and TIP 42, Substance Abuse 
Treatment for Persons With Co-Occurring 
Disorders [CSAT 2005e]). According to the 
National Comorbidity Study of women diagnosed 
with alcohol abuse, 72.4 percent have lifetime 
co-occurring mental disorders and 86 percent of 
women diagnosed with alcohol dependence have 
co-occurring disorders (Kessler et al. 1997). 
In comparison to men, women are more likely 
to have multiple comorbidity (three or more 
psychiatric diagnoses in addition to substance 
use disorder; Zilberman et al. 2003). Various 
literature on co-occurring disorders highlights 
the role of substance abuse as a means of self-
medicating distressing affect. While differences 
are noted in prevalence rates of co-occurring 
disorders among women of specifi c ethnic 
populations, Corcoran and Corcoran (2001) 
assert, based on their retrospective study, that 
gender (specifically female), appears to play a 
more salient role than ethnicity in endorsing the 
use of substances to manage negative affect. 
For women, anxiety disorders and major 
depression are positively associated with 
substance use, abuse, and dependence and 
are the most common co-occurring diagnoses 
(Agrawal et al. 2005). Other common mental 
disorders in women with substance use disorders 
are eating disorders and PTSD, a common 
sequel to violence and trauma. In a study 
screening women veterans for substance abuse 
and psychiatric disorders, 57 percent of the 
women who screened positive for depression, 
Protective Factor—Coping Skills: Engaging in problemsolving skills, mobilizing support from 
others, and learning to cope with one’s feelings are key protective ingredients (Mrazek and 
Haggerty 1994). 
. 
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eating and panic disorders, and PTSD also 
screened positive for substance abuse (including 
tobacco use). This sample demonstrated that 
women with a positive screen for psychiatric 
conditions were twice as likely to have abused 
drugs in the last year (Davis et al. 2003). While 
it is likely that mental disorders can play a 
primary role in initiating substance use to 
gain relief, it is as important to acknowledge 
that psychiatric disorders may occur as a 
consequence of substance use or develop 
independently, yet concurrently, of the current 
pattern of substance use. 
Preliminary investigations and discussions 
suggest that some co-occurring mental disorders 
may be likely risk factors for the initiation of 
substance use and the subsequent development 
of substance use disorders (such as anxiety 
disorders and major depression), while other co­
occurring disorders may be more likely to occur 
after the development of substance use disorders 
(Conway and Montoya 2007). For many women, 
the onset of the mental illness may precede 
the substance abuse, particularly in cases of 
PTSD (Brady and Randall 1999). One study 
reveals that women with PTSD were fi ve times 
more likely than women without PTSD to have 
substance use disorders (Brady et al. 2000). A 
review of several studies reveals that current 
PTSD rates among women who abuse substances 
range between 14 and 60 percent (Brady 2001; 
Najavits et al. 1998; Triffleman 2003), and that 
women who use substances are still more than 
twice as likely to have PTSD than men (Najavits 
et al. 1997). The planned TIP, Substance Abuse 
and Trauma (CSAT in development h), provides 
more information on this topic. 
Regarding eating disorders (anorexia nervosa 
and bulimia nervosa), women who are diagnosed 
with these disorders are more likely to develop 
alcohol use disorders later on (Franko et al. 
2005). Specifically, the behavioral pattern 
of purging, but not bingeing, appears to be 
associated more strongly with substance use. 
This finding is consistent with a theory that 
overeating or bingeing competes with substance 
use for the reward sites in the brain (Kalarchian 
et al. 2007; Kleiner et al. 2004; Warren et al. 
2005), and that obesity may be a protective 
factor against developing substance use 
disorders. 
Discrimination 
Discriminatory acts range from mundane 
slights to devastating violent acts. Women may 
experience varied levels of discrimination— 
based on gender, race, ethnicity, language, 
culture, socioeconomic status, sexual 
orientation, age, and disability—that affect 
their substance use and may affect their 
recovery (see chapter 6). For some women, 
substance abuse may become a way of coping 
with the additional stresses of discrimination. 
When women experience more than one 
type of discrimination, the effect can be 
compounded (Krieger 1999). Discrimination 
can result in fewer educational and employment 
opportunities, lower socioeconomic status, 
fewer choices in housing, and poorer health 
outcome (Mays et al. 2007). Less access to health 
care and difficulty in funding treatment due to 
a lack of health insurance can result in later 
referral for substance abuse treatment. These 
circumstances can lead directly and indirectly to 
negative health consequences and psychological 
distress, requiring special considerations during 
treatment (Krieger 1999). 
Acculturation 
Studies have found that as immigrants become 
increasingly acculturated into American 
society, and even as African Americans move 
closer to mainstream European/Caucasian 
lifestyles, alcohol and drug use increases. 
Acculturation can involve intergenerational 
conflict and feelings of disconnection, a struggle 
for cultural identity, and feelings of grief 
and loss related to the life left behind—all of 
which can put a woman at risk for substance 
abuse. For example, foreign-born Mexican 
Americans and foreign-born non-Hispanic 
Caucasians are at significantly lower risk 
for substance use disorders than are their 
American-born counterparts (Grant et al. 
2004). Second- and third-generation Hispanics/ 
Latinas are more likely than their mothers to 
use alcohol and illicit drugs (Mora 2002). A 
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Clinical Activity: Sample Timeline 
Clinical Activity: Timeline Exercise 
When working with individuals with co-occurring disorders, it is often a challenge to understand 
the history and development of symptoms and the chronological relationship between each 
disorder. While it would be valuable to understand the temporal relationship between disorders 
and to determine which set of symptoms and disorder came fi rst, it is generally information 
that is diffi cult to obtain. Nonetheless, clinicians can help clients gain awareness of the 
interrelationship between disorders and symptoms and how one disorder may exacerbate the 
other or serve as a coping mechanism to manage symptoms. To lay the groundwork to help clients 
understand this relationship, a simple timeline exercise can be implemented to highlight the 
prevalence and presenting symptoms across time. 
Directions: On a piece of paper, draw a straight line from birth to current age. Mark the line 
either in 1-year or 5-year increments depending on the age of the client and the duration of the 
disorders. Start with one disorder and mark the approximate onset of the initial symptoms, 
then write in the symptoms starting with the initial occurrence (approximate) and add the 
subsequent symptoms across the timeline. Once you have completed one disorder, go back (use a 
different color pen or marker) and do the same for the next. Use the timeline as a tool to promote 
discussion. Don’t forget to process feelings that may surface during this exercise. Note: As a 
clinician, it can be enticing to add other variables from the start, but usually it is better to start 
out simple and then return to the timeline in the next individual or group session to explore other 
issues, such as rating severity of use on the timeline 
A sample timeline is provided below. This timeline was developed for a patient with a history of 
an eating disorder (anorexia nervosa) and alcohol dependence. Not all symptoms have been noted 
on this timeline for either disorder. 
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suggested explanation for this increase in use 
among younger Latinas is confl icting cultural 
expectations; their mothers and grandmothers 
are more constrained by traditional cultures. 
Socioeconomic Status 
Women with substance use disorders are more 
likely to have lower incomes and less education 
and are less likely to be employed. Employment 
status appears to be a factor associated with 
alcohol and drug abuse and dependence. Drug 
abuse and dependence are higher among women 
who are unemployed; in 2003, 12.5 percent of 
women aged 18 to 49 who were unemployed 
abused or were dependent on alcohol or an illicit 
drug compared with 8 percent of women who 
were employed full time (SAMHSA 2004). The 
temporal relationship between unemployment 
and the development of substance use disorders 
is rather complex and not well understood. 
Patterns and Prevalence 
of Substance Use Among 
Women 
This section covers specific prevalence rates 
associated with women’s initiation of substance 
use. Similar to males, females initiate use 
based on, but not limited to, alcohol and 
drug availability, level of ease in obtaining 
the substances, price of substances, the ratio 
between perceived drug benefit versus perceived 
risk associated with use, and general attitude 
toward substance use. Yet, women typically 
display different patterns of use with alcohol, 
illicit and prescription drugs, and tobacco. 
The following segment highlights these unique 
patterns. 
Prevalence of Substance Use: 
Alcohol, Illicit Drugs, Prescription 
Drugs, and Tobacco 
Alcohol and illicit drugs 
SAMHSA’s National Survey on Drug Use 
and Health (NSDUH) interviews yearly more 
than 67,000 persons ages 12 or older to assess 
their use of alcohol and illicit drugs and their 
symptoms of substance abuse or dependence 
during the past year (SAMHSA 2007). Results 
of NSDUH for 2006 indicate that 45.2 percent 
of females ages 12 or older used alcohol during 
2006, and 6.2 percent reported current illicit 
drug use. Figure 2-1 (p. 29) provides more 
specific information about the use of illicit 
drugs, alcohol, and tobacco by females ages 12 
and older. 
Prescription drugs 
An analysis of data from the National Medical 
Expenditures Survey shows women not only use 
significantly more prescription drugs than men, 
they also use significantly more prescription 
drugs with addictive properties. Compared with 
men, women are 48 percent more likely to use a 
prescription drug that can be abused (Simoni-
Wastila 2000). According to the NSDUH 2004 
survey, between 2003 and 2004, the number 
of persons aged 12 or older with lifetime 
nonmedical use of pain relievers increased from 
31.2 million to 31.7 million including the use of 
Vicodin, Lortab, Lorcet, Percocet, Percodan, 
Tylox, hydrocodone products, OxyContin, 
and oxycodone products (SAMHSA 2005). The 
NSDUH 2003 survey found that 55 percent of 
new people who used these prescription drugs 
were female (SAMHSA 2004). 
Tobacco 
The importance of tobacco use should not be 
underestimated in a discussion of substance 
abuse. The negative physical consequences are 
well documented and can be fatal—increased 
risk for cardiovascular disease and stroke; 
chronic obstructive pulmonary disease; and 
lung, bladder, and other cancers—and specifi c 
risks are related to gender (see chapter 3). 
Tobacco use among American women has 
decreased from a high of 34 percent in 1965 to 
23.3 percent in 2006 (SAMHSA 2007). Among 
females ages 12 or older, 22.2 percent smoked 
cigarettes in the past month during 2006. Less 
than 1 percent of women reported current 
use of a smokeless tobacco product, and 2.1 
percent reported smoking cigars. Women who 
use smokeless tobacco (ST) reported using ST to 
manage weight and in response to mood states. 
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Six Patterns Associated with Women’s Substance Use 
1. Narrowing of the Gender Gap: In comparing male and female rates of alcohol use across 
10 years (Grant et al. 2006), there is significant evidence of the gender gap narrowing. Overall, 
younger adult females are more likely to mirror male patterns of alcohol and illicit drug use 
than older females. This shrinking gender gap for alcohol and drug use has been noted across 
ethnic groups, especially among younger women. 
2. People of Introduction and Relationship Status: Women are more likely to be introduced 
to and initiate alcohol and drug use through significant relationships including boyfriends, 
spouses, partners, and relatives. According to the National Center on Addiction and Substance 
Abuse and Columbia University (CASA) research report, females are often introduced to 
substances in a more private setting (2003). In addition, marital status plays an important role 
as a protective factor in the development of substance use disorders. 
3. Drug Injection and Relationships: Even though women are less likely to inject drugs than 
men, research suggests that women accelerate to injecting at a faster rate than men (Bryant 
and Treloar 2007). When women inject drugs for the first time, they are more likely than men 
who are first-time injectors to be introduced to this form of administration by a sexual partner 
(Frajzyngier et al. 2007). Women are more likely to be involved with a sexual partner who also 
injects. While various personality and interpersonal factors influence needle sharing among 
women (Brook et al. 2000), women are more likely to inject with and borrow needles and 
equipment from their partner, spouse, or boyfriend. Among women who use with their sexual 
partners, Bryant and Treloar (2007) highlight a division of labor where men are responsible for 
obtaining, purchasing, and injecting the drug for them. Thus, needle sharing and drug using 
with a sexual partner may engender a sense of emotional intimacy among women or refl ect 
inequity of power in the relationship. Other “people of introduction” besides sexual partners 
are groups that are predominantly female. While women may initiate drug injection through 
relational means, it is important to recognize that some women are as likely to initiate drug 
injection on their own. 
4. Earlier Patterns Reflect Later Problems: Drinking low to moderate levels of alcohol 
in early adulthood is a predictor of later heavy drinking and alcohol-related substance use 
disorders among women (Andersen et al. 2003; Morgen et al. 2008). In addition to amount of 
alcohol intake, frequency of use appears positively associated with risk of alcohol dependence, 
particularly for women (Flensborg-Madsen et al. 2007). Females who begin smoking at a young 
age are more likely to initiate alcohol and drug use than females who do not smoke. 
5. Responsibilities and Pattern of Use: Women are more likely to temporarily alter their 
pattern of use in response to caregiver responsibilities. As an example, women are likely to 
curtail or establish abstinence of alcohol and illicit drugs while pregnant (SAMHSA 2004), even 
though they are as likely to resume use later on. In addition, some women report that they use 
stimulants to help meet expectations associated with family responsibilities (Joe 1995). 
6. Progression and Consequences of Use: Women experience an effect called telescoping 
(Piazza et al. 1989), whereby they progress faster than men from initial use to alcohol and 
drug-related consequences even when using a similar or lesser amount of substances. While 
extensive research is available pertaining to the telescoping effect of alcohol and alcohol-related 
consequences among women, more recent research (Hernandex-Avila et al. 2004; Ridenour et 
al. 2005) supports a preliminary finding—a similar pattern of rapid progression for illicit drugs. 
While women have a greater biological vulnerability to the adverse consequences of substance 
use, it is important to note that variations in progression and the biopsychosocial consequences 
of substance use may also be linked to socioeconomic status, racial/ethnic differences, and age 
(Johnson et al. 2005). As an example, African Americans generally begin regular alcohol use 
later than most population groups yet demonstrate more rapid transition from initiation of use 
to abuse. 
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In addition, women reported that initiation of 
use was signifi cantly influenced by other females 
who use (Cohen-Smith and Severson 1999). 
Data from the 1997–1998 National Center for 
Health Statistics’ National Health Interview 
Survey revealed that among racial or ethnic 
groups, American-Indian and Alaska-Native 
women have the highest prevalence of tobacco 
use with 34.5 percent; Asian- or Pacifi c-
American women have the lowest prevalence 
at 11.2 percent (Office of the Surgeon General 
2001b). Women with more education tend to 
smoke less than women with less education. 
According to the survey, the lowest rates among 
people who smoke were for women with more 
than 16 years of education, and the highest rates 
were for women with 9 to 11 years of education. 
There is increasing evidence that children of 
parents who smoke cigarettes are more likely to 
smoke than the children of parents who do not 
smoke. Although some studies show confl icting 
results, girls seem to be more influenced by their 
parents’ smoking and are particularly more 
likely to model maternal behavior. This applies 
not just to smoking but also to cessation. The 
Office of the Surgeon General (2001b) reports 
one study that found when mothers stopped 
smoking, it helped delay or deter smoking in 
adolescent daughters, but not in sons. 
Although there is debate about the relevance 
of the “gateway” concept (in which use of 
one substance leads to use of other more 
“dangerous” substances), many studies show 
that tobacco use precedes alcohol and drug 
use. Young women in particular who smoke 
tobacco are more likely than young women who 
do not smoke to drink alcohol or use drugs, 
especially when they begin smoking at a young 
age (Ellickson et al. 1992; Lai et al. 2000; Torabi 
et al. 1993). Based on these studies, associated 
behaviors and environmental factors play a 
probable role in initiating tobacco, alcohol, and 
drug use. 
Prevalence of Substance Use 
Patterns Among Women Who Are 
Pregnant 
NSDUH includes questions about the use of 
alcohol, illicit drugs, tobacco, and pregnancy 
status among women ages 15 to 44; results show 
past-month rates for substance use are curtailed 
substantially during pregnancy (see Figure 2-2 
on p. 30; SAMHSA 2008). These rates are likely 
to be conservative because they reflect only past-
month use, not use during the entire pregnancy. 
They also are limited to women who were aware 
of their pregnancies at the time of the survey. 
Responses are affected by an unknown degree of 
stigma associated with using substances during 
pregnancy. 
Among pregnant women ages 15 to 44 years, 
5 percent reported using illicit drugs in the 
past month, based on combined 2006 and 2007 
NSDUH data. This rate is signifi cantly lower 
than the rate among women ages 15 to 44 who 
were not pregnant (10.0 percent). The rate of 
past-month cigarette use was also lower among 
those who were pregnant (16.4 percent) than it 
was among those who were not pregnant (28.4 
percent). Alcohol use followed a similar pattern 
among pregnant women ages 15 to 44 with an 
estimated 11.6 percent reporting past-month 
alcohol use. This rate was signifi cantly lower 
than the rate for nonpregnant women in the 
same age group (53.2 percent). 
These data are encouraging, indicating that 
women tend to reduce their substance use 
during pregnancy. However, women’s reduction 
of substance use during pregnancy appears to 
be temporary (SAMHSA 2008). NSDUH data 
suggest that women ages 15 to 44 use alcohol, 
tobacco, and illicit drugs less during pregnancy 
but are likely to resume substance use after 
pregnancy. 
Women who continued to use illicit drugs 
occasionally or regularly after their last 
menstrual period are more likely to have a 
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Figure 2-1 
Use of Illicit Drugs, Alcohol, and Tobacco by Females Aged 12 or 
Older,  Past Year and Past Month, Numbers in Thousands and 
Percentages, 2006 
Past Past Past Year Past Year Month Month Number Percent Number Percent 
Any Illicit Drug 15,007 11.8 7,816 6.2 
 Marijuana (includes hashish) 9,785 7.7 5,162 4.1 
Any Illicit Drug Other Than Marijuana 9,310 7.4 4,019 3.2
 Cocaine 2,116 1.7 797 0.6
 Crack 453 0.4 182 0.1
 Heroin 184 0.1 77 0.1 
 Hallucinogens (LSD, PCP, Ecstasy) 1,593 1.3 428 0.3
 Inhalants 875 0.7 257 0.2 
 Nonmedical Use of Any 
Psychotherapeutics 7,509 5.9 3,141 2.5
 Pain Relievers 5,427 4.3 2,206 1.7
 Tranquilizers 2,622 2.1 801 0.6
 Stimulants/Methamphetamine 1,677 1.3 599 0.5
 Sedatives 519 0.4 250 0.2 
Any Tobacco 34,751 27.4 29,484 23.3 
Alcohol 79,140 62.5 57,283 45.2 
 Binge Alcohol Use — — 19,276 15.2 
 Heavy Alcohol Use — — 4,172 3.3 
Source: SAMHSA 2007. 
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higher number of pregnancies, less prenatal 
care, greater likelihood of substance use among 
family and friends, and greater severity of 
substance use (Derauf et al. 2007; Shieh and 
Kraavitz 2006). Continued substance abuse 
during pregnancy is a major risk factor for 
fetal distress, developmental abnormalities, 
and negative birth effects. It is also associated 
with delayed prenatal care, and it is quite likely 
that this delay is exacerbated as a result of 
fears pertaining to potential legal consequences 
(Jessup et al. 2003). Timely prenatal care for 
pregnant women who continue to use illicit drugs 
provides a significant buffer against adverse 
pregnancy outcomes, including premature 
births, small for gestational age status, and 
low birth weight (El-Mohandes et al. 2003; 
Quinlivan and Evans 2002). 
Prevalence of Substance 
Abuse and Dependence 
Among Women 
The Shrinking Gender Gap of 
Substance Abuse and Dependence 
Even though studies have consistently shown a 
greater prevalence of substance use disorders 
among men, evidence is also mounting on the 
narrowing of the gender gap for these disorders 
(see Figure 2-3 on p. 31). According to the 
NSDUH 2006 survey, females were as likely as 
males to abuse or be dependent on substances 
between 12 and 17 years of age, while older 
adolescent males and females continue to show a 
greater gender gap in percentages of substance-
related disorders. In comparing epidemiologic 
surveys from 1992 to 2002, an analysis found 
a significant increase in risk for alcohol abuse 
and dependence among women born after 1944, 
except for African-American women (Grucza et 
al. 2008). 
Across the Life Span 
As women become older, the prevalence of 
substance abuse and dependence becomes lower 
(Grant et al. 2006). The 2003 NSDUH estimated 
that 15.7 percent of women ages 18 to 25 abused 
or were dependent on alcohol or an illicit drug 
in the past year compared with 1.5 percent 
of those ages 50 or older (see Figure 2-4 on p. 
32). However, it is important to remember that 
women remain vulnerable to substance use, 
abuse, and dependence and its consequences 
across their life spans. As women encounter 
major life transitions, they are at a heightened 
risk for substance use and abuse (Poole and Dell 
2005). 
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Figure 2-2 
 Past-Month Substance Use, Based on Combined 2006 and 2007 Data:
National Survey on Drug Use and Health (NSDUH), 2007 
Pregnant, Aged 15–44 Not Pregnant, Aged 15–44 
Any alcohol use 11.6 percent 53.2 percent 
Binge alcohol use 3.7 percent 24.1 percent 
Any illicit drug use 5.2 percent  9.7 percent 
Cigarette use  16.4 percent 28.4 percent 
Source: SAMHSA 2008. 
  
 
 
Characteristics of Treatment 
Admissions Among Women 
Data from treatment admissions provides 
considerable information on the patterns of 
substance use among women. Yet caution needs 
to be taken when generalizing this information 
across the entire population of women who have 
substance use disorders, since most women 
who have substance use disorders never receive 
treatment. According to TEDS data (SAMHSA 
2004), women are less likely to report alcohol 
as their primary substance of abuse compared 
with males. Although alcohol is still the primary 
substance of abuse, women are more likely than 
men to be in treatment for drug use. For women, 
37 percent report that opiates (20 percent) 
or cocaine (17 percent) are their primary 
substances of abuse. 
While women often receive other healthcare 
services prior to identification of substance use 
disorders, referrals from healthcare providers 
(other than alcohol and drug use treatment 
providers) are one of the lowest referral routes 
to treatment for women. Currently, self-referral, 
social service agencies, and the criminal justice 
system are the primary sources of referral to 
treatment for women (Brady and Ashley 2005; 
SAMHSA 2004). In comparison to men, women 
are more likely to be identified with a substance 
use disorder through child protective services 
(Fiorentine et al. 1997). 
Women who enter treatment are more likely to 
identify stress factors as their primary problem 
rather than substance use (Green et al. 2002; 
Thom 1987). They also exhibit more severity 
and problems related to substance use upon 
entering substance abuse treatment, including 
medical and psychological problems (Arfken 
et al. 2001). This heightened level of severity 
and symptomotology may, in part, be a result 
of delayed access to treatment due to various 
barriers, a reflection of rapid progression from 
initiation to alcohol and drug use consequences 
(telescoping), a manifestation of a woman’s 
tendency to consume alcohol and use cocaine 
more frequently than men (Pettinati et al. 
2000), or the lack of appropriate screening or 
identification of treatment need until severity is 
paramount. 
In Figure 2-5 (p. 33), the percentage of female 
admissions to substance abuse treatment 
Figure 2-3 
Percentages of Past-Year Abuse of or Dependence on Alcohol or Any 
Illicit Drug by Gender and Age, 2006 
Source: SAMHSA 2007. 
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 Figure 2-4 
Percentages of Past-Year Abuse of or Dependence on Alcohol or Any 
Illicit Drug Among Women Aged 18 or Older by Age Group: 2003 
Source: SAMHSA 2007. 
programs by racial/ethnic groups is shown. 
For more detailed information on ethnicity 
and substance abuse, refer to chapter 6. In 
addition, the planned TIP, Improving Cultural 
Competence in Substance Abuse Treatment
(CSAT in development a) provides additional 
information on ethnicity and substance abuse 
patterns. 
TEDS data also provide information about 
substance preferences for women of specifi c 
population/ racial/ethnic groups. Figure 2-6 
shows the percentage of treatment admissions 
by substance for each ethnic or racial group of 
women. Except for the “alcohol plus another 
substance” category, only the woman’s primary 
substance of abuse is indicated in the table; 
the prevalence of polydrug abuse cannot be 
determined (SAMHSA 2004). 
As Figure 2-6 (p. 34) indicates, the primary 
substance of abuse reported on admission of 
Caucasian and American-Indian/Alaska-Native 
women is alcohol. Asian- and Pacifi c-American 
women reported methamphetamine most 
often. African-American women were more 
likely to name crack/cocaine as the primary 
substance of abuse, whereas some subgroups 
of Hispanic/Latina women were more likely to 
enter treatment for heroin use. For most ethnic 
or racial groups, alcohol and a secondary drug 
were abused by the next largest percentage of 
women. 
In 2002, women constituted about 30 percent 
of admissions for substance abuse (Brady and 
Ashley 2005), but they represented a larger 
proportion of admissions for prescription 
and over-the-counter (OTC) drug abuse (46 
percent; OAS 2004b). Depending on treatment 
level, admission rates varied from 29 percent 
in hospital inpatient facilities to 39 percent 
in outpatient methadone programs. Women 
were admitted in notable proportions for all 
types of prescription and OTC drug abuse: 47 
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percent for prescription narcotics, 44 percent 
for prescription stimulants, 50 percent for 
tranquilizers, 51 percent for sedatives, and 
42 percent for OTC medications (OTC drugs 
include aspirin, cough syrup, and any other 
medication available without prescription). The 
majority of individuals admitted for prescription 
and OTC drug treatment were Caucasian (88 
percent; OAS 2004b). 
According to TEDS data (OAS 2004c), 15,300 
(4 percent) of women admitted to substance 
abuse treatment in 2002 were pregnant at the 
time of admission. Compared with the women in 
treatment who were not pregnant at admission, 
the pregnant women in treatment were more 
likely to report cocaine/crack (22 versus 17 
percent), amphetamine/methamphetamine (21 
versus 13 percent), or marijuana (17 versus 13 
percent) as their primary substance of abuse. 
Alcohol was the primary substance of abuse 
among almost one-third of women aged 15 to 
44 (31 percent) who were not pregnant at the 
time of admission. In contrast, only 18 percent 
of women who were pregnant at admission 
reported alcohol as their primary substance of 
abuse. 
Figure 2-5 
Percentage of Admissions to Substance Abuse Treatment
Programs by Racial/Ethnic Group in 2006 
Group Percentage of Total Admissions 
Female Admissions 31.8
 Caucasian 20.1
 African American 6.4 
Hispanic (Mexican Origin) 1.6 
Hispanic (Puerto Rican Origin) 0.8 
American Indian/Alaska Native 0.9
 Asian/Pacifi c Islander 0.4 
Source: HHS, SAMHSA, OAS 2008 
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 Note to Clinicians 
For a woman entering treatment, the tendency to focus on problems or stressors other than 
her substance abuse is quite normal. Women are socialized to assume more caregiver roles 
and to focus attention on others. Even if she has not appropriately cared for others (such as 
her children) during her addiction, it does not mean that she will not see this as an important 
issue immediately upon entering a detoxification or treatment program. The clinician needs to 
appreciate this gender difference; instead of assuming that the client’s worries and her tendency 
to be other-focused is a detriment or an issue of resistance for treatment, use the client’s concerns 
as a means of motivation throughout treatment. 
Figure 2-6 
Primary Substance of Abuse Among Women Admitted for 
Substance Abuse Treatment by Racial/Ethnic Group by Percentage 
Hispanic Hispanic American Asian/ TWO 
Substance Cauca­ African (Mexi­ (Puerto Indian/ Pacifi c OR 
of Abuse sian American can Rican Alaska Island­ MORE 
Origin) Origin) Native er RACES 
Alcohol 35.5 24.8 22.6 20.4 39.5 26.4 21.7 
Cocaine/crack 13.3 35.0 12.0 18.4 8.0 9.2 12.0 
Heroin 12.7 16.3 11.8 38.5 9.7 8.2 5.7 
Other opioids 7.7 1.3 1.7 1.8 4.7 3.1 4.0 
Marijuana/hashish 11.8 17.6 15.6 15.2 10.2 16.3 19.4 
Methamphetamines 13.3 1.7 34.0 2.2 25.2 33.1 31.9 
Benzodiazepines 1.0 0.2 0.1 0.4 0.4 0.3 0.6 
Other amphet­
amines 0.6 0.1 0.3 0.1 0.5 0.7 0.8 
Other sedatives/ 
hypnotics 0.4 0.1 0.3 0.1 0.2 0.1 0.2 
Hallucinogens 0.1 0.1 0.1 0.1 0.1 0.2 0.1 
PCP 0.0* 0.4 0.5 0.3 0.1 0.2 0.2 
Inhalants 0.1 0.1 0.2 0.0* 0.2 0.1 0.2 
Over-the-counter 
(OTC) medications 0.1 0.0* 0.1 0.0* 0.1 0.1 0.1 
* Less than 0.05 percent 
Source: HHS, SAMHSA, OAS 2008. 
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Advice to Clinicians and Administrators: 
Using Patterns of Use as a Clinical Guide 
For Clinicians: 
Foremost, it is important to remember that women are as likely as men to become• 
addicted to alcohol and drugs if given an opportunity. By making an assumption that 
women are less likely to have a substance use disorder, important information may 
not be obtained in the screening and assessment process, thus leading to misdiagnosis 
or under diagnosis. 
Depending on the specific drug class, some women may have considerable concerns • 
regarding potential weight gain if they enter treatment and establish abstinence. 
Among women, weight loss is more likely a major benefit in continuing drug use. 
In assessing risk factors or potential triggers for relapse, don’t underestimate that • 
the initial reasons for use may be the same reasons for relapse, even if initial use 
occurred many years ago. As a clinician, it is important to prepare for a premature 
termination of treatment and establish an intervention plan tailored to address these 
initial reasons for use. More times than not, women generally will underestimate the 
risks associated with these issues. For example, women who initiated use due to a 
relationship will often deny that relationships are a current risk factor. Nonetheless, 
the counselor should not immediately follow the client’s self-assessment but rather 
proceed with creating roleplays that simulate possible scenarios to provide practice 
in how to handle relationship issues before they actually occur in treatment; i.e., 
roleplay a telephone call from a boyfriend who believes that the client does not have 
a problem and begs her to come home. More often than not, other women in the 
treatment group have a better handle on the actual scenarios that are high risk for 
each other. 
Remember that women are socialized to be other-focused. Just because they may not • 
have attended to some of their responsibilities during active substance use does not 
mean that they will not be focused on these responsibilities upon entering treatment. 
Rather than pushing the idea that they need to “get their head into treatment and 
not be so focused on outside issues,” use their ability to be other-focused as a tool in 
developing motivation for recovery. Assuming that a woman is resistant to treatment 
because she is other-focused in the program is a form of gender bias. Women are 
socialized to think about others. 
Because substance abuse tends to run in families, a woman’s parents and children • 
as well as her partner need to be considered in planning treatment. As important, a 
woman needs to be aware of the influence of substance abuse in her family. Using a 
family geneogram or family tree to mark who has used substances can be a valuable 
tool in assessing the degree of influence in her family. 
A partner’s substance use and attitudes toward substance use can infl uence a • 
woman’s substance use. A woman who uses illicit drugs is more likely to have a 
partner who also uses illicit drugs. The counselor should work with all individuals who 
have influence on the client so that each person develops attitudes and behaviors 
that will be supportive of the client’s recovery. 
Remember to assess for personality traits that are more conducive to substance abuse• 
among women, namely sensation-seeking. 
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 Advice to Clinicians and Administrators: 
Using Patterns of Use as a Clinical Guide (continued) 
• 	 Trauma is both a risk factor for and a consequence of substance abuse. Women with 
histories of trauma may be using substances to self-medicate symptoms. Subsequently, 
interventions should be immediately put into place to help build coping strategies to 
manage strong affect, including relaxation training and other anxiety management 
skills. Start skills-building immediately rather than waiting for an incident to occur. It 
is far more difficult to manage symptoms when they are heightened than when they 
are at lower levels of intensity. 
• 	 From the outset, counselors need to be aware of the potential and common 
occurrence and impact of co-occurring disorders among women with substance use 
disorders, especially mood, anxiety, and eating disorders. 
For Administrators: 
• 	 Administrators need to develop and incorporate policies and procedures that support 
family involvement from the onset. Beginning with the initial contact, staff need 
to convey the importance of family involvement and the program’s expectations 
regarding the necessity of family participation. 
• 	 Adminstrators need to develop policies and procedures to address co-occurring issues, 
including screening, assessment, and referral processes. They need to secure funding 
and endorse programs that are effective with various populations, such as trauma-
informed services and culturally responsive programs. 
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Effects of Alcohol, 

Drugs, and Tobacco 

on Women 
Overview 
Based on human and animal studies, women are more sensitive to 
the consumption and long-term effects of alcohol and drugs than 
men. From absorption to metabolic processes, women display more 
difficulty in physically managing the consequences of use. In general, 
with higher levels of alcohol and drugs in the system for longer 
periods of time, women are also more susceptible to alcohol- and 
drug-related diseases and organ damage. 
This chapter provides an overview of the physiological impact 
of alcohol and drugs on women, with particular emphasis on the 
significant physiological differences and consequences of substance 
use in women. It begins with a general exploration of how gender 
differences affect the way alcohol and drugs are metabolized in 
the body and then highlights several biopsychosocial and cultural 
factors that can influence health issues associated with drugs and 
alcohol. The chapter goes on to explore the physiological effects of 
alcohol, drugs (both licit and illicit), and tobacco on the female body. 
A summary of key research on the impact of these substances when 
taken during pregnancy follows, and the chapter closes with a review 
of the effect that substance abuse has on women’s HIV/AIDS status. 
Counselors can use the information presented in this chapter to 
educate their female clients about the negative effects substances can 
have on their physical health. A sample patient lecture is included 
that highlights the physiological effects of heavy alcohol use. 
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Physiological Effects 
and Consequences of 
Substance Abuse in 
Women 
Alcohol and drugs can take a heavy toll on the 
human body. The same general statements can 
be made for both men and women about their 
long-term effects—for example, both genders 
incur liver problems resulting from alcohol 
abuse, respiratory impairment and lung cancer 
as a consequence of smoking, HIV/AIDS and 
hepatitis from injection drug use, and memory 
difficulties associated with the use of marijuana. 
Yet women have different physical responses to 
substances and greater susceptibility to health-
related issues. Women differ from men in the 
severity of the problems that develop from use of 
alcohol and drugs and in the amount of time be­
tween initial use and the development of physi­
ological problems (Greenfield 1996; Mucha et al. 
2006). For example, a consequence of excessive 
alcohol use is liver damage (such as cirrhosis) 
that often begins earlier in women consuming 
less alcohol over a shorter period of time. By 
and large, women who have substance use dis­
orders have poorer quality of life than men on 
health-related issues. 
In addition, women who abuse substances have 
physiological consequences, health issues, and 
medical needs related to gynecology (Peters et 
al. 2003). Specifically, drugs and alcohol affect 
women’s menstrual cycles, causing increased 
cramping and heavier or lighter periods. Women 
sometimes use illicit drugs and alcohol as medi­
cation for cramping, body aches, and other dis­
comforts associated with menstruation (Stevens 
and Estrada 1999). On the other hand, women 
who use heroin and methadone can experience 
amenorrhea (absence of menstrual periods; Abs 
et al. 2000), leading them to believe that they are 
unable to conceive and misreading early signs 
of pregnancy as withdrawal symptoms. Subse­
quently, they are unaware that they are preg­
nant. Women’s substance use also poses risks to 
fetuses and nursing infants. 
Limitations of Current Research on 
Gender Differences in Metabolism 
In general, research on the unique physiological 
effects of alcohol and drugs in women is lim­
ited and sometimes inconclusive. Although the 
differences in the way women and men metabo­
lize alcohol have been studied in some depth, 
research on differences in metabolism of illicit 
drugs is limited. For many years, much of the 
research on metabolism of substances either 
used male subjects exclusively or did not report 
on gender differences. Historically, women were 
omitted due to the potential risk of pregnancy 
and the possibility that hormonal changes across 
the menstrual cycle would wreak havoc on the 
drugs’ effects and subsequent results. 
Available research is typically based on small 
sample sizes and has not been replicated. Race 
and ethnic background can affect metabolism 
and the psychological effects of alcohol and il­
licit drugs, as can the psychopharmaceuticals 
sometimes used in treatment (Rouse et al. 1995), 
but their effects have not been studied. Similar 
to men, few women abuse only one substance. 
Polysubstance use complicates the ability to 
study and understand the physiological effects 
of specific drugs on women, while increasing 
the risk associated with synergistic effects when 
substances are combined. Significant gaps in 
knowledge exist regarding physiological effects 
across the continuum of a woman’s life. 
Physiological Effects: 

Factors of Infl uence
 
Ethnicity and Culture 
The level of acculturation and cultural roles and 
expectations play a significant role in substance 
use patterns among women of color (Caetano 
et al. 2008). The prevalence of substance abuse 
among ethnic women typically coincides with 
higher levels of acculturation in the United 
States, thus leading to greater health issues. 
Literature suggests that women from ethnically 
diverse backgrounds who have substance use 
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disorders possess greater risks for developing 
certain conditions and disorders, such as hy­
pertension, high blood pressure, and HIV/AIDS 
(Centers for Disease Control [CDC] 2000a, b; 
Steffens et al. 2006; Vernon 2007). These health 
disparities arise from many sources, including 
difficulty in accessing affordable health care, 
delays in seeking treatment, limited socioeco­
nomic resources, racism, and discrimination 
(Gee 2002; Mays et al. 2007; Williams 2002). 
In addition, mistrust of health care providers 
is a significant barrier to receiving appropriate 
screening, preventive care, timely interventions, 
and adequate treatment (Alegria et al. 2002). 
More recent studies have explored the role of 
gender in perceived discrimination and health, 
and some studies have noted differences in the 
type of stressors, reactions, and health conse­
quences between men and women (Finch et al. 
2000; Flores et al. 2008). For example, the Black 
Women’s Health Study found that perceived 
experiences of racism were associated with an 
increased incidence of breast cancer (Taylor et 
al. 2007). 
Sexual Orientation 
Lesbian/bisexual women exhibit more prevalent 
use of alcohol, marijuana, prescription drugs, 
and tobacco than heterosexual women, and they 
are likely to consume alcohol more frequently 
and in greater amounts (Case et al. 2004; Co­
chran et al. 2001, 2004). Based on the Substance 
Abuse and Mental Health Services Administra­
tion’s (SAMHSA’s) 1996 National Household 
Survey on Drug Abuse, researchers compared 
patterns of use between homosexual and het­
erosexual women and found that lesbians have 
greater alcohol-related morbidity (Cochran et 
al. 2001). Likewise, they are less likely to have 
health insurance and to use preventive screen­
ings, including mammograms and pelvic exami­
nations. With less utilization of routine screen­
ings, lesbians and bisexual women may not be 
afforded the benefit of early detection across 
disorders, including substance use disorders, 
breast cancer, and cardiovascular disease. 
Socioeconomic Status and 
Homelessness 
Overall, lower socioeconomic status is associated 
with higher mortality rates and greater risks for 
cervical cancer, coronary heart disease, HIV/ 
AIDS, and other health conditions and medical 
disorders (Adler and Coriell 1997). More than 
ethnicity, socioeconomic status heavily infl u­
ences the health risks associated with substance 
abuse. Research suggests that when the socio­
economic conditions of ethnically diverse popu­
lations are similar to those of the White popu­
lation, consequences of substance use appear 
comparable (Jones-Webb et al. 1995). Among 
women, alcohol and drug-related morbidity 
and mortality are disproportionately higher in 
individuals of lower socioeconomic status, which 
is associated with insufficient healthcare ser­
vices, difficulties in accessing treatment, lack of 
appropriate nutrition, and inadequate prenatal 
care. Subsequently, impoverished women who 
abuse substances often experience greater health 
consequences and poorer health outcomes. 
Similarly, homelessness is associated with higher 
mortality rates for all life-threatening disorders, 
including greater risks for infectious diseases. 
With greater high-risk sexual behaviors and re­
peated exposure to overcrowded shelters, home­
less women who use injection drugs are more 
likely to be infected with HIV/AIDS and other 
infectious diseases, including airborne infections 
such as tuberculosis, thereby leading to greater 
health consequences (for review, see Galea and 
Vlahov 2002). 
Developmental Issues and Aging 
Although little is known regarding the effect of 
alcohol and drugs on development across the 
lifespan, there is some evidence in alcohol-relat­
ed research that there are different vulnerabili­
ties at different ages for women. Even though 
developmental research on alcohol is not easily 
transferred to other drugs of abuse, it can give 
us a glimpse of the potential physiological issues 
associated with age and aging. For example, ado­
lescent women are more likely than their male 
counterparts to experience cognitive impairment 
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despite less alcohol consumption. Women of 
child-bearing age are more likely to experience 
infertility with heavier drinking (Tolstrup et al. 
2003). Postmenopausal women are more likely 
to exhibit significant hormonal changes with 
heavy consumption of alcohol, leading to poten­
tially higher risks for breast cancer, osteopo­
rosis, and coronary heart disease (Weiderpass 
et al. 2001). Older women are more sensitive to 
alcohol and display a decrease in tolerance and 
alcohol metabolism (Center for Substance Abuse 
Treatment [CSAT] 1998d). While research has 
been more devoted to examining gender dif­
ferences, limited data are available for other 
substances and less is known regarding the effect 
of these substances on development and aging. 
Co-Occurring Disorders: A 
Bidirectional Infl uence 
According to SAMHSA’s National Survey on 
Drug Use and Health (NSDUH) report (Offi ce 
of Applied Studies [OAS] 2004b), women with 
co-occurring mental and substance use disorders 
are likely to experience serious physical health 
problems. Co-occurring disorders have a bidi­
rectional relationship and often a synergistic ef­
fect on one another. As much as substance abuse 
can increase the risk of, exacerbate, or cause 
medical conditions, medical disorders can also 
increase substance abuse as a means of self-med­
icating symptoms or mental distress associated 
with the disorder. Similar to men, women who 
have mental disorders can have more diffi culty 
adhering to health-related treatment recom­
mendations, such as treatment attendance, diet 
restrictions, or medication compliance. 
Physiological Effects of 
Alcohol 
Gender Differences in Metabolism 
and Effects 
Alcohol is a leading cause of mortality and 
disability worldwide. According to the World 
Health Organization, alcohol is one of the fi ve 
most significant risk factors for diseases, with 
more than 60 percent of alcohol-related diseases 
being chronic conditions, including cancer, cir­
rhosis of the liver, diabetes, and cardiovascular 
disease (Chisholm et al. 2004). 
Alcohol’s effects on women have been studied 
more than those of illicit drugs. Compared with 
men, women become more cognitively impaired 
by alcohol and are more susceptible to alcohol-
related organ damage. Women develop damage 
at lower levels of consumption over a shorter 
period of time (for review, see Antai-Otong 
2006). When men and women of the same weight 
consume equal amounts of alcohol, women have 
higher blood alcohol concentrations. Women 
have proportionately more body fat and a lower 
volume of body water compared with men of 
similar weight (Romach and Sellers 1998). As 
a result, women have a higher concentration of 
alcohol because there is less volume of water to 
dilute it. 
In comparison with men, women, at least those 
younger than 50, have a lower fi rst-pass metabo­
lism of alcohol in the stomach and upper small 
intestine before it enters the bloodstream and 
reaches other body organs, including the liver. 
One researcher concluded that women’s lack 
of a functional gastric protective barrier means 
that “for an alcoholic woman to drink alcohol 
is the same as taking the alcohol directly into a 
vein,” contributing to her greater vulnerability 
to alcohol-related organ damage (Lieber 2000, p. 
417). 
These factors may be responsible for the in­
creased severity, greater number, and faster rate 
of development of complications that women 
experience from alcohol abuse when compared 
with men, according to reviews of several studies 
(Blum et al. 1998; Greenfield 1996). Women de­
velop alcohol abuse and dependence in less time 
than do men, a phenomenon known as telescop­
ing (Piazza et al. 1989). At a rate of consumption 
of two to three standard drinks per day, women 
have a higher mortality rate than men who drink 
the same amount. Men do not experience an 
increased mortality risk until they consume four 
drinks daily (Holman et al. 1996). 
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Women develop other alcohol-related diseases at 
a lower total lifetime exposure than men, includ­
ing such disorders as fatty liver, hypertension, 
obesity, anemia, malnutrition, gastrointestinal 
hemorrhage, and ulcers that require surgery 
(Van Thiel et al. 1989). Heavy alcohol use also 
increases the risk of hemorrhagic stroke, ac­
cording to one study cited by Nanchahal and 
colleagues (2000). Older women respond to 
alcohol somewhat differently than do younger 
women. They have even less body water, a 
heightened sensitivity to and decreased tolerance 
for alcohol, and a decrease in alcohol metabo­
lism in the gastrointestinal tract (CSAT 1998d). 
The following sections identify specifi c physi­
ological effects related to alcohol use by women. 
These effects are not distinct from one another; 
rather, they interact in a synergistic way in the 
body. 
Liver and Other Organ Damage 
Females are more likely than their male coun­
terparts to experience greater organ damage as a 
result of consuming similar amounts of alcohol. 
Compared with men, women develop alcohol-
induced liver disease over a shorter period of 
time and after consuming less alcohol (Gavaler 
and Arria 1995). Women are more likely than 
men to develop alcoholic hepatitis and to die 
from cirrhosis (Hall 1995). One researcher has 
theorized that women’s faster alcohol elimina­
tion rate can endanger the liver by subjecting it 
to high, though transient, levels of acetaldehyde, 
a toxic byproduct of alcohol metabolism. This 
exposure may explain the higher liver cirrhosis 
rates among women (e.g., Thomasson 2000). 
Cardiac-Related Conditions 
According to current studies, women who drink 
exhibit a greater propensity to develop alcohol-
induced cardiac damage. While light consump­
tion (less than one drink per day) can serve as 
a protective factor for women who have a risk 
for coronary artery disease, studies suggest that 
protection is not evident for younger women, 
women who drink heavily, and women without 
risk factors associated with heart disease. Wom­
en who are dependent on alcohol or consume 
heavier amounts are more likely to die prema­
turely from cardiac-related conditions (Bradley 
et al. 1998a; Fernandez-Sola and Nicolas-Arfelis 
2002; Hanna et al. 1992). 
Heavy consumption (more than four drinks per 
day) is associated with increased blood pressure 
in both women and men (Bradley et al. 1998a). 
A major epidemiological study found that wom­
en between ages 30 and 64 who consumed 15–21 
units of alcohol per week had an increased risk 
of hypertension compared with those who drank 
14 or fewer units; those who drank 1–7 units per 
week had an overall decrease in 10-year risk of 
cardiovascular disease compared with those who 
drank more (Nanchahal et al. 2000). The female 
heart appears to experience a functional decline 
at a lower level of lifetime exposure to alcohol 
than does the male heart (Urbano-Marquez et 
al. 1995). 
What constitutes light, moderate, or heavy 
drinking? 
The U.S. Department of Health and Human 
Services and U.S. Department of Agricul­
ture’s definition of moderate alcohol con­
sumption (2005) varies by gender: In women, 
moderate drinking is considered to be no more 
than one drink per day, compared with no 
more than two drinks per day for men. These 
differences stem from gender differences in 
body composition and metabolism. 
Reproductive Consequences 
Research into the adverse impact of alcohol con­
sumption on fertility is growing. While numer­
ous studies have shown a consistent relationship 
between heavy drinking and infertility (Eggert 
et al. 2004; Tolstrup et al. 2003), additional 
studies examining moderate consumption are 
more inconsistent. Nevertheless, fi ndings suggest 
a need to educate and screen women for alcohol 
use while they are seeking infertility treatment 
(Chang et al. 2006). In addition, heavy drink­
ing is associated with painful and/or irregular 
menstruation (Bradley et al. 1998a). The repro-
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ductive consequences associated with alcohol use 
disorders range from increased risk for miscar­
riage to impaired fetal growth and development 
(Mello et al. 1993). 
There are considerable variations among women 
in their capacity to consume and metabolize 
alcohol. Early literature suggests that variations 
in alcohol metabolism among women may be 
linked to the different phases of the menstrual 
cycle, but more recent reviews suggest that there 
are no consistent effects of the menstrual cycle 
on the subjective experience of alcohol intake or 
alcohol metabolism (Terner and de Wit 2006). 
Studies reviewed by Romach and Sellers (1998) 
found that significant hormonal changes are re­
ported in postmenopausal women who consume 
alcohol. Women taking hormone replacement 
therapy (HRT), now referred to as menopausal 
hormone therapy, and consuming 14 or more 
standard drinks weekly had signifi cantly higher 
estradiol levels. These high levels are associated 
with a greater risk of breast cancer and coro­
nary heart disease. 
Breast and Other Cancers 
Numerous studies have documented associations 
and suggested causal relationships between al­
cohol consumption and breast cancer risk (Key 
et al. 2006; Li et al. 2003; Zhang et al. 2007). 
A review of data from more than 50 epidemio­
logical studies from around the world revealed 
that for each drink of alcohol consumed daily, 
women increased their risk of breast cancer by 7 
percent (Hamajima et al. 2002). Postmenopausal 
women have an increased risk of breast cancer 
as well if they currently drink alcohol (Lenz et 
al. 2002; Onland-Moret et al. 2005). Women who 
drink alcohol have elevated estrogen and andro­
gen levels, which are hypothesized to be con­
tributors to the development of breast cancer in 
this population (Singletary and Gapstur 2001). 
In addition, postmenopausal women who are 
moderate alcohol drinkers (one to two drinks a 
day) and who are using menopausal hormone 
therapy have an increased risk of breast cancer, 
with even greater risk at higher rates of alcohol 
consumption (Dorgan et al. 2001; Onland-Moret 
et al. 2005). 
While the risk for in situ and invasive cervical 
cancer and cancer of the vagina may be associ­
ated with other environmental factors including 
high-risk sexual behavior, human papilloma vi­
ruses, smoking, hormonal therapy, and dietary 
deficiency, Weiderpass and colleagues (2001) 
concluded, based on 30 years of retrospective 
data, that women who are alcohol dependent are 
at a higher risk for developing these cancers. 
Similarly, Bagnardi et al. (2001) conducted a 
meta-analysis of more than 200 studies whereby 
they found that alcohol signifi cantly increased 
the risks for cancers of the oral cavity, pharynx, 
esophagus, larynx, stomach, colon, rectum, 
liver, and ovaries. Although further investiga­
tion is needed to explore the role of alcohol 
consumption on gastric cancer, preliminary 
findings suggest that the type of alcoholic bever­
age, namely medium-strength beer, creates an 
increased risk of gastric cancer (Larsson et al. 
2007). Based on a multiethnic cohort study, the 
risk of endometrial cancer increases when post­
menopausal women consume an average of two 
or more drinks per day (Setiawan et al. 2008). 
Additional risks are associated with tobacco use, 
particularly for cancers of the upper digestive 
and respiratory tract. 
Osteoporosis 
According to Bradley and colleagues (1998a), 
evidence suggests “decreased bone forma­
tion and abnormal vitamin D metabolism may 
predispose alcohol-dependent premenopausal 
women to osteoporosis” (p. 631). Heavy alcohol 
use clearly has been shown to harm bones and to 
increase the risk of osteoporosis by decreasing 
bone density. These effects are especially strik­
ing in young women, whose bones are develop­
ing, but chronic alcohol use in adulthood also 
harms bones (Sampson 2002). In addition, ani­
mal studies suggest that the damaging effects of 
early chronic alcohol exposure are not overcome 
even when alcohol use ceases (Sampson 1998). 
Tobacco use also may increase the risk of osteo­
porosis and fractures; people who drink are 75 
percent more likely to smoke, and people who 
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Clinical Activity: Sample Client-Educating Lecture Outline for 
Counselors Physiological Effects of Alcohol 
This 60-minute lecture provides a general outline highlighting the physiological effects of moder­
ate-to-heavy alcohol use. Refer to this TIP chapter for additional information to support your 
lecture. To increase participation, first ask women in the group to identify medical problems 
they believe to be related to their alcohol use. The format of this lecture can also be used with 
illicit and prescription drugs. Many conditions do occur in men, but it is important to emphasize 
the enhanced risk and the earlier appearance of these diseases and conditions among women. 
The list of physiological consequences identifies the most common disorders; it is not intended as 
a comprehensive review. 
I. 	 Rationale: Women’s positive response to health education 
II. 	Objectives: 
A. 	 To review what constitutes moderate-to-heavy drinking among women 
B. 	 To describe physiological differences in how alcohol is metabolized in a woman’s body 
C. 	 To explore the long-term consequences of drinking, with emphasis on specifi c conse­
quences unique to women 
III. Equipment: Using an easel with newspaper print or a board, draw a human body. As you 
lecture, write in the effects of alcohol on the body to demonstrate how dramatically alcohol 
affects women. At the end of the lecture, the body should be covered with physiological con­
sequences. 
IV.  Definition: In women, moderate drinking is considered to be no more than one drink per 
day (U.S. Department of Health and Human Services and U.S. Department of Agriculture 
[2005]). 
V.	 Alcohol Metabolism and Women: 
A. 	 Women have higher blood alcohol concentrations after drinking the same amount of 
alcohol as men. 
B. 	 Women have more body fat and a lower volume of body water than men of equal weight. 
Consequently, women are less able to dilute alcohol once it enters the body, and this 
leads to a higher concentration of alcohol in the bloodstream and organs. 
C. 	 Women have a lower concentration of gastric dehydrogenase, an enzyme responsible for 
metabolism. Because alcohol takes longer to metabolize in women, it has more deleteri­
ous effects on major organs for a longer period of time. Longer metabolism and less dilu­
tion is a potent mixture for women! In addition, women have smaller organs than men, 
causing greater vulnerability to the long-term effects of alcohol. 
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 Clinical Activity: Sample Client-Educating Lecture Outline for 
Counselors Physiological Effects of Alcohol (continued) 
VI. Long-Term Consequences: Women experience negative physical consequences and complica­
tions from alcohol sooner and at lower levels of consumption than men. Evidence suggests 
that women progress significantly faster in developing dependence, organ damage, and 
diseases with much lower levels of alcohol consumption. Women are more likely to die many 
years earlier from alcohol abuse and dependence. 
A. 	 Liver and Other Gastrointestinal Disorders 
1. Fatty Liver 
2. 	 Alcohol Hepatitis 
3. 	 Cirrhosis 
4. 	 Liver Cancer 
5. 	 Ulcers/Gastritis 
6. 	 Pancreatitis 
7. 	 Diabetes 
B. 	 Cardiac-Related Conditions 
1. 	 High Blood Pressure (hypertension) 
2. 	 Cardiomyopathy 
3. 	 Stroke 
4. 	 Arrhythmia 
C. 	 Nutritional Defi ciencies 
1. Malnutrition 
2. 	 Vitamin and Mineral Defi ciencies 
D. 	Reproductive Consequences 
1. 	 Fetal Alcohol Spectrum Disorders: Fetal alcohol syndrome, alcohol-related birth 
defects (ARBD), partial fetal alcohol syndrome (pFAS), and alcohol-related neu­
rodevelopmental disorder (ARND) 
2. 	 Low Birth Weight 
3. 	 Miscarriage 
4. Painful/Irregular Menstruation 
5. 	 Underproduction of Hormones 
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Clinical Activity: Sample Client-Educating Lecture Outline for 
Counselors Physiological Effects of Alcohol (continued) 
E. Breast and Other Cancers 
1. Breast Cancer 
2. Throat and Mouth Cancer 
3. Stomach and Colon Cancer 
4. Other Cancers 
F. Osteoporosis 
G. Cognitive and Other Neurological Effects 
1. Brain Shrinkage 
2. Peripheral Neuritis/Neuropathy 
3. Dementia 
4. Korsakoffs/Wernickes 
5. Cerebellar Degeneration 
H. Infections: Greater Susceptibility and Progression 
1. HIV/AIDS 
2. Tuberculosis 
3. Pneumonia 
I. Other Disorders and Conditions 
smoke are 86 percent more likely to drink (Shiff­
man and Balabanis 1995).Women in menopause 
who enter treatment need bone density assess­
ment, nutritional guidelines, and medication 
consultations. 
Neurological Effects 
Starting with adolescence, women appear to be 
more susceptible to the toxic effects of alcohol 
or its metabolites on the nervous system and 
more vulnerable to alcohol-induced brain dam­
age than men (Bradley et al. 1998a; Hommer et 
al. 1996; Mann et al. 2005; Mumenthaler et al. 
1999). Research supports that adult and adoles­
cent women who are alcohol dependent experi­
ence greater declines in cognitive and motor 
function than men despite less alcohol consump­
tion, shorter history of overall use, and shorter 
duration of alcohol dependence (Acker 1986; 
Flannery et al. 2007; Sullivan et al. 2002). 
In comparison with men who are alcohol depen­
dent and female controls (women who are not 
dependent on alcohol), women who are alcohol 
dependent exhibit deterioration in planning, 
visuospatial ability, working memory, and psy­
chomotor speed. They also show brain abnor­
malities and shrinkage after a shorter drink­
ing history and lower peak consumption than 
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do men. Studies demonstrate that in general, 
women with alcohol dependence disorders have 
significantly smaller volumes of gray and white 
matter, less hippocampal volume (memory), and 
greater peripheral neuropathy than either men 
who abused alcohol or women who did not abuse 
alcohol (Ammendola et al. 2000; Hommer et al. 
2001; Romach and Sellers 1998; Schweinsburg 
et al. 2003). 
Women appear to be at greater risk than men 
for Alzheimer’s disease, although women’s lon­
ger life spans may contribute to this higher risk 
(Sohrabji 2002). Heavy alcohol consumption 
is known to result in memory deficits and may 
increase the risk for Alzheimer’s disease in both 
genders, but particularly in women, who ap­
pear to be more vulnerable than men to alcohol-
induced brain damage (Sohrabji 2002). 
Physiological Effects of 
Licit and Illicit Drugs 
Gender Differences in Metabolism 
and Effects 
Research (Hernandez-Avila et al. 2004) sup­
ports the concept of an accelerated progression 
to treatment entry among women dependent on 
opioids, cannabis, or alcohol, and suggests the 
existence of a gender-based vulnerability to the 
adverse consequences of these disorders. No 
gender difference was noted for age at onset of 
regular use, but the women had used opioids, 
cannabis, and alcohol for fewer years before 
entering treatment. The severity of drug and 
alcohol dependence did not differ by gender, but 
women reported more severe psychiatric, medi­
cal, and employment complications than did 
men. In one substance abuse treatment study 
focused on urban outpatient clinics, women had 
more symptoms than men across substances 
(Patkar et al. 1999). They reported more 
cardiovascular, mood, nose and throat, neu­
rological, skin, and gastrointestinal symptoms 
than did men. In addition, there is evidence 
that women who use injection drugs are more 
susceptible to medical disorders and conditions 
(Zolopa et al. 1994). Similarly, women who 
use cocaine, heroin, or injection drugs have a 
heightened risk of developing herpes, pulmo­
nary tuberculosis, and/or recurrent pneumonia 
(Thorpe et al. 2004). 
To date, little is known regarding the conse­
quences of specific drug use among women. 
Complicated by polysubstance use, studies are 
often unable to obtain adequate sample sizes of 
women who abuse only one drug. The following 
section highlights specific physiological effects of 
licit and illicit drugs that are unique to women. 
This is not a general primer on drugs, but 
rather a compendium of known physiological 
effects that are gender-specifi c. 
Cocaine, Amphetamine, and 
Methamphetamine 
Hormonal changes across the menstrual cycle 
have the greatest effect on stimulant drugs, par­
ticularly cocaine and amphetamine. Literature 
highlights a consistent and greater mood-alter­
ing effect of stimulant use during the follicular 
phase of the cycle (for review, see Terner and de 
Wit 2006), and the fluctuations in progesterone 
levels may account, in part, for this sex dif­
ference (Evans 2007; Evans and Foltin 2006). 
More specifically, Evans and colleagues (2002) 
investigated whether cocaine effects vary as a 
function of menstrual cycle phase; they found 
that heart rate and ratings such as “good drug 
effect” were increased more during the folli­
cular phase than the luteal phase. Conversely, 
injection drugs and/or crack cocaine appear to 
produce changes in the menstrual cycle, includ­
ing the development of amenorrhea, degree of 
blood flow, and the intensity of cramps (Stevens 
and Estrada 1999). Overall, women who use 
cocaine report more positive subjective drug 
effects, including greater euphoria and desire 
to use, while physiological responses to the drug 
did not change (McCance-Katz et al. 2005). 
Methamphetamine use has an array of possible 
adverse effects (for review, see Winslow et al. 
2007), but data regarding specific gender differ­
ences are limited. Psychoactive effects of meth­
ylenedioxy- methamphetamine (ecstasy) have 
been found to be more intense in women than in 
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men; women report experiencing a higher degree 
of perceptual changes, thought disturbances, 
and fear of the loss of control of their bodies. 
Acute adverse effects, such as jaw clenching, dry 
mouth, and lack or loss of appetite, are more 
common among women (Liechti et al. 2001). 
Heroin and Other Opioids 
Research is lacking that would allow defi nitive 
conclusions about gender similarities or dif­
ferences in the following effects of heroin use: 
scarred and collapsed veins, bacterial infections 
of blood vessels and heart valves, abscesses, 
cellulitis, and liver or kidney disease (National 
Institute on Drug Abuse [NIDA] 2000). 
Research suggests that there are no menstrual 
cycle differences in women’s subjective experi­
ence or physiological reaction to opioids (Gear 
et al. 1996), but women using heroin or metha­
done do experience menstrual abnormalities, 
particularly amenorrhea or an irregular men­
strual cycle (Abs et al. 2000; Santen et al. 1975; 
Smith et al. 1982). It can take up to a year for 
regular menstrual cycles to resume after drug 
use is stopped. Deficits in sexual desire and 
performance are also consequences of heroin 
use (Smith et al. 1982). These symptoms prob­
ably are related to the lower levels of luteinizing 
hormone, estradiol, and progesterone found 
in these women (Abs et al. 2000). Amenorrhea 
and other symptoms often make women believe 
they are permanently sterile, a fear that can be 
lessened with education. TIP 43 Medication-As­
sisted Treatment for Opioid Addiction in Opioid 
Treatment Programs (CSAT 2005b) provides 
more information. 
Marijuana 
Studies on marijuana effects have not focused 
specifically on gender differences; therefore, 
little is known about how marijuana affects men 
and women differently. In studies evaluating 
hormonal changes and the physiological and 
psychological effects of marijuana use, fi ndings 
suggest that the effects of marijuana do not vary 
markedly across the menstrual cycle (Block et 
al. 1991; Griffin et al. 1986; Lex et al. 1984). 
Effects of marijuana on birth outcomes are dis­
cussed below. 
Prescription and Over-the-Counter 
Medications 
Women are significantly more likely to use 
and abuse prescription medications, includ­
ing anxiolytics (antianxiety medications) and 
narcotic analgesics (pain medications), than are 
men (Simoni-Wastila 2000). Little research is 
available, however, on the gender differences 
and differential physiological effects of abuse of 
prescription medications. Moreover, research 
into the influence of hormonal changes across 
the menstrual cycle on subjective, behavioral, 
and physiological effects is limited to benzodi­
azepines, and findings are minimal (Bell et al. 
2004; Kamimori et al. 2000). 
Over-the-counter (OTC) medications include 
cold remedies, antihistamines, sleep aids, and 
other legally obtained nonprescription medica­
tions. It is not uncommon for individuals with 
eating disorders, particularly those diagnosed 
with bulimia nervosa, to abuse laxatives, di­
uretics, emetics, and diet pills. Misuse of these 
medications can result in serious medical com­
plications for those with eating disorders, who 
primarily are women (U.S. Department of 
Health and Human Services, Office on Women’s 
Health 2000). Complications can involve the 
gastrointestinal, neuromuscular, and cardiac 
systems and can be lethal. Many prescription 
and OTC medications interact negatively with 
alcohol and drugs. 
Gender Differences and 
OTC Drugs 
Across studies, prevalence rates comparing the 
use and misuse of OTC medications among men 
and women vary according to age and race/eth­
nicity. For individuals 65 years of age and older, 
women are more likely to use OTC drugs (Halon 
et al. 2001). NSDUH evaluated the misuse of 
OTC cough and cold medications among persons 
aged 12 to 25 (SAMHSA 2007) and found that 
women aged 12 to 17 were more likely than men 
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to have misused OTC cough and cold medica­
tions in the past year, while men between 18 and 
25 years of age were more likely to have misused 
these medications. Whites and Hispanics had 
higher rates of misuse than African Americans. 
Similar to men, women who had ever misused 
OTC cough and cold medications also had life­
time use of marijuana and inhalants. In evaluat­
ing prescription and OTC drug treatment admis­
sions, women represented a larger proportion 
of prescription and OTC 
medication admissions 
(46 percent) than treat­
ment admissions for all 
substances (30 percent;
SAMHSA 2004). 
Physiological 
Effects of 
Tobacco Use 
The health risks associ­
ated with nicotine use 
are considerable, par­
ticularly among women.
In comparison with men, 
women who smoke show 
higher disease risk re­
gardless of smoking level 
or intensity (Mucha et al. 
2006). Currently, can­
cer is the second leading
cause of death among 
women, with mortality 
rates higher for lung 
cancer than breast cancer. According to the Of­
fice of the Surgeon General (2001 b), women who 
smoke: 
• 	 Have an increased risk of peptic ulcers and 
Crohn’s disease. 
• 	 Have an increased risk of estrogen defi ciency; 
difficult, irregular or painful menstruation; 
and amenorrhea. 
• 	 Are more likely to be diagnosed with cancer, 
including cancer of the lung, bladder, cervix, 
pancreas, kidney, larynx, esophagus, liver, 
and colon. 
• 	 Have a higher risk for delayed conception 
and infertility. 
• 	 Are more likely to deliver premature and low-
birth-weight infants. 
• 	 Have an increased risk for ischemic stroke, 
subarachnoid hemorrhage, peripheral 
vascular atherosclerosis, and an abdominal 
aortic aneurysm rupture. 
• 	 Are more likely to have premature decline in 
lung function, chronic obstructive pulmonary 
disease, and coronary heart disease. 
• 	 Have an increased risk of developing 
cataracts and macular degeneration. 
• 	 Reach menopause at a younger age. 
• 	 Have lower bone densities and an increased 
risk for hip fracture after menopause. 
Effects of Alcohol, Drugs, 
and Tobacco Use on 
Pregnancy and Birth 
Outcomes 
The use of alcohol, drugs, and tobacco can 
affect a pregnant woman in a variety of ways. 
Substance use can result in obstetric complica­
tions, miscarriage, or significant problems for 
the fetus. It is difficult to tease out individual 
effects of licit and illicit substances on fetal and 
infant development because women who abuse 
these substances typically abuse more than one, 
and the substance abuse can be accompanied 
by psychological distress, victimization, and 
poverty. A detailed discussion of alcohol- and 
drug-related problems in infants and children is 
beyond the scope of this TIP except insofar as 
these problems create additional demands and 
stressors for women as well as guilt and shame 
about the use of alcohol, drugs, and/or to­
bacco during pregnancy. This section highlights 
specific effects of alcohol and drugs during the 
course of pregnancy. 
Alcohol Use and Birth Outcomes 
Above all other drugs, alcohol is the most 
common teratogen (any agent that interrupts 
development or causes malformation in an 
embryo or fetus) in pregnancy (Randall 2001). 
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In utero, alcohol use is associated with an 
increased risk of spontaneous abortion and 
increased rates of prematurity and abruptio 
placentae (premature separation of the placenta 
from the uterus). A study found that women who 
consumed five or more drinks per week were 
three times as likely to deliver a stillborn baby 
compared with those who had fewer than one 
drink per week (Kesmodel et al. 2002). 
Maternal alcohol use during pregnancy 
contributes to a wide range of effects on 
exposed offspring, known as fetal alcohol 
spectrum disorders (FASDs), and the most 
serious consequence is fetal alcohol syndrome 
(FAS). FAS is characterized by abnormal facial 
features, growth deficiencies, and central 
nervous system problems (Jones and Smith 
1973). Symptoms can include hyperactivity 
and attention problems, learning and memory 
deficits, and problems with social and emotional 
development. Infants who show only some of 
these features were previously identifi ed as 
having fetal alcohol effects (FAE). Since 1996, 
the term FAE has been replaced by alcohol-
related birth defects (ARBD), partial fetal 
alcohol syndrome (pFAS), and alcohol-related 
neurodevelopmental disorder (ARND; Stratton 
et al. 1996). Children with ARBD have problems 
with major and sensory organs, as well as 
structural abnormalities; children with ARND 
have central nervous system abnormalities 
(Green 2007). Despite alcohol-related birth 
defects being completely preventable, FASDs 
are the most common nonhereditary causes of 
mental retardation (CDC 2002). 
Another risk factor associated with alcohol 
exposure in utero is the potential of substance 
use disorders. Alati et al (2006) found an 
association of early-onset of alcohol disorders 
among children exposed to alcohol prenatally; 
this association was more pronounced with 
early pregnancy exposure. While little is known 
about the prevalence of FASD among individuals 
with substance use disorders, this co-occurring 
condition is likely to further challenge recovery 
effects. For guidelines in identifying and 
referring persons with FAS, see CDC (2005). 
Women who drink during breastfeeding pass 
alcohol on to the baby. Although numerous 
studies of laboratory animals have demonstrated 
a variety of adverse outcomes in breastfed 
offspring during periods when their mothers 
are consuming alcohol, human data are limited. 
A review of empirical literature on women who 
drink while breastfeeding provides evidence that 
maternal alcohol consumption does not promote 
lactation and may affect infant sleep patterns. 
(for review, see Giglia and Binns 2006) 
Cocaine Use and 
Birth Outcomes 
According to reviews 
of several studies 
conducted during the 
late 1980s and early 
1990s, there are a 
variety of adverse effects 
of cocaine use during 
pregnancy (Zuckerman 
et al. 1995; Burkett et al. 
1994). Studies reported 
that cocaine-exposed 
infants had smaller 
head circumference; 
lower birth weight and 
length; irritability; poor 
interactive abilities; and 
an increased incidence of 
stillbirth, prematurity, 
and sudden infant death 
syndrome (SIDS; Bell 
and Lau 1995). Other 
studies dispute many 
previously reported 
severe effects of prenatal 
exposure of cocaine on 
the offspring. Frank and 
colleagues’ review (2001) 
of the literature found 
that the most consistent 
effects were small size 
and less-than-optimal 
The SAMHSA 
FASD’s Center for 
Excellence Web site 
provides information
and resources 
about FASD and 
related information 
on legislation,
treatment and
training curricula,
and community
awareness (http:// 
www.fascenter. 
samhsa.gov/).
motor performance. 
Eyler and colleagues (2001) found no evidence 
of the previously reported devastating effects of 
prenatal cocaine exposure. Hurt and colleagues 
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Advice to Clinicians: 
Substance Use and Birth Outcomes 
• 	 Counselors should be sensitive to female clients who are pregnant and help them 
manage the additional stresses, demands, and guilt that pregnancy can cause in a 
woman already struggling with a substance use disorder. 
• 	 Counselors can take the opportunity to educate their pregnant clients about how 
alcohol, tobacco, and cocaine affect the fetus in a variety of ways that are dose and 
timing dependent, which is an optimistic basis for encouraging pregnant women to 
remain abstinent during pregnancy and while breastfeeding. 
• 	 Pregnant women using opioids should enter methadone maintenance treatment, 
which protects the fetus from repeated episodes of withdrawal, eliminates the risks 
of infection from needles, and creates a mandatory link to prenatal care. 
(1995) followed a cohort of cocaine-exposed 
infants from birth to age 6; although they found 
lower weight and head circumference, they 
found no difference in developmental scores 
between cocaine-exposed and non–cocaine­
exposed infants. However, other evidence 
suggests that children exposed to cocaine during 
the first trimester were smaller on all growth 
parameters at 7 and 10 years of age compared 
with children who were not exposed to cocaine 
(Richardson et al. 2007). This longitudinal 
analysis indicated that the disparity in growth 
between both groups did not converge over time. 
An extensive review by Frank and colleagues 
(2001) of all studies published in English 
from 1984 to 2000 (N = 74) that met rigorous 
methodological criteria (N = 36) concluded that 
many apparent adverse outcomes of cocaine use 
during pregnancy “can be explained … by other 
factors, including prenatal exposure to tobacco, 
marijuana, or alcohol and the quality of the 
child’s environment” (p. 1624). Other studies 
(Hurt et al. 2001; Kaltenbach 2000; Lewis et al. 
2004b; Messinger et al. 2004) have supported 
this conclusion. Singer et al. (2004) reported 
that the quality of the caregiving environment 
was the strongest independent predictor of 
cognitive outcomes among children exposed to 
cocaine. 
Nonetheless, the effects of cocaine on the 
fetus may be dose and timing dependent, and 
significant cocaine use during pregnancy, with 
or without other drug use, is associated with 
negative consequences for the offspring and 
the mother (Thaithumyanon et al. 2005). Birth 
weight, length, and head circumference of 
infants with high exposure to cocaine differed 
from those with low or no exposure (Bateman 
and Chiriboga 2000). Heavily cocaine-exposed 
infants were found to have more jitteriness 
and attention problems than infants with light 
or no exposure to cocaine and lower auditory 
comprehension than unexposed infants (Singer 
et al. 2000). Evidence suggests that subtle 
deficits exist in cognitive and attentional 
processes in cocaine-exposed preschool and 
6-year-old children (Leech et al. 1999; Mayes et 
al. 1998). In addition, infants exposed to cocaine 
during pregnancy had more infections, including 
hepatitis and HIV/AIDS exposure (Bauer et 
al. 2005). Much is still unknown about the 
effects of prenatal cocaine exposure. However, 
cocaine use by a pregnant woman should be 
viewed as an indication of multiple medical and 
social risk factors (Eyler and Behnke 1999; 
Tronick and Beeghly 1999); her ability to access 
prenatal care, gain supportive and effective 
case management services, and obtain substance 
abuse treatment can make all the difference in 
outcome. 
Opioid Use and Birth Outcomes 
Opioid use in pregnant women presents a 
difficult situation because of the many medical 
complications of opioid use, such as infections 
passed to the fetus by the use of contaminated 
needles. Obstetric complications in pregnant 
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Note to Clinicians 
Since timely treatment for HIV/AIDS can virtually eliminate the chance of a pregnant woman 
passing the infection to her fetus, all women with substance use histories should have an HIV/ 
AIDS evaluation at the first sign of any possible pregnancy. 
women who use opioids often are compounded 
by lack of prenatal care. Complications 
include spontaneous abortion, premature 
labor and delivery, premature rupture of 
membranes, preeclampsia (high blood pressure 
during pregnancy), abruptio placentae, and 
intrauterine death. The fetus is at risk for 
morbidity and mortality because of episodes of 
maternal withdrawal (Kaltenbach et al. 1998). 
Reviews of several studies recommend 
methadone maintenance treatment (MMT) as 
the only treatment for the management of opioid 
dependence during pregnancy because, when 
methadone is provided within a treatment setting 
that includes comprehensive care, obstetric 
and fetal complications, including neonatal 
morbidity and mortality, can be reduced (Jarvis 
and Schnoll 1995; Kaltenbach et al. 1998). 
Effective MMT prevents the onset of withdrawal, 
reduces or eliminates drug craving, and blocks 
the euphoric effects of illicit self-administered 
opioids (Dole et al. 1966a, b; Kreek 1988). The 
use of methadone in pregnancy prevents erratic 
maternal opioid levels and protects the fetus 
from repeated episodes of withdrawal. Because 
needle use is eliminated, MMT reduces the risk 
of infectious diseases. The mandatory link to 
prenatal care, frequent contact with program 
staff, and elimination of the stress of obtaining 
opioids daily to feel “normal” are additional 
benefits from MMT (Burns et al. 2006). 
Reviews of the literature note that studies 
consistently have found that fetuses exposed 
to opioids (i.e., heroin and methadone) have 
lower birth weights than unexposed fetuses and 
usually undergo neonatal abstinence syndrome 
(NAS) at birth. NAS is a generalized disorder 
characterized by signs and symptoms of central 
nervous system irritability, gastrointestinal 
dysfunction, respiratory distress, vomiting, and 
fever, among other symptoms. NAS can be more 
severe and prolonged with methadone exposure 
than heroin exposure, but with appropriate 
pharmacotherapy, NAS can be treated 
effectively (Kaltenbach 1994; Kaltenbach et al. 
1998). 
Although findings among studies are diverse, 
most suggest that methadone-exposed infants 
and children through age 2 function well within 
the normal range of development and that 
methadone-exposed children between ages 2 
and 5 do not differ in cognitive function from 
a population that was not drug exposed and 
was of comparable socioeconomic and racial 
background (Kaltenbach 1996). Data suggest 
that such psychosocial factors as environment 
and parenting can have as much of an effect on 
development as prenatal exposure to opioids 
(Johnson et al. 1987; Lifschitz et al. 1985). 
In more recent years, buprenorphine treatment 
has been examined as an alternative to 
maintenance therapy for opioid dependence 
during pregnancy. Nonetheless, research is 
limited and only two randomized, double-
blind studies have been conducted comparing 
methadone with buprenorphine (Fischer et al. 
2006; Jones et al. 2005; Kayembe-Kay’s and 
Laclyde 2003; Raburn and Bogenschultz 2004). 
For additional information on maintenance 
therapies during pregnancy, see TIP 43 
Medication-Assisted Treatment for Opioid 
Addiction in Opioid Treatment Programs (CSAT 
2005a) and TIP 40 Clinical Guidelines for the 
Use of Buprenorphine in the Treatment of 
Opioid Addiction (CSAT 2004a). 
Marijuana Use and Birth 
Outcomes 
The limited research on the effects of prenatal 
exposure to marijuana shows somewhat 
inconsistent results (Bell and Lau 1995). 
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Longitudinal studies by Day and colleagues 
(1992) found marijuana to be associated 
with reduced length at birth, but it did not 
affect weight or head circumference. Hurd 
et al. (2005) found that exposed fetuses had 
significantly reduced body weight and length, 
even when the data were adjusted to account 
for maternal alcohol consumption and smoking. 
Children prenatally exposed to marijuana
functioned above average on the Bayley Scale 
of Infant Development (BSID) at 9 months, but 
third-trimester marijuana use was associated 
with decreased BSID mental scores. Followup 
assessment of these children at age 10 found that 
prenatal marijuana exposure was associated 
with higher levels of behavior problems 
(Goldschmidt et al. 2000). In a review of existing 
data, Fried and Smith (2001) reported that 
although global IQ is unaffected by prenatal 
marijuana exposure, aspects of executive 
function appear to be negatively associated 
with prenatal exposure in children beyond the 
toddler stage. 
Amphetamine and 
Methamphetamine Use and Birth 
Outcomes 
Exposure to amphetamines in utero has been 
associated with both short- and long-term 
effects, including abnormal fetal growth, 
withdrawal symptoms after birth, and impaired 
neurological development in infancy and 
childhood (Wagner et al. 1998). Both animal and 
human studies have shown that fetal exposure 
to amphetamines increases the risk of reduced 
fetal growth, cardiac anomalies, and cleft lip 
and palate (Winslow et al. 2007). Unfortunately, 
knowledge of the effects of methamphetamine 
during pregnancy is limited. While there is 
evidence of increased rates of premature 
delivery, placental abruption, reduced fetal 
growth, and heart abnormalities, studies 
are confounded by other issues, including 
polysubstance abuse among participants and 
methodological issues in the research design. 
In one study, which took into account several 
confounding variables, fi ndings suggest 
that methamphetamine exposure in utero is 
associated with decreased growth (including 
lower birth weight) and smaller gestational age 
for exposed neonates (Smith et al. 2006). 
Tobacco Use and Birth Outcomes 
Women who smoke tobacco increase their 
chances of ectopic pregnancy (development of a 
fetus outside the uterus), spontaneous abortion, 
premature rupture of membranes, abruptio 
placentae, placenta previa, preeclampsia, 
and preterm delivery. Infants born to women 
who smoke are more likely to have lower birth 
weights and have an increased risk of SIDS 
(Office of the Surgeon General 2001b; Visscher 
et al. 2003). Children of parents who smoke 
heavily can be affected adversely in their 
auditory, language, and cognitive performance; 
hyperactivity and attention defi cit disorders 
are also common, according to the literature 
(Bell and Lau 1995). Studies have also drawn an 
association between maternal smoking during 
pregnancy and disruptive behavior earlier in 
development (NIDA 2008; Wakschlag et al. 
2006; Wakschlag et al. 2002). 
Effects of Alcohol and 
Illicit Drugs on HIV/AIDS 
Status 
People who inject drugs have a high prevalence 
of co-infection with tuberculosis, hepatitis, and 
HIV (Cohn 2002; Martin et al. 2000). Evidence 
suggests that women who inject drugs often 
incur added risk by injecting after men, who 
often procure the drugs and injection equipment 
(Pugatch et al. 2000). According to CDC (2002), 
57 percent of HIV infections among women 
are attributable to use of injection drugs or 
intercourse with a person who injects drugs. 
Some substances make women more vulnerable 
to STDs because of physiological changes. For 
example, women who abuse large amounts of 
alcohol tend to have drier mucous membranes, 
which results in abrasions and small tears that 
allow HIV easier access to the bloodstream 
during intercourse (Norris and Hughes 1996). 
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Douching increases vulnerability to HIV by 
removing protective bacteria (Cottrell 2003; 
Funkhouser et al. 2002). 
Since timely treatment for HIV/AIDS can 
virtually eliminate the chance of a pregnant 
woman passing the infection to her fetus, all 
women with substance use histories should have 
an HIV/AIDS evaluation at the first sign of any 
possible pregnancy. 
Although highly active antiretroviral therapy 
(HAART) has extended survival time, evidence 
suggests that the gains are not equal when 
comparing gender and status as a person who 
uses injection drugs. Poundstone and colleagues 
(2001) concluded that women who inject drugs 
do not benefit as much as men and women 
who do not use injectable drugs. CDC (1998) 
reports that antiretroviral drugs administered to 
pregnant women and their newborns have been 
shown to reduce greatly the risk of perinatal 
mother-to-child HIV/AIDS transmission. 
Aggressive combinations of drugs currently are 
recommended, but the specific regimens that 
can both treat a client’s HIV/AIDS infection 
and reduce perinatal transmission depend on 
many factors. The ability to provide effective 
health care to women who are HIV positive 
can be infl uenced significantly by their use of 
substances and adherence to therapy (Lucas 
et al. 2006). Once women are in treatment, 
counselors need to ensure that they are provided 
with or referred for medical and prenatal 
care as soon as possible to prevent medical 
complications. For more detailed information 
regarding HIV/AIDS, refer to TIP 37 Substance 
Abuse Treatment for Persons with HIV/AIDS
(CSAT 2000c). 
HCV and Women 
The hepatitis C virus (HCV) is the primary 
cause of cirrhosis and liver cancer in United 
States. An estimated 4.1 million people in the 
United States are infected with HCV. Of these, 
80 to 85 percent will develop chronic hepatitis 
C, but the rate is lower for women. In 2006, 
the rate of HCV in women was 0.25 cases per 
100,000 (CDC 2008). 
HCV can remain silent for many years; most 
people infected with chronic hepatitis C thus 
may not be aware that they are infected because 
they are not chronically ill (Heintges and Wands 
1997). For some, the only sign of an infection is 
found in blood test results. A positive result can 
occur when the liver enzyme ALT is abnormally 
high. Women’s ALT levels are naturally lower 
than men’s, yet the cutoff number for abnormal 
liver tests is the same for both sexes. This can 
result in women being misdiagnosed as having 
a normal ALT level. If a woman’s liver enzymes 
are on the high side of normal or she has any 
risk factors for HCV, testing is recommended for 
HCV (Porter 2008). 
Approximately 250,000 women are infected with 
HCV due to blood they received after a cesarean 
section prior to 1992 (Porter 2008). Since 1992, 
screening and regulations on U.S. blood supplies 
ensure that the recipient is free from risks of 
contracting any blood-borne illness. Currently, 
risk factors for contracting HCV are generally 
the same for men and women, yet women are 
at higher risk of contracting HCV from sexual 
contact with an HCV-positive partner, and 
women are more likely to be initiated into drug 
use or share equipment for injection drugs with 
a sexual partner. Below is a list of risk factors 
for acquiring HCV: 
• 	 Injection drug use (56 percent of HCV cases 
in men and women reported in 2006; CDC 
2008). 
• 	 Sexual contact with HCV positive partner 
(0–3 percent for women in monogamous 
heterosexual relationships; the risk increases 
with multiple partners, the presence of a 
sexually transmitted disease, hepatitis B 
virus [HBV], or open sores, cuts, or wounds 
[Porter 2008]; 1–12 percent among female 
prostitutes [The C. Everett Koop Institute 
2008]). 
• 	 Occupational exposure (1.5 percent of HCV 
cases reported in 2006; CDC 2008) through 
the use of razors, needles, nail fi les, a 
barber’s scissors, tattooing equipment, or 
body piercing or acupuncture needles if these 
items are contaminated by blood from an 
infected person. 
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• 	 Perinatal or vertical transmission (5 
percent in children of mothers with HCV 
monoinfection; 18.7 percent rate in mothers 
with HIV/HCV co-infection; Bell et al. 2004). 
Almost one out of four newly diagnosed cases 
of HIV in the United States is a woman, and 
approximately 20 percent of these newly 
diagnosed women with HIV are co-infected 
with HCV (Orenstein and Tsogas 2001). Among 
pregnant and nonpregnant women, HCV and 
HIV co-infection is signifi cantly associated 
with injection drug use (Nikolopoulou et al. 
2005). The rate of HIV/HCV co-infection may 
be as high as 50 to 90 percent for those who 
contracted HIV through injection drug use. HIV 
co-infection with HCV appears to raise the risk 
of mother-to-child transmission to 18.7 percent. 
The risk for transmission from a woman with 
HCV monoinfection to her infant is 5.4 percent 
(Bell et al. 2004). 
Prevention and intervention 
Prevention strategies are gender neutral and 
include screening blood, plasma, organ, tissue, 
and sperm donors; effective infection control 
practices; identification, testing, and counseling 
of at-risk persons; and medical management of 
infected persons (Bell 2004). 
Although this is by no means an overview of 
the disease or its treatment process, a review of 
interventions can prove beneficial when working 
with clients who are infected with HCV. Gender-
specific guidelines for intervention are minimal. 
Early medical intervention is helpful even 
though people infected with HCV infection often 
experience mild symptoms and subsequently 
do not seek treatment. Not everyone with 
hepatitis C needs medical treatment. Treatment 
is determined by HCV genotype, viral load, liver 
enzyme levels, and extent of liver damage. There 
are many elements to consider when undergoing 
treatment for chronic hepatitis C virus. Women 
are slightly more likely to respond favorably 
to HCV treatment; however, there are gender-
specific issues that factor into the decision to 
start treatment. 
Issues of treatment specifi c to 
women 
• 	 Women should not get pregnant during and 
up to 6 months following HCV treatment; for 
those who are in treatment after childbirth, 
breastfeeding should be avoided. 
• 	 Autoimmune conditions occur more often 
in women than men. One of the HCV 
medications, interferon, can aggravate 
autoimmune diseases. 
• 	 Women have less hemoglobin (a component 
of red blood cells that carries oxygen to the 
cells) than men. Menstruating women have 
even lower hemoglobin levels because of 
monthly blood loss, which can sometimes 
cause anemia. HCV-positive women 
undergoing treatment should talk to their 
medical advisor about ribavirin (one of the 
treatment medications for HCV) and its 
connection to hemolytic anemia—a type of 
anemia that causes red blood cells to burst 
before the body has a chance to use them. 
Women, especially menstruating women, are 
vulnerable to this kind of anemia and need to 
be monitored with regular blood tests during 
treatment. 
In general, women are two times more likely 
than men to have depression. Depression 
is a common side effect of HCV treatment 
medications. Some providers recommend 
starting an antidepressant prior to starting 
treatment for HCV (Porter 2005). 
Women are less likely to need HCV treatment 
because they tend to have less severe liver 
damage due to the virus (Highleyman 2005). 
Approximately 3 to 20 percent of clients with 
chronic HCV will develop cirrhosis over a 20- to 
30-year period (CDC 1998). Alcoholic beverage 
consumption accelerates HCV-associated fi brosis 
and cirrhosis. A study by Chen et al. (2007) 
reveals that heavy alcohol use affects females 
more strongly than males, resulting in a higher 
mortality rate. This difference may be due to 
the more detrimental effect of alcohol on the 
progression of liver injury among women than 
among men with a similar level of alcohol use 
(Becker et al. 1996). Current guidelines strongly 
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recommend that HCV patients be vaccinated 
for hepatitis A and B if they have not yet 
been exposed to these viruses, as these would 
radically worsen their liver disease. 
Some ways addiction counselors can contribute 
to treatment are (for review, see Sylvestre 2007): 
• 	 Providing education and lifestyle guidelines. 
• 	 Distributing information on HCV in 
substance abuse treatment programs. 
• 	 Providing information on intervention 
programs such as the Healthy Liver Group. 
The Healthy Liver Group, launched in 2005, 
is an hour-long intervention comprising 
a 30-minute group educational session 
followed by an individualized meeting with 
the attending registered nurse to discuss 
laboratory results (Hagedorn et al. 2007). 
• 	 Teaching coping skills for side effects to 
clients undergoing medical therapy. 
• 	 Promoting self-care by urging clients to 
abstain from alcohol, to get vaccinated for 
hepatitis A and hepatitis B, and to inform 
themselves of HCV and its risk factors. 
• 	 Providing moral support and hope to clients 
of obtaining the best possible results by 
maintaining treatment. 
Accessing screening and care on behalf of 
addicted clients with HCV can take persistence. 
Although the HCV antibody screening test is 
relatively inexpensive, the HCV viral test is not, 
but most county medical clinics and hospitals 
will provide it (Sylvestre 2007). Substance abuse 
treatment providers are more apt to spot the 
signs of depression or mania in those patients on 
medical therapy for HCV. Early detection and 
stabilization of any psychiatric side effect should 
not interrupt the progression of treatment. 
People with a substance use disorder can 
participate successfully in HCV therapy. For 
more information, see the planned TIP Viral 
Hepatitis and Substance Use Disorders (CSAT 
in development j). 
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Overview 
Understanding the extent and nature of a woman’s substance use
disorder and its interaction with other life areas is essential for careful
diagnosis, appropriate case management, and successful treatment.
This understanding begins during the screening and assessment process,
which helps match the client with appropriate treatment services. To
ensure that important information is obtained, providers should use
standardized screening and assessment instruments and interview
protocols, some of which have been studied for their sensitivity, validity,
and accuracy in identifying problems with women.
Hundreds of screening instruments and assessment tools exist. Specifi c 
instruments are available to help counselors determine whether further
assessment is warranted, the nature and extent of a client’s substance
use disorder, whether a client has a mental disorder, what types of
traumatic experiences a client has had and what the consequences
are, and treatment-related factors that impact the client’s response
to interventions. This TIP makes no specific recommendations of
screening and assessment tools for women and does not intend to
present a comprehensive discussion of this complex topic. Rather, the
TIP briefly describes several instruments that providers often use to
examine areas of female clients’ lives. Attention is given to instruments
that have gender-specific normative data or are useful in attending to
the biopsychosocial issues unique to women. Several of the screening
and assessment instruments discussed in this chapter are provided in
Appendix C.
This chapter introduces and provides an overview of current screening
and assessment processes that may best serve women across the
continuum of care. It covers several areas for which to screen, such as
acute safety risk, mental disorders, sexual victimization, trauma, and
eating disorders. The chapter also discusses factors that may infl uence
the overall assessment, and reviews screening for substance abuse and
dependence in settings other than substance abuse treatment facilities.
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It provides information about instruments for 
use by drug and alcohol counselors, primary 
healthcare providers, social workers, and others. 
The assessment section includes general principles 
for assessing women, the scope and structure of 
assessment interviews, and selected instruments. 
Finally, other considerations that apply to 
screening and assessment are discussed, including 
women’s strengths, coping styles, and spirituality. 
The Difference Between 
Screening and Assessment 
The purpose of screening is to determine 

whether a woman needs assessment. The 

purpose of assessment is to gather the detailed 

information needed for a treatment plan that 

meets the individual needs of the woman. 

Many standardized instruments and interview 

protocols are available to help counselors 

perform appropriate screening and assessment 

for women.
 
Screening involves asking questions carefully 
designed to determine whether a more thorough 
evaluation for a particular problem or disor­
der is warranted. Many screening instruments 
require little or no special training to administer. 
Screening differs from assessment in the follow­
ing ways: 
• 	 Screening is a process for evaluating the 
possible presence of a particular problem. 
The outcome is normally a simple yes or no. 
• 	 Assessment is a process for defi ning the 
nature of that problem, determining a 
diagnosis, and developing specifi c treatment 
recommendations for addressing the problem 
or diagnosis. 
Screening and Assessment: 
Factors of Infl uence 
Ethnicity and Culture 
The treatment field depends on tools or 

questionnaires that, for the most part, have 

been found valid and reliable with two 

populations of women—Caucasians and 
African Americans. Although translations of 
some instruments for non–English-speaking 
populations have been made, the validity of the 
adapted instruments is not always documented. 
Women need a thorough explanation of the 
screening and assessment process. Some women 
from diverse ethnic groups may find the process 
threatening, intrusive, and foreign. In some 
cultures, for example, questions about personal 
habits can be considered unnecessarily intrusive 
(Paniagua 1998). Many immigrant women have 
little experience with American medical care 
and do not understand the assessment process. 
Some women may have had negative experiences 
with human service agencies or other treatment 
programs and felt they were stereotyped or 
treated with disrespect. 
Screening and assessment must be approached 
with a perspective that affi rms cultural 
relevance and strengths. An understanding of 
the cultural basis of a client’s health beliefs, 
illness behaviors, and attitude toward and 
acceptance of treatment provides a foundation 
for building a successful treatment program 
for the client. Whenever possible, instruments 
that have been normed, adapted, or tested on 
specific cultural and linguistic groups should 
be used. Instruments that are not normed for 
the population being evaluated can contain 
cultural biases and produce misleading results 
and perhaps inappropriate treatment plans and 
misunderstandings with clients. 
Counselors and intake personnel may hold 
preconceived beliefs concerning the prevalence 
of substance abuse among women from particu­
lar ethnic groups. For example, counselors may 
overlook the need to screen and assess Asian 
women (Kitano and Louie 2002). All assessment 
staff members should receive training about 
the cultural and ethnic groups they serve; the 
appropriate interpersonal and communica­
tion styles for effective interviews; and cultural 
beliefs and practices about substance use and 
abuse, mental health, physical health, violence, 
and trauma. Through training, counselors can 
learn what cultural factors need to be consid­
ered to test accurately. 
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Advice to Clinicians and Administrators: 
Culturally Responsive Screening and Assessment 
For Clinicians: 
• 	 Foremost, instruments should be used that have been adapted and tested on women 
in specific cultural groups and special populations.  
• 	 Even though a woman may speak English well, she may have trouble understanding 
the subtleties of questions on standard assessment tools. 
• 	 Acculturation levels can affect screening and assessment results. A single question 
may need to be replaced with an in-depth discussion with the client or family 
members in order to understand substance use from the client’s point of view. 
• 	 Interviews should be conducted in a client’s preferred language by trained staff 
members or an interpreter from the woman’s culture. 
• 	 It is important to remember that many instruments have not been tested on women 
across cultural groups, and that caution should be taken in interpreting the results. 
Counselors need to discuss the limitations of instruments they use with clients 
(Gopaul-McNicol and Brice-Baker 1998). 
For Administrators: 
• 	 Treatment programs can ask community members, professionals, and other treatment 
staff from culturally diverse communities to assist in tailoring assessment instruments 
and protocols for their clients. CSAT’s planned TIP Improving Cultural Competence in 
Substance Abuse Treatment (CSAT in development a) discusses these issues in greater 
detail. 
Acculturation and 
Language Issues 
Acculturation level may affect screening and 
assessment results. The counselor may need 
to replace standard screening and assessment 
approaches with an in-depth discussion with 
the client and perhaps family members to 
understand substance use from the client’s 
personal and cultural points of view. The 
migration experience needs to be assessed; some 
immigrants may have experienced trauma in 
their countries of origin and will need a sensitive 
trauma assessment. 
Specifically, the counselor may begin by asking 
the client about her country of birth and, if she 
was not born in the United States, the length 
of time she has lived in this country. Several 
screening tools are available to determine gen­
eral acculturation level. The Short Accultura­
tion Scale for Latinos (Marin et al. 1987) is a 
12-item acculturation scale available in English 
and Spanish. Acculturation, as measured by 
this scale, correlates highly with respondents’ 
generation, length of residence, age at arrival, 
and ethnic self-identification. The scale can be 
adapted easily for other groups. Two other use­
ful scales are the Acculturation Rating Scale for 
Mexican Americans II (ARSMA; Cuéllar et al. 
1980) and the Oetting and Beauvais Question­
naire, available at www.casaa.unm.edu, which 
assesses cultural identification for Caucasian 
Americans, Hispanics, American Indians, and 
African Americans. Scales also have been devel­
oped for Asian-American groups (Chung et al. 
2004). 
Counselors should be aware that although a cli­
ent speaks English relatively well, she still may 
have trouble understanding assessment tools in 
English. It is not adequate to simply translate 
items from English into another language. Some 
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words, idioms, and examples do not translate 
directly into other languages but need to be 
adapted. Ideally, interviews should be conduct­
ed in a woman’s preferred language by trained 
staff who speak the language or by professional 
translators from the woman’s culture. Differ­
ences in literacy level may require that some 
clients be screened and assessed by interview or 
that self-administered questions be adapted to 
appropriate reading levels. For women with low 
literacy levels, language comprehension prob­
lems, or visual impairments, screening person­
nel can read the questions to them; however, re­
sults may not be as accurate. Self-administered 
questionnaires should be available in a woman’s 
preferred language if possible. 
Socioeconomic Status 
Counselors may have conscious or subconscious 
expectations based on socioeconomic status. 
Such perceptions have led to failures to diagnose 
drug or alcohol abuse in pregnant middle- and 
upper-class women, with tragic consequences 
for their infants. For example, primary care 
providers are much less apt to ask private 
middle-income patients about their use of 
drugs. Some healthcare providers may fear 
offending their patients by asking them about 
their substance use. Weir and colleagues (1998) 
found that clients with more than a high school 
education are less apt to disclose the use of 
drugs or alcohol during pregnancy. 
Specific Populations: Other 
Noteworthy Considerations 
Cognitive and learning disabilities 
Prior to screening and assessment, the counselor 
should inquire about current or past diffi culties 
in learning, past participation in special 
education, a diagnosis of a learning disability, 
prior involvement in testing for cognitive 
functioning or learning disability, and problems 
related to self-care and basic life management 
skills. 
Depending on the type and severity of the 
disability or impairment, these women will likely 
need more assistance throughout the screening 
and assessment process. Moreover, women 
with developmental disabilities or cognitive 
impairments are more likely to respond to 
items they do not understand by stating “yes” 
or by responding in a manner they think the 
assessment counselor will approve of instead of 
asking for clarifi cation. 
Sexual orientation 
The Institute of Medicine’s (IOM) report on 
lesbian health identifies substance abuse as one 
of the primary heath concerns among lesbians 
(Solarz 1999). While research has concluded 
that the CAGE instrument has similar reliability 
and concurrent validity among lesbian and 
heterosexual women, very few studies have 
addressed the issue of validity and reliability 
in screening and assessment tools for lesbians 
(Johnson and Hughes 2005). Consequently, 
counselors need to cautiously interpret 
screening and assessment results. 
Screening 
Screening often is the initial contact between a 
woman and the treatment system, and the client 
forms her first impression of treatment during 
screening and intake. For women, the most 
frequent points of entry from other systems of 
care are obstetric and primary care; hospital 
emergency rooms; social service agencies in 
connection with housing, child care, disabilities, 
and domestic violence; community mental 
health services; and correctional facilities. How 
screening is conducted can be as important as 
the actual information gathered, as it sets the 
tone of treatment and begins the relationship 
with the client. 
Screening processes always should defi ne a 
protocol or procedure for determining which 
clients need further assessment (i.e., screen 
positive) for a condition being screened and for 
ensuring that those clients receive a thorough 
assessment. That is, a professionally designed 
screening process establishes precisely how 
to score responses to the screening tools or 
questions and what constitutes a positive score 
for a particular possible problem (often called 
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Advice to Clinicians: 
Substance Abuse Screening and Assessment Among Women 
• How screenings and assessments are conducted is as important as the information
gathered. Screening and assessment are often the initial contact between a woman 
and the treatment system. They can either help build a trusting relationship or create 
a deterrent to engaging in further services. 
• Self-administered tools may be more likely to elicit honest answers; this is especially
true regarding questions related to drug and alcohol use. 
• Face-to-face screening interviews have not always been successful in detecting
alcohol and drug use in women, especially if the counselor is uncomfortable with the 
questions. 
• Substance abuse screening and assessment tools, in general, are not as sensitive in
identifying women as having substance abuse problems. 
• Selection of screening and assessment instruments should be examined to determine
if they were developed using female populations. If not, counselors need to explore 
whether or not there are other instruments that may be more suitable to address 
specific evaluation needs.  
a “cutoff” score). The screening protocol details 
the actions taken after a client scores in the 
positive range and provides the standard forms 
for documenting the results of the screening, 
the actions taken, the assessments performed, 
and that each staff member has carried out his 
or her responsibilities in the process. Although 
a screening can reveal an outline of a client’s 
involvement with alcohol, drugs, or both, it 
does not result in a diagnosis or provide details 
of how substances have affected the client’s life. 
The most important domains to screen for when 
working with women include: 
• 	 Substance abuse 
• 	 Pregnancy considerations 
• 	 Immediate risks related to serious 
intoxication or withdrawal 
• 	 Immediate risks for self-harm, suicide, and 
violence 
• 	 Past and present mental disorders, including 
posttraumatic stress disorder (PTSD) and 
other anxiety disorders, mood disorders, 
and eating disorders 
• 	 Past and present history of violence and 
trauma, including sexual victimization and 
interpersonal violence 
• 	 Health screenings, including HIV/AIDS, 
hepatitis, tuberculosis, and STDs 
Substance 
Abuse Screening 
The goal of substance 
abuse screening is to 
identify women who 
have or are developing 
alcohol- or drug-
related problems. 
Routinely, women are 
less likely than men 
to be identifi ed as 
having substance abuse 
problems (Buchsbaum 
et al. 1993); yet, they 
are more likely to 
exhibit signifi cant 
health problems after 
consuming fewer 
substances in a shorter 
Substance abuse 

screening and 

assessment tools, 

in general, are 

not as sensitive in 

identifying women 

as having substance 

abuse problems.
 
period of time. 
Screening for substance use disorders is 
conducted by an interview or by giving a 
short written questionnaire. While selection 
of the instrument may be based on various 
factors, including cost and administration time 
(Thornberry et al. 2002), the decision to use an 
interview versus a self-administered screening 
tool should also be based upon the comfort level 
of the counselor or healthcare professional 
(Arborelius and Thakker 1995; Duszynski et al. 
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 1995; Gale et al. 1998; Thornberry et al. 2002). 
If the healthcare staff communicates discomfort, 
women may become wary of disclosing their full 
use of substances (Aquilino 1994; see also Center 
for Substance Abuse Prevention [CSAP] 1993). 
Many instruments have been developed to 
screen for alcohol consumption, and several 
measures have been adapted to screen for 
specific drugs. While numerous screening tools 
are available, information about the reliability 
and validity of these instruments with women 
is limited. The following listing, while not 
exhaustive, individually reviews tools with 
available gender-specifi c information. 
General Alcohol and Drug 
Screening 
AUDIT 
The Alcohol Use Disorder Identifi cation Test 
(AUDIT; Babor and Grant 1989) is a widely 
used screening tool that is reproduced with 
guidelines and scoring instructions in TIP 26 
Substance Abuse Among Older Adults (CSAT 
1998d). The AUDIT is effective in identifying 
heavy drinking among nonpregnant women 
(Bradley et al. 1998c). It consists of 10 questions 
that were highly correlated with hazardous or 
harmful alcohol consumption. This instrument 
can be given as a self-administered test, or the 
questions can be read aloud. The AUDIT takes 
about 2 minutes to administer. Note: Question 
3, concerning binge drinking, should be revised 
for women to refer to having 4 (not 6) or more 
drinks on one occasion. 
TCUDS II 
The Texas Christian University Drug Screen 
II (TCUDS II) is a 15-item, self-administered 
substance abuse screening tool that requires 
5–10 minutes to complete. It is based in part 
on Diagnostic Interview Schedule and refers to 
Diagnostic and Statistical Manual of Mental 
Disorders, 4th Edition, Text Revision (DSM­
IV-TR; American Psychiatric Association 
[APA] 2000a) criteria for substance abuse 
and dependence. TCUDS II is used widely in 
criminal justice settings. It has good reliability 
among female populations (Knight 2002; Knight 
et al. 2002). This screen, along with related 
instruments, is available at www.ibr.tcu.edu. 
CAGE 
CAGE (Ewing 1984) asks about lifetime alcohol 

or drug consumption (see Figure 4-1). Each 

“yes” response receives 1 point, and the cutoff 
point (the score that makes the test results 
positive) is either 1 or 2. Two “yes” answers 
results in a very small false-positive rate and 
the clinician will be less likely to identify clients 
as potentially having a substance use disorder 
when they do not. However, the higher cutoff of 
2 points decreases the sensitivity of CAGE for 
women—that is, increases the likelihood that 
some women who are at risk for a substance 
problem will receive a negative screening score 
(i.e., it increases the false-negative rate). Note: 
It is recommended that a cutoff score of 1 be 
employed in screening for women. This measure 
has also been translated and tested for Hispanic/ 
Latina populations. 
Figure 4-1 
The CAGE Questionnaire 
• Have you ever felt you ought to Cut down on your drinking [or drug use]? 
• Have people Annoyed you by criticizing your drinking [or drug use]? 
• Have you ever felt bad or Guilty about your drinking [or drug use]? 
• 	 Have you ever had a drink [or used drugs] first thing in the morning (  Eye opener) to steady 
your nerves or get rid of a hangover [or get the day started]? 
Source: Mayfield et al. 1974.
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A common criticism of the CAGE is that it is 
not gender-sensitive—that is, women who have 
problems associated with alcohol use are less 
likely than male counterparts to screen positive 
when this instrument is used. One study of more 
than 1,000 women found that asking simple 
questions about frequency and quantity of 
drinking, coupled with a question about binge 
drinking, was better than the CAGE in detecting 
alcohol problems among women (Waterson and 
Murray-Lyon 1988). 
The CAGE is “relatively insensitive” with 
Caucasian females, yet Bradley and colleagues 
report that it “has performed adequately in 
predominantly black populations of women” 
(1998c, p. 170). Johnson and Hughes (2005) 
conclude that CAGE has similar reliability and 
concurrent validity among women of different 
sexual orientations. The CAGE-AID (CAGE 
Adapted to Include Drugs) modifies the CAGE 
questions for use in screening for drugs other 
than alcohol. This version of the CAGE shows 
promise in identifying pregnant, low-income 
women at risk for heavier drug use (Midanik et 
al. 1998). 
Screening for Tobacco Use 
Similar to other substances, women pay an 
exceptional price for using tobacco. The second 
leading cause of death in women is cancer 
(CDC 2004), with tobacco accounting for 90 
percent of all lung cancers, according to the 
Surgeon General’s Report on Women and 
Smoking (2001). Yet, women are less likely to 
be referred to smoking cessation programs or 
provided smoking cessation products (Steinberg 
et al. 2006). Therefore, screening for tobacco 
use and referral for nicotine cessation should 
be standard practice in substance abuse 
treatment. Counselors can simply screen for 
tobacco use beginning with current and past 
patterns of use, including type of tobacco, 
number of cigarettes smoked per day, frequency 
of use, circumstances surrounding use, and 
specific times and locations. For individuals 
who currently smoke, a more comprehensive 
assessment needs to be completed with 
recommendations incorporated into the 
woman’s treatment plan. 
Women who smoked 
in the month before 
pregnancy are nine
times more likely to
be currently using
either drugs or
alcohol or both while 
pregnant (Chasnoff 
et al. 2001). 
Screening 
Instruments for 
Pregnant Women 
Considering the 
devastating impact 
of substances on the 
developing fetus, routine 
screening for drug, 
alcohol, and tobacco use 
among pregnant women 
is imperative. Face-to­
face screening interviews 
are not always 
successful in detecting 
alcohol and drug use, 
especially in pregnant 
women. However, self-
administered screening 
tools have been found to 
be more likely to elicit 
honest answers (Lessler and O’Reilly 1997; 
Russell et al. 1996; Tourangeau and Smith 
1996). Three screening instruments for use with 
pregnant women are TWEAK, T-ACE, and 5Ps 
Plus (CSAP 1993; Morse et al. 1997). 
TWEAK 
TWEAK (Russell et al. 1991) identifi es pregnant 
women who are at risk for alcohol use (Figure 
4-2). It consists of five items and uses a 7-point 
scoring system. Two points are given for positive 
responses to either of the first two questions 
(tolerance and worry), and positive responses 
to the other three questions score 1 point. A 
cutoff score of 2 indicates the likelihood of risk 
drinking. In a study of more than 3,000 women 
at a prenatal clinic, the TWEAK was found to 
be more sensitive than the CAGE and Michigan 
Alcohol Screening Test (MAST), and more 
specific than the T-ACE (Russell et al. 1996). 
The tolerance question scores 2 points for an 
answer of three or more drinks. However, if the 
criterion for the tolerance question is reduced to 
two drinks for women, the sensitivity of TWEAK 
increases, and the specificity and predictive 
ability decrease somewhat (Chang et al. 1999). 
In comparison with T-ACE, TWEAK had higher 
sensitivity and slightly lower specifi city (Russell 
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Figure 4-2 
The TWEAK Questionnaire: Women 
How many drinks does it take for you to feel high? [Tolerance] (2 or more drinks = 2 points) 
Does your partner (or do your parents) ever Worry or complain about your drinking? (yes = 2 

points)
 
Have you ever had a drink first thing in the morning to steady your nerves or get rid of a 

hangover? (Eye opener) (yes = 1 point)
 
Have you ever Awakened the morning after some drinking the night before and found that you 

could not remember part of the evening? (yes = 1 point)
 
Have you ever felt that you ought to K/cut down on your drinking? (yes = 1 point) 
Source: Morse et al. 1997. 
et al. 1994, 1996). It can also be used to screen 5 points. A total of 2 or more points indicates 
for harmful drinking in the general population risk drinking (Chang et al. 1999). T-ACE has 
(Chan et al. 1993). sensitivity equal to the longer MAST and greater 
than CAGE (Bradley et al. 1998c). It has been 
validated only for screening pregnant womenT-ACE 
with risky drinking (Russell et al. 1994).The T-ACE is a 4-item instrument appropriate 
for detecting heavy alcohol use in pregnant In a study with a culturally diverse population 
women (Sokol et al. 1989). T-ACE uses the A, C, of pregnant women, Chang and colleagues 
and E questions from CAGE and adds one on (1998) compared T-ACE with the MAST (short 
tolerance for alcohol (see Figure 4-3). The fi rst version) and the AUDIT. The study found 
question assesses tolerance by asking if it takes T-ACE to be the most sensitive of the three tools 
more than it used to to get high. A response of in identifying current alcohol consumption, 
two or more drinks is scored as 2 points, and risky drinking, or lifetime alcohol diagnoses 
the remaining questions are assigned 1 point (Chang et al. 1998). Although T-ACE had the 
for a “yes” response. Scores range from 0 to lowest specificity of the three tests, it is argued 
Figure 4-3 
The T-ACE Questionnaire 
How many drinks does it take you to feel high? [Tolerance] (2 or more drinks = 2 points) 
Have people Annoyed you by criticizing your drinking? (yes = 1 point) 
Have you ever felt you ought to Cut down on you drinking? (yes = 1 point) 
Have you had an Eye opener (a drink first thing in the morning) to steady your nerves? (yes = 1 

point)
 
Source: Sokol et al. 1989 
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that false positives are of less concern than false 
negatives among pregnant women (Chang et al. 
1998). 
Prenatal substance abuse screen 
(5Ps) 
This screening approach has been used to 
identify women who are at risk for substance 
abuse in prenatal health settings. A “yes” 
response to any item indicates that the woman 
should be referred for assessment (Morse et 
al. 1997). Originally, four questions regarding 
present and past use, partner with problem, 
and parent history of alcohol or drug problems 
were used (Ewing 1990). However, several 
adaptations have been made, and recently a 
question about tobacco use in the month before 
the client knew she was pregnant was added 
(Chasnoff 2001). Chasnoff and colleagues (2001) 
reported that women who smoked in the month 
before pregnancy were 11 times more likely to 
be currently using drugs and 9 times more likely 
to be currently using either drugs or alcohol or 
both while pregnant. This version, the 5Ps, is 
shown in Figure 4-4. 
In a study evaluating prevalence of substance 
use among pregnant women utilizing this 
screening tool, the authors suggest that it not 
only identified pregnant women with high levels 
of alcohol and drug use but also a larger group 
of women whose pregnancies were at risk from 
smaller amounts of substance use (Chasnoff 
et al. 2005). For a review on how to improve 
screening for pregnant women and motivate 
healthcare professions to screen for risk, refer 
to the Alcohol Use During Pregnancy Project 
(Kennedy et al. 2004). 
Acute Safety Risk Related 
to Serious Intoxication or 
Withdrawal 
Screening for safety related to intoxication and 
withdrawal at intake involves questioning the 
woman and her family or friends (with client’s 
permission) about current substance use or 
recent discontinuation of use, along with past 
and present experiences of withdrawal. If a 
woman is obviously severely intoxicated, she 
needs to be treated with empathy and fi rmness, 
and provision needs to be made for her physical 
safety. If a client has symptoms of withdrawal, 
formal withdrawal scales can be used by trained 
personnel to gather information to determine 
whether medical intervention is required. Such 
tools include the Clinical Institute Withdrawal 
Assessment for Alcohol Withdrawal (Sullivan 
et al. 1989; See Appendix C for specifi c 
Figure 4-4 
5Ps Screening 
Peers: Do any of your friends have a problem with drug or alcohol use?
 
Partner: Does your partner have a problem with alcohol or drugs?
 
Parents: Did either of your parents ever have a problem with alcohol or drugs?
 
Past Use: Before you knew you were pregnant, how often did you drink beer, wine, wine coolers, 

or liquor? Not at all, rarely, sometimes, or frequently?
 
Present Use: In the past month, how often did you drink beer, wine, wine coolers, or liquor? Not 

at all, rarely, sometimes, or frequently?
 
Smoke: How many cigarettes did you smoke in the month prior to pregnancy? 
Source: Morse et al. 1997; Chasnoff et al. 2001 
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Advice to Clinicians: 
At-Risk Screening for Drug and Alcohol Use During Pregnancy 
• 
• 
• 
• 
In screening women who are pregnant, face-to-face screening interviews have not 
always been successful in detecting alcohol and drug use. 
Self-administered tools may be more likely to elicit honest answers; this is especially 
true regarding questions related to drug and alcohol use during pregnancy. 
While questions regarding past alcohol and drug use or problems associated with 
self, partner, and parents will help to identify pregnant women who need further 
assessment, counselors should not underestimate the importance of inquiring about 
previous nicotine use in order to identify women who are at risk for substance abuse 
during pregnancy. 
There are other factors that are associated with at-risk substance abuse among 
women who are pregnant, including moderate to severe depression, living alone or 
with young children, and living with someone who uses alcohol or drugs (for review, 
see Chasnoff et al. 2001). 
information) and the Clinical Institute Narcotic 
Assessment for Opioid Withdrawal (Zilm and 
Sellers 1978). While specific normative data 
are unavailable, it is important to screen for 
withdrawal to assess risk and to implement 
appropriate medical and clinical interventions. 
Not all drugs produce physiological withdrawal; 
counselors should not assume that withdrawal 
from any drug of abuse requires medical 
intervention. Only in the case of opioids, 
sedative-hypnotics, or benzodiazepines (and in 
some cases of alcohol), is medical intervention 
likely to be required. Nonetheless, specifi c 
populations may warrant further assessment 
and assistance in detoxifi cation, including 
pregnant women, women of color, women with 
disabilities or co-occurring disorders, and older 
women. (Review TIP 45 Detoxifi cation and 
Substance Abuse Treatment, [CSAT 2006a], pp. 
105–113.) Specific to women who are pregnant 
and dependent on opioids, withdrawal during 
pregnancy poses specific medical risks including 
premature labor and mortality to the fetus. 
Note: Women who are dependent on opioids 
may misinterpret early signs of pregnancy as 
opioid withdrawal symptoms (review TIP 43 
Medication-Assisted Treatment for Opioid 
Addiction in Opioid Treatment Programs [CSAT 
2005a], pp. 211–224). 
Mental Illness Symptoms and 
Mental Disorders 
Considering that women are twice as likely as 
men to experience mood disorders, excluding 
bipolar and anxiety disorders (Burt and Stein 
2002), all women entering substance abuse 
treatment should be screened for co-occurring 
mental disorders. If the screening indicates the 
possible presence of a disorder, a woman should 
be referred for a comprehensive mental health 
assessment and receive treatment for the co­
occurring disorder, as warranted. Depression, 
anxiety, eating disorders, and PTSD are 
common among women who abuse substances 
(McCrady and Raytek 1993). 
Because certain drugs as well as withdrawal 
symptoms can mimic symptoms of mental 
disorders, the continual reassessment of mental 
illness symptoms is essential to ensure accurate 
diagnosis and treatment planning. TIP 42 
Substance Abuse Treatment for Persons With 
Co-Occurring Disorders (CSAT 2005e) contains 
information on screening and treatment of 
persons with co-occurring substance use and 
mental disorders.
Screening and Assessment 66 
  
 
General mental disorder screening 
instruments 
Symptom screening involves questions about 
past or present mental disorder symptoms that 
may indicate the need for a full mental health 
assessment. Circumstances surrounding the 
resolution of symptoms should be explored. For 
example, if the client is taking psychotropic 
medication and is no longer symptomatic, this 
may be an indication that the medication 
is effective and should be continued. Often, 
symptom checklists are used when the counselor 
needs information about how the client is 
feeling. They are not used to screen for specifi c 
disorders, and responses are expected to change 
from one administration to the next. Symptom 
screening should be performed routinely and 
facilitated by the use of formal screening tools. 
Basic mental health screening tools are available 
to assist the substance abuse treatment team. 
The 18 questions in the Mental Health Screening 
Form-III (MHSF-III) screen for present or past 
symptoms of most mental disorders (Carroll 
and McGinley 2001). It is available at no charge 
from the Project Return Foundation, Inc., 
and is reproduced in TIP 42 Substance Abuse 
Treatment for Persons With Co-Occurring 
Disorders (CSAT 2005e), along with instructions 
and contact information (a Spanish-language 
form and instructions can be downloaded from 
www.asapnys.org/resources.html). MHSF-III 
was developed in a substance abuse treatment 
setting and is referred to as a “rough screening 
device” (Carroll and McGinley 2001, p. 35). 
The Mini-International Neuropsychiatric 
Interview (M.I.N.I.) is a brief, structured 
interview for more than 20 major psychiatric 
and substance use disorders (Sheehan et al. 
2002). Administration time is 15–30 minutes. 
Scoring is simple and immediate. M.I.N.I. can 
be administered by clinicians after brief training 
and by lay personnel with more extensive 
training. M.I.N.I. can be downloaded from www. 
medical-outcomes.com and used for no cost in 
nonprofit or publicly owned settings. 
The Brief Symptom Inventory is a research 
tool that can be adapted for use as a screening 
checklist. This tool’s 53 items measure 9 
primary symptom 
dimensions as well as 3 
global indices of distress. 
Respondents rate the 
severity of symptoms on 
a 5-point scale ranging 
from “Not at all” (0 
points) to “Extremely” 
(4 points) (Derogatis and 
Melisaratos 1983). 
Depression and 
anxiety disorders 
Many formal tools 
screen for depression, 
including the Beck 
Depression Inventory-
II (Beck et al. 1996a, 
b; Smith and Erford 
2001; Steer et al. 
1989), the Center 
for Epidemiologic 
Study Depression 
Scale (Radloff 1977), and the General Health 
Questionnaire—a self-administered screening 
test to identify short-term changes in mental 
health (depression, anxiety, social dysfunction, 
and somatic symptoms)—are available. 
Programs that screen for depression should 
ensure that “yes” answers to these questions 
are followed by a comprehensive assessment, 
accurate diagnosis, effective treatment, and 
careful followup. Asking these two questions 
may be as effective as using longer instruments 
(U.S. Preventive Services Task Force 2002). 
Little evidence exists to recommend one 
screening method over another, so clinicians 
can choose the method that best fi ts their 
preference, the specific population of women, 
and the setting. Refer to TIP 48 Managing 
Depressive Symptoms in Substance Abuse 
Clients During Early Recovery (CSAT 2008) 
for more guidance in working with clients who 
have depressive symptoms. Note: Women who 
are depressed are more likely to report bodily 
symptoms, including fatigue, appetite and sleep 
disturbance, and anxiety (Barsky et al. 2001; 
Kornstein et al. 2000; Silverstein 2002). 
The U.S. Preventive 
Services Task Force 
(2002) recommends 
two simple questions 
that are effective in 
screening adults for 
depression: 
1. 	 Over the past 2 
weeks have you felt 
down, depressed, 
or hopeless? 
2. 	 Over the past 2 
weeks have you felt 
little interest or 
pleasure in doing 
things? 
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An example of an instrument that can detect 
symptoms of anxiety is the 21-item Beck Anxiety 
Inventory (BAI; Beck 1993; Hewitt and Norton 
1993). Among a group of psychiatric patients 
with a variety of diagnoses, women’s BAI scores 
indicated higher levels of anxiety than men’s 
BAI scores. However, the nature of the anxiety 
reported appears similar for women and men 
(Hewitt and Norton 1993). 
Assessing Risk of Harm to Self or 
Others 
Suicidal attempts and parasuicidal behavior 
(nonfatal self-injurious behavior with clear 
intent to cause bodily harm or death; Welch 
2001) are more prevalent among women. The 
greatest predictor of eventual suicide is prior 
suicidal attempts and deliberate self-harm 
inflicted with no intent to die (Joe et al. 2006). 
While substance dependence and PTSD are 
associated with self-harm and suicidal behavior 
(Harned et al. 2006), the most frequent 
diagnoses associated with suicide are mood 
disorders, specifically depressive episodes 
(Kessler et al. 1999). Considering the prevalence 
of suicidal attempts, self-injurious behavior, 
and depression among women, employing safety 
screenings should be a standard practice. From 
the outset, clinicians should specifi cally ask 
the client and anyone else who is providing 
information whether she is in immediate danger 
and whether she has any immediate intention 
to engage in violent or self-injurious behavior. 
If the answer is “yes,” the clinician should 
obtain more information about the nature and 
severity of the thoughts, plan, and intent, and 
then arrange for an in-depth risk assessment 
by a trained mental health clinician. The client 
should not be left alone. 
No tool is definitive for safety screening. 
Clinicians should use safety screening 
tools only as an initial guide and proceed 
to detailed questions to obtain relevant 
information. In addition, care is needed to 
avoid underestimating risk because a woman is 
using substances or has frequently engaged in 
self-injurious behavior. For example, a woman 
who is intoxicated might seem to be making 
empty threats of self-harm, but all statements 
about harming herself or others must be taken 
seriously. Overall, individuals who have suicidal 
or aggressive impulses when intoxicated are 
more likely to act on those impulses; therefore, 
determination of the seriousness of threats 
requires a skilled mental health assessment, plus 
information from others who know the client 
very well. Screening tools and procedures in 
evaluating risk are discussed in depth in TIP 50 
Addressing Suicidal Thoughts and Behaviors in 
Substance Abuse Treatment (CSAT 2009a). 
Substance abuse treatment programs need 
clear mental health referral and follow-up 
procedures so that clients receive appropriate 
psychiatric evaluations and mental health 
care. The American Association of Community 
Psychiatrists (AACP) developed the Level of 
Care Utilization System for Psychiatric and 
Addiction Services (LOCUS) that evaluates 
clients along six dimensions and defines six levels 
of resource intensity. It includes an excellent 
tool for helping the counselor determine the 
risk of harm (AACP 2000; See Appendix C 
for specific information on the LOCUS). The 
potential risk of harm most frequently takes 
the form of suicidal intentions, and less often 
the form of homicidal intentions. The scale has 
five categories, from minimal risk of harm to 
extreme risk of harm. It is available at www. 
comm.psych.pitt.edu/fi nds/LOCUS2000.pdf 
and can be easily adapted for use in treatment 
facilities. 
Trauma and Posttraumatic Stress 
Disorder 
PTSD can follow a traumatic episode that 
involves witnessing, being threatened, or 
experiencing an actual event involving death or 
serious physical harm, such as auto accidents, 
natural disasters, sexual or physical assault, 
war, and childhood sexual and physical 
abuse (APA 2000a). During the trauma, the 
individual experiences intense fear, helplessness, 
or horror. PTSD has symptoms that last 
longer than 1 month and result in a decline in 
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functioning in several life areas, such as work 
and relationships. A diagnosis of PTSD cannot 
be made without a clear history of a traumatic 
event (Figure 4-5 presents sample screening 
questions for identifying a woman’s history of 
trauma). General symptoms of PTSD include 
persistently re-experiencing the traumatic event, 
numbness or avoidance of cues associated with 
the trauma, and a pattern of increased arousal 
(APA 2000a).
Historically, women have not been routinely 
screened for a history of trauma or assessed 
to determine a diagnosis of PTSD across 
treatment settings (Najavits 2004). Among 
women in substance abuse treatment, it has 
been estimated that 55–99 percent have 
experienced trauma—commonly childhood 
physical or sexual abuse, domestic violence, or 
rape (Najavits et al. 1997; Triffl eman 2003). 
Studies have reported that current PTSD rates 
among women who abuse substances range 
between 14 to 60 percent (Brady 2001; Najavits 
et al. 1998; Triffleman 2003). In comparison to 
men, women who use substances are still more 
than twice as likely to have PTSD (Najavits 
et al. 1997). Brief screening is paramount in 
not only establishing past or present traumatic 
events but in identifying PTSD symptoms. Upon 
identification of traumatic stress symptoms, 
counselors need to refer the women for a mental 
health evaluation in order to further assess 
the presenting symptoms, to determine the 
appropriateness of a PTSD diagnosis, and to 
assist in establishing an appropriate treatment 
plan and approach. Brief screenings are used 
to identify clients who are more likely to have 
Figure 4-5 
Questions to Screen for Trauma History 
Responses include yes, no, or maybe. Maybe is used if the client is unsure (e.g., she was too young 
to remember but suspects it happened). If answering these questions is upsetting, the counselor 
may need to stop the interview or redirect the questions, provide support and reassurance to the 
client, and seek consultation from a clinical supervisor. 
In your lifetime, have you suffered any of the following experiences or seen them happen to 
someone else? (Answers are yes, no, or maybe.) 
Child physical abuse (e.g., hitting that caused bruises or injury)• 
Child sexual abuse (e.g., being molested, touched, or forced into any sexual activity)• 
Child neglect (e.g., not enough to eat, inadequate shelter)• 
Domestic violence (e.g., a partner who hurt you physically)• 
Crime victimization (e.g., rape, holdup)• 
Serious accident (e.g., car crash, chemical spill, or fi re) • 
Life-threatening illness (e.g., cancer)• 
Natural disaster (e.g., hurricane, earthquake)• 
War • 
Captivity or kidnapping• 
The• threat of any of the events listed above, even if it wasn’t completed (e.g., threat of being 
raped or murdered) 
Violence by you (e.g., you physically hurt someone, such as abusing a child, murdering • 
someone, or attacking someone with a weapon) 
Other upsetting events (make a list)• 
Source: Najavits 2002a. 
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were not normal and were abusive. Some women 
do not remember the abuse. Therefore, a 
negative finding on abuse at an intake screening 
should not be taken as a final answer. The 
Substance Abuse and Mental Health Services 
Administration (SAMHSA)-funded Women, 
Co-Occurring Disorders and Violence Study 
includes questions about sexual abuse in its 
baseline interview protocol, presented in 
Figure 4-6. In addition, SAMHSA’s CSAT has 
developed a brochure for women that defi nes 
childhood abuse and informs the reader of how 
to begin to address childhood abuse issues while 
in treatment (CSAT 2003a). TIP 36 Substance 
Abuse Treatment for Persons With Child Abuse 
and Neglect Issues (CSAT 2000b) includes 
detailed information on this topic. 
Interpersonal violence 
Studies estimate that between 50 to 99 percent 
of women with substance use disorders have a 
history of interpersonal violence (Miller et al. 
1993; Rice et al. 2001). In one study focused on 
sensitivity and specificity of screening questions 
for intimate partner violence, Paranjape 
and Liebschutz (2003) concluded that when 
three simple screening questions were used 
together, identification of lifetime interpersonal 
violence was effectively identified for women. 
This screening tool, referred as the STaT, is 
presented in Figure 4-7 (p. 72). Along with a 
sample personalized safety plan, additional 
screening tools, including the Abuse Assessment 
Screen (English and Spanish version), Danger 
Assessment, The Psychological Maltreatment 
of Women Inventory, and The Revised Confl ict 
Tactics Scale (CTS2), are available in TIP 25 
Substance Abuse Treatment and Domestic 
Violence (CSAT 1997b). Note: It is important to 
assess for interpersonal violence in heterosexual 
Figure 4-6 
Questions Regarding Sexual Abuse 
Have you ever been bothered or harassed by sexual remarks, jokes, inappropriate touching, or 
demands for sexual favors by someone at work or school? 
• How often has this happened? 
• How old were you when this fi rst happened? 
• Has this happened in the past 6 months? 
Were you ever touched or have you ever touched someone else in a sexual way because you felt 
forced or coerced or threatened by harm to yourself or someone else? 
• How old were you when this fi rst happened? 
• How often did this happen before age 18? 
• How often has this happened since you turned 18? 
• Has this happened in the past 6 months?
 
Did you ever have sex because you felt forced or threatened by harm to yourself or someone else?
 
• How old were you when this fi rst happened? 
• How often did this happen before age 18? 
• How often has this happened since you turned 18? 
• Has this happened in the past 6 months? 
Have you ever had sex when you did not want to in exchange for money, drugs, or other material 
goods such as shelter or clothing? 
• How often has this happened? 
• How old were you when this fi rst happened? 
• Has this happened in the past 6 months? 
Source: SAMHSA n.d. 
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Be aware that 
weight gain during
recovery can be a
major concern and 
a relapse risk factor
for women. 
 
Figure 4-7 
STaT: Intimate Partner Violence Screening Tool 
1. Have you ever been in a relationship where your partner has pushed or Slapped you? 
2. Have you ever been in a relationship where your partner Threatened you with violence? 
3. Have you ever been in a relationship where your partner has thrown, broken, or punched 
Things?
 
Source: Paranjape and Liebschutz 2003. 

and homosexual relationships. 
Interpersonal violence and 

disabilities
 
Women with disabilities are at a signifi cantly 
greater risk for severe interpersonal violence 
and neglect (Brownridge 2006). As a counselor, 
additional screening questions tailored to 
address unique vulnerabilities associated 
with the specific physical disability may be 
warranted. For example, 
• 	 Has anyone ever withheld food or 
medication from you that you asked for or 
needed? 
• 	 Has anyone ever refused to let you use your 
wheelchair or other assistive devices at home 
or in the community? 
• 	 Has anyone ever refused to assist you with 
self-care that you needed, such as getting out 
of bed, using the toilet, or other personal 
care tasks? 
• 	 Has anyone used restraints on you to keep 
you from getting out of bed or out of your 
wheelchair? 
Initial questions about trauma should be general 
and gradual. While ideally you want the client to 
control the level of disclosure, it is important as 
a counselor to mediate the level of disclosure. At 
times, clients with PTSD just want to gain relief; 
they disclose too much, too soon without having 
established trust, an adequate support system, 
or effective coping strategies. 
Preparing a woman to respond to trauma-

related questions is important. By taking the 

time with the client to prepare and explain 
how the screening is done and the potential 
need to pace the material, the woman has 
more control over the situation. Overall, she 
should understand the screening process, why 
the specific questions are important, and that 
she can choose not to answer or to delay her 
response. From the outset, counselors need to 
provide initial trauma-informed education and 
guidance with the client. 
Eating Disorders 
Eating disorders have one of the highest 
mortality rates of all psychological disorders 
(Neumarker 1997; Steinhausen 2002). 
Approximately 15 percent of women in 
substance abuse treatment have had an eating 
disorder diagnosis in their lifetimes (Hudson 
1992). Three eating disorders are currently 
included in the DSM-IV-TR: anorexia nervosa, 
bulimia nervosa, and eating disorder not 
otherwise specified (APA 2000a). Compulsive 
eating, referred to as 
binge-eating disorder, 
is not included as 
a diagnosis in the 
DSM. Currently, it is 
theorized that substance 
use disorders and 
compulsive overeating 
are competing disorders, 
in that compulsive 
overeating (binge­
eating) is not as likely 
to appear at the same 
time as substance use 
disorders. Consequently, 
disordered eating in 
Screening and Assessment 72 
  
Figure 4-8 
General and Specific Screening Questions for Persons With Possible  
Eating Disorders



 
General Screening Questions 
• How satisfied are you with your weight and shape?  
• How often do you try to lose or gain weight? 
• How often have you dieted? 
• What other methods have you used to lose weight? 
Specifi c Screening Questions 
• Have you ever lost weight and weighed less than others thought you should weigh? 
• Have you had eating binges in which you eat a large amount of food in a short period of time? 
• Do you ever feel out of control when eating? 
• Have you ever vomited to lose weight or to get rid of food that you have eaten? 
• What other sorts of methods have you used to lose weight or to get rid of food? 
Source: CSAT 2005e. 
the form of compulsive overeating is more 
likely to appear after a period of abstinence, 
thus enhancing the risk of relapse to drugs and 
alcohol to manage weight gain. 
Bulimia nervosa, characterized by recurrent 
episodes of binge and purge eating behaviors, 
has the highest incidence rates in the general 
population for eating disorders (Hoek and 
van Hoeken 2003), and it is the most common 
eating disorder among women in substance 
abuse treatment (Corcos et al. 2001; Specker et 
al. 2000; APA 2000a). For specifi c information 
regarding the co-occurring disorders of eating 
and substance use disorders, counselors should 
refer to TIP 42 Substance Abuse Treatment for 
Persons With Co-Occurring Disorders (CSAT 
2005e). 
Screening for eating disorders in substance 
abuse treatment is based on the assumption that 
identification of an eating disorder can lead 
to earlier intervention and treatment, thereby 
reducing serious physical and psychological 
complications and decreasing the potential risk 
for relapse to manage weight. Eating disorder 
screenings are not designed to establish an 
eating disorder diagnosis but instead to identify 
the need for additional psychological and 
medical assessments by a trained mental health 
clinician and medical personnel. The EAT-26 
(Garner et al. 1982), or Eating Attitudes Test, 
is a widely used screening tool that can help 
identify behaviors and symptoms associated 
with eating disorder risk (Garner et al. 1998). 
It is recommended that a two-stage process be 
employed using the EAT-26: screening followed 
by a clinical interview. Specifically, if the woman 
scores at or above a cutoff score of 20 on the 
EAT-26, she should be referred for a diagnostic 
interview. For a copy of the screening tool and 
scoring instructions, refer to Appendix C. 
Figure 4-8 lists questions that probe for an 
eating disorder. A woman with an eating 
disorder often feels shame about her behavior, 
so the general questions help ease into the topic 
as the counselor explores the client’s attitude 
toward her shape, weight, and dieting. 
Screening by Healthcare Providers 
in Other Settings 
Healthcare providers such as nurse 
practitioners, physicians, physicians’ 
assistants, and social service professionals have 
opportunities to screen women to determine 
whether they use or abuse alcohol, drugs, or 
tobacco. The most frequent points of entry 
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from other systems of 
care are obstetric and
primary care; hospital 
emergency rooms;
probation offi cer visits; 
and social service
agencies in connection 
with housing, child
care, and domestic 
violence. 
Between 5 and 40 
percent of people
seeing physicians and/ 
or reporting to hospital
emergency rooms for 
care have an alcohol 
use disorder (Chang 
1997), but physicians 
often do not identify, 
refer, or intervene 
with these patients
(Kuehn 2008). Even 

clinicians who often

use the CAGE or other 
screening tools for
certain patients are less 
likely to ask women 
these questions because 
women—particularly older women, women 
of Asian descent, and those from middle and 
upper socioeconomic levels—are not expected 
to abuse substances (Chang 1997). Volk and 
colleagues (1996) found that, among primary 
care patients who were identified as “at risk”  
for alcohol abuse or dependence by a screening 
questionnaire, men were 1.5 times as likely as 
women to be warned about alcohol use and 
three times as likely to be advised to stop or 
modify their consumption. Women may be less 
likely to have problems with alcohol or drugs 
than men (Kessler et al. 1994, 1995); however, 
when women have substance use disorders, 
they experience greater health and social 
consequences. 
Screening must lead to appropriate referrals 
for further evaluation and treatment in order 
to be worthwhile. Missed opportunities can 
be especially unfortunate during prenatal 
care. In one study of ethnically diverse women 
reporting to a university-based obstetrics clinic, 
38 percent screened positive for psychiatric 
disorders and/or substance abuse. However, 
only 43 percent of those who screened positive 
had symptoms recorded in their chart, and only 
23 percent of those screening positive were given 
treatment. This low rate of treatment is of great 
concern, given the untoward consequences of 
substance use for maternal and infant health 
(Kelly et al. 2001). 
To address the disconnection that often happens 
(beginning with the lack of identifi cation of 
substance-related problems of the patient and 
extending to the failure of appropriate referrals 
and brief interventions), SAMHSA has invested 
in the Screening, Brief Intervention, and 
Referral to Treatment Initiative (SBIRT)— 
research, resources development, training, and 
program implementation across healthcare 
settings. Although studies have not focused on 
gender comparisons, SBIRT programs have 
yielded short-term improvements in individual 
health (for review, see Babor et al. 2007).
Specifically, some SBIRT programs on the State 
level have tailored SBIRT to provide assistance 
to pregnant women (Louisiana Department of 
Health and Hospitals 2007). 
Assessment 
The assessment examines a client’s life in 
far more detail so that accurate diagnosis, 
appropriate treatment placement, problem lists, 
and treatment goals can be made. Usually, a 
clinical assessment delves into a client’s current 
experiences and her physical, psychological, 
and sociocultural history to determine specifi c 
treatment needs. Using qualified and trained 
clinicians, a comprehensive assessment enables 
the treatment provider to determine with the 
client the most appropriate treatment placement 
and treatment plan (CSAT 2000c). Notably, 
assessments need to use multiple avenues to 
obtain the necessary clinical information, 
including self-assessment instruments, clinical 
records, structured clinical interviews, 
assessment measures, and collateral information. 
Rather than using one method for evaluation, 
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Advice to Clinicians: 
Mental Health Screening and Women 
• 
• 
• 
• 
• 
• 
Women need to be routinely screened for depressive, eating, and anxiety disorders 
including PTSD. 
Women tend to report higher levels of anxiety and somatic symptoms associated with 
depression. 
Explicit details, especially related to traumatic subject matter that may make a woman 
uncomfortable, are not necessary early in the process. 
For some women, drugs have had a secondary effect and purpose, i.e., weight 
management. Be aware that weight gain during recovery can be a concern and a 
relapse risk factor for women and that clinical and medical issues surrounding body 
image, weight management, nutrition, and healthy lifestyle habits are essential 
ingredients in treatment for women. 
Bulimia nervosa is the most common eating disorder among women in substance 
abuse treatment, and counselors should become knowledgeable about the specifi c 
behavioral patterns associated with this disorder, e.g., compensatory and excessive 
exercise for overeating, routine pattern of leaving after meals, persistent smell of 
vomit on the woman’s breath or in a particular bathroom, taking extra food (from 
dining room), or hoarding food, etc. 
Be aware that women with bulimia nervosa are usually of normal weight. 
assessments should include multiple sources 
of information to obtain a broad perspective 
of the client’s history, level of functioning and 
impairment, and degree of distress. 
Assessment should be a fluid process throughout 
treatment. It is not a once-and-done event. 
Considering the complexity of withdrawal and 
the potential influence of alcohol and drugs 
on physical and psychological functioning, it 
is very important to reevaluate as the client 
engages into recovery. Periodic reassessment 
is critical to determine the client’s progress 
and her changing treatment needs. In addition, 
reassessment is an opportunity to solicit input 
from the client on what is and is not working 
for her in treatment and to alter treatment 
accordingly. 
The following section reviews core assessment 
processes tailored for women, including gender-
specific content for biopsychosocial histories and 
assessment tools that are either appropriate or 
possess normative data for women in evaluating 
substance use disorders and consequences. It 
is beyond the scope of this chapter to provide 
specific assessment guidelines or tools for other 
disorders outside of substance-related disorders. 
The Assessment Interview 
To provide an accurate picture of the client’s 
needs, a clinical assessment interview requires 
sensitivity on the part of the counselor and 
considerable time to complete thoroughly. While 
treatment program staff may have limited time 
or feel pressure to conduct initial psychosocial 
histories quickly, it is important to portray to 
clients that you have sufficient time to devote 
to the process. The assessment interview is the 
beginning of the therapeutic relationship and 
helps set the tone for treatment. 
Initially, the interviewer should explain the 
reason for and role of a psychosocial history. 
It is equally important that the counselor or 
intake worker incorporate screening results 
into the interview, and make the appropriate 
referrals within and/or outside the agency to 
comprehensively address presenting issues. The 
notion that the women’s substance use is not 
an isolated behavior but occurs in response to, 
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Advice to Administrators: 
General Guidelines for Selecting and Using Screening 
and Assessment Tools 
What are the goals of the screening and assessment?• 
Is the screening and assessment process appropriate for the particular setting with• 
women? 
What costs are associated with the screening process; e.g., training, buying the• 
screening/assessment instruments or equipment (computer), wages associated with 
giving and scoring the instrument, and time spent providing feedback to the client 
and establishing appropriate referrals? 
What other staff resources are needed to administer and score the instrument, • 
interpret the results, review the findings with the client, arrange referrals, or establish 
appropriate services to address concerns highlighted in the screening and assessment 
process? 
While screening measures can be completed in just a few minutes, positive screenings• 
involve more work. Does staff see a need for and value of the additional work? 
Did you prepare and train staff? What strategies did you employ to obtain staff or 
administrative buy-in? What other obstacles have you identified if the screening is 
implemented? Have you developed strategies to target their specifi c obstacles? 
Do you have a system in place to manage the results of the screening and assessment• 
process? 
Note: While formal assessment tools are consistently used in research associated 
with substance use disorders, treatment providers and counselors are less likely to 
use formalized tools and more likely to only use clinical interviews (Allen 1991). The 
standardization of formal assessment measures offers consistency and uniformity in 
administration and scoring. If the implementation of these tools is not cost prohibitive 
and staff maintain adherence to administration guidelines, formal assessment tools can 
be easily adopted regardless of diverse experience, training, and treatment philosophy 
among clinicians. Using psychometrically sound instruments can offset clinical bias and 
provide more credibility with clients. 
and affects, other behaviors and areas of her 
life is an important concept to introduce during 
the intake phase. This information can easily 
disarm a client’s defensiveness regarding use 
and consequences of use. 
The focus of the assessment may vary depending
on the program and the specific issues of an
individual client. A structured biopsychosocial
history interview can be obtained by using
The Psychosocial History (PSH) assessment
tool (Comfort et al. 1996), a comprehensive
multidisciplinary interview incorporating
modifications of the Addiction Severity Index
(ASI) designed to assess the history and needs
of women in substance abuse treatment.
Investigators have sought to retain the
fundamental structure of ASI while expanding
it to include family history and relationships,
relationships with partners, responsibilities for
children, pregnancy history, history of violence
and victimization, legal issues, and housing
arrangements (Comfort and Kaltenbach 1996).
PSH has been found to have satisfactory test-
retest reliability (i.e., the extent to which the
scores are the same on two administrations of the
instrument with the same people) and concurrent
validity with the ASI (Comfort et al. 1999).
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Psychosocial and Cultural History 
Treatment programs have their own prescribed 
format for obtaining a psychosocial history 
that coincides with State regulations as well 
as other standards set by Joint Commission 
on Accreditation of Healthcare Organizations 
(JCAHO) and Commission on Accreditation 
of Rehabilitation Facilities (CARF). While 
many States require screening and assessment 
for women, specific guidelines and specifi city 
in incorporating women-specific areas vary 
in degree (CSAT 2007). Note: When using 
information across State standards, the 
following psychosocial and cultural subheadings 
should be included in the initial assessment for 
women, and these areas need to be addressed 
in more depth as treatment continues. Keep in 
mind that the content within each subheading 
does not represent an entire psychosocial and 
cultural history. Only biopsychosocial and 
cultural issues that are pertinent to women 
were included in the list below. 
Medical History and Physical Health: Review 
HIV/AIDS status, history of hepatitis or 
other infectious diseases, and HIV/AIDS risk 
behavior; explore history of gynecological 
problems, use of birth control and hormone 
replacement therapy, and the relationship 
between gynecological problems and substance 
abuse; obtain history of pregnancies, 
miscarriages, abortions, and history of 
substance abuse during pregnancy; assess need 
for prenatal care. 
Substance Abuse History: Identify people who 
initially introduced alcohol and drugs; explore 
reasons for initiation of use and continued use; 
discuss family of origin history of substance 
abuse, history of use in previous and present 
significant relationships, and history of use with 
family members or signifi cant others. 
Mental Health and Treatment History: Explore 
prior treatment history and relationships with 
prior treatment providers and consequences, 
if any, for engaging in prior treatment; review 
history of prior traumatic events, mood or 
anxiety disorders (including PTSD), as well 
as eating disorders; evaluate safety issues 
including parasuicidal behaviors, previous 
or current threats, history of interpersonal 
violence or sexual abuse, and overall feeling of 
safety; review family history of mental illness; 
and discuss evidence and history of personal 
strengths and coping strategies and styles. 
Interpersonal and Family History: Obtain 
history of substance abuse in current 
relationship, explore acceptance of client’s 
substance abuse problem among family and 
significant relationships, discuss concerns 
regarding child care needs, and discuss the 
types of support that she has received from 
her family and/or significant other for entering 
treatment and abstaining from substances. 
Family, Parenting, and Caregiver History: 
Discuss the various caregiver roles she may play, 
review parenting history and current living 
circumstances. 
Children’s Developmental and Educational 
History (applicable to women and children 
programs): Assess child safety issues; explore 
developmental, emotional, and medical needs of 
children. 
Sociocultural History: Evaluate client’s 
social support system, including the level of 
acceptance of her recovery; discuss level of 
social isolation prior to treatment; discuss the 
role of her cultural beliefs pertaining to her 
substance use and recovery process; explore 
the specific cultural attitudes toward women 
and substance abuse; review current spiritual 
practices (if any); discuss current acculturation 
conflicts and stressors; and explore need or 
preference for bilingual or monolingual non-
English services. 
Vocational, Educational, and Military History: 
If employed, discuss the level of support that
the client is receiving from her employer; review
military history, then expand questions to
include history of traumatic events and violence
during employment and history of substance
abuse in the military; assess fi nancial self-
reliance. 
Legal History: Discuss history of custody and 
current involvement with child protective 
services, if any; obtain a history of restraining 
orders, arrests, or periods of incarceration, 
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TIPs that provide assessment information relevant to 
women in specifi c settings: 
TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment Programs,
 
2005 

TIP 44 Substance Abuse Treatment for Adults in the Criminal Justice System, 2005 
TIP 45 Detoxification and Substance Abuse Treatment, 2006 
TIP 49 Incorporating Alcohol Pharmacotherapies Into Medical Practice, 2009b 
Additional TIPs that address assessment strategies and tools for co-occurring 

disorders and interpersonal childhood and adult violence that are highly 

prevalent among women: 

TIP 25 Substance Abuse Treatment and Domestic Violence, 1997 
TIP 36 Substance Abuse Treatment for Persons with Child Abuse and Neglect Issues, 2000 
TIP 42 Substance Abuse Treatment for Persons With Co-Occurring Disorders, 2005 
TIP 50 Addressing Suicidal Thoughts and Behaviors in Substance Abuse Treatment, 2009a 
Planned TIP, Substance Abuse and Trauma, in development h 
if any; determine history of child placement 
with women who acknowledge past or current 
incarceration. 
Barriers to Treatment and Related 
Services: Explore financial, housing, health  
insurance, child care, case management, and 
transportation needs; discuss other potential 
obstacles the client foresees. 
Strengths and Coping Strategies: Discuss the 
challenges that the client has faced throughout 
her life and how she has managed them, review 
prior attempts to quit substance use and identify
strategies that did work at the time, identify 
other successes in making changes in other areas 
of her life. 
Assessment Tools for Substance 
Use Disorders 
Addiction Severity Index (ASI): The ASI 
(McLellan et al. 1980) is the most widely used 
substance abuse assessment instrument in both 
research and clinical settings. It is administered 
as a semi-structured interview and gathers 
information in seven domains (i.e., drug use, 
alcohol use, family/social, employment/fi nances, 
medical, psychiatric, and legal). The ASI has 
demonstrated high levels of reliability and
validity across genders, races/ethnicities, types
of substance addiction, and treatment settings
(McCusker et al. 1994; McLellan et al. 1985;
Zanis et al. 1994; See Appendix C for specifi c 
information on the ASI). 
ASI-F (CSAT 1997c): The ASI-F is an expanded
version of ASI; several items were added
relevant to the family, social relationships, and 
psychiatric sections. Additional items refer to
homelessness; sexual harassment; emotional,
physical, and sexual abuse; and eating disorders.
The supplemental questions are asked after the 
administration of ASI. Psychometric data for
ASI-F are limited. 
Texas Christian University Brief Intake, 
the Comprehensive Intake, and Intake for 
Women and Children: These instruments are 
available electronically and are administered 
by a counselor. The seven problem areas in 
the Brief Intake Interview were derived from 
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the ASI: drug, alcohol, 
medical, psychological,
employment, legal, and 
family/social. Scoring
is immediate, and the 
program generates a
one-page summary of 
the client’s functioning 
in 14 domains (Joe 
et al. 2000). The
Comprehensive Intake 
has an online version for 
women (Simpson and 
Knight 1997; For review, 
visit: http://www.utexas. 
edu/research/cswr/nida/ 
instrumentListing.html).
Drinker Inventory of 
Consequences (DrinC): 
This measurement is 
a self-administered 
Since women are 
more likely to 
experience greater 
consequences earlier 
than men, using 
an instrument that 
highlights specifi c 	
consequences of use 
is crucial.	 
50-item, true-false questionnaire that elicits 
information about negative consequences 
of drinking in five domains: physical,  
interpersonal, intrapersonal, impulse control, 
and social responsibility (Miller et al. 1995). 
This instrument has normative data for women, 
men, inpatient and outpatient, and has good 
psychometric properties. Since women are 
more likely to experience greater consequences 
earlier than men, using an instrument that 
highlights specific consequences of use is crucial.  
A version that assesses drug use consequences 
is also available (Tonigan and Miller 2002). 
For a copy of the assessment tool, scoring, and 
gender profile in interpreting severity of lifetime  
consequences, see Appendix C. 
Available screening and 
assessment tools: Language 
availability 
Figure 4-9 (p. 80) provides available 
information on screening and assessment 
versions in languages other than English. This 
is not an exhaustive list, and counselors and 
administrators should not assume language 
availability is a sign that the instrument is 
appropriate for a particular culture, ethnic, or 
racial group. 
Other Considerations in 
Assessment: Strengths, Coping 
Styles, and Spirituality 
Looking at women’s strengths 
Focusing on a woman’s strengths instead of 
her deficits improves self-esteem and self- 
efficacy . Familiarity with a woman’s strengths 
enables the counselor to know what assets the 
woman can use to help her during recovery. In 
the Woman’s Addiction Workbook (Najavits 
2002a), the author provides a self-assessment 
worksheet that focuses on individual strengths. 
In addition to assessing strengths, coping styles 
and strategies should be evaluated (see Rotgers 
2002). 
Measurements of spirituality and 
religiousness 
Spirituality and religion play an important 
role in culture, identity, and health practices 
(Musgrave et al. 2002). In addition, women 
are more likely to embrace different coping 
strategies (including emotional outlets and 
religion) to assist in managing life stressors 
(Dennerstein 2001). Practices such as 
consulting religious leaders or spiritual healers 
(curanderas, medicine men) and attending 
to spiritual activities (including sweats and 
prayer ceremonies, praying to specific saints or  
ancestors) are common. The consensus panel 
believes it is important that programs assess 
the spiritual and religious beliefs and practices 
of women and incorporate this component into 
their treatment with sensitivity and respect. 
A challenge in determining the effect of 
spirituality on treatment outcomes is how to 
assess the extent and nature of a person’s 
spirituality or religiousness. Several assessment 
tools are available; however, they are more 
often used for research. They include, but 
are not limited to, the Religious Practice and 
Beliefs measurement (CASAA 2004), a 19­
item self-assessment tool that reviews specifi c 
activities associated with religious practices; 
the Multidimensional Measure of Religiousness/ 
Spirituality, an assessment device that examines 
domains of religious or spiritual activity such as 
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 Figure 4-9 
Available Screening and Assessment Tools 
in Multiple Languages 
Instrument Language 
Addiction Severity Index Spanish 
Alcohol Use Disorders Identifi cation Test 
(AUDIT) 
Numerous language versions including Spanish, 
French, German, Russian, Chinese, etc. 
Beck Depression Inventory (BDI) 
Numerous language versions including Spanish, 
French, German, Swedish, Chinese, Korean, etc. 
Brief Symptom Inventory (BSI) Spanish and French 
CAGE 
Numerous language versions including Spanish, 
Flemish, French, Hebrew, Japanese, etc. 
Eating Attitudes Test (EAT-26) 
Numerous language versions including Spanish 
and Japanese 
General Health Questionnaire (GHQ) 
Numerous language versions including Spanish, 
Japanese, Chinese, Farsi, etc. 
Mini International Neuropsychiatric 
Interview (MINI) 
Available in 43 languages including Spanish 
Spiritual Well-Being Scale Spanish 
Texas Christian University Drug Screen II 
(TCUII) 
Spanish 
TWEAK Spanish 
daily spiritual experiences, values and beliefs, 
and religious and spiritual means of coping 
(Fetzer Institute 1999); and the Spiritual Well-
Being Scale, a 20-item scale that examines the 
benefits of spirituality for African-American 
women in recovery from substance abuse 
(Brome et al. 2000; See Appendix C for specifi c 
information on the Spiritual Well-Being Scale). 
Health Assessment and Medical 
Examination 
Because women develop serious medical 
problems earlier in the course of alcohol use 
disorders than men, they should be encouraged 
to seek medical treatment early to enhance 
their chances of recovery and to prevent serious 
medical complications. Health screenings and 
medical examinations are essential in women’s 
treatment. In particular, women entering 
substance abuse treatment programs should be 
referred for mental health, medical, and dental 
examinations. In many cases, they may not have 
had adequate health care because of lack of 
insurance coverage or transportation, absence 
of child care, lack of time for self-care, chaotic 
lifestyle related to a substance abuse, or fear of 
legal repercussions or losing custody of children. 
The acute and chronic effects of alcohol and 
drug abuse, the potential for violence, and other 
physical hardships (e.g., homelessness) greatly 
increase the risk for illness and injury. 
Women may practice behaviors that put them at 
high risk for contracting sexually transmitted 
diseases (STDs) and other infectious diseases 
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Advice to Clinicians: 
General Guidelines of Assessment for Women 
• 	 Similar to the screening process, women should know the purpose of the assessment. 
• 	 To conduct a good quality assessment, counselors need to value and invest in the 
therapeutic alliance with the client. Challenging, disagreeing, being overly invested in 
the outcome, or vocalizing and assuming a specific diagnosis without an appropriate 
evaluation can quickly erode any potential for a good working relationship with the 
client. 
• 	 The assessment process should include various methods of gathering information: 
clinical interview; assessment tools including rating scales; behavioral samples 
through examples of previous behavior or direct observation; collateral information 
from previous treatment providers, family members, or other agencies (with client 
permission); and retrospective data including previous evaluations, discharge 
summaries, etc. 
• 	 Assessment is only as good as the ability to follow through with the 
recommendations. 
• 	 Assessments need to incorporate sociocultural factors that may infl uence behavior 
in the assessment process, interpretation of the results, and compliance with 
recommendations. 
• 	 The assessment process should extend beyond the initial assessment. As the 
woman becomes more comfortable, additional information can be gathered and 
incorporated into the revised assessment. Subsequently, this new information will 
guide the reevaluation of presenting problems, treatment priorities, and treatment 
planning with input and guidance from the client. 
• 	 Reassessments help monitor progress across the continuum of care and can be used 
as a barometer of effective treatment. Moreover, the presenting problems and 
symptoms may change as recovery proceeds. 
(Greenfield 1996). Testing for HIV/AIDS, 
hepatitis, and tuberculosis is important; 
however, it is as essential to have adequate 
support services to help women process test 
results in early recovery. Anticipation of the 
test results is stressful and may place the client 
at risk for relapse. Residential centers may 
offer medical exams onsite, but outpatient 
service providers may need to refer patients 
to their primary care provider or other 
affordable health care to ensure that each 
client has a thorough medical exam. Healthcare 
professionals may benefit in using the Women-
Specific Health Assessment (Stevens and Murphy 
1998), which assesses health and wellness and 
addresses gynecological exams, HIV/AIDS, drug 
use, STDs, pregnancy/child delivery history, 
family planning, mammography, menstruation, 
disease prevention, and protection behaviors. 
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5 Treatment 
Engagement, 
Placement, and 
Planning 
Overview 
Women often encounter numerous obstacles and barriers prior to and 
during the treatment process. While these hurdles may not be entirely 
unique to women, they are often more common for women due to the 
myriad pressures associated with assuming various caregiver roles, 
intrinsic socioeconomic and health conditions (particularly for women 
with substance use disorders), and societal bias and stigma associated 
with substance abuse. These challenges often interfere with treatment 
initiation and engagement. 
This chapter is devoted to the exploration of treatment barriers as 
well as to the engagement strategies conducive to supporting treatment 
initiation for women. Considerations in treatment placement and the 
importance of client involvement are reviewed. The chapter ends 
with an overview of American Society of Addiction Medicine (ASAM) 
placement criteria for each treatment level with emphasis on issues 
specific to women, pregnant women, and women and children. 
Barriers to Treatment Engagement 
Making a decision to change is an essential step toward fulfi lling any 
goal, but is only one ingredient of a successful outcome. Many times, 
the idea of making a change is shortsighted: How often has a decision 
been made without looking beyond the initial necessity or enthusiasm 
for the change? To support change across time, obstacles need to be 
anticipated and strategies need to be developed either to decrease the 
occurrence of the barriers or to find alternative routes around the 
potential obstacles. 
Treatment Engagement, Placement, and Planning 83 
  
 
 
 
 
 
 
Barriers to treatment are not exclusive to 
women (for review, see Appel et al. 2004), 
yet identifying potential challenges and 
obstacles can help enable successful treatment 
engagement and outcome. Historically, women 
have identified multiple factors as barriers to 
entering treatment, to engaging and continuing 
the utilization of treatment services across 
the continuum of care, and in maintaining 
connections with community services and self-
help groups that support long-term recovery (see 
Figure 5-1 for an overview of barriers identifi ed 
in the Substance Abuse and Mental Health 
Services Administration’s (SAMHSA’s) National 
Survey on Drug Use and Health [NSDUH]). 
While the identification of barriers is essential 
to effective case management and treatment 
planning, it is equally important to develop 
specific strategies to address each barrier as 
early as possible. As highlighted in the Center 
for Substance Abuse Treatment’s (CSAT’s) 
Comprehensive Substance Abuse Treatment 
Model for Women and Their Children (for 
review, see Appendix B; HHS 2004), strategies 
to overcome these barriers need to focus on 
three core areas: clinical treatment services, 
clinical support services, and community 
support systems. Without a proactive plan to 
address barriers, women will not be as able 
to engage in or benefit from substance abuse 
treatment. 
At the outset, barriers may exist on several 
levels: 
• 	 Intrapersonal: Individual factors including 
health problems, psychological issues, 
cognitive functioning, motivational status, 
treatment readiness, etc. 
• 	 Interpersonal: Relational issues including 
significant relationships, family dynamics, 
support systems, etc. 
• 	 Sociocultural: Social factors including 
cultural differences; the role of stigma, bias, 
and racism; societal attitudes; disparity 
in health services; attitudes of healthcare 
providers toward women; and others. 
• 	 Structural: Program characteristics 
including treatment policies and procedures, 
program design, and treatment restrictions. 
• 	 Systemic: Larger systems including Federal, 
State, and local agencies that generate 
public policies and laws; businesses 
including health insurance companies; and 
environmental factors such as the economy, 
drug trafficking patterns, etc. 
Intrapersonal Obstacles 
Various individual factors impede interest in 
and commitment to entering treatment. The 
anticipation of not being able to use substances 
to cope with stress, to manage weight, or to deal 
with symptoms associated with other mental 
disorders creates considerable apprehension in 
making a commitment to treatment. While the 
level of motivation and the degree of treatment 
readiness may also obstruct a woman’s 
commitment to treatment (Miller and Rollnick 
2002), there are other individual characteristics 
that may serve as a barrier to treatment, 
including feelings related to previous treatment 
failures, feelings of guilt and shame regarding 
use and behavior associated with use, fear of 
losing custody of children if the drug or alcohol 
problem is admitted and treatment is sought, 
feelings of helplessness, and a belief that change 
is not possible (Allen 1995; Greenfi eld 1996). 
Moreover, health issues can serve as a powerful 
roadblock for women. Depending on the 
medical diagnosis and severity of the disorder, 
women may encounter difficulties in accessing 
treatment, securing appropriate services, and 
coordinating medical and substance abuse 
treatment needs. Many women neglect their 
health while they are actively using substances, 
hence treatment entry may be delayed or 
difficult to coordinate due to the additional 
burden imposed by health issues (including 
HIV/AIDS, viral hepatitis and other infectious 
diseases, mental disorders, and gynecological 
and obstetric needs). Thus, poor physical health 
may hinder entry into treatment (Jessup et al. 
2003). 
Interpersonal Obstacles 
Because women are usually the primary 
caregivers of children as well as of other 
family members, they are often unable or not 
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Figure 5-1 
Percentages of Reasons for Not Receiving Substance Use Treatment in 
the Past Year Among Women Aged 18 to 49  Who Needed Treatment 
and Who Perceived a Need for It: 2004–2006 
Not Ready to Stop Using 
Cost/Insurance Barriers 
Social Stigma 
Did Not Feel Need for Treatment/Could 
Handle the Problem without Treatment 
Did Not Know Where to Go for Treatment 
Did Not Have Time 
Treatment Would Not Help 
Other Access Barriers 
0% 10% 20% 30% 40% 
15.5 
4.7 
2.7 
15.7 
13.2 
28.9 
34.4 
36.1 
Sources: SAMHSA 2004, 2005, 2006. 
encouraged to enter and remain in treatment. 
Also, sometimes their families and friends are 
involved with substance use and abuse. Further, 
women may share a social network in which 
drug or alcohol use is a central activity. This 
group of family and friends may see no benefi t 
in and offer no encouragement for becoming 
alcohol and drug free (Amaro and Hardy-
Fanta 1995; Finkelstein 1993; Salmon et al. 
2000). While women report fear of losing their 
partner during treatment, they are particularly 
vulnerable to losing their partner upon entering 
treatment (Lex 1991). In addition, women 
generally fear family or partner reactions or 
resistance to asking for help outside the family. 
Sociocultural Obstacles 
Women are more stigmatized by alcohol and 
illicit drug use than men, being characterized 
sometimes as morally lax, sexually promiscuous, 
and neglectful as mothers. In addition, women 
who have children often fear that admitting 
a substance use problem will cause them to 
lose custody of their children. They worry 
that they will be perceived as irresponsible or 
neglectful—as “bad mothers” if they admit to 
substance abuse or dependence. These fears 
and stereotypes compound a woman’s shame 
and guilt about substance use (Finkelstein 1994) 
and subsequently interfere with help-seeking 
behavior. 
To compound the issue, women in some cultural 
groups experience more negative attitudes 
toward their substance use in general and 
may express more difficulty in engaging in 
help-seeking behavior and treatment services 
based on gender roles and expectations. For 
example, Asian women, in conjunction with 
cultural practices and level of acculturation, 
may have considerable difficulty in engaging 
in mix-gender groups due to the value placed 
upon male offspring, gender role expectations, 
and patriarchal family hierarchy (Chang 2000). 
African-American and Native-American women 
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are likely to mistrust 
treatment services. 
Specifi cally, Jumper 
Thurman and Plested
(1998) reported that 
Native-American women
list mistrust as one of 
the primary barriers to
engaging in treatment 
services. A more recent 
study evaluating barriers 
among African-American 
women identifi ed staff 
attitudes as a signifi cant 
obstacle in maintaining 
treatment engagement 
and retention (Roberts 
and Nishimoto 2006). 
The barriers 	
that exist before 
treatment are often 
the same obstacles 
that interfere 
with successfully 
completing treatment 
or maintaining 
abstinence.	 Similar to men, women 
may face language and 
cultural barriers that 
impede involvement or retention in substance 
abuse treatment. Women whose fi rst language 
is not English may have language diffi culties 
(Mora 2002). Women with specific needs or from  
specific groups can face social indifference, lack  
of culturally appropriate programming, and 
limited cultural competence among staff. For 
example, lesbians who are seeking treatment 
may not trust the service provider or treatment 
staff to appropriately handle their personal 
information in a group setting––fearing their 
sexual orientation will be prematurely disclosed. 
Structural Obstacles 
According to SAMHSA’s 2005 National Survey 
of Substance Abuse Treatment Services, 87 
percent of these programs accepted women as 
clients, but only 41 percent provided special 
programs or groups for women. Overall, only 
17 percent of treatment facilities offered groups 
or programs for pregnant or postpartum women 
(SAMHSA 2006). Being responsible for the 
care of dependent children is one of the biggest 
barriers to women entering treatment (Wilsnack 
1991). Women who do not have access to a 
treatment program that provides child care or 
who cannot arrange alternative child care may 
have to choose between caring for their children 
or entering treatment. 
Unfortunately, few residential programs have 
provisions that allow mothers to have their 
children with them, and outpatient programs 
often do not provide services for children or 
child care (Drabble 1996; Finkelstein 1994; 
Finkelstein et al. 1997). Only 8 percent of 
substance abuse treatment facilities provided 
child care in 2003, and only 4 percent provided 
residential beds for clients’ children (SAMHSA 
2004). Even when children are accepted into 
residential treatment, programs often impose 
age restrictions and limit the number of children 
a mother is permitted to bring to treatment. 
Treatment resources for pregnant women 
who abuse substances are also scarce. Few 
programs can simultaneously combine the 
necessary prenatal care with substance abuse 
treatment and services for older children 
(Amaro and Hardy-Fanta 1995; Finkelstein 
1993). Finkelstein (1993) stresses that the major 
barriers to providing resources for pregnant 
women are based on administrative concerns 
about medical issues for mothers, infants, and 
children; fear of program liability; inability to 
care for infants and lack of services for other 
children while mothers are in treatment; lack 
of financial resources; and limited staff training  
and knowledge about pregnancy and substance 
use. 
Substance abuse treatment providers may 
not fully understand the needs and the types 
of interventions most conducive to assisting 
women in recovery. Vannicelli (1984) found that 
treatment staff attitudes and unsubstantiated 
myths about women actually may act as barriers 
to successful treatment completion among 
women. In addition, programs may lack cultural 
competence in addressing treatment issues for 
women from different cultural or language 
backgrounds; thus ethnic women may be 
reluctant to seek treatment if treatment staff or 
the programs feel foreign, judgmental, hostile, 
or indifferent. 
Even women who are highly motivated for 
treatment face additional program barriers 
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that may produce significant challenges. These 
barriers include waiting lists, delayed admission, 
limited service availability, and preadmission 
requirements (e.g., paperwork requirements, 
detoxification). Other barriers are related to 
program structure, policies, and procedures 
and include program location, lack of case 
management services, limited funding sources, 
and lack of transportation (Wechsberg et al. 
2007). Because women are more likely to be 
poor, their ability to obtain transportation may 
make it difficult to receive treatment (Lewis et 
al. 1996). Also, women may have to travel with 
their children and use public transportation 
to reach treatment agencies; this can be a 
hindrance for women in rural areas and for 
those who have limited income. 
Treatment services continue to struggle to 
effectively broaden the scope of clinical services, 
secure adequate resources, and adopt gender-
responsive policies to address co-occurring 
disorders. While more programs have endorsed 
trauma-informed services in conjunction with 
programming for women, the coordination and 
integration of these specific services remains 
limited. In addition to the barriers mentioned 
above, others may exist regarding compliance 
with the Americans with Disabilities Act, such 
as no translators for women who are deaf, lack 
of materials for individuals who are visually 
impaired, and lack of treatment program 
policies and procedures and acceptance of 
women who are using methadone maintenance. 
Systems Obstacles 
Many women in need of treatment are involved 
in multiple social service systems that have 
different expectations and purpose. According 
to Young and Gardner (1997), the co-occurrence 
of a substance use disorder and involvement 
in the child welfare system ranges from 50 to 
80 percent. Moreover, collaboration among 
substance abuse treatment, child welfare, 
and welfare reform systems is challenging and 
often not integrated because of differences in 
timetables, definition of clients, complexity of 
client needs, staff education and training, and 
funding streams (Goldberg 2000; Young et al. 
1998). 
Services may be fragmented, requiring a woman 
to negotiate a maze of service agencies to obtain 
assistance for housing, transportation, child 
care, substance abuse treatment, vocational 
training, education, and medical care. In 
addition, many agencies have requirements that 
conflict with each other or endorse repetitive 
intake processes, including different forms that 
gather the same information. Overall, these 
simultaneous demands can discourage a woman, 
particularly when seeking treatment or during 
early recovery. 
Women who have substance use disorders often 
fear legal consequences. In entering treatment, 
they sometimes risk losing custody of their 
children as well as public assistance support 
(Blume 1997). Likewise, women who have 
substance use disorders often fear prosecution 
and incarceration if they seek treatment during 
pregnancy. The public debate over privacy and 
the fetus’s right to be born free from harm fuels 
a legal focus on pregnant women who smoke, 
drink alcohol, or use illicit drugs. “These 
conflicts have impeded the diagnosis of women 
with substance abuse problems, the availability 
of services, and access to appropriate care” 
(Chavkin and Breitbart 1997, p. 1201). 
Treatment Engagement 
Strategies 
Treatment engagement approaches are 
important regardless of gender, yet women 
are likely to benefit from services that support 
the initiation of treatment and address the 
diverse challenges that often hamper treatment 
involvement. Engagement services include 
an array of strategies that begin in the initial 
intake and can extend across the continuum of 
care. Ultimately, they are designed to promote 
appropriate access to treatment, to increase 
treatment utilization, to promote treatment 
retention, and to enhance treatment outcome. 
Promising engagement practices have evolved 
by integrating and centralizing services to 
meet the wide range of treatment needs and 
social services for women and children (Niccols 
and Sword 2005). Today, some programs and 
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Challenges in Maintaining a Therapeutic Alliance: 
Child Welfare and Issues of Confi dentiality 
State law can require substance abuse treatment providers to report individuals for child abuse 
and neglect and to supersede Federal confidentiality laws that cover substance abuse treatment. 
It is critical, therefore, that admissions staff, program materials, and counselors clearly present 
and discuss the limits of confidentiality as regulations require. Without this explicit discussion, 
women in treatment may have questions and feel uneasy with regard to mandated reporting. For 
instance, when counselors intervene to protect a client’s children, this may seem contradictory to 
the client and raise questions about confi dentiality. 
A great barrier to treatment for women is fear of losing their children, a fear that engenders 
intense mistrust on the part of clients who are mothers. Therapeutic alliance and trust are vital 
to the treatment process, yet treatment providers must protect children. To resolve this, women 
must understand that although providers will report their concerns for the safety of children, 
providers are advocates for the women and their families (CSAT 1996; Lopez 1994; U.S. 
Department of Health and Human Services, Office for Civil Rights 2002). 
communities provide very formal strategies 
such as comprehensive case management and 
incentive programs to promote engagement 
(Jones et al. 2001). Other engagement 
strategies include more specific services such 
as transportation and escorts to appointments, 
phone calls to initiate services and to remind 
clients of appointments, and child care during 
scheduled appointments or sessions (for review, 
see Comfort et al. 2000). 
Women who are offered services during the 
intake period are more likely to engage in similar
services throughout the treatment process than 
women from a comparison group (Comfort et al. 
2000). Three core engagement strategies that are
particularly beneficial for women are outreach 
services, pre-treatment intervention groups, and
comprehensive case management. 
Outreach Services 
Women are more likely to gain awareness of 
substance abuse treatment if outreach services 
are implemented. Outreach and engagement 
services can be clinically effective in increasing 
the likelihood of entering substance abuse 
treatment, particularly for those individuals 
who are less likely to access treatment services 
(Gottheil et al. 1997). Effective outreach 
programs, such as the one described in Figure 
5-2 (p. 91), are designed to connect women to 
substance abuse treatment regardless of point 
of service entry. For example, programs that 
address domestic violence, HIV/AIDS, or crisis 
intervention can be a vital conduit for helping 
women take the first step in connecting to  
substance abuse services. 
Gross and Brown (1993) outlined three major
components of outreach: (1) identifying a
woman’s most urgent concerns and addressing 
those first, until she is ready to take on other  
issues; (2) empathizing with the woman’s fears 
and resistances, while assisting her in following 
through on commitments; and (3) assisting the 
woman in negotiating the human service system, 
particularly when the decision to seek drug 
or alcohol treatment is stymied by the lack of 
adequate, appropriate, or accessible programs 
or when relapse alienates the woman from 
institutional connections. Although outreach
appears to benefit women—in that they are  
more likely to initiate contact with treatment
providers—women’s response to outreach 
services appears related to level of readiness,
history of trauma, and degree of support. For
instance, Melchior et al. (1999) reported that
women who have a history of trauma are more
reluctant to follow through with referrals than
men. 
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Clinical Tools and Activities 
Helping Women Overcome Barriers to Treatment 
Strategy: Success Stories 
To counter stigma, counselors might provide clients with stories or information about women 
who have achieved and maintained recovery, such as Marty Mann (www.ncadd.org) or Betty 
Ford. These stories can be used to stimulate group discussions or could be a part of regular 
client readings. 
Strategy: Barriers to Treatment Assessment Tool 
Counselors can gain significant information pertaining to current, potential, or perceived 
barriers through evaluation. Beyond a comprehensive psychosocial history, counselors and 
administrators can gain insight into the current obstacles to treatment (for review, see Allen’s 
Barriers to Treatment, Appendix D). 
Strategy: Decisional Balancing Exercise 
The decisional balancing exercise was designed to identify cognitive appraisals associated with 
benefits and costs of substance use (Cunningham et al. 1997). Both cognitive–behavioral therapy 
and motivational interviewing endorse this strategy. By easily adapting this activity to analyze 
pros and cons associated with entering treatment or not entering treatment, counselors are more 
likely to discover barriers that were not identified in the initial assessment. Counselors may 
want to demonstrate the activity by using examples, such as the pros and cons of going on a diet 
or not smoking. This exercise is not a simple pros-and-cons list for one side of the argument, 
but rather it involves looking at the benefits and costs for both sides of the argument; e.g., pros 
and cons for going on a diet as well as pros and cons for not going on a diet. This is an important 
aspect of this exercise. While many issues can be identified with one side of the argument, there 
are often other subtle issues that are acknowledged by discussing both sides of the argument. 
Following is the format for the decisional balancing exercise involving the pros and cons of 
entering or not entering substance abuse treatment. 
Pros (Benefi ts) Cons (Costs) 
Entering 
Treatment 
Better role model for my children 
Knowing that I can quit 
Maybe I can do some things that I 
haven’t been able to do while I have 
been using, e.g., working toward a 
GED 
Boyfriend may leave 
Don’t like other people 
watching my children 
Not Entering 
Treatment 
Don’t have to think about my use 
Don’t have to worry about leaving 
my family 
Can continue to use 
May end up having more 
legal problems 
May lose my children 
Not HIV positive now, but 
it may happen if I continue 
to use 
Strategy: Finishing the Story Exercise 
Counselors can “reframe” a woman’s misgivings about treatment so she may see that the feared 
outcome of seeking or staying in treatment is, in reality, the likely outcome of ending or not 
starting treatment. For example, a woman who fears she will lose her children if she enters or 
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Clinical Tools and Activities 
Helping Women Overcome Barriers to Treatment (continued) 
stays in treatment should be asked to look into the future. This exercise might clarify for her 
that continued addiction virtually guarantees that she will lose her children in the long run, 
whereas treatment and recovery will most likely ensure a long-term and stable relationship with 
her children. By asking the woman to imagine how her story will end if she continues to use 
substances, she is less likely to glorify her current use and more likely to withstand the common 
hassles associated with initiating and engaging in treatment. 
Strategy: Caregiver Portrait 
Women typically assume caregiver roles that may prevent, complicate, or interfere with 
treatment. They may feel they should not leave their spouse or significant other and fear the 
consequences of doing so. In entering treatment, they may express worry because they carry the 
burden of primary caretaker for their parents, children, or other relatives. They may feel that 
they are being disloyal to friends and family members for leaving them—believing the message 
that their substance abuse problem is “not that bad.” Women may also maintain primary 
financial responsibilities for housing and food for others and fear they will not be able to provide 
support during treatment. In addition, they may worry about child care during treatment 
regardless of treatment level. Hence, beyond identifying these concerns and potential barriers, 
it is important to provide a way to discuss these as well as to determine their level of importance 
based on their perception. 
In a group setting, first introduce the idea that everyone has specific and perceived obstacles 
that can interfere with treatment and it is important to give a voice to these challenges. Next, 
state that at least one or two people will have an opportunity to create a visual picture of these 
obstacles—similar to taking a family picture. Next, ask a woman to identify each current or 
potential obstacle to treatment and assign each obstacle to a particular group member. Emphasize 
to group members that if they are selected to participate, they don’t need to say anything in this 
assigned role. This decreases anxiety and hesitancy in participating. 
After the obstacles are assigned, ask the client to arrange the obstacles (group members) as if 
she were a photographer setting up a family portrait. Remind her to arrange (only verbally 
directing other group members) the portrait in one area of the room according to how important 
she perceives the obstacles, e.g., placing the most challenging or fearful barriers in front of 
others. Next, have the client discuss each obstacle and the rationale for her placement. As the 
exercise unfolds, obstacles may end up being rearranged in the picture. In addition, counselors 
may want to help the client identify feelings related to specific obstacles in the picture by walking 
around the portrait. Other strategies may be used in conjunction with this activity including 
problemsolving, cognitive restructuring, or motivational interviewing strategies. However, it 
is often best to keep it simple and to encourage other group members to do the same exercise. 
You can involve the entire group through discussion or by using a paper-pencil drawing that 
demonstrates their barriers. While this exercise is ideal for group, you can modify it by using a 
paper-pencil drawing for individual sessions. 
Note: To reinforce appropriate boundaries, remind participants not to touch others during the 
exercise. 
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Pretreatment Intervention Groups	 that brief interventions are not consistently 
helpful for women (Chang 2002), more specifi c 
Early identification and intervention may research is needed to examine differences
prevent more significant alcohol- and drug- in factors that influence early intervention 
related consequences. Pretreatment intervention outcomes, including client-matching studies
groups are typically designed to initially provide targeting gender. 
personalized or structured feedback to clients 
about their alcohol and drug use, to provide 
information regarding available treatment Case Management 
services and treatment processes, and to utilize Comprehensive case management helps bridge 
strategies to enhance motivation and to decrease the gap between services and agencies. It is 
alcohol and drug use. Specific to women, based on the premise that services need to 
pretreatment groups are designed to address match the client’s needs rather than force the 
certain psychosocial barriers, including the client to fit into the specific services offered 
stigma that is associated with women’s substance by the agency. With the wide range of services 
use. Similar to frequent misconceptions held often warranted for most women (especially 
by clients that detoxification is treatment, for women who are pregnant or who have 
pretreatment can be perceived as treatment 	 children), comprehensive case management that 
rather than an initial step. This is particularly involves medical and social case management is 
the case with women who are either reluctant an essential ingredient (Sorensen et al. 2005). 
or suspicious to use treatment services or who According to Brindis and Theidon (1997), 
are unable to use treatment services at the time case management serves several functions and 
(Wechsberg et al. 2007). While research reports provides numerous services for the client, 
Figure 5-2 
PROTOTYPES 
The PROTOTYPES Outreach Program in Culver City, California, is a pretreatment program 
that helps women form therapeutic alliances by providing outreach services that help women 
enter treatment. 
PROTOTYPES began in 1987 in Los Angeles County with outreach to women who used 
substances and were at risk for HIV/AIDS. The pretreatment program staff grew to include more 
than two dozen outreach workers. PROTOTYPES staff see outreach as a strategy of sustained 
contact and support that helps women move from contemplation to action. 
Outreach workers learned that even though PROTOTYPES provided a healing and 
nurturing environment, a large treatment program of this type could be frightening to 
women contemplating treatment, especially women coming from the streets or other diffi cult 
environments. To allay their fears, women were brought in for visits before they entered 
or committed to enter the residential treatment program. In these visits, the women had an 
opportunity to talk to counselors and other clients, return home, and revisit at will. Every effort 
was made to make them feel comfortable. The workers learned that it was best that women enter 
treatment on their own schedules and terms. 
Once in treatment, a woman maintained a relationship with her outreach worker, who usually 
conducted group sessions in the residential setting. The client decided when to move her primary 
therapeutic relationship from the outreach worker to the in-house counselor, and the outreach 
worker could withdraw gradually. If a woman did not wish to return to her home community 
following residential treatment, the outreach worker helped her settle into a new community 
(Melchior et al. 1999). 
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including outreach, needs assessment, planning 
and resource identification, service linkages, 
monitoring and ongoing reassessment, and 
client advocacy. In recent years, communities 
and agencies have shown considerable progress 
in developing formal linkages, protocols, 
and integrated care systems. To date, case 
management services are key to overseeing 
the appropriate referral and utilization of 
services. According to OAS (SAMHSA 2004), 
approximately 55 percent of facilities provide 
assistance with obtaining social services, 43 
percent provide assistance in locating housing, 
and 69 percent provide case management 
services. For an in-depth review, see TIP 
27 Comprehensive Case Management for 
Substance Abuse Treatment (CSAT 1998a). 
Research sheds light on the potential value of 
case management, in that it may be particularly 
useful for individuals with complex problems 
(Havens et al. 2007; Morgenstern et al. 2003). 
Morgenstern and colleagues (2006) completed 
a study on intensive case management with 
women receiving Temporary Assistance for 
Needy Families (TANF). The results show that 
women assigned to intensive case management 
had significantly higher levels of substance 
abuse treatment initiation, engagement, and 
retention in comparison to women who received 
only screening and referral. In addition, alcohol 
and drug abstinence rates were higher and 
length of abstinence was longer among women 
involved in case management. An earlier study 
showed similar results, emphasizing that women 
assigned to intensive case management accessed 
a greater variety of services (Jansson et al. 
2005). Improvement in abstinence rates and 
family and social functioning are also noted 
when case management services are employed 
(McLellan et al. 2003). 
Considerations in 
Treatment Placement and 
Planning 
Based on the assessment process, appropriate 
treatment placement for a client depends on 
many factors, including the nature and severity 
of a woman’s substance use disorder, the 
presence of co-occurring mental or physical 
illnesses or disabilities, and the identifi cation 
of other needs related to her current situation. 
Placement decisions are also affected by other 
psychosocial factors. Once the comprehensive 
assessment is completed, the placement can be 
determined. 
Women need to be able, whenever possible, 
to contribute to the planning and placement 
discussion for their treatment. For example, 
when residential care is recommended, barriers 
such as being unable to bring her children may 
cause a woman to reject the placement option. 
In this situation, it is critical to work with the 
woman to make appropriate arrangements to 
help her enter treatment. Treatment planning 
must also include assistance in helping her to 
express needs, make decisions and choices, 
and recognize that she is the expert on her life. 
Overall, active client involvement in all aspects 
of treatment planning signifi cantly contributes 
to recovery, validates and builds on a woman’s 
strengths, and models collaborative and mutual 
relationships, including, most importantly, the 
client–counselor relationship. 
To date, limited literature has examined 
placement criteria specific to women. However, 
some States have developed criteria for placing 
women in appropriate treatment options 
(CSAT 2007). The available State substance 
abuse treatment standards listed in Figure 5-3, 
Services Needed in Women’s Substance Abuse 
Treatment, should be considered in placing 
female clients in specifi c services. 
Levels of Care 
The need for appropriate level of care and 
treatment is not gender specific; both men and 
women require a range of treatment services at 
various levels of care. In 1991, ASAM developed 
patient placement criteria based on matching 
severity of symptoms and treatment needs with 
five levels of care. ASAM’s Patient Placement 
Criteria (ASAM’s PPC; ASAM 2001) identifi es 
six clinical dimensions: alcohol intoxication and/ 
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Figure 5-3 
Services Needed in Women’s Substance Abuse Treatment 
The following services are recommended by the consensus panel and reinforced by some State 
standards (CSAT 2007), and these services may be warranted across the continuum of care 
beginning with early intervention and extending to continuing care services. More than ever, 
services need to be tailored to women’s needs and to address the specific hardships they often 
encounter in engaging treatment services. Promising practices designed to treat women with 
substance use disorders include comprehensive and integrated clinical and community services 
that are ideally delivered at a one-stop location. Note: This list does not incorporate the 
customary services that are provided in standard substance abuse treatment, but rather services 
that are more reflective of women’s needs. 
Medical Services 
Gynecological care
 
Family planning
 
Prenatal care
 
Pediatric care
 
HIV/AIDS services
 
Treatment for infectious diseases, including viral hepatitis
 
Nicotine cessation treatment services
 
Health Promotion 
Nutritional counseling 
Educational services about reproductive health 
Wellness programs 
Education on sleep and dental hygiene 
Education about STDs and other infectious diseases; e.g., viral hepatitis and HIV/AIDS 
Preventive healthcare education 
Psychoeducation 
Sexuality education 
Assertiveness skills training 
Education on the effects of alcohol and other drugs on prenatal and child development 
Prenatal education 
Gender-Specifi c Needs 
Women-only programming; e.g., is the client likely to benefit more from a same-sex versus 
mix-gender program due to trauma history, pattern of withdrawal among men, and other 
issues? 
Lesbian services 
Cultural and Language Needs 
Culturally appropriate programming 
Availability of interpreter services or treatment services in native language 
Life Skills 
Money management and budgeting
 
Stress reduction and coping skills training
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Figure 5-3 
Services Needed in Women’s Substance Abuse Treatment (continued) 
Family and Child-Related Services 
Childcare services, including homework assistance in conjunction with outpatient services 
Children’s programming, including nurseries and preschool programs 
Family treatment services including psychoeducation surrounding addiction and its 
impact on family functioning 
Couples counseling and relationship enrichment recovery groups 
Parent/child services, including developmentally age-appropriate programs for children 
and education for mothers about child safety; parenting education; nutrition; children’s 
substance abuse prevention curriculum; and children’s mental health needs, including 
recreational activities, school, and other related activities 
Comprehensive Case Management 
Linkages to welfare system, employment opportunities, and housing 
Integration of stipulations from child welfare, TANF, probation and parole, and other 
systems 
Intensive case management, including case management for children 
Transportation services 
Domestic violence services, including referral to safe houses 
Legal services 
Assistance in establishing financial arrangements or accessing funding for treatment 
services 
Assistance in obtaining a GED or further education, career counseling, and vocational 
training, including job readiness training to prepare women to leave the program and 
support themselves and their families 
Assistance in locating appropriate housing in preparation for discharge, including 
referral to transitional living or supervised housing 
Mental Health Services 
Trauma-informed and trauma-specifi c services 
Eating disorder and nutrition services 
Services for other co-occurring disorders, including access to psychological and 
pharmacological treatments for mood and anxiety disorders 
Children’s mental health services 
Disability Services 
Resources for learning disability assessments
 
Accommodations for specifi c disabilities
 
Services to accommodate illiteracy
 
Services to accommodate women receiving methadone treatment
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Figure 5-3 
Services Needed in Women’s Substance Abuse Treatment (continued) 
Staff and Program Development 
Strong female role models in terms of both leadership and personal recovery 
Peer support 
Adequate staffing to meet added program demands 
Staff training and gender-competence in working with women 
Staff training and program development centered upon incorporating cultural and 
ethnic influences on parenting styles, attitudes toward discipline, children’s diet, level of 
parenting supervision, and adherence to medical treatment 
Flexible scheduling and staff coordination (Brown 2000) 
Adequate time for parent–child bonding and interactions 
Administrative commitment to addressing the unique needs of women in treatment 
Staff training and administrative policies to support the integration of treatment services 
with clients on methadone maintenance 
Culturally appropriate programming that matches specific socialization and cultural 
practices for women 
Source: Consensus Panel. 
or withdrawal potential; biomedical conditions 
and complications; emotional, behavioral, 
or cognitive conditions and complications; 
readiness to change; relapse, continued use 
or continued problem potential; and recovery 
environment. The levels of care are determined 
by the presence and severity of issues within 
each dimension. The current version (PPC-2R) 
lists five broad levels of care: 
• 	 Level 0.5: Early intervention 
• 	 Level I: Outpatient treatment/partial 
hospitalization 
• 	 Level II: Intensive outpatient treatment 
• 	 Level III: Residential/inpatient treatment 
• 	 Level IV: Medically managed intensive 
inpatient treatment (ASAM 2001) 
ASAM’s PPC-2R (2001) is used widely and 
standardizes treatment placement. It is focused 
on identifying individual treatment needs, but 
does not focus specifically on the placement 
of women or treatment needs that extend to 
children or family. Counselors needing detailed 
criteria for each level of care should consult 
ASAM’s PPC-2R Manual. The following review 
of ASAM’s levels of care contains information 
that is unique and important to women; it is 
not meant to be a comprehensive overview of 
ASAM’s placement criteria. When there are 
relevant issues, the specific needs of pregnant 
women and children are discussed at the end of 
each level of care. 
Early Intervention 
(ASAM Level 0.5) 
Early intervention, or ASAM Level 0.5, can be 
considered a pretreatment service that provides 
an opportunity for treatment providers to 
intervene across a wide variety of settings. It 
is designed for individuals with risk factors or 
problems associated with substance abuse but 
with whom an immediate substance-related 
disorder cannot be confirmed. Services that 
represent this level of care include assessment, 
psychoeducational services, and counseling. 
In essence, the goals for this level of care are 
prevention and intervention. For example, 
educational experiences allow clients to gain 
further awareness of their current substance 
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use and the expected consequences of this use, 
along with the future consequences of use if 
they continue on their present course. This 
level of care also provides a forum to assist 
individuals in developing skills associated with 
behavioral change, in creating strategies to 
avoid future problems related to substance use, 
and in establishing a supportive pretreatment 
environment and therapeutic alliance. 
Early intervention approaches can be provided 
through many channels—a drop-in model, 
in-home or mobile treatment services, or a 
pretreatment group in a treatment setting. It 
can also be provided 
through involuntary 
venues such as drug 
courts, or voluntary 
settings such as 
outpatient or primary 
medical care clinics.
Faith-based initiatives 
can also provide
opportunities for early 
interventions.
For women, early 
intervention services
appear quite valuable in 
enhancing motivation,
decreasing anxiety and 
reluctance in initiating
current and future 
treatment services, 
gaining support, and 
establishing strategies
to address obstacles 
associated with 
treatment access and 
engagement (Wechsberg 
et al. 2007). Programs
that provide fl exibility 
in attendance, easy
access to care, and 
at-home or mobile 
services are particularly conducive for women, 
especially those who have the primary role of 
parenting. TIP 34 Brief Interventions and Brief 
Therapies for Substance Abuse (CSAT 1999a), 
discusses how to implement brief interventions 
in substance abuse treatment and other settings. 
96 
Healthcare providers 
have a window 
of opportunity 
in working with 
women who abuse 
substances. Brief 
interventions can 
provide an opening 
to engage women 
in a process that 
may lead toward 	
treatment and 
wellness. 
Early intervention during 
pregnancy 
Pregnancy creates an increased sense of urgency 
for both clients and counselors because of the 
temporary upswing in motivation to change 
and the need for problem resolution. For some 
women who abuse substances, pregnancy creates 
a window of opportunity to enter treatment, 
become abstinent, quit smoking, eliminate 
risk-taking behaviors, and lead generally 
healthier lives (Hankin et al. 2000; Nardi 1998). 
Brief interventions are sometimes effective in 
helping pregnant women stop using substances 
(Hankin et al. 2000). Abstinence for pregnant 
women should be construed to include alcohol, 
tobacco, caffeine, and many over-the-counter 
medications, in addition to illicit substances. 
Some studies have found that brief interventions 
using motivational interviewing (MI) in prenatal 
care can reduce problem drinking by pregnant 
women (Handmaker and Wilbourne 2001; Miller 
2000). Therapists using MI employ a gentle, 
empathic style to avoid client defensiveness and 
constructively and compassionately explore 
ambivalence about change and motivation for 
recovery (refer to TIP 35 Enhancing Motivation 
for Change in Substance Abuse Treatment 
[CSAT 1999b]). MI may be more effective for 
those women who are primarily dependent 
on alcohol; studies targeting pregnant women 
identified as primarily abusing drugs have  
shown no differences between MI and other 
standard practices in reducing substance use 
(Winhusen et al. 2007). 
Detoxification (ASAM Levels I–IV)  
Detoxification is a set of procedures employed  
to manage acute intoxication and withdrawal 
symptoms from drug and alcohol dependence. 
During this process, the body’s physiology 
adjusts to the absence of alcohol or drugs. 
Detoxification alone is not substance abuse  
treatment; it is only the beginning of the 
treatment process. Issues such as retaining 
clients in detoxification, stabilization, and  
fostering treatment entry are discussed in 
TIP 45 Detoxification and Substance Abuse  
Treatment (CSAT 2006a). 
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Not all communities have detoxifi cation services. 
Furthermore, women’s programs do not often 
have adequate medical supervision to perform 
detoxification, hence women must be detoxifi ed 
at another facility. Typically detoxifi cation 
from alcohol or addictive drugs has been a 3- to 
5-day inpatient procedure, but as more and 
more health insurers have declined to reimburse 
inpatient detoxification, it increasingly is done 
on an outpatient basis. Yet, if severe withdrawal 
is expected (as from severe alcohol or sedative-
hypnotic dependence), detoxifi cation should 
be done in a medical facility. Withdrawal 
from severe alcohol use, sedatives, and 
benzodiazepines can have severe medical 
complications. 
Some women who are dependent on sedative-
hypnotics (tranquilizers) may need a 30-day 
withdrawal regimen with pharmacological 
medical intervention to prevent seizures. 
Concerning alcohol, more recent studies have 
begun to focus on the effects of sex-specifi c 
hormones in response to alcohol dependence and 
withdrawal. Although research on sex-specifi c 
hormonal differences in alcohol withdrawal is 
in its infancy, currently there appears to be a 
robust sex difference in seizure susceptibility, in 
that women appear to have less risk for alcohol 
withdrawal-induced seizures (Devaud et al. 
2006). Women also tend to display fewer and less 
severe alcohol withdrawal symptoms than men. 
However, even though research reflects less risk 
associated with withdrawal from alcohol among 
women, clinicians and health professionals 
need to maintain vigilance in evaluating 
withdrawal symptoms and other health 
concerns. Detoxification can be a vulnerable 
period for women who have a history of trauma 
and violence. They may have signifi cant 
distress associated with not feeling physically 
or psychologically safe, and anxiety associated 
with the anticipation of trying to manage 
their emotions and trauma-related symptoms 
without being able to self-medicate. From the 
outset of treatment, women need interventions 
and education surrounding traumatic stress 
reactions. Along with supportive and frequent 
contact with staff, trauma-informed services can 
help create or increase a sense of safety and a 
feeling of control. 
For all intents and purposes, if a woman’s 
contact with a substance abuse treatment agency 
stops at detoxification, the treatment system has 
failed. Women without treatment subsequent 
to detoxification are likely to relapse and be 
lost to followup. Thus, detoxifi cation programs 
should have adequate funding to include case 
management, brief interventions, and discharge 
planning. Immediately after detoxifi cation, 
a woman may be more likely to be ready for 
treatment, and this opportunity for engaging 
the woman in treatment should be maximized. 
Aggressive case management, referral networks, 
and treatment linkages are needed to prevent 
women from disengaging from treatment. From 
initial contact with the client, the ability to 
follow up, to coordinate care, and to provide 
comprehensive services (such as transportation 
and child care), is essential to effective 
treatment. 
Considerations for women who 
are parents with dependent 
children 
The safety of children often is a chief concern 
and one of the principal barriers to treatment 
engagement and retention for parents— 
especially women—entering detoxifi cation 
programs. Even if women do not have custody 
of their children, they often are the ones who 
continue to care for them. Thus, ensuring 
that children have a safe place to stay while 
their mothers are in detoxification is of vital 
importance. Working with parents to identify 
supportive family or friends may help identify 
available temporary child care resources. A 
consult or referral to the treatment facility’s 
social services while the patient is being 
detoxified is indicated when the care of children 
is uncertain (CSAT 2006). 
Detoxification and methadone 
treatment during pregnancy 
Some detoxification programs will not treat a 
pregnant woman because they lack the necessary 
obstetrical support and are concerned about 
liability. Detoxification presents critical risks to 
a fetus, and withdrawal of a pregnant woman 
from addictive drugs or alcohol should always 
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be accompanied by close medical supervision 
and monitoring. Risks of detoxifi cation depend 
on the drug being abused, but the primary drugs 
of concern are typically opioids and, potentially, 
sedative-hypnotics. Sudden withdrawal of 
these drugs results in withdrawal by a fetus 
and sometimes leads to fetal distress or death. 
Withdrawal should be done under supervised 
conditions and with proper substitutes, such as 
methadone for opioids. TIP 45 Detoxifi cation 
and Substance Abuse Treatment (CSAT 2006a), 
TIP 43 Medication-Assisted Treatment for 
Opioid Addiction in Opioid Treatment Programs 
(CSAT 2005b), and TIP 40 Clinical Guidelines 
for the Use of Buprenorphine in the Treatment 
of Opioid Addiction (CSAT 2004a), have more 
comprehensive information on this subject. 
In general, it is neither recommended nor 
necessary for pregnant women to cease 
methadone treatment. In situations where 
withdrawal is being contemplated, a thorough 
assessment should be conducted to determine 
whether the woman is an appropriate candidate 
for medical withdrawal. It is important to 
note that relapse rates among women who use 
heroin are high, thus placing their fetuses at 
risk for adverse consequences (Jones et al. 
2001). Situations in which medically supervised 
methadone withdrawal during pregnancy may 
be considered include the following: 
• 	 The client moves to an area where methadone 
maintenance is not available. 
• 	 The client has been stable during treatment 
and requests withdrawal before delivery. 
• 	 The client refuses to be maintained on 
methadone. 
• 	 The client plans to detoxify through a 
structured treatment program (Archie 1998; 
Kaltenbach et al. 1998). 
If withdrawal is elected, it should be conducted 
under the supervision of physicians experienced 
in perinatal addiction and under the guidance 
of a protocol using fetal monitoring. Medical 
withdrawal usually is conducted in the second 
trimester because of the danger of miscarriage 
in the first trimester and because withdrawal-
induced stress may cause premature delivery 
or fetal death in the third trimester (Donaldson 
2000; Kaltenbach et al. 1998). While 
pharmaceutical agents other than methadone 
have been introduced to treat symptoms 
of opioid withdrawal, the research is still 
preliminary (Anderson et al. 1997; Dashe et 
al. 1998; Jones and Johnson 2001; McElhatton 
2001). 
Outpatient Treatment 
(ASAM Level I) 
Outpatient, or ASAM Level I, treatment usually 
consists of one or two weekly sessions of group 
or individual therapy. Outpatient treatment 
settings are the most common, are widely 
available, and are the setting in which most 
women receive treatment. In general, outpatient 
treatment is most appropriate for women with 
less severe substance use problems and with 
greater social support and resources. While 
outpatient services are used for less severe 
symptoms of substance use disorders, this level 
of treatment can be employed at various points 
across the continuum of care. Specifi cally, 
continuing care services use outpatient 
treatment to provide support for ongoing 
recovery and treatment in a less restrictive 
environment as recovery evolves. (Refer to 
chapter 8 for review of continuing care services.) 
Women who benefit most from outpatient therapy
frequently have some stability in their lives, such
as housing and employment. Effective outpatient
treatment programs for women should be more
comprehensive than traditional programs and
should provide a constellation of services (refer
to Figure 5-3). For example, outpatient services
should evaluate the need for and provide child
care and children’s treatment services. 
Although few women-only outpatient programs 
exist, mix-gender programs can be made more 
responsive to women’s needs by providing 
comprehensive case management, services, and 
programs that support more client-provider 
contact, more opportunities for individual 
therapy, and referral to other community 
services. The development of interagency 
relationships is essential, yet referral alone 
will not guarantee utilization of these services. 
Beyond staff support, it is often necessary to 
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initiate the first contact with the agency referral, 
to assist the client in developing or making the 
necessary arrangements to access the community 
service or referral, and to provide followup to 
obtain the outcome of the referral. Throughout 
the last two decades, substance abuse programs 
have acknowledged the necessity of establishing 
formalized relationships among community 
agencies to streamline services and to effectively 
address and manage the diverse needs of women 
seeking treatment for substance use disorders. 
TIP 46 Substance Abuse: Administrative 
Issues in Outpatient Treatment (CSAT 2006b), 
provides more information on this level of care. 
Intensive Outpatient Treatment 
(ASAM Level II) 
Intensive outpatient treatment (IOP), or ASAM 
Level II, provides a higher treatment level than 
traditional outpatient programs but does not 
require structured residential living. Generally, 
IOP provides many of the same services as 
residential treatment; however, the intensity 
of treatment, the time of engaging services, 
and level of counselor involvement are less. 
IOP appears to have higher completion rates 
than traditional outpatient services among 
postpartum women (Strantz and Welch 1995). 
The flexibility of IOP may help women overcome 
barriers to treatment, provided the program 
attends to the unique needs identifi ed during 
intake (refer to Figure 5-3). Although IOP 
historically provides more accommodating 
schedules and offers treatment during the 
evening, weekends, and other times of the day, 
it will not be as useful for some women unless 
child care and transportation are available. TIP 
47 Substance Abuse: Clinical Issues in Intensive 
Outpatient Treatment (CSAT 2006c), provides 
more information on this level of care. 
Residential and Inpatient 
Treatment (ASAM Level III) 
Residential treatment, or ASAM Level III, is for 
women who have multiple and complex needs 
and require a safe environment for stabilization, 
intensive treatment, and an intensive recovery 
support structure. Professional staff are 
available 24 hours a day, and the facility is 
clinically managed. The type of residential 
or inpatient placement depends in part on 
the severity and complexity of the woman’s 
conditions, including but not limited to co­
occurring medical and psychiatric disorders, 
history of trauma (including sexual and domestic 
violence), and pregnancy. Clinical experience 
has shown that women in residential care 
frequently require some or all of the services 
listed in Figure 5-3 in addition to specifi c 
substance abuse treatment services. 
Residential treatment can take place in various 
settings, including halfway houses and other 
extended care facilities, primary residential or 
inpatient programs, and recovery homes. As an 
example, SHIELDS for Families (a Los Angeles 
agency) uses a combination of day treatment and 
housing to provide comprehensive residential 
treatment for families. Overall, the effectiveness 
of residential treatment appears to rely on at 
least one key element—length of treatment. 
Greenfield and colleagues (2004) reviewed data 
about the effectiveness of residential substance 
abuse treatment for women from CSAT’s 
Residential Women and Children/Pregnant and 
Postpartum Women (RWC/PPW) Cross-Site 
Study and two other national studies. Despite 
differences in treatment programs, client 
profiles, followup intervals, data collection 
methods, and other factors, all three studies 
found high treatment success rates—ranging 
from 68 to 71 percent abstinence—among 
women who spent 6 months or more in 
treatment. Success rates were lower for clients 
with shorter stays in treatment. 
While length of stay seems paramount, 
residential treatment has several other 
components that must be in place to meet the 
various roles, needs, and other presenting 
issues of women with substance use disorders. 
Whether short or long term, residential 
treatment must maintain a healing, nurturing, 
and safe environment. This may require special 
accommodations for women, particularly 
in mix-gender treatment centers. These 
accommodations include adequate facilities 
for visits with children, safety precautions, 
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and treatment programming and policies that 
decrease the likelihood of potential assaults and 
sexual involvement in mix-gender residential 
settings and women-only space. Women who are 
trauma survivors benefit from secure sleeping 
accommodations where they can maintain their 
sense of security and control over bedroom 
access (except staff rounds; Harris 1994). 
Children in residential treatment 
programs 
For many women, having their children with 
them in treatment is essential to their recovery 
and removes a barrier to treatment entry. 
Research suggests that allowing children to 
accompany their mothers to a residential 
program has a positive effect on engagement, 
retention, and recovery (Lungren et al. 2003; 
Szuster et al. 1996). For example, studies have 
found that length of stay in residential treatment 
is associated with women being able to bring 
their children with them (Hughes et al. 1995; 
Wobie et al. 1997). One study suggested that the 
earlier a mother’s infant resides with her in the 
treatment setting, the longer the mother’s stay 
in treatment will be (Wobie et al. 1997). Overall, 
women in residential treatment accompanied 
by their children showed better outcomes 
(abstinence, employment, child custody, and 
involvement with continuing care or support 
groups) than women not accompanied by their 
children at 6 months after discharge (Stevens 
and Patton 1998). Review Appendix B to 
obtain an overview of CSAT’s Comprehensive 
Substance Abuse Treatment Model for Women 
and Their Children. 
Since 2004, CSAT has funded over 50 grants 
to treatment facilities under its Residential 
Women and Children/ Pregnant and Postpartum 
Women (RWC/PPW) programs. This cross-
site evaluation found that the 6- to 12-month 
treatment programs had several positive 
outcomes. First, alcohol and drug use was 
much lower 6 months after discharge compared 
with pretreatment. The percentage of women 
reporting alcohol use decreased from 65 
percent at pretreatment to 27 percent 6 months 
after discharge, and the percentage of women 
reporting crack/cocaine use decreased from 51 
to 20 percent. Second, 60 percent of the women 
reported being completely abstinent throughout 
the 6 months following discharge. Third, 
criminal involvement dropped markedly, and 
economic well-being improved. Next, pregnancy 
outcomes improved (fewer premature deliveries, 
fewer low-birth-weight babies, and lower infant 
mortality) compared with expected rates for 
this population. In addition, 75 percent of the 
women had custody of one or more children 
6 months after discharge, up from 54 percent 
before initiating treatment, and fewer clients 
had children in foster care (CSAT 2001a). 
Women who completed treatment that allowed 
children in residence had less psychological 
distress and improved skills for independent 
living, parenting, employment, and relationships 
(Saunders 1993). In fact, one study found 
that outcomes from a treatment environment 
that welcomed children were more positive 
for women both with and without children. 
Researchers suggest that “living with and 
helping with other women’s children may 
provide a sense of shared responsibility and 
community” in a therapeutic community 
(Wexler et al. 1998, p. 232). Chapter 7 addresses 
parenting and the need for children services; 
it also emphasizes the importance of providing 
assessment and treatment for both mothers and 
their children. 
The amount of responsibility the mother has 
for her children during her stay needs to 
be determined on an individual basis; some 
mothers can keep their children with them 
almost continually, whereas others may need 
to attend treatment apart from their children. 
Specifically, some women may not want the 
responsibility of parenting at such a stressful 
time in their lives but may feel social pressure to 
keep their children with them during treatment. 
These mothers should be supported in their 
decision to place their children in the care of 
others (such as reliable family members) during 
their treatment. The following questions can 
be used by agencies to determine some key 
decisions regarding children: 
• 	 How will child care be handled if the mother 
is hospitalized? 
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• 	 Are there limits on the severity of illness of 
mothers or children beyond which they will 
not be accepted by the program? 
• 	 What rule infractions will result in expulsion 
from the program? 
• 	 How will suspected child abuse or neglect be 
identified and reported? 
• 	 Does the program allow overnight home 
visits? What guidelines and rules need to be 
in place to permit mothers and their children 
to leave residential treatment overnight 
(Metsch et al. 1995)? 
• 	 How will children be disciplined? 
• 	 How will visitation by the mother’s partner 
be handled when court-ordered visitation 
privileges have been issued but the partner 
continues to abuse alcohol and/or drugs? 
Maintenance of relationships with noncustodial 
children is important. Reunifi cation with 
children in the care of child protective service 
agencies is a sensitive issue. Staff of residential 
programs should be knowledgeable about child 
welfare issues and develop collaborations with 
child protective services to facilitate an effective 
and supportive reunification process for mothers 
and children. 
Residential services for pregnant 
women 
Acknowledging the urgency of treating women
who are pregnant, Federal law requires that
pregnant women receive priority admission into
substance abuse treatment programs, allowing
them to bypass waiting lists and gain immediate
admission when a bed in a residential program
is available (42 U.S.C. § 300x-27[a]). The
primary treatment provider must secure
prenatal care if a pregnant woman is not
already receiving such care. 
Notably, collaboration among providers of 
substance abuse treatment, obstetric care, and 
pediatric care is a necessity. A comprehensive 
care program for pregnant women that includes 
prenatal care and substance abuse treatment 
has been shown to improve birth outcomes 
and increase the chances of being drug free at 
delivery for women who used cocaine (Burkett 
et al. 1998). Corse and colleagues (1995) looked 
at innovative possibilities 
such as bringing 
primary obstetric care 
providers (usually 
a nurse practitioner 
or certifi ed nurse 
midwife) onsite. They 
found that educating 
nurse midwives about 
substance use disorders 
and pregnancy enhanced 
their effectiveness 
and level of comfort 
in working with this 
population. Foremost, 
residential staff should 
learn the danger signs of 
pregnancy complications 
and when to triage a 
woman to an emergency 
department or to the 
doctor of the woman’s 
choice. An internal 
or external medical 
or nursing resource is 
helpful to evaluate need 
for emergency care. 
Upon delivery, some 
infants have withdrawal symptoms that require 
supportive care. In individual cases, depending 
on symptom severity, babies may need to be 
managed pharmacologically, and most experts 
agree that newborns should remain hospitalized 
while on medication related to drug withdrawal. 
In a residential center, public health nursing 
visits are critical to the evaluation of infant and 
maternal status. If a program does not have a 
nursing staff, public health nurses can provide 
some service. 
The consensus panel recommends that 
residential programs provide a number of 
specialized services for pregnant women, 
including: 
• 	 Nutrition services 
• 	 Prenatal care 
• 	 Transportation to obstetric appointments 
• 	 Childbirth education and preparation and a 
coach, if possible 
Telling Their 
Stories: Refl ections 
of the 11 Original 
Grantees That 
Piloted Residential 
Treatment for 
Women and Children 
for CSAT (CSAT 
2001c), provides 
profiles of residential 
programs for women 
and children, along 
with issues that 
arose in treatment 
and management, 
evaluation 
information, and 
lessons learned. 
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• 	 Mental health evaluation at least twice during 
the pregnancy and postpartum periods, and 
treatment as needed to rule out (or treat) 
postpartum depression or other disorders 
• 	 Education about alcohol and drug use 
specifically related to pregnancy, including 
education about neonatal abstinence 
syndrome and, if possible, a tour of the 
delivery site’s nursery for the woman in 
anticipation of the need for infant monitoring 
in the hospital 
• 	 Education about HIV/AIDS risk and 
management during pregnancy, especially 
because HIV/AIDS transmission to the fetus 
and infants can be prevented 
• 	 Education about breastfeeding and strong 
support for mothers who nurse their babies 
unless they are HIV positive 
Comprehensive programs for women who are 
parents or pregnant typically include outreach, 
family support services, medical care, case 
management, and continuing care for women 
and their children (Finkelstein 1993, 1994). 
Some researchers recommend individual and 
group counseling services, independent living 
skills training, and parenting classes (Haskett 
et al. 1992). Childbirth education and family 
planning also are recommended for women 
in treatment at childbirth and postpartum, 
along with activities that address bonding 
and attachment. Home visits help in assessing 
a woman’s needs and in identifying family 
members who can support her in recovery 
(Grella 1996). Children who accompany 
their mothers to treatment can benefi t from 
separate, developmental- and age-appropriate 
programming, health care, and education 
programs including substance abuse prevention. 
For an overview of CSAT’s Comprehensive
Substance Abuse Treatment Model for Women 
and Their Children, refer to Appendix B. 
Medically Managed Intensive 
Inpatient Treatment 
(ASAM Level IV) 
Treatment in a medically managed intensive 
inpatient setting, or ASAM Level IV, commonly 
is used for a person who is medically 
compromised and meets ASAM Level IV criteria. 
This patient is at high risk for complications 
associated with withdrawal and requires the full 
resources provided by a hospital. Typically, this 
type of acute inpatient treatment lasts between 
3 and 5 days; stays of 10 to 14 days are more 
likely in an acute care psychiatric unit. It most 
often includes medical detoxifi cation, client 
education, group therapy, individual therapy, 
family therapy, and medical treatment. 
As discussed in the detoxifi cation section, 
appropriate referral from inpatient care to 
subsequent long-term treatment is needed. 
Repeat assessments are performed to indicate 
when a client is ready for a less intrusive or 
less intense setting for treatment. This referral 
should include case management and linkage to 
other treatment services, community services, 
and support groups. 
Advice to Clinicians and Medical Staff: 
The Impact of Trauma and Prenatal Care 
Women who have been sexually traumatized may experience considerable emotional 
discomfort with prenatal care, labor, and delivery in part because of the necessity of 
frequent vaginal exams and the physical contact necessary to support women during 
labor and delivery. The optimal situation for many pregnant women with a history of 
sexual trauma is to have a female prenatal care provider or a female obstetrician. These 
clients should have a labor coach or a support person to accompany them on all medical 
visits and during the labor process and delivery. 
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Overview 
Gender-appropriate and culturally responsive health care improves 
both short- and long-term outcomes, not just for women with 
substance use disorders but also for clients with almost any type of 
healthcare problem. The likelihood of good health or the prevalence 
of certain disorders is, in part, a product of gender. Certain health 
issues are unique to women; others affect women disproportionately 
compared to men; and still others have a different effect on women 
than on men. To add to these gender differences, the National 
Institutes of Health (NIH) has identified critical racial and ethnic 
disparities in health that result in different outcomes or consequences 
in some groups. Other factors such as sexual orientation also have 
been shown to affect health status (Dean et al. 2000). 
The risks of substance abuse, its consequences, and the processes for 
treatment and recovery also differ by gender, race, ethnicity, sexual 
orientation, age, and other factors. Women’s risks for substance use 
disorders are best understood in the context in which the infl uences 
of gender, race and ethnicity, culture, education, economic status, 
age, geographic location, sexual orientation, and other factors 
converge. Understanding group differences across segments of the 
women’s population is critical to designing and implementing effective 
substance abuse treatment programs for women. 
This chapter provides an overview of available substance-related 
research for women in specific racial and ethnic groups, settings, 
and special populations in the United States across four domains: 
demographics, substance abuse patterns, clinical treatment issues, 
and resiliency factors. It highlights the need for cultural competence 
in the delivery of substance abuse treatment and suggests specifi c 
and culturally congruent clinical, programmatic, and administrative 
strategies. For more detailed information on substance related 
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disorders and substance abuse treatment across 
racially and ethnically diverse populations; 
the influence of culture on substance abuse 
patterns, help-seeking behavior, and health 
beliefs; and guidelines for culturally congruent 
and competent treatment services, see the 
planned TIP Improving Cultural Competence 
in Substance Abuse Treatment (Center for 
Substance Abuse Treatment [CSAT] in 
development a). 
Main sections of this chapter address clinical 
issues related to treating women of different 
racial and ethnic groups, women of different 
sexual orientations, older women, and 
women living in rural areas. Although certain 
elements of their substance use disorders are 
common to all these groups (such as trauma 
and/or socioeconomic stresses), each group 
also has unique features that will further 
influence their engagement and successful 
completion of treatment (including cultural 
values, beliefs about health care, and help-
seeking behavior). Each group of women also 
brings a unique capacity for resiliency and 
recovery, and these factors are explored as 
well. The chapter concludes with a brief review 
of special populations and settings—women 
with disabilities, women in the criminal justice 
system, and women who are homeless. 
Racially and Ethnically 
Diverse Women 
Hispanic/Latina Women 
Demographics 
Of the approximately 40 million Hispanic/ 
Latino people living in the United States and its 
Territories, Mexican Americans are the largest 
group (64 percent), followed by Puerto Ricans 
(10 percent), Central and South Americans 
(13 percent), Cubans (4 percent), and other 
Hispanics or Latinos (9 percent) (U.S. Census 
Bureau 2007). Half the U.S. Hispanic/Latino 
population is concentrated in California and 
Texas. An additional 23 percent reside in 
Florida, Illinois, New Jersey, Arizona, and New 
York (U.S. Census Bureau 2007). Women of 
Hispanic origin in the United States numbered 
17 million or slightly less than half the total 
U.S. Hispanic population (U.S. Census Bureau 
2001d). 
The Hispanic/Latino population is a young, 
rapidly growing ethnic and cultural group 
in the United States. At 14 percent of the 
population, Hispanics/Latinos currently are 
the largest ethnic subpopulation (U.S. Census 
Bureau 2007). The recent population growth of 
Hispanics/Latinos is mainly due to the relative 
youth and high birth rates of this population 
(Bachu and O’Connell 2001) and, in part, to 
immigration. Yet, most Hispanics/Latinos are 
born in the U.S. and are not immigrants (U.S. 
Census Bureau 2007). By 2050, Hispanics/ 
Latinos are expected to nearly triple in number 
(U.S. Census Bureau 2000b). 
The socioeconomic status of the U.S. Hispanic/ 
Latino population may reflect the circumstances 
of immigration; that is, those who immigrated 
for economic reasons (the vast majority) tend to 
be poorer, less well educated, and younger than 
the overall population. More than a quarter 
of all Hispanics/Latinos lack health insurance 
coverage for more than 1 year (Cohen et al. 
2004). Approximately 40 percent of Hispanic/ 
Latino families headed by women live in poverty 
(U.S. Census Bureau 2007), and many of these 
women are likely to face the combined stresses 
of poverty, lack of health insurance, and lack of 
health care (U.S. Census Bureau 2002). 
Substance use among Hispanics/ 
Latinas 
Alcohol 
Most research on substance abuse among 
Hispanics/Latinas has focused on alcohol (e.g., 
Ames and Mora 1988; Canino 1994; Gilbert 
1991) and has confirmed the widely held belief 
that, regardless of national origin, Hispanics/ 
Latinas generally have higher rates of abstinence 
from alcohol and drink alcohol less frequently 
than Hispanic/Latino men. In a survey of 
764 Hispanic/Latino men and 817 Hispanic/ 
Latina women of all ages, 33 percent of the 
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men reported frequent and/or heavy drinking, 
compared with 12 percent of the women. 
Conversely, 57 percent of the women versus 35 
percent of the men reported that they abstained 
from alcohol use. Thirty-one percent of the 
women reported infrequent drinking (Aguirre-
Molina et al. 2001). This phenomenon has been 
attributed to strict cultural sanctions against 
drinking by women that are typical throughout 
Latin America (Mora 1998) and are maintained 
by many Hispanics/Latinas in the United States. 
Research indicates that some Hispanics/Latinas 
generally maintain the cultural norms of their 
countries of origin and resist social pressures to 
engage in substance use (Mora 2002). However, 
other research (e.g., Caetano 1988, 1989; 
Caetano et al. 2007) comparing substance abuse 
both by gender and within and across Hispanic/ 
Latino subgroups suggests a far more complex 
relationship between Hispanics/Latinas and 
substance abuse (Mora 2002). For instance, 
Mexican-American women show higher rates 
of abstinence than Cuban and Puerto Rican 
women. However, they also exhibit the highest 
rates of frequent heavy drinking of all Hispanic/ 
Latina subgroups (Caetano 1989; Mora 1998). 
Thus, Mexican-American women who consume 
any alcohol at all tend to drink frequently and 
heavily. Mora (1998) explains that this paradox 
originates from differences between immigrant 
Mexican women and their American-born 
counterparts. More established generations of 
U.S. Hispanics/Latinas—in particular young 
Mexican-American and Puerto Rican women— 
drink more alcohol than immigrant women of 
their subgroups. These differences in alcohol 
use among Hispanics/Latinas appear to depend 
primarily on age, generational status, level of 
acculturation, and country of origin (Collins and 
McNair 2002; Randolph et al. 1998). 
Illicit drug use 
The pattern of illicit drug use among Hispanics/ 
Latinas is influenced by level of acculturation 
and country of origin. In one study based on 
the Hispanic Health and Nutrition Examination 
Survey (HHANES) data, illicit drug use 
among Hispanics/Latinas generally increased 
with acculturation (Amaro et al. 1990). The 
2006 Treatment Episode Data Set (TEDS), a 
Substance Abuse and Mental Health Services 
Administration (SAMHSA) data set that 
provides information on treatment completion, 
length of treatment stay, and discharge 
demographics, indicated that Hispanic/Latina 
women admitted to substance abuse treatment 
were more likely to report opiates (19 percent) 
as their primary substance of abuse followed 
by cocaine/crack (18 percent), marijuana (14 
percent), and methamphetamine. In addition, 
the primary substance of abuse varied according 
to Hispanic origin: Puerto Rican and Cuban-
American women reported more opiate use, 
whereas Mexican-American women reported 
more methamphetamine use (SAMHSA 2008). 
Sociodemographic factors 
associated with substance use and 
substance use disorders 
Socioeconomic status, age, and length of time in 
the United States are associated with substance 
use and substance use disorders among 
Hispanic/Latina women. Among this population, 
those with the most notable risks for substance 
use disorders are women who immigrated to 
the U.S. at an earlier age (before 7 years of 
age) or who were born in the U.S. (Canino 
et al. 2008; Vega et al. 2003). Of particular 
concern, the 2007 Youth Risk Behavior Survey 
found a growing prevalence of alcohol and 
other drug use among adolescent Hispanic/ 
Latina females (Eaton et al. 2008). Studies 
have also isolated employment, marital status, 
and educational level as predictors of alcohol 
consumption and substance use disorders 
among Hispanics/Latinas. In a study evaluating 
racial/ethnic differences among women with co­
occurring mental and substance use disorders, 
Hispanic/Latina women possessed signifi cant 
social vulnerability characterized by lower 
socioeconomic and educational status, exposure 
to violent crimes, and higher rates of criminal 
justice involvement (Amaro et al. 2005). 
Gender socialization 
In the Hispanic/Latina culture, women often 
are afforded special status and respect as 
matriarchs of extended family networks (Mora 
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Advice to Clinicians and Administrators 
Substance Abuse Treatment and Hispanic/Latina Women 
Clinical: 
• 	 Conduct initial assessment to determine the women’s level of acculturation, 
development and identification of ethnic identity , and worldview (Baron 2000). 
• 	 Provide clients with opportunities to identify and express feelings about their heritage 
and self-perception. 
• 	 Encourage exploration of strengths in their cultural backgrounds, histories, and 
heritages, including opportunities to explore old and new ways to incorporate 
spirituality into their lives. 
• 	 Develop opportunities to build alliances and relationships with women (including 
staff and other clients) from other groups and cultures. 
Program Development: 
• 	 Generate a program philosophy that supports personal growth and empowerment 
within a cultural and family context. 
• 	 Develop linkages with other community resources and case management to help with 
legal issues, education, job training, domestic violence, medical care, housing, and 
other support systems. 
• 	 Plan for interpreter services and develop access to bilingual providers. 
• 	 Adopt acculturation assessment tools that include information on migration patterns, 
acculturation level, experiences, stress, country of origin, and specific endorsement of  
Hispanic/Latina values. 
• 	 Develop and provide psychoeducational family programs. 
Staff Training: 
• 	 Invest in culturally competent staff training that promotes an understanding of: 
− Common Hispanic/Latina cultural beliefs, worldview, customs, spirituality, and 
religion. 
− The possible relational needs of many Hispanics/Latinas. 
− The centrality of family and knowledge of approaches for incorporating family in 
treatment. 
− The immigration experience and effects of acculturative stress on many Hispanics/ 
Latinas’ roles, responsibilities, family life, substance abuse, and recovery. 
Source: Alvarez and Ruiz 2001; Caetano et al. 2007; CSAT 2003b; and Medina 2001 
 
2002). Some Hispanics/Latinas, especially those 
who are more acculturated, may deemphasize 
or reject these cultural expectations, but early 
childhood messages (e.g., the “proper role of a 
señorita”) may remain embedded in the cultural 
and personal identities of many in this group 
(Mora 1998). The stresses of negotiating and 
integrating traditional cultural expectations with 
new cultural values may result in or exacerbate 
the prevalence of mental and substance use 
disorders for many Hispanics/Latinas; more 
research is needed on this subject (Gloria and 
Peregoy 1996; Mora 1998). 
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Acculturation 
It has been suggested that acculturation, the 
process of adapting and adjusting to new 
surroundings while maintaining a cultural 
identity, more than any other factor, affects 
Hispanics/Latinas’ substance abuse (Caetano 
1989, 1994; Gilbert 1991; Keefe and Padilla 
1987; Markides et al. 1988). The onset of 
alcohol and drug abuse among some Hispanics/ 
Latinas may be explained by acculturative 
and environmental stresses (e.g., new roles, 
expectations, opportunities) that result 
in greater exposure to these substances 
(Gilbert 1991; Mora 1998). HHANES data 
study revealed that, for women of all ages in 
three major subgroups (Mexican American, 
Puerto Rican, and Cuban American), level of 
acculturation was correlated consistently with 
both increased frequency of consumption and 
increased probability of being a drinker at all 
(Black and Markides 1993). 
Studies consistently have shown that 
acculturation is positively correlated with 
consumption of greater quantities of alcohol, 
greater frequency of alcohol use, and higher 
rates of drug abuse among Hispanics/Latinas 
(Amaro et al. 1990; Mora 1998). These fi ndings 
have significant implications in providing 
substance abuse treatment, in that the role of 
acculturation and gender socialization should 
be a central theme in treatment planning. 
Specifically, Mora (1998) suggests that clinicians 
explore with Hispanic/Latina clients several 
key questions: How have their traditional roles 
changed since immigration or in comparison to 
their own mothers? How have these changes in 
roles influenced their substance use behavior? 
In what ways have educational and employment 
opportunities influenced or altered their 
substance use? 
Clinical treatment issues 
At first glance, the heterogeneity of Hispanics/ 
Latinas in terms of language, values, and 
backgrounds may seem to challenge the 
creation of effective, culturally responsive 
treatment programs for Hispanic/Latina women. 
Programs committed to serving Hispanics/ 
Latinas, however, can develop effective services 
by endorsing culturally competent practices, 
such as culturally specific assessment tools, 
counseling that endorses the clients’ worldviews, 
staff training to increase cultural awareness 
and knowledge, and programs that refl ect 
and respect cultural values. For example, 
substance abuse treatment programs can create 
a treatment environment that honors cultural 
heritage and incorporates values such as 
familismo (reliance on and regard for family and 
family cohesiveness), when appropriate. 
Some treatment issues reflect beliefs or 
traditions more specific to Hispanics/Latinas. 
A strong cultural prohibition exists against 
discussing family matters such as substance 
use or abuse during childhood, thus the 
use of psychoeducational groups to provide 
information on these topics may be more 
effective initially than therapy groups, where 
experiences are discussed openly. However, 
substance abuse counseling based on a family 
model often is well suited and is more culturally 
congruent for many Hispanics/Latinas. When 
engaging in family therapy, therapists need to 
enter the family relationship as a “learner,” 
since Hispanic/Latino families are so diverse. 
Counselors need to take the time to understand 
each client’s family history within a cultural 
context (Rotter and Casado 1998), including 
the initial identification of the country of origin 
and family members’ acculturation history 
and levels. Counselors also need to embrace a 
more expansive definition of family that may 
include extended family members and others. 
Early on in treatment, counselors need to assess 
how the current substance-related problems 
affect the family’s culture and how the culture 
affects the current presenting issues. Because 
the exalted role of motherhood in Hispanic/ 
Latino culture often makes loss of child custody 
especially stigmatizing, treatment programs 
need to provide support for appropriate family 
reunification. On a more fundamental level, 
Hispanics/Latinas may benefit from assistance in 
gaining English language skills, in job training 
that leads to employment, in fi nding stable 
housing, and in negotiating the requirements for 
treatment entry (Amaro et al. 1999; Kail and 
Elberth 2002). 
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Another treatment concern expressed among 
some Hispanics/Latinas in treatment— 
particularly those who are highly acculturated 
or isolated from a larger Hispanic/Latino 
community—is alienation from their cultural 
heritage. It may be difficult to address cultural 
alienation in treatment because a client may 
be far removed from her cultural background. 
A therapeutic decision must be made whether 
a cultural framework for recovery and 
empowerment should be utilized for all clients 
or only for those who request or show interest 
in this approach. Cultural knowledge can be 
empowering for many women of color, but 
not for all; care should be taken to adopt this 
approach only for those who are comfortable 
with it. 
Hispanics/Latinas represent 14 percent of all 
new HIV/AIDS cases among women (CDC 2007). 
Among Hispanic women, 65 percent acquired 
HIV/AIDS through high-risk heterosexual 
transmission and 33 percent were infected 
through injection drug use. Since Hispanic 
women represent the second largest ethnically 
diverse group of women living with HIV/AIDS at 
the end of 2005, education and other prevention 
services should be essential components of 
substance abuse treatment. 
Similar to other population groups of women, 
Hispanics/Latinas with substance use disorders 
experience a high rate of co-occurring mental 
disorders (Amaro et al. 2005). These disorders 
also need to be identified and treated if 
substance abuse treatment is to lead to recovery. 
A study of 66 Hispanics/Latinas enrolled in a 
residential substance abuse treatment program 
found that most (80 percent) reported a 
childhood history of abuse, as well as mental 
health problems (76 percent) and physical 
health problems (68 percent) (Amaro et al. 
1999). Compared with women who had not 
experienced childhood abuse, those with such 
a history experienced more severe health 
problems and were more likely both to lose 
custody of their children and to drop out of 
treatment. To treat these problems adequately, 
the relationship between a woman’s abuse 
history and substance use or co-occurring 
mental disorders must be determined. See TIP 
36 Substance Abuse Treatment for Persons With 
Child Abuse and Neglect Issues (CSAT 2000b) 
for more information. 
Resiliency factors 
The counselor should evaluate and adopt 
treatment approaches that are strength-based 
and that build on the resources and strengths 
of the client’s culture, individual traits and 
experiences, spirituality, and family. Among 
Hispanic/Latina clients, families are typically an 
important part of the support network and can 
function as a resource in recovery. Similarly, the 
centrality of family ties may provide motivation 
for treatment and a sense of responsibility to 
family. In a study that evaluated the role of 
family in reducing or delaying alcohol use among 
young Hispanic/Latina females, services that 
help improve parental connections can have 
long-term positive effects (Sale et al. 2005). 
In addition, culturally defined gender roles can 
also serve as a strength-based metaphor for 
the challenges that clients face as they begin 
their journeys in recovery. These gender roles, 
if properly acknowledged during treatment, 
can emphasize the most positive aspects of 
marianismo and hembrismo (the counterparts 
to machismo), such as “strength, perseverance, 
flexibility, and an ability to survive . . . [that 
can] . . . promote non-use while respecting 
Based on the knowledge and experience gained from the Demonstration Grant Program for 
Residential Women and their Children (RWC) and the Services Grant Program for Residential 
Treatment for Pregnant and Postpartum Women (PPW), the publication Lessons Learned: 
Residential Substance Abuse Treatment for Women and Their Children (CSAT 2003b) was 
developed. Along with other important aspects of residential treatment for women and children, 
this report provides insight into how to integrate culturally congruent services among Hispanic/ 
Latina women in residential substance abuse treatment. 
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“La Casita” (which means “the little house” in Spanish) is a residential chemical dependency 
treatment program designed to meet the needs of low-income Hispanic/Latina mothers. 
The treatment program places emphasis on the importance of family and its critical role in 
promoting therapeutic change. La Casita integrates culturally relevant strategies and Hispanic/ 
Latina cultural values with other effective treatment approaches, such as, “simpatia” (the 
promotion of pleasant social relationships), “lineality” (importance of authority fi gures in 
the solution of problems), and “reciprocity” (giving back, in some way, what was given). By 
adapting these cultural values in treatment, women have an opportunity to use their ethnic 
heritage as a catalyst for recovery (CSAT 2003b). 
and maintaining the role of the woman within 
the family” (Gloria and Peregoy 1996; p. 122). 
Similarly, religion and spiritual practices are 
very important for many traditional Hispanics/ 
Latinas in the United States and may serve as 
a source of sustenance in recovery. Religious 
beliefs may involve a combination of traditional 
practices and rituals, world religions, and 
religious practices in and outside the structure 
of church (Altarriba and Bauer 1998). 
African-American Women 
Demographics 
There are major differences in cultural 
identification, income, education, marital status, 
occupation, and lifestyle between African-
American women born in the United States 
and foreign-born women of African descent 
(Gray and Littlefield 2002; NIH, ORWH 1999). 
While this section focuses primarily on African-
American women born in the United States, 
further research is needed to identify intragroup 
variations in substance abuse etiology and 
effective treatments. 
More than 32 million African Americans live in 
the United States, including sizable numbers 
of both African and African-Caribbean 
immigrants. It is a relatively young population: 
32 percent of all African Americans are under 
age 18. More than half live in a central city 
within a metropolitan area. African Americans 
represent 12.3 percent of the U.S. population 
(U.S. Census Bureau 2001f). Nineteen million, 
or more than half, of all African Americans are 
females (U.S. Census Bureau 2001d). Among 
African-American women, poverty is more 
prevalent than in the general population (Gray 
and Littlefield 2002). Among African-American 
single mothers, approximately 35 percent live in 
poverty compared to 19 percent of non-Hispanic 
single white mothers. 
Although genetics account for differential rates 
of some diseases among African Americans 
(e.g., sickle cell anemia), biology alone 
explains very little about the disparities in 
health status between African Americans and 
Caucasians. Overall, African Americans have 
disproportionately higher rates of disease and 
illness, a wider variety of undetected diseases, 
more chronic health conditions, and shorter 
life expectancies than Caucasians. African-
American women experience higher morbidity 
and mortality rates than do Caucasian women 
for many health conditions (Minino et al. 2002). 
Substance use among African 
Americans 
Even though the total substance abuse 
admissions among African Americans has been 
steadily declining since the 1990s, TEDS reports 
that 21 percent of admissions to substance abuse 
treatment facilities were African American 
in 2006 in comparison to 12 percent of non-
Hispanic population (HHS 2008a). The primary 
source of referral to treatment among African-
American women was through self-referral or by 
family and friends (SAMHSA 2004). 
Alcohol 
According to TEDS (HHS 2008a), alcohol 
accounted for 25 percent of substance abuse 
treatment admissions among African-American 
women. While most research highlights 
differences in alcohol use patterns between 
African-American women and men, and between 
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African-American women and other diverse 
groups of women, little attention is given in 
reporting on the diversity of use among African-
American women within their cohort group 
and throughout their lifespan. In one study 
comparing differences in alcohol prevalence 
across age groups, ethnicity, and gender, 
prevalence rates among African-American 
females from 19 to 29 years of age rose from 
2 percent to 4 percent between 1992 and 2002 
(Grant et al. 2006). In a study evaluating the 
correlates of alcohol consumption of African-
American women, women age 40 to 49 have 
shown the highest prevalence of alcohol 
consumption (Rosenberg et al. 2002). 
Illicit drug use 
Among African-American women, most 
admissions to treatment facilities were for 
cocaine/crack abuse (35 percent; HHS 2008a). 
From the same data set, opioids, primarily 
heroin, accounted for 18 percent of substance-
related admissions. In a study that focused 
on severity of alcohol use and crack/cocaine, 
evidence suggests that as the level of alcohol 
consumption increases among African-American 
women, the severity of symptoms associated 
with comorbid mental disorders, sexual risk 
behaviors, and consumption of crack/cocaine 
increases significantly (Zule et al. 2002). Among 
African Americans identified as individuals 
who use crack-cocaine, more than 70 percent 
reported concerns regarding food, clothing, 
and transportation, and approximately 50 
percent reported problems associated with 
shelter, medical issues, and employment (Zule 
et al. 2003). With less adequate housing, 
financial resources, medical care, and higher 
cumulative stress, African-American women 
face an increased susceptibility to substance use 
disorders and other health conditions. 
Clinical treatment issues 
Beginning in the 1990s, research on African-
American women with substance use disorders 
focused on low-income, urban women who 
were dependent on cocaine (Roberts et al. 
2000). Now, literature on substance abuse and 
treatment among African-American women 
has expanded and environmental stressors 
have been examined, including psychosocial, 
sociodemographic, and economic disparities. 
While research remains limited in the area of 
treatment approaches and strategies, literature 
is beginning to reflect promising practices for 
African-American women. 
From the outset, it is vital that African-
American women have access to services that 
provide social support during their pursuit 
of recovery. Research suggests that African-
American women are at risk for substance abuse 
due to the level of exposure to biopsychosocial 
and economic stressors and the subsequent 
difficulty in coping with these life circumstances 
(Gray and Littlefield 2002). They often 
experience greater emotional distress and 
more relationship problems (Liepman et al. 
1993; Henderson 1994). Similar to all groups 
of women, African Americans have very high 
rates of trauma and abuse, so treatment needs to 
utilize trauma-informed services. 
Coupled with direct and indirect effects of 
historical trauma (including a history of slavery, 
lynchings, and racism) (Barnes-Josiah 2004), 
African-American women disproportionately 
experience negative health and social 
consequences of alcohol and drug use (Boyd 
et al. 2006). For example, African-American 
women are more likely to have their children 
legally removed from their custody, in part, 
as a result of societal bias and discrimination 
(Wallace 1990). Additionally African-American 
women are 10 times more likely than Caucasian 
women to have positive drug screens. Yet, 
this difference may be directly related to a 
disproportionate percentage of testing among 
African-American women (Neuspiel 1996). 
Subsequently, this threat of loss of child custody 
or legal sanctions for drug use during pregnancy 
may prevent African-American women from 
obtaining prenatal care or seeking substance 
abuse treatment. Nonetheless, once treatment 
is initiated, issues surrounding pregnancy, child 
care, parenting, and custody need be addressed 
in a nonthreatening but constructive manner–– 
showing support and guidance in promoting and 
nourishing a healthy parent–child relationship. 
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Other health consequences include a higher 
risk for developing alcohol-related disorders, 
including liver cirrhosis, and a greater 
propensity to experience toxic effects of cocaine 
that may lead to earlier onset or greater risk for 
health problems, particularly cardiovascular 
disease (D’Avanzo et al. 2001). According to the 
HIV/AIDS Surveillance Report (CDC 2007), 
African-American women are 23 times as likely 
to be diagnosed with HIV/AIDS in comparison 
to white women, and 4 times more likely than 
Hispanic women. Among African-American 
women with HIV/AIDS, 74 percent acquired 
HIV/AIDS through high-risk heterosexual 
transmission and 24 percent were infected with 
HIV through injection drug use. To effectively 
address pertinent health and clinical issues, 
treatment programs also need to incorporate 
HIV/AIDS prevention, intervention, and 
treatment services. 
Coupled with these risk factors, there is a 
common myth that African-American women 
“can withstand any amount of pain and keep 
on working” (McGee et al. 1985; p. 7). This 
myth may have significant consequences for 
African-American women who have substance 
use disorders––delaying treatment, sacrifi cing 
self to care for others, and negating the need 
for preventive health care and substance abuse 
treatment. (For further review of roles and 
expectations of African-American women, see 
Reid 2000.) 
Once in treatment, African-American women 
need a gender-responsive, strengths-based 
model to develop or enhance a sense of 
empowerment by recognizing their assets 
and history of fortitude (Roberts et al. 2000; 
p. 905). This model provides a framework 
whereby treatment shifts the focus away from 
individual internal deficits. For African-
American women with substance use disorders, 
treatment approaches need to extend beyond 
the general parameters of gender-responsive 
treatment to include interventions that focus on 
social contexts across multisystems including 
social networks or groups, family involvement 
and therapy, and community involvement and 
interventions (Boyd-Franklin 1989; Bell 2002). 
Likewise, spiritual components and Afrocentric 
perspectives need to be incorporated into 
treatment to ensure a holistic approach and 
to assist African-American women in recovery 
(Brome et al. 2000; Rhodes and Johnson 1997; 
Roberts et al. 2000). 
Role of spirituality and faith-
based recovery 
Although there is no “one size fits all” defi nition 
of spirituality, spiritual activities nevertheless 
offer women in recovery an outlet to express 
problems, seek guidance from others or from 
a higher power, and move from disharmony to 
harmony with self and others without fear of 
repercussion, shame, or punitive actions (Brome 
et al. 2000). America has an extensive history 
of religious movements and spiritually led 
programs that address substance abuse (White 
and Whiters 2005). Today, there is more focus 
on the importance of integrating these faith-
based approaches into addiction treatment, 
and more recognition that African-American 
churches can be a vital recovery tool. 
Spirituality has been an important source of 
support for many African-American women 
(Lewis 2004). Historically, spirituality and 
religion have provided a central organizing 
framework for self-defi nition, problemsolving, 
and connection to self and others, especially 
among African-American women. Black 
churches have led the promotion of health care, 
disease prevention, and psychological well-being 
(Leong 2006). Overall, women in recovery from 
substance use disorders who express high levels 
of spirituality demonstrate a more positive self-
concept, better attitude toward parenting and 
perception of family climate, more active coping 
style, and greater satisfaction with their social 
support than women who are in recovery but 
expressed lower levels of spirituality (Brome et 
al. 2000). Notably, treatment providers need to 
understand how African-American women relate 
to traditional religion and spirituality and how 
that relates to positive mental health outcomes. 
For an overview of spirituality and religion and 
its implications for psychotherapy with African-
American families, refer to Boyd-Franklin and 
Lockwood 2009. 
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 Role of an Afrocentric perspective 
Though it is important not to make the 
assumption that all African-American women 
want to identify with a particular African 
tradition, acknowledgment of the richness of 
the African-American heritage or adoption of 
an Afrocentric perspective is another crucial 
component of a culturally and gender-responsive 
treatment program for many African-American 
women. As an example, The Iwo San Program, 
located in Cleveland, Ohio, incorporated an 
Afrocentric component in treatment, along 
with cognitive–behavioral therapy and an 
Afrocentric approach to the 12-Step program, 
with a primary goal of increasing the women’s 
understanding of what it means to be African 
American and of promoting self-pride through 
embracing African ancestry, history, and culture 
(CSAT 2003b). Women learned and used the 
“Seven Principles” from the Swahili tradition 
and community as a guide for daily living. (For 
review, see text box below.) 
The concepts of empowerment, the positive role 
of African-American women in the family and 
larger community, and the ability to build on 
their inherent strengths in the face of adversity 
are important to culturally responsive treatment 
(Rhodes and Johnson 1997). By incorporating 
an Afrocentric worldview in substance abuse 
treatment, African-American women will likely 
benefit from this critical protective factor  
in enhancing self-image, self-esteem, and 
centeredness in recovery (Roberts et al. 2000). 
Role of group, cognitive– 
behavioral, and family therapy 
Group therapy and adapted cognitive– 
behavioral therapy (CBT) show promise when 
grounded in the African-American worldview 
(Brown et al. 1995; Holcomb-McCoy 2004; 
Washington and Moxley 2003). By placing 
emphasis on the importance of community, 
group therapy can be a powerful and culturally 
appropriate approach that provides a 
supportive recovery environment and acts as 
a buffer to stressors associated with recovery. 
In essence, it is an opportunity to reinforce or 
rebuild a community connection that supports 
health. (Refer to Figure 6-1 for a review of 
promising practices and strategies.) 
CBT may be a noteworthy substance abuse 
treatment approach if adapted to fit the African- 
American worldview. Yet, minimal research 
has been carried out on the effectiveness of 
CBT and substance use disorders. Between 
1950 and 2006, only 12 studies have examined 
CBT among ethnically diverse populations, 
with only one study focused on substance abuse 
and CBT (Horrell 2008). While this one study 
suggests effectiveness with CBT (as measured 
by reduction in frequency and amount of drug 
Nguzo Saba: The Seven Principles 
Umoja (Unity) 
Kujichagulia (Self-Determination) 
Ujima (Collective Work and Responsibility) 
Ujamaa (Cooperative Economics) 
Nia (Purpose) 
Kuumba (Creativity) 
Imani (Faith) 
Source: Karenga 1998. Note: These seven principles are associated with each day of 
celebration of Kwanzaa. 
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Figure 6-1 
Group Therapy: Promising Practices and Strategies for 
African-American Women 
• 	 Endorse group work to promote values of strong kinship and emphasis on community. 
• 	 Promote cohesiveness through closed group formats (same group members from start to 
fi nish). 
• 	 If feasible, limit group participation to African-American women to enhance safety and 
comfort. 
• 	 Use meditative, spiritual, and experiential exercises to build upon internal strengths. 
• 	 Use opening and closing rituals, including a termination ritual at the end of the group. 
• 	 Incorporate African ancestry and cultural practices. 
• 	 Adapt language to involve recovery in context of family and community. 
• 	 Adopt culturally specific content in treatment modules including themes surrounding 
relationships, spirituality, family, ethnic, and cultural identity. 
• 	 Draw upon African-American history as a foundation of recovery, using examples from the 
work of artists, writers, musicians, heroes, spiritual and political leaders, etc. 
Sources: CSAT 2003b; Holcomb-McCoy 2004; Kohn et al. 2002. 
use among African-American clients), the 
results need to be cautiously interpreted due to 
a high participant dropout rate. To date, more 
research is needed to examine the effectiveness 
of CBT with ethnically diverse adult populations 
with substance use disorders. While research 
is limited, there is emerging evidence that CBT 
can be a helpful approach among African-
American clients. Kelly (2006) states that 
CBT may offer African-American women an 
opportunity of empowerment, supported by a 
nonjudgmental and collaborative therapeutic 
relationship, and centered on skill and support 
system development. It can be easily adapted to 
match a strength-based approach rather than a 
deficit model. To help decrease the Eurocentric 
bias in CBT, clinicians should avoid projecting 
or overemphasizing the value of cognition 
without incorporating the relevance of emotional 
expression and spirituality. As important, CBT 
should recognize and emphasize the importance 
of family and community support as an integral 
part of recovery. 
Regardless of approach, treatment should 
evolve around the premise that family and 
community are essential elements to healing and 
recovery. Treatment programs and counselors 
can endorse these values within the program by 
using mentors from the community for women 
in early stages of recovery (Stahler et al. 2005). 
Overall, more attention is needed to involve and 
incorporate a multisystems framework including 
a family systems approach in treatment. Family 
therapy is characteristically a more pertinent 
mode of therapy for African-American women 
(Boyd-Franklin 1989). 
Resiliency factors 
Consistent with earlier work (Hill 1972), Gary 
and Littlefield (1998, p. 99) identifi ed the 
following resiliency factors in their study of 
African-American families: 
• 	 A high degree of religious or spiritual 
orientation (as evidenced by church 
membership, church attendance, a sense of 
right and wrong, teaching moral values, and 
a shared religious core) 
• 	 A sense of racial pride (telling their children 
about Black history, discussing racism in 
one’s family, telling children what it is like to 
be African American, preference for being 
identified as an African American) 
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 Advice to Clinicians and Administrators: 
Substance Abuse Treatment and African-American Women 
Clinical: 
• 	 Incorporate a strengths-based approach versus reliance on a traditional defi cit model. 
• 	 Use an Afrocentric perspective, when appropriate and welcomed, to provide a 
framework for recovery. 
• 	 Involve family members and community to build a network of safety and support. 
• 	 Recognize the relevance of spirituality with the client, and encourage involvement to 
enhance or secure recovery. 
Program Development: 
• 	 Use elements of the African-American heritage or adopt an Afrocentric perspective to 
provide a more culturally responsive treatment program. 
• 	 Create program policies and procedures that support rather than limit family and 
community involvement. 
• 	 Develop treatment strategies that strengthen a sense of community within the 
treatment program, and create avenues to broaden this sense of community beyond 
the program; i.e., providing outreach activities or inviting community members to 
treatment graduation exercises. 
• 	 Invest in workforce development for African-American staff. 
Staff Training: 
• 	 Provide culturally competent staff trainings promoting an understanding of— 
− African-American history and heritage. 
− The role of racism and discrimination in stress-related health issues and substance 
abuse. 
− The potential role and importance of spirituality in recovery. 
− Various African traditions and beliefs, and the knowledge of resources to support 
an Afrocentric perspective with the client. 
− The value and necessity of outreach services to the African-American community. 
• 	 A strong achievement orientation (high 
expectations for achievement and attainment, 
goal directedness, etc.) 
• 	 Resourcefulness (possessing personal talents 
and skills, self-reliance, self-suffi ciency, 
independence, and the ability to cope with 
crises) 
• 	 Family unity (possessing a sense of 
cohesiveness, family pride, family 
togetherness, and commitment; i.e., the 
family comes fi rst) 
• 	 Display of love and acceptance (the ability 
to affirm one another and to respect,  
appreciate, and trust one another) 
• 	 An adaptability of family roles (having 
role flexibility , sharing responsibility, and 
communicating with one another) 
• 	 A strong kinship bond (e.g., a high degree of 
commitment to the family, a feeling of mutual 
obligation, kin interaction, and support) 
• 	 Community involvement (service to others 
and membership and active involvement in 
community organizations) 
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Asian- and Pacifi c-American 
Women 
Demographics 
Asian origins can be traced to many countries, 
including Cambodia, China, India, Japan, 
Korea, Laos, the Philippines, Vietnam, and 
others. By some counts, the number of national 
and ethnic groups is nearly 50, representing 
more than 60 primary languages (Barnes and 
Bennett 2002; Grieco 2001; New York State 
Education Department 1997). The three largest 
groups of Pacific Islanders are Hawaiians, 
Guamanians or Chamorros, and Samoans 
(from the Mariana Islands, of which Guam 
is the largest). In all, 24 different groups are 
considered Pacific Islander, and individuals 
from many of these groups have migrated to the 
United States. More than half of U.S. residents 
who are Pacific Islanders live in California and 
Hawaii (Grieco 2001). Yet, over the past few 
decades, the Asian-American and Pacifi c-Island 
populations have become increasingly dispersed 
across the United States (U.S. Census Bureau 
2001f). 
Asian and Pacific Americans are a rapidly 
growing group, increasing by more than 7 
million over the last 20 years (U.S. Census 
Bureau 2001c). According to the 2002 Census, 
Asian and Pacific Americans constitute about 
4.4 percent of the total U.S. population (12.5 
million individuals), of whom slightly more than 
half (51.6 percent) are women (U.S. Census 
Bureau 2001d). Asian- and Pacifi c-American 
women represent 13 percent of all women of 
color (U.S. Census Bureau 2001d). They are a 
relatively young group with 25 percent under 
age 18. Asian and Pacific Americans are both 
more likely to occupy one or the other end 
of the continuum in educational and income 
levels––either obtaining the highest educational 
and income levels or experiencing considerable 
poverty and a lack of education in comparison 
to non-Hispanic whites (Reeves and Bennett 
2003). 
Substance abuse among Asian 
and Pacifi c Americans 
Although Asian and Pacifi c Americans 
constitute about 4 percent of the population, 
they represent less than 1 percent of admissions 
to substance abuse treatment facilities in 
1999. However, this represents an increase in 
treatment admissions of 37 percent from 1994 to 
1999 among this population (SAMHSA 2004). 
Alcohol 
In comparison to other ethnic groups, this 
population has the lowest percentage of 
current drinking history and of past year 
alcohol dependence or abuse (SAMHSA 2006). 
According to the results from SAMHSA’s 2006 
National Survey on Drug Use and Health 
(NSDUH; SAMHSA 2007), the rate of binge 
alcohol use was also the lowest among Asian 
Americans. Of the 3,951 Asian- and Pacifi c-
American women admitted for substance abuse 
treatment in 1999, 27 percent of admissions were 
for alcohol abuse, a relatively low proportion 
(SAMHSA 2004). 
Lower percentages of alcohol intake may be, 
in part, a result of the genetic disposition of 
the “flushing” response among Asians (Collins 
and McNair 2002). More than 25 percent of 
Asians possess a gene that causes a slower 
metabolism of normal oxidation of acetaldehyde. 
With elevated levels of acetaldehyde in the 
blood, individuals may experience a range 
of physical reactions including perspiration, 
heart palpitations and tachycardia, nausea, 
headaches, and facial fl ushing. Individual 
reactions can vary in intensity and time of onset, 
which also contributes to the amount of alcohol 
consumed (Weatherspoon et al. 2001). 
Alcohol patterns are largely influenced by the 
norms established within Asian communities 
in the United States, or by the cultural norms 
established in the country of origin. The low 
drinking rates among women of all Asian- and 
Pacific-American groups seem to derive in part 
from the large numbers of abstainers among 
the foreign-born population. Those born in 
the United States are more likely to use alcohol 
and tobacco. Various studies have shown that 
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 educated, young, middle-aged Asian-American 
women, with higher levels of acculturation, are 
more likely to drink than other subpopulations 
of Asian-American women (Gilbert and Collins 
1997; Towle 1988). Among Asian-American 
groups of recent immigrant status, it is more 
difficult to determine specific substance abuse   
and dependence patterns. In addition, recent 
immigrants are less likely to seek treatment and 
less able to access treatment services; therefore, 
they are not as likely to be represented when 
assessing prevalence. 
Regarding cultural norms, solitary drinking 
practices generally are discouraged and 
often carry significant consequences. Among  
recent and other fi rst-generation immigrants, 
the importance of maintaining face, coupled 
with insufficient understanding of substance  
use–related problems, can result in denial of 
substance abuse problems, family sanctioning, 
or collusion in substance abuse–related 
behaviors if drinking practices exceed cultural 
practices and expectations (Chang 2000). 
According to the TEDS (SAMHSA 2006), 26 
percent of Asian and Pacific Americans identify  
alcohol as their primary drug of choice upon 
treatment admission. 
Illicit drug use 
The rates of illicit drug use are relatively 
low among Asian- and Pacifi c-American 
women compared with other racial and ethnic 
groups. Currently, methamphetamine (33 
percent) bypasses alcohol as the primary drug 
Advice to Clinicians and Administrators: 
Substance Abuse Treatment and Asian- and Pacifi c-American Women 
Note: Minimal treatment research is available pertaining to substance abuse treatment among Asian- 
and Pacifi c-American women. Therefore, information was gathered using literature across various 
modalities in behavioral health to help support the following recommendations. 
Clinical: 
• 	 Address the importance of ethnic heritage and assess the level of acculturation in 
the beginning of treatment in order to avoid making assumptions regarding cultural 
values, family structure, gender roles, and styles of communication. 
• 	 Incorporate drug and alcohol education in order to reduce the stigma attached to 
substance abuse and dependence. 
• 	 Approach treatment from the vantage point of promoting overall health rather than 
focusing solely on substance abuse; include a holistic connection between body, mind, 
and spirit. There is value in reframing the presenting problem by placing emphasis on 
the positive aspects for change. 
• 	 Provide a nurturing environment that does not encourage cultural and gender-related 
tendencies toward self-blame (Kitano and Louie 2002). 
• 	 Develop trust and build a therapeutic alliance to help decrease internalized feelings of 
guilt and shame. 
• 	 Honor the importance of family as the focal point, and that maintaining family honor, 
obligations, and responsibilities are central to women. 
• 	 Focus on problemsolving, goal-oriented, and symptom-reduction strategies to 
circumvent the likely shame associated with delving into past alcohol or drug use 
behavior. 
• 	 Explore the history of trauma and the potential for posttraumatic stress symptoms and 
disorder. Many older immigrant Asian-American women have been exposed to losses, 
torture, and other types of war-related trauma. 
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Advice to Clinicians and Administrators: 
Substance Abuse Treatment and 
Asian- and Pacific-American Women (continued) 
Program Development: 
Use a psychoeducational model as an integral ingredient in treatment.• 
Consider the appropriateness of home visits to engage families from the outset prior• 
to individual treatment services. 
Incorporate native language services or community resources, e.g., interpreter• 
services. 
Provide separate treatment groups for women to reduce restrictions imposed by• 
gender role expectations. 
Develop a psychoeducational family treatment program to support the individual in• 
relation to her family and to provide education regarding addiction. 
Implement a lecture series that addresses both Western and traditional concepts of • 
disease and treatment. 
Consider the adaptation of a peer-to-peer support group to establish or support • 
culturally appropriate individual and community supports for recovery. 
Staff Training: 
Provide culturally competent staff training to promote an understanding: • 
Of the diversity of Asian- and Pacific-American women and of the relevance of • 
cultural, language, and socioeconomic barriers. 
Of the role of acculturation in alcohol and drug use practices.−
That reporting substance abuse problems can be a significant source of shame for −
women and her family, and can be perceived as hurtful toward family. 
Of the importance of “otherness” and the relevance of community and family in−
the perception of self-identity as a women. 
That family is central, along with the maintenance of family obligations.−
That individuals with socially stigmatized behaviors, such as drug abuse, may−
experience significant consequences from their family and community. 
That traditional gender roles are often restrictive and influenced by generational −
and acculturation levels. 
That communication is more likely to follow a hierarchy pattern whereby elders−
are respected. 
Sources: Chang 2000; Kitano and Louie 2002; McGoldrick et al. 1996; Torsch and Xuequin 2000. 
of abuse upon treatment admission. After 
methamphetamine, the most frequent cause 
of admission for illicit drug use among Asian-
American women is marijuana (16 percent), 
followed by opioids (11 percent), and cocaine/ 
crack (11 percent) (HHS 2008a). Yet, variations 
exist across subpopulations in drug and alcohol 
patterns. 
Clinical treatment issues 
Foremost, treatment providers need to 
understand, acknowledge, and incorporate 
cultural values within the treatment process. 
The family is the center of most Asian and 
Pacific Island cultures and is an important 
consideration for effective treatment for 
women. The definition of family is expansive 
Substance Abuse Among Specific Population Groups and Settings 117 
  
 
 
 
 
 
 
 
“Acculturation… 
refers to the manner 	
in which individuals 
negotiate two or 
more cultures 
where one culture is 
considered dominant 
while the other 
culture is perceived 
to have less cultural 
value” (Leong et al. 	
2007, p. 424). 
and includes not only 
immediate and extended
family members 
determined by blood 
and marriage, but also
other members of the 
community. Among 
women, family ties,
loyalties, cultural
expectations, and 
beliefs can serve as a
protective factor against
substance abuse (Joe 
1996). Moreover, the 
concept and value of
interrelatedness among 
family, community, 

environment, and

the spiritual world is 
essential in many Asian 
and Pacifi c Island 
cultures, and these tenets should be woven 
throughout the treatment program and clinical 
services (for an overview of treating Asian- and 
Pacific-American clients and their families, refer  
to Chang 2000). 
More than 65 percent of the Asian-American 
population is foreign-born (U.S. Census Bureau 
2004). Thus, stress specific to immigration  
and acculturation is more likely. This has 
significant implications for treatment planning  
and services in a variety of ways, particularly 
in accessing and addressing acculturation stress 
and its relationship to substance use and other 
psychological symptoms, specifi cally depression 
(Chen et al. 2003). 
A complex set of barriers to care can discourage 
Asian- and Pacific-American women from  
availing themselves of substance abuse treatment 
and other health care. Asian-American women 
who do not speak English or whose cultural 
traditions include a sense of shame for ill health 
often do not seek medical care (Leigh 2006). The 
problem is compounded by the unsurprising 
denial of substance abuse in a climate that 
favors family ties, a reverence for authority, and 
the dearth of culturally responsive substance 
abuse treatment services (Kitano and Louie 
2002, p. 352). In addition, women typically 
assume the role of primary caretaker, holding 
the essential responsibility of nurturing and 
supporting the family, even at the expense of 
individual health concerns. 
The development of empirically supported 
methods is evolving, yet research relevant to 
specific treatment needs among Asian- and 
Pacific-American women is sparse. Borrowing 
from the field of cross-cultural psychotherapy 
(Chang 2000; Leong and Lee 2006), treatment 
requires thorough assessment that includes such 
factors as circumstances of immigration, degree 
of assimilation, ethnic background, and health 
beliefs. The Asian American Multidimensional 
Acculturation Scale shows considerable promise 
in assessing women’s multidimensional levels of 
acculturation (Chung et al. 2004). It provides a 
more comprehensive assessment of acculturation 
and its effect on psychological functioning. 
Although outcome research specific to Asian- 
and Pacific-American women in substance abuse 
treatment is lacking, preliminary research with 
Asian Americans in community-based substance 
abuse treatment found no overall group 
differences in treatment retention and outcomes 
(Niv et al. 2007). 
Resiliency factors 
As mentioned above, Asian and Pacifi c 
Americans share an ethic of hard work and 
family orientation, as well as a cultural concept 
of interrelatedness among family, community, 
environment, and spiritual world. In addition, 
the following observations have been noted in 
the literature: 
• 	 If incorporated thoughtfully into the 
treatment process, the family can have a 
signifi cant influence on treatment outcome. 
At the very least, consideration should be 
given to the family’s role in substance abuse 
as well as to members’ participation in 
treatment and influence on recovery (Chang 
2000). 
• 	 Some clients might find incorporation of 
indigenous treatment modalities—such 
as healing ceremonies, acupuncture, 
meditation, massage, tai-chi, and herbal 
medicines—helpful (Kitano and Louie 2002). 
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American-Indian and Alaska-
Native Women 
Demographics 
In the 2000 census, those who reported Alaska
Native or American Indian as their only race/ 
ethnic group totaled nearly 2.5 million, while the
number reporting Alaska Native or American
Indian in combination with another race/ethnic
group numbered 4.1 million (U.S. Census Bureau
2001e), or 1.5 percent of the U.S. population.
Alaska Native/American Indian is the smallest
of the four major racial/ethnic groups currently
recognized in the United States. Their small
numbers, however, mask signifi cant diversity. 
The largest concentrations of Native people 
reside in three States: Arizona, California, 
and Oklahoma (U.S. Census Bureau 2001f). 
However, American Indians and Alaska Natives 
may live anywhere in North America on and 
off reservations or other forms of tribal land, 
in rural or urban areas, and within villages 
(Coyhis 2000). Today, American-Indian and 
Alaska-Native nations (e.g., Navajo, Iroquois) 
encompass more than 560 federally recognized 
Tribes, including more than 220 Alaskan 
villages, in addition to numerous Tribes that are 
not yet federally recognized. Historically, this 
diversity, as well as the separation of this group 
into many small segments scattered throughout 
the United States, has complicated efforts to 
identify commonalities through classifi cation 
(NIH; ORWH 1999). Nevertheless, some 
experiences shared by many Tribes have been 
noted (NIH; ORWH 1999): 
• 	 Rapid change from a cooperative, self-
sufficient, clan-based society to a family-
based community dependent on trade 
• 	 Prior government criminalization of the use 
of native language and spiritual practices 
• 	 Deaths of members of the older generations 
to infectious diseases and war 
• 	 Loss of the ancestral lands 
The rates of unemployment, poverty, and 
education; poor health status; and alcohol 
and drug use vary by Tribe and by region. 
The current poverty level is 27 percent among 
Native Americans (U.S. Census Bureau 2006). 
Unemployment hovers at about 13 percent 
for females older than age 16 (Indian Health 
Service [IHS] 2002). The proportion of family 
households maintained by women with no 
spouse is approximately 21 percent (U.S. Census 
Bureau 2000). 
Substance use among American 
Indians and Alaska Natives 
Although representing only 1.5 percent of 
the U.S. population, American Indians/ 
Alaska Natives represented 2.1 percent of all 
admissions to publicly funded substance abuse 
treatment facilities. Of these, 36 percent were 
female (SAMHSA 2004). Based on the NSDUH, 
including alcohol and illicit drugs, Native 
American women were more likely than any 
other ethnic group to have met criteria for past 
year need for substance abuse treatment (OAS 
2006a). For more comprehensive information 
on substance abuse treatment, see the planned 
TIP Substance Abuse Treatment with American 
Indians and Alaska Natives (CSAT in 
development e). 
Alcohol 
Nearly 14 percent of Native-American women 
were dependent on or abused alcohol between 
2004 and 2005 (SAMHSA 2007). Compared 
with other substances, alcohol was by far the 
most frequently reported reason (52 percent) 
for admission to a treatment facility among 
women (OAS 2006a). The data also show that 
this group initiates alcohol use at an earlier 
age than other racial/ethnic groups (SAMHSA 
2004). Among women of all races aged 35 to 44, 
4.9 per 100,000 died of alcohol-related disease. 
However, the alcohol-related death rate among 
American-Indian and Alaska-Native women in 
this age range is 67.2 per 100,000 (IHS 2002). 
According to the CDC (2001), American-Indian 
women have higher rates of alcohol abuse, 
chronic liver disease, and cirrhosis than any 
other racial/ethnic group in the United States. 
Illicit drug use 
Among Native Americans, the rate of current 
illicit drug use (12.6 percent) is higher than 
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any other race or ethnicity in United States 
according to the NSDUH (SAMHSA 2006). 
After alcohol abuse, the most common cause for 
Alaska Native and American Indian admission 
to treatment is methamphetamine (15 percent; 
SAMHSA 2006), followed by marijuana 
(13 percent), and cocaine/crack (7 percent; 
SAMHSA 2006). According to one study 
investigating gender differences among Alaska 
Natives in inpatient treatment (Malcolm et al. 
2006), women reported higher rates of cocaine 
dependence in addition to alcohol dependence 
while men had higher rates of marijuana and 
alcohol dependence. Although the trend for 
inhalant abuse is declining among American 
Indians, studies have shown that American-
Indian females are using inhalants more than 
American-Indian males (Beauvais et al. 2002). 
Among urban American-Indian women who 
abuse drugs, Stevens (2001) found that most 
lived below the poverty level, were unemployed 
and homeless, experienced a particularly high 
number of pregnancies and stillbirths, and had 
children remanded to the custody of State and 
tribal child protective services. 
Clinical treatment issues 
Substance use patterns and treatment issues 
among many groups of American Indians 
and Alaska Natives have not been studied 
adequately; as a result, many issues specifi c to 
these groups are not well known. Overall, wide 
variations in alcohol and drug use patterns— 
along with access to treatment and other needed 
health services—exist across American-Indian 
and Alaska-Native communities (Berkowitz et 
al. 1998; Vernon 2007). While similar barriers 
exist for Native-American women in comparison 
to other women with substance use disorders, 
Native-American women often encounter more 
barriers that impede access to treatment; i.e., 
economic hardships, treatment accessibility, 
lack of screening and assessment, and gender-
responsive programming (Berkowitz et al. 1998; 
Parks et al. 2003). 
Comprehensive attention to health care 
and health status is crucial for treatment of 
American-Indian and Alaska-Native women. 
Stevens (2001) suggests that medical and 
substance abuse treatment providers need 
to work hand-in-hand to meet the needs of 
Native-American women, and that primary care 
providers should routinely screen for alcohol 
and drug abuse and discuss the negative health 
consequences of substance use in a culturally 
responsive manner during regular examinations. 
Unfortunately, few American-Indian and 
Alaska-Native women who abuse alcohol and 
illicit drugs are referred or enrolled in treatment 
programs of any type. For Native-American 
women living in rural areas, available treatment 
programs usually are neither woman-centered 
nor culturally specific. Moreover, many Native-
American women are reluctant to attend 
treatment programs with non-Native Americans 
(Hussong et al. 1994). Some prefer participating 
in reservation-based programs, while others may 
be reluctant to participate in small community 
programs or urban health centers due to 
concerns surrounding confi dentiality (Jumper 
Thurman and Plested 1998). Others may seek 
treatment elsewhere but express concerns 
surrounding available support upon reentering 
the reservation after treatment (Berkowitz et al. 
1998). Subsequently, Native-American women 
are more likely to need help deciding on the 
location of their treatment program. 
Trauma-informed services 
American-Indian women are disproportionately 
affected by violent crimes, childhood sexual 
abuse, and physical abuse. Nearly three-fourths 
(73.3 percent) of Alaska-Native women in 
one program reported sexual abuse histories 
(Brems 1996). Beyond specific traumas among 
Native Americans, treatment programs need to 
incorporate a culturally responsive framework 
that understands and addresses the legacy 
of historical and cumulative trauma (Robin 
et al. 1997), including forced acculturation 
and deculturalization (e.g., loss of cultural, 
community, individual identity) of American-
Indian and Alaska-Native communities. These 
losses have sometimes been expressed in higher 
suicide and homicide rates among Native-
American community members. As part of 
recovery, women will likely need to address the 
loss of family members or friends. Likewise, 
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Advice to Clinicians and Administrators: 
Substance Abuse Treatment and Native-American Women 
Clinical: 
• 	 Assess for the history of traumatic events, including sexual and physical abuse, and 
the diagnosis of PTSD. 
• 	 Provide trauma-informed services that encompass the impact of cumulative stress 
from historical trauma to specifi c trauma. 
• 	 Recognize that the role of “helper” may extend beyond substance abuse counseling 
to seeking advice for other health concerns, for other family members, or for other 
life circumstances or stressors. 
• 	 Acknowledge the importance of family history and extended family members, and as 
deemed appropriate, involve family members during the course of treatment. 
• 	 Explore the woman’s beliefs regarding healing and knowledge of cultural practices. 
Don’t assume that a Native-American woman follows traditional practices. 
• 	 Understand and acknowledge the specific Tribe’s cultural values, beliefs, and practices, 
including customs, habits, sex roles, rituals, and communication styles. 
Program Development: 
• 	 Take time to invest in the individual Native community and learn the perceptions 
toward non-Native counselors. 
• 	 Use treatment as a prevention opportunity for FASD. Provide an interactive program 
that not only educates women on the cause and prevalence of FAS and Fetal Alcohol 
Effects (FAE), but provides an understanding of the behavioral effects that are often 
associated with this syndrome. 
• 	 Incorporate comprehensive HIV/AIDS prevention and intervention services into 
treatment. 
• 	 Adopt trauma-informed services and consider an integrated model of specifi c services 
for substance-use disorders and trauma. 
• 	 Combine contemporary approaches with traditional/spiritual practices; i.e., medicine 
wheel, “Red Road to Wellbriety” (White Bison), smudging, sweat lodge ceremony, 
and talking circle. 
• 	 Implement a skills training program to help Native-American clients learn how to 
successfully negotiate both traditional and majority cultures after treatment (Hawkins 
and Walker 2005). 
Staff Training: 
• 	 Promote an understanding of the role of historical and intergenerational trauma as 
well as cultural oppression along with its impact on Native-American clients and its 
role in substance abuse. 
• 	 Provide learning opportunities that highlight the nature, history, and diversity of 
American-Indian and Alaska-Native communities. 
• 	 Address biases and myths associated with Native-American clients; e.g., fi rewater 
myth. 
• 	 Invest in learning the various and specific cultural patterns in coping with stress that 
may be unique to the specific community or Tribe. 
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Advice to Clinicians and Administrators:Substance Abuse 
Treatment and Native-American Women (continued) 
Staff Training (continued): 
Review and discuss the prevalence of HIV/AIDS, FASD, suicide and violence, and other • 
health related risks among Native-American communities. 
Use local tribal members as resource people in training and as staff members in • 
treatment programs. 
Source: Coyhis 2000; Evans-Campbell 2008; and Trimble and Jumper Thurman 2002. 
screening for traumatic events, posttraumatic 
stress disorder (PTSD), grief, and depressive 
symptoms should be routine. Treatment 
programs for Native-American women need 
to incorporate culturally congruent trauma-
informed and integrated trauma services to 
build a stronger bridge to recovery (Saylors and 
Daliparthy 2006). 
HIV/AIDS prevention and 
intervention comprehensive 
services 
In 2005, Native Americans ranked third in 
HIV/AIDS rates, with Native-American women 
accounting for 29 percent of the diagnoses. 
While rates vary from community to community 
(Vernon and Jumper Thurman 2005), the rise 
in HIV/AIDS cases among Native-American 
communities refl ects the 
need for attention in 
program development 
and treatment services
for substance use
disorders among women. 
Simoni and colleagues 
(2004) coined the term
“Triangle of Risk” in 
reference to the HIV 
risk factors: history of 
sexual trauma, injection
drug use, and HIV
sexual risk behaviors. 

Each risk factor is 
highly interrelated to 
the other factors and 
strongly associated 
“The work we 
do today will 
provide for the 
freedom of our 
future generations 
(Mohawk).” 
Source: The Freedom 
Way: The Native American 

Program at the Margaret 
A. Stutzman Addiction 	
Treatment Center, NY	 
with substance use disorders. While risk 
factors are not limited only to the “triangle of 
risk” (Vernon 2007), the prevalence of these 
risk factors clearly represents the necessity 
of comprehensive HIV/AIDS prevention and 
intervention services among Native-American 
women seeking treatment for substance abuse. 
Fetal alcohol prevention services 
Fetal Alcohol Spectrum disorders (FASD) 
are very serious problems in some Native 
communities. A four-State study showed that 
fetal alcohol syndrome (FAS) among American 
Indians and Alaska Natives occurred at the 
rate of 3.2 per 1,000 population over a 2-year 
period, compared with 0.4 per 1,000 in the total 
population of the same four States (Hymbaugh 
et al. 2002). As a means of prevention, 
gender-responsive treatment services have an 
opportunity to educate Native-American women 
on the impact of alcohol and drugs on fetal 
development. By adding prevention approaches 
for FASD in treatment, women can make better 
and more informed decisions regarding alcohol 
use during pregnancy. 
Culturally congruent substance 
abuse services 
Treatment professionals must approach health 
and well-being through the complementary 
lenses of culture, history, and the beliefs of 
Native-American people (LaFromboise et 
al. 1998; Stevens 2001). For many Native-
American women, the journey to reclaim their 
identities and culture is central to recovery 
(Brems 1996). The most critical feature for 
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treatment of American-Indian and Alaska-
Native women is that programs be culturally 
responsive, gender-responsive, and community-
based, and that they “reaffirm cultural values 
and consider the individual in the context of 
the community” (LaFromboise et al. 1998, p. 
150). A series of IHS-funded focus groups for 
women in treatment found that an emphasis on 
cultural activities was important to the women 
(Berkowitz et al. 1998), including sweat lodges, 
powwows, talking circles, tribal music and 
crafts, traditional foods, and meetings with 
medicine people and tribal elders. For many 
women, participating in tribal activities gave 
them a sense of belonging—some for the fi rst 
time (Berkowitz et al. 1998). This is important 
because the reasons that some Native-American 
women have given for alcohol and drug use 
include low self-esteem and “not fitting in with 
the white world” (Hussong et al. 1994). While 
it should not be assumed that every Native-
American woman is traditional; traditional 
healing should be made available as a treatment 
option or as an adjunct to treatment. 
Family and community 
involvement 
Strong ties to family and community make 
community-based approaches appropriate 
because substance abuse is considered a family 
and community problem (Berkowitz et al. 1998). 
In some Native-American communities, alcohol 
consumption is the norm; abstainers may be 
ostracized. When drinking together is a major 
family activity, the woman who abstains may, 
in effect, lose her family. With such high rates 
of alcohol and drug use, a woman’s family and 
friends are unlikely to offer strong support for 
recovery. By acknowledging the role and the 
importance of family and community in either 
perpetuating the substance use or in providing 
a nurturing recovery environment, treatment 
providers must involve family and community 
members from the outset. As highlighted in 
the IHS-funded research on substance abuse 
treatment for Native Americans, comprehensive 
treatment must embrace and encourage 
community involvement and commitment to 
support long-term recovery (Berkowitz et al. 
1998). Literature suggests that the key factor in 
maintaining abstinence among Native-American 
women is the presence of tangible support 
(Oetzel et al. 2007). 
Resiliency factors 
In recent years, American-Indian communities 
have organized to promote their economies 
and cultures. In the mid-1990s, an Executive 
Order mandated the establishment of tribal 
colleges on or near reservations, and at least 50 
percent of the registered student population of 
these colleges must, by definition, be American 
Indians or Alaska Natives. Currently, American 
Indians are developing economic enterprises in 
the casino, recreation, and computer industries. 
Along with these advances, American-Indian 
and Alaska-Native peoples are revitalizing their 
native languages and cultures. Recent trends 
include movement back to the reservation. In 
addition, many American-Indian communities 
are very proactive about substance abuse issues. 
On reservations, many women have gone back to 
talking circles and are promoting the need to do 
things within cultural, family, and community 
contexts, including the creation of communities 
that are alcohol free (Berkowitz et al. 1998). The 
Williams Lake Band in Canada, for example, 
has become entirely alcohol and drug free. 
Another success story involves the Alkali Lake 
Band in British Columbia, which achieved a 
communitywide sobriety rate of 95 percent over 
a 15-year period (Berkowitz et al. 1998). 
Sexual Orientation and 
Women 
Demographics 
Several factors prevent an accurate measure 
of the number of women who identify as 
lesbian or bisexual, among them the absence 
of standardized terms and definitions of sexual 
orientation and gender identity (Dean et al. 
2000). However, general estimates of sexual 
orientation as lesbian or bisexual range from 1 
to 10 percent of the female population (Laumann 
et al. 1994; Michaels 1996). 
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Hughes and Eliason (2002) present defi nitions 
that are inclusive and highlight the differences 
between sexual orientation and gender identity. 
Their definition of “lesbian” or “gay” is “a 
woman or man whose primary sexual and 
emotional attachments are to persons of the 
same sex” (p. 266). “Bisexual” refers to “men 
or women who have sexual and/or emotional 
attachments to both men and women” (p. 266), 
although typically not at the same time. 
Substance Use Among Lesbian 
and Bisexual Women 
Limited research on alcohol and drug abuse has 
focused on issues related to sexual orientation 
(Hughes and Eliason 2002). What is known, 
however, is that within-group differences are 
significant. Early research attempts, specifi cally 
methods of data collection, may have reinforced 
misconceptions and stereotypical interpretations 
of substance use within these groups. Studies 
in the 1970s and 1980s revealed high rates of 
alcohol use and abuse among lesbians,, yet
most surveys were conducted at bars. Other
methodological limitations that remain consistent
to the present time are sample size and absence
of control groups (Hughes and Eliason 2002).
In addition, studies that evaluate drug patterns
are often focused on gay men. Little is known
about illicit and prescription drug abuse
patterns among lesbian and bisexual women.
In two population-based studies, researchers
found more drug use and heavy drinking
among bisexual and lesbian women than among
heterosexual women (Diamant et al. 2000). 
Alcohol 
Later research (Cochran et al. 2000; Hughes et 
al. 2000) supports the idea that earlier estimates 
of the relationship between sexual orientation 
and alcoholism are inflated. Nonetheless, these 
and other studies (Case et al. 2004; Cochran et 
al. 2000, 2001; Cochran and Mays 2000; Gilman 
et al. 2001; Parks and Hughes 2005; Sandfort 
et al. 2001) suggest that lesbian women—in 
comparison to heterosexual women—are more 
likely to use and abuse alcohol, less likely to 
decrease their use of alcohol with age, and 
more likely to report alcohol-related problems. 
Literature suggests that this greater prevalence 
of substance use and abuse may be related to 
more opportunities to drink, fewer traditional 
sex role expectations, and different social 
conventions about drinking (Hughes and 
Wilsnack 1997). 
Illicit drugs 
While little is known about drug patterns 
among lesbian and bisexual women, research 
suggests that they are at a heightened risk for 
drug use, with specific subpopulations showing 
more prevalence, such as young adult lesbian 
women (Hughes and Eliason 2002). In two 
studies (Cochran et al. 2004; Corliss et al. 2006), 
researchers report that women with female 
sexual partners had at least one symptom of 
dysfunctional drug use and were more likely to 
display impairment and meet criteria for any 
drug dependence in comparison to heterosexual 
women. Lesbians report greater problems 
associated with marijuana, cocaine, and 
hallucinogens. In a study conducted in urban 
primary care sites, bisexual women were about 
twice as likely as heterosexual women to report 
having used illicit drugs in the past month (Koh 
2000). 
Clinical Treatment Issues 
Few studies of substance use disorders have 
included sufficient numbers of lesbian women 
to permit separate analyses, and no studies 
have focused exclusively on bisexual women. 
In the few studies that are available, fi ndings 
are inconclusive regarding the effi cacy of 
separate treatment groups. Only 6 percent of 
substance abuse treatment services offer special 
programs or group therapy for gay men and 
women (SAMHSA 2005). For a comprehensive 
overview of treatment issues among lesbian and 
bisexual women, review SAMHSA’s Center for 
Substance Abuse Treatment (CSAT) manual, 
A Provider’s Introduction to Substance Abuse 
Treatment for Lesbian, Gay, Bisexual, and 
Transgender Individuals (CSAT 2001b). This 
manual provides information to administrators 
and clinicians about appropriate diagnosis and 
treatment approaches that will help ensure 
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 Advice to Clinicians and Administrators: 
Substance Abuse Treatment and Lesbian and Bisexual Women 
Clinical: 
• Explore coping style and enhance coping skills needed to manage stress associated
with self-disclosure and the habitual “coming out” process, to deal with attitudes 
from others regarding sexual orientation, and to address feelings of alienation from 
family members who are rejecting of sexual orientation. 
• In addition to appropriate family members, consider friends as a vital component
of treatment and support structure. Studies (Kurdek and Schmitt 1986; Mays et al. 
1994) report that lesbians generally receive greater support from friends than from 
family. By using social support from family and friends, counselors will likely enhance 
psychological well-being. 
• Assess for interpersonal violence. Rates pertaining to partner violence or abuse among
lesbian women are similar to those of heterosexual women (see, e.g., Coleman 1994; 
Renzetti 1994) and partner abuse often is accompanied by alcohol use (Schilit et al. 
1990). Assess for the history of traumatic events, including sexual and physical abuse, 
and the diagnosis of PTSD. 
Program Development: 
• Consider a specialized group that addresses issues unique to lesbians in recovery. 
• Implement policies that address the potential woman-to-woman sexual relationships
that can develop in residential treatment (similar to man-to-woman relationship 
policies in treatment). 
• Incorporate educational components in treatment that address relevant legal issues
and the inherent issues that may arise in addressing medical, child custody, and 
fi nancial needs. 
Staff Training: 
• Provide education on the multiple risk and protective factors that may either increase
or buffer risk for substance use disorders. 
• Impart knowledge about legal issues, including living wills, powers of attorney, 
advance directives, restrictions imposed by HIPAA, as well as a referral base to assist 
lesbians in securing these services. 
• Address myths and stereotypes associated with gender roles and sexual behaviors,
including the possible assumption that lesbians in relationships play either male 
or female roles or they are hypersexual or promiscuous. It is important for staff to 
recognize that lesbian relationships maintain the same patterns of stability and sexual 
behavior as heterosexual relationships. 
• Review supportive strategies in assisting clients in determining whether or not to self­
disclose sexual orientation in treatment. 
• Assist staff to understand the impact of stigma associated with lesbian and bisexual 
women. 
• Review the “coming out” process and the stages of identity. 
Source: Ayala and Coleman 2000; CSAT 2001b; Jordan and Deluty 1998; Oetjen and 
Rothblum 2000; Wayment and Peplau 1995. 
Substance Abuse Among Specific Population Groups and Settings 125 
  
 
  
  
 
the development or enhancement of effective 
lesbian, gay, bisexual, and transgender (LGBT)­
sensitive programs. 
Sexual Orientation and 
Women of Color 
Prevalence studies of substance use and abuse 
in lesbian, gay, and bisexual populations rarely 
have included sufficient numbers of racial and 
ethnic minority persons to permit separate 
analyses. However, limited available data 
suggest that patterns of substance use among 
lesbian women of color are more similar to those 
of their Caucasian lesbian counterparts than 
to those of their heterosexual racial and ethnic 
counterparts (Hughes and Eliason 2002). All 
racially and ethnically diverse group members 
face similar responses to their sexual orientation 
that can be stressful to psychological well­
being, and reluctance to seek professional help 
can increase further their risk for negative 
psychological outcomes (Greene 1997). 
Social support for treatment is known to be 
important in helping women stay in treatment 
and avoid relapse. Although African-American 
lesbian and bisexual women may receive support 
from fewer sources than African-American 
heterosexual women when they are in treatment 
for alcohol dependence, the quality of that 
support appears the same for the two groups 
(Mays et al. 1994). African-American gay women 
may prefer counselors of the same race who 
identified themselves as lesbians (Matthews and 
Hughes 2001). 
Relatively little is known about alcohol abuse 
among Hispanic/Latina lesbian and bisexual 
women, although some researchers (Nicoloff and 
Stiglitz 1987; Peluso and Peluso 1988) believe 
it is more prevalent among Hispanic/Latina 
lesbian women than heterosexual Hispanic/ 
Latina women (Reyes 1998). 
For Asian Americans, cultural issues play a 
major role in sexual identity and culturally 
normative behavior. Asian-American lesbian 
women pose a cultural dilemma by virtue of 
their individual and sexual identifi cation. If 
sexuality is expressed without jeopardizing 
family integrity and the individual’s role in the 
family, then it may be tolerated (Chan 1997). 
Many Asians find it difficult to conceive of 
losing that familial connection and are therefore 
uncomfortable with assuming a minority sexual 
identity. Given this context, it is likely that Asian 
Americans who are openly lesbian probably are 
relatively acculturated. Chan (1989) found that, 
although they identify both with their Asian-
American and lesbian identities, most of these 
women identify more strongly as lesbian. The 
implications of this with regard to substance 
abuse remain unexplored. 
American Indians and Alaska Natives 
traditionally uphold a worldview that all things 
are interrelated and dependent upon one 
another. Identity formation, specifi cally sexual 
identity, is conceptualized through this broader 
lens. Therefore, sexual identity is typically 
not defined using definitive terms, such as 
lesbian or bisexual, but rather through more 
expansive concepts that embrace roles within 
the culture and community. Native Americans 
are more likely to use the term “two-spirit” to 
capture both male and female sexuality and 
gender expression (Evans-Campbell et al. 2005). 
Research focused on substance use disorders 
among two-spirited Native Americans is limited, 
and empirical literature highlighting two-spirit 
women is non-existent. In a study comparing 
two-spirited men and women with Native 
heterosexual peers, two-spirit individuals had 
significantly higher rates of lifetime illicit drug 
use; greater sustained drinking among urban 
Natives; and greater likelihood to use alcohol to 
increase sociability, regulate mood, and decrease 
anxiety and feelings of inferiority (Balsam et al. 
2004). 
Resiliency Factors 
In general, lesbian women are more likely to 
have long-term relationships and friendships 
similar to heterosexual women. The stability 
in relationships may provide a strong platform 
in recovery provided the environment does not 
support or encourage continued alcohol abuse 
or drug use. Moreover, the woman’s fortitude 
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in managing prejudice and discrimination as a 
direct result of sexual orientation may provide 
a powerful example and symbol of personal 
strength in working toward recovery. 
Women in Later Life 
Demographics 
Approximately 21 million women aged 65 
and older reside in the United States. In 
2003, women accounted for 58 percent of 
the population aged 65 and older (Federal 
Interagency Forum on Aging-Related Statistics 
[FIFARS] 2004); women older than age 65 
constitute 7.3 percent of the total population. 
The oldest of the population (persons 85 years 
and older) are among the most rapidly growing 
age cohort in the Nation. The increasing number 
of older women corresponds to a growing 
incidence of health-related problems that were 
once considered solely men’s diseases. 
A Hidden Disease 
Older years are filled with many adjustments 
and challenges, often including loss of spouse 
and close friends, retirement, and reduced 
income. Some women turn to alcohol or drugs to 
help meet these life changes. Because many older 
women live alone (40 percent of those aged 65 
and older [FIFARS 2004]), their substance use 
is difficult to measure (Moore et al. 1989). Older 
women tend to hide their substance use because 
they attach greater stigma to it than men do 
(CSAT 1998d). Older women are less likely than 
older men to drink or use drugs in public, so 
they are less likely to drive while intoxicated 
or engage in other behavior that might reveal a 
substance use disorder (SAMHSA 2008). 
Substance use disorders in older women often 
go undetected by primary care professionals 
because of a lack of appropriate diagnostic 
criteria and because many signs of abuse can be 
mistaken for other conditions more prevalent 
in later life (e.g., cognitive impairment, anemia, 
physiological consequences from falls). It is 
not unusual for older patients to show poor 
compliance with the recommended use of 
their medications (Menninger 2002). TIP 26 
Substance Abuse Among Older Adults (CSAT 
1998d), recommends best practices to identify, 
screen, assess, and treat alcohol, prescription 
medication, and other drug abuse among people 
aged 60 and older. 
Risk Factors 
Alcohol dependence and prescription drug abuse 
are the top two substance use issues for older 
women (CSAT 1998d). Numerous risk factors 
are associated with substance-related problems 
among older women including losses or deaths, 
financial problems, health problems, age-related 
changes in metabolism, synergistic effects 
in combining alcohol and other drugs, and 
changing roles (Epstein et al. 2007). Researchers 
found that when women were deprived of their 
usual roles as wife, mother, or employee, their 
problem drinking increased. Older women 
with fewer role demands have fewer competing 
activities (Wilsnack and Cheloha 1987). 
Timing of Onset 
Alcohol- and drug-related problems in older 
women can be longstanding or can begin in later 
life. Women with early-onset alcohol dependence 
have a high incidence of major depression, 
anxiety, and bipolar disorder and simply 
continue their drinking habits as they age (CSAT 
1998d). Women with late-onset use appear both 
physically and psychologically healthier. They 
are more likely than those with early-onset use 
to have begun or increased drinking in response 
to a recent loss such as death or divorce. Both 
groups appear to use alcohol almost daily 
outside the home and at home alone and are 
likely to use alcohol to respond to hurts and 
losses (CSAT 1998d). 
Substance use among women in 
later life 
Alcohol 
In comparing trends from 1992 to 2002 in 
alcohol abuse and dependence among women 
as they age, the National Epidemiologic Survey 
on Alcohol and Related Conditions showed a
significant inverse relationship between rates of
dependence and successive age groups—that as
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Signs of Alcohol-Dependence and/or Drug Abuse in an Older Woman 
• Neglected appearance and poor hygiene 
• Frequent car accidents 
• Numerous physicians and prescriptions 
• Neglect of home, bills, pets, etc. 
• Malnutrition and anemia, and empty food cupboards 
• Withdrawal from social activities and self-isolation from family and friends 
• Mood swings or erratic behavior 
• Repeated falls or evidence of falls (leg bruises) 
• Urinary incontinence 
• Cigarette burns 
• Attempts or thoughts of suicide 
• Depression 
• Unexplained chronic pain or other health complaints 
• Confusion and/or memory impairment 
• Blurred vision or blackouts 
• Seizures or tremors 
Source: Cohen 2000; CSAT 1998d 
women age, prevalence of alcohol dependence
decreases (Grant et al. 2006). While there is
earlier empirical evidence to support that late-
middle-age to older women have fewer drinking
problems (known as “maturing-out”; Brennan
et al. 1993), this trend has to be approached
with a conservative lens since older women
tend to hide their use and not seek alcohol
treatment. In addition, the prevalence and
risk of alcohol abuse and dependence among
women appears to vary among subgroups. For
example, widowed women were found to be
three times more likely than married women
to drink heavily (The National Center on
Addiction and Substance Abuse at Columbia
University [CASA] 1996). The most consistent
predictors of alcohol-related problems among
women were friends’ approval of alcohol use,
financial stressors, and avoidance coping (Moos
et al. 2004). 
Prescription Drugs 
Prescribed medications are the most common 
drugs of abuse, outside of alcohol, among 
older adults (National Institute on Drug Abuse 
[NIDA] 2001). Approximately 30 percent 
of all prescriptions and 40 percent of all 
benzodiazepine prescriptions are prescribed 
to elderly individuals. An older woman is more 
likely than an older man to visit a physician 
and to be prescribed a psychoactive drug. 
Problems can result if prescriptions are written 
by several physicians who do not know the 
full range of prescribed and over-the-counter 
medications being taken. Older women often 
are prescribed medications highly susceptible 
to abuse (NIDA 2001). Medications frequently 
prescribed for and used by older women include 
anxiolytics and sedative-hypnotics. Alcohol– 
drug interactions are more likely to occur 
among older adults simply because they take 
more medications than younger adults and may 
continue to drink at levels consistent with earlier 
patterns. These interactions can cause problems 
in older adults because of slowed metabolism in 
later life and greater reliance on medications for 
chronic medical conditions (CSAT 1998d). With 
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 Advice to Clinicians and Administrators: 
Substance Abuse Treatment and Older Women 
Review TIP 26 Substance Abuse Among Older Adults (CSAT 1998d), for further guidance 
in providing substance abuse treatment to older women. 
Clinical: 
• Introduce coping strategies, including relaxation methods, to enhance feelings of
self-efficacy in handling life stressors.  
• Incorporate counseling services that address issues of grief along with substance
abuse treatment as needed. 
• Use additional resources to reinforce the need for and support of treatment
including, but not limited to, extended family members, healthcare providers, faith-
based services, etc. 
• Incorporate behavioral activation therapy to help address depressive symptoms
among older women who have substance use disorders. This behavioral approach 
helps clients to recognize the connection between life stressors, mood, and less 
effective coping behaviors. It encourages and provides strategies to help the client 
to monitor mood and daily activities with an emphasis on strategies to increase the 
number of enjoyable activities (Cuijpers et al. 2007). 
• Recognize and address the potential losses associated with changes in caregiver roles.
Program Development: 
• Create access to treatment through nontraditional delivery; e.g., home-based or
mobile community services. 
• Provide educational programs on metabolism and interaction of alcohol and drugs,
particularly prescription medications, at senior citizen centers. 
• Create addiction treatment services or programs designed for older adults only. 
• Provide home services or develop a one-stop multidisciplinary program that provides
needed healthcare and nutritional services, psychoeducational groups, fi nancial 
services, transportation, counseling, etc. 
Staff Training: 
• Review the more common signs of drug misuse among older women, including
mental and physical symptoms as well as suspicious requests for refi lls. 
• Provide an introduction to prescription drugs with emphasis on the physiological
effects of anxiolytics and sedative hypnotics. 
• Provide education on the physiological impact of alcohol and drug intake among
older women. 
• Emphasize the heightened alcohol sensitivity among women and the increased
vulnerability among older women. 
• Explore the relationship between alcohol problems and higher rates of depression
and prescription drug use. 
• Address the need and roles of a multidisciplinary treatment to ensure quality of care
for older women in substance abuse treatment. 
Source: Eliason and Skinstad 2001; Satre et al. 2004; Scogin et al. 2007. 
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age-related changes, prescription medications 
are more potent, less predictable in effects, and 
more likely to increase negative outcomes (Allen 
et al. 2006). 
Clinical Treatment Issues 
Screening and brief interventions, particularly 
cognitive–behavioral and case management 
approaches, may be especially useful in limiting 
alcohol abuse in older women; although research 
with older women has been limited, results 
are promising (Blow and Barry 2002). Alcohol 
dependence in an older woman may be observed 
first when she presents at an acute-care medical 
setting with complaints such as depression, 
memory loss, frequent falls, or chronic pain that 
may have been exacerbated by alcohol. These 
are not and should not be presumed to be normal 
consequences of aging. This is an appropriate 
time to intervene and discuss the benefi ts of 
sobriety as well as treatment options. 
Treatment should be supportive, respectful, 
and non-confrontational. If possible, providers 
should gather personal information about the 
client from family members, neighbors, clergy, or 
others with the client’s permission. Labels such 
as “alcoholic” or “addict” should be avoided 
and replaced with words such as “drinking” 
and “drinking problem” (Cohen 2000). It is 
important to be direct and honest, to explain 
that assistance is available, and to provide 
instructions on where help can be secured. A 
substance abuse treatment professional can 
help the older woman develop a support system. 
Some women may respond better if approached 
about their drinking in the safety of their homes 
or at a familiar medical facility where they 
feel comfortable. Programs such as Alcoholics 
Anonymous can be an important resource, 
particularly if the group meets during the day 
and is composed of older women. 
A well-coordinated approach to substance abuse 
treatment for older women should include an 
interdisciplinary treatment team with family 
or significant others involved in a plan of 
individualized support services. Since it may 
be difficult to address the needs of older women 
in residential treatment programs (where the 
majority of clients are much younger), treatment 
may be more effective when delivered at senior 
centers, congregate meal sites, outpatient 
geriatric medical programs, nursing homes, 
home care programs, or peer outreach (Cohen 
2000). Recent studies are providing promising 
results. In an outcome study comparing men’s 
and women’s abstinence rates in an outpatient 
group, 79 percent of women reported abstinence 
from alcohol at the 6-month followup, compared 
to 54 percent of the men (Satre et al. 2004). 
Resiliency Factors 
Using a strengths-based narrative approach can 
help capitalize on each woman’s life experiences 
and give meaning to her recovery. By providing 
an opportunity to explore her life events, 
history, personal attributes, and triumphs in 
spite of adversity, counselors can use this history 
to help reinforce the woman’s resilience and 
abilities to support recovery. 
Women in Rural America 
Demographics 
Rural America contains 17 percent of the U.S. 
population (Economic Research Services 2007). 
In many rural areas, the population is aging 
steadily. Rural areas have a higher proportion 
of older persons and higher poverty rates 
among the elderly than urban areas, and women 
constitute 65 percent of the rural poor age 65 
and older. In addition, poverty rates in rural 
settings are three times higher for widows than 
for married women (USDA 2007). 
In reviewing specific hardships that may not 
be independent of the effects of either chronic 
or acute alcohol and drug use, a welfare 
study identified common material hardships 
experienced by women. More than 56 percent 
of rural women respondents report unmet 
medical needs and telephone disconnection 
as the most prevalent hardships, followed by 
food insufficiency, housing problems, improper 
winter clothing, and utility disconnection (USDA 
2007). With added burdens generated by age, 
substance abuse, and poverty, local communities 
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 are faced with many challenges in meeting the 
diverse needs of women in rural settings. 
Substance Use Among Women in 
Rural Settings 
Substance abuse is a major rural health 
concern. While alcohol and drug patterns vary 
little across most age groups in urban and rural 
settings, emerging patterns among rural youth 
show a rise in use—thus providing a forecast 
of potential patterns of abuse and dependence. 
While rural and urban areas experience similar 
drug-use problems, the consequences may 
be greater in rural areas because of limited 
access to health care and substance abuse 
treatment. For example, only 10.7 percent of 
hospitals in rural areas offer substance abuse 
treatment services compared to 26.5 percent of 
metropolitan hospitals (Dempsey et al. 1999). 
Currently, there are minimal studies focused 
on substance use disorders among rural women 
(Boyd 2003). 
Risk factors for substance use disorders among 
women living in rural areas of the United 
States are significant. Many rural families are  
impoverished, and women often experience 
stress associated with limited resources (Boyd 
1998). A history of childhood victimization is 
another risk factor for substance use disorders 
among rural women, as for all women. A 
qualitative study described rural women’s 
perspectives on becoming alcohol dependent, 
and many reported some form of sexual abuse. 
This study reported that some rural women 
began drinking in adolescence as a means of self-
medication to ease the pain of their problems 
(Boyd and Mackey 2000a, b). 
Alcohol 
Beliefs and expectations about alcohol strongly 
predict potential alcohol abuse. Women in some 
rural communities hold more positive beliefs 
about alcohol than those in other communities 
or in comparison to urban women. The beliefs 
involve the notion that alcohol enhances sexual, 
physical, and social pleasure; reduces tension; 
and increases arousal, power, and control over 
life circumstances (Boyd 1998; Marlatt et al. 
1988). 
Clinical Treatment Issues 
Poverty is a significant barrier in obtaining  
health services, and this barrier is more
common for women than for men, especially in 
rural areas. Women in some segments of rural 
America perceive financial barriers to health  
care significantly more than men in rural areas  
and, consequently, experience poorer health 
than men (Beck et al. 1996b).
substance use disorders 
who live in rural areas 
may face a unique set 
of clinical issues that 
may challenge substance 
abuse professionals. 
These issues can include 
greater geographic 
and personal isolation, 
limited access to 
substance abuse 
treatment and mental 
health services (Ryland 
and Lucas 1996), 
poverty, and issues of 
confi dentiality. While 
rural women often face 
the same obstacles in 
obtaining substance 
abuse treatment services 
that challenge women 
anywhere, rural women 
are more likely to 
encounter a lack of child 
care, available treatment 
slots, transportation, 
and phone service, and 
possess a reluctance to 
address and disclose to 
staff (Tatum 1995). 
Treatment programs 
need to be culturally and 
ethnically appropriate 
for the community. 
Clinicians and other 
staff members may need 
to consider issues such 
as distance (e.g., how 
many miles from home to 
clinic), time and season 
 Women with 
Beyond the 
traditional therapy 
method used in 
many urban areas, 
the Appalachian 
tradition of 
storytelling has 
been used to help 
rural clients engage 
in treatment, gain 
insight into their 
problems, and 
learn new coping 
skills to address 
problems associated 
with substance use 
(Leukefeld et al. 
2000). 
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Advice to Clinicians and Administrators: 
Substance Abuse Treatment and Women in Rural Areas 
Clinical: 
Screen for co-occurring disorders, and refer as needed.• 
Obtain a history of traumatic events, including sexual abuse.• 
Incorporate screening procedures to aid in appropriate referral to other health and• 
social services. 
Explore potential reluctance in seeking help outside of immediate community. • 
Assess for a history of interpersonal violence, and recognize that rural women have• 
often reported learning that violence toward women is acceptable. 
Explore beliefs and attitudes toward alcohol and drug use.• 
Program Development: 
Develop partnerships among other local agencies and neighboring communities to• 
share resources to aid in the delivery of services in remote areas. 
Develop a center that houses a network of services including health, mental health,• 
substance abuse, and other social services. 
Develop a screening, assessment, and referral service for substance use disorders• 
within the Temporary Assistance to Needy Families (TANF) program. 
Provide services that support substance abuse treatment attendance including child• 
care, transportation, and mobile treatment. 
House support groups in the treatment facility, and consider providing or subsidizing • 
transportation as a means of continuing care support. 
Create professional training, network activities, and opportunities for staff to • 
decrease feelings of isolation and staff turnover and to invest in workforce 
development. 
Develop psychoeducational community programs to help reduce alcohol and nicotine• 
use during pregnancy. 
Consider the use of telecounseling services in rural areas for assessment, pre­• 
treatment, counseling, and/or follow-up services. 
Develop outreach services to address substance use and abuse issues among the aging• 
population of rural women. 
Staff Training: 
Emphasize the prevalence of social shame among rural women who have substance• 
use disorders. 
Discuss the cultural issues that may support a reluctance to seeking treatment outside• 
of the immediate community. 
Review the challenges of anonymity in small communities, the strategies that can• 
enhance privacy, and the need to address and ensure confidentiality in treatment. 
Examine the potential hidden attitudinal barriers among women seeking substance• 
abuse treatment including distrust of the “system,” expectation of failure, and 
positive beliefs regarding the benefits of alcohol and/or drug use. 
Source: Baca et al. 2007; Boyd 1998; 2003; CSAT 2003b; Howland 1995; Wilkins 2003. 
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(e.g., the demands of planting and harvesting, 
coordinating appointments with other trips to 
town), and even weather conditions to provide 
culturally acceptable services to rural clients 
(Bushy 1997). Another aspect of rural life is that 
communities are smaller and more close-knit 
so that everyone is familiar with the personal 
affairs of his or her neighbors. If, for example, 
a woman is arrested for driving under the 
influence, the chances are significant that the 
person in authority knows her or her family 
(Boyd 1998). Similarly, women in rural areas 
may know the law enforcement authority and, 
perhaps, know the substance abuse treatment 
provider as well. For rural women entering 
treatment who have been abused, their abusers 
may also be well known to the community. Prior 
reports of abuse may or may not be believed, 
and may set off counter-reactions against her. 
Women may wish to seek treatment outside the 
community, even if they have to travel long 
distances. They may choose not to be seen 
going to the counselor’s office or may have a 
preexisting relationship with the counselor. 
Conversely, women from rural communities 
may be reluctant to seek treatment outside of 
their communities, viewing treatment providers 
as “outsiders.” As to other identifi ed clinical 
issues among rural women with substance 
use disorders, the incidence of co-occurring 
disorders is suspiciously lower than among 
women from major metropolitan areas, perhaps 
because it is underdiagnosed and, as a result, 
undertreated (Kessler et al. 1994). 
Several treatment programs have been 
developed for use with rural residents. Among 
these is Structured Behavioral Outpatient Rural 
Therapy (SBORT), a cognitive–behavioral 
intensive outpatient approach consisting of two 
phases: pretreatment and treatment. The three-
session pretreatment phase consists of individual 
counseling to increase readiness for change. 
The treatment phase involves 12 sessions in 6 
weeks and consists of storytelling and “thought 
mapping” to develop recovery skills (Clark et al. 
2002). Storytelling is used to encourage clients to 
share their experiences and to help them relate 
to the presenting material in treatment. During 
thought mapping, the group examines important 
incidents before and after prior use of alcohol 
or drugs. Treatment focuses on problemsolving 
strategies and other cognitive strategies, 
relaxation techniques, coping skills to deal with 
cravings, and encourages the utilization of self-
help (Hall 1999). Specific outcome studies on 
SBORT for rural women in substance abuse 
treatment are lacking. 
Resiliency Factors 
In rural communities, there is typically a 
pattern of stability in residence, interpersonal 
relationships, and community. This stability can 
be a protective factor in recovery by providing 
sustained support. Likewise, large extended 
families, involvement in religious activities, 
and faith are attributes that are not only 
common in rural America but can serve as a 
conduit for treatment (Van Gundy 2006). From 
prevention to continuing care, counselors and 
administrators need to take advantage of these 
qualities in programming and clinical practice. 
Resources for Other 
Special Populations and 
Settings 
Women With Physical and 
Cognitive Disabilities 
Review TIP 29 Substance Use Disorder 
Treatment for People with Physical and 
Cognitive Disabilities. This is a practical 
resource for information on addressing 
treatment issues in this population (CSAT 
1998e). 
The 2000 Census reported that about 44 million 
noninstitutionalized adults have disabilities, 
including approximately 20 percent of adults 
younger than age 65 and 40 percent of those 
older than 65 (U.S. Census Bureau 2002). These 
individuals span all ages and racial, ethnic, and 
cultural backgrounds. One study (Larson et al. 
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2005) found that women with trauma histories 
and co-occurring substance use and mental 
disorders had high rates of physical disabilities, 
with the greatest number (15 percent) of 
disabilities being injury/musculoskeletal/ 
connective tissues problems. Although little 
research exists regarding the extent of combined 
disability and substance abuse, people with 
disabilities generally use substances at the same 
or higher rates than those without disabilities 
(CSAT 1994e). In some cases, the disability can 
exacerbate the risk factors for substance use 
disorders. 
Women with disabilities are affected by several 
factors that can increase the likelihood of 
substance abuse and dependence (Ferreyra 
2005): 
• 	 Increased dependence on others for basic 
needs 
• 	 Potential use of prescription medication for 
chronic pain 
• 	 Facilitation of substance use by family and 
friends to help cope with the disability 
• 	 Social isolation (lack of social support, 
unemployment, etc.) 
• 	 Insufficient referral for substance abuse 
treatment by primary physician or caregiver 
caused by lack of recognition 
• 	 Inaccessible substance abuse treatment 
programs 
Women in the Criminal 
Justice System 
Women in criminal justice facilities face 
numerous challenges including, but not limited 
to, greater health issues and higher prevalence 
of co-occurring disorders; increased likelihood 
Review TIP 44 Substance Abuse Treatment 
for Adults in the Criminal Justice System. 
This is a practical resource for information 
on addressing treatment issues in this setting 
(CSAT 2005c) 
of pregnancy and need for prenatal care; 
history of sexual violence and other forms of 
abuse; and childcare, custody, and parenting 
issues. The number of female inmates in all 
criminal justice facilities has been increasing at 
a faster rate than the number of male inmates. 
Between 1995 and 2002, the average annual 
growth rate of incarcerated females was 5.4 
percent, compared with 3.6 percent for males 
(Harrison and Karberg 2003). Among the prison 
population, from 1990 to mid-2001, the number 
of female inmates jumped 114 percent; the 
male population grew by 80 percent in the same 
period (Beck et al. 2002). African Americans 
and Hispanics/Latinas account for nearly two-
thirds of incarcerated women. Their median 
age is in the 30s. Nearly half of those in State 
prisons and other correctional facilities have 
never been married (Greenfeld and Snell 1999). 
Among State prisoners, females were more likely 
than males to be sentenced for drug offenses (29 
percent versus 19 percent; Sabol et al. 2007). 
Among Federal defendants in 2004, the leading 
drug arrests and sentences among women were 
related to methamphetamine (Bureau of Justice 
Statistics 2004). Women were more likely than 
men to have used methamphetamines in the 
month before their offense (Bureau of Justice 
Statistics 2006). According to U.S. Department 
of Justice, an estimated 52 percent of females in 
comparison to 44 percent of males incarcerated 
in local jails were dependent on or abusing 
drugs. In the last decade, more than half of 
all female prisoners reported being under the 
influence of alcohol or drugs at the time they 
committed the crime, with drug use being 
more prevalent (Greenfield and Snell 1999). In 
addition to TIP 44 Substance Abuse Treatment 
for Adults in the Criminal Justice System (CSAT 
2005c), refer to Gender-Responsive Strategies: 
Research, Practice, and Guiding Principles for 
Women Offenders (Bloom, Owen, and Covington 
2003) for more information. 
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Women Who Are 
Homeless 
Review the planned TIP Substance Abuse 
Treatment for People Who Are Homeless. 
This TIP is a practical resource for 
information on addressing treatment issues 
in this setting (CSAT in development g). 
According to the Annual Homeless Assessment 
Report to Congress (2008), nearly 3 percent of 
Americans experience homelessness at any one 
time. Approximately 23 percent are chronically 
homeless with homelessness disproportionately 
affecting African Americans (44 percent of 
the total homeless population). Less is known 
about homeless women. Data collections often 
have missing personal identifiers, leading to less 
than reliable estimates of homeless women and 
homeless women and their children. 
In exploring factors associated with women who 
are homeless (literal definition of homelessness: 
sleeping in shelters, public places, abandoned 
buildings, etc.), literature suggests signifi cantly 
higher prevalence rates of domestic violence and 
serious health problems including HIV. Most 
women who are homeless do not have a criminal 
record. Nearly half never lived independently 
prior to losing their housing arrangement, and 
that housing arrangement mainly disintegrated 
between the woman and extended family 
members, spouse, or significant other. More 
than 25 percent reported loss of employment 
as the immediate cause of homelessness, while 
another 25 percent of women reported domestic 
violence as the cause (Levin et al. 2004). Other 
factors that contribute to homelessness include 
illness, recent relocation (Lehmann et al. 2007), 
hospitalization, severe mental illness, substance 
use disorders, high-risk pregnancy, increased 
rents, or fire (SAMHSA 2003b; Levin et al. 
2004). The majority of women who are homeless 
using shelters have children (83 percent; HUD 
2008). It is estimated that 84 percent of homeless 
adults with families are women (AHAR 2007). 
Substance abuse among women 
who are homeless 
Alcohol abuse and drug use has increased among 
homeless women in the past 20 years (North 
et al. 2004). Numerous studies (Koegel et al. 
1999; North et al. 2004a; Robertson et al.1997) 
provide estimates on lifetime and current 
substance use disorders among homeless women 
with lifetime estimates ranging from 56 to 63 
percent and current estimates spanning 38 to 58 
percent. Twenty percent of homeless admissions 
to substance abuse treatment are women, with 
admission rates higher among African-American 
women. Upon admission, prevalence rates of 
alcohol-related admissions were similar to all 
female admissions, while prevalence of cocaine/ 
crack and heroin were more likely reported 
among homeless women (OAS 2004a). 
SAMHSA offers a Homelessness Resource Center, a virtual community located at www. 
homeless.samhsa.gov. For providers who serve the homeless, this site offers information on a 
wide range of programmatic and clinical topics, provides access to related resources, including 
a one-stop site for all Federal Government materials on homelessness, and provides a place to 
share ideas and to gain support. 
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7 Substance Abuse 
Treatment for Women 
Overview 
While women are as likely to stay and engage in treatment as men, 
substance abuse counselors need to attend to individual, counselor, 
and environmental variables to secure the best retention rates based 
on level of care and presenting problems. This chapter begins with 
gender-specific factors that signifi cantly influence treatment retention 
of women. Other highlights include women’s treatment issues and 
needs (beginning with the role of relationships—including family and 
partners), parenting issues and treatment needs (including pregnancy 
and children), and several co-occurring disorders (including anxiety, 
mood, and eating disorders) that are most prevalent among women 
and are likely to require attention during the course of treatment. 
Significant consideration is also given to trauma, trauma-informed 
services, and integrated treatment for women with trauma-related 
symptoms and substance use disorders. 
Treatment Retention 
The many factors that influence clients to enter treatment are often 
the same ones that keep them in treatment. Treatment retention refers 
to the quantity or amount of treatment received by a client. Today, 
retention is more likely defined using the term “length of stay,” and 
is measured by months or a timeframe rather than by the number of 
sessions (Comfort and Kaltenbach 2000; Greenfield et al. 2007a). His­
torically, literature has reflected that treatment duration (retention) 
has served as one of the most consistent predictors of posttreatment 
outcome, yet literature remains limited regarding the specifi c relation­
ship between retention and outcome among women with substance use 
disorders. (For literature reviews on retention and outcome factors 
for women with substance use disorders, see Sun 2006; Greenfi eld et 
al. 2007a.) 
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Gender is not likely to predict retention in 
substance abuse treatment. For some time, it 
has been assumed that women are more likely 
to leave treatment, but some literature counters 
this view (Joe et al. 1999). Do women have lower 
retention rates than men? This is a diffi cult 
question to answer because treatment retention 
often involves the contribution and interaction 
of numerous variables. Studies have begun to 
identify these variables and how they relate 
to each other to influence treatment retention 
rates among women (see Ashley et al. 2004), but 
further research is needed to understand the 
complexity and interactions of these variables. 
Psychiatric symptoms, drugs of choice, 
motivation levels, class, race, ethnicity, 
criminal justice history, addiction severity, 
and patterns of use are common factors that 
typically influence or predict retention among 
clients in general (see Simpson 1997). Among 
women, several factors have been identifi ed that 
influence or predict retention. The following 
section highlights these factors. Nonetheless, this 
is not an exhaustive list of retention conditions 
or issues, but one that is limited to factors 
that are evident across several studies or that 
provide some insight into women’s issues that 
need further empirical exploration. 
Factors That Infl uence Retention 
Among Women 
Sociodemographics 
Relationships: Support from a partner 
during treatment and recovery can contribute 
significantly to long-term maintenance of 
abstinence. Some treatment studies suggest that 
including a partner or significant other in a 
client’s treatment also contributes signifi cantly 
to successful short-term outcomes (Price and 
Simmel 2002). For example, couples therapy 
for women in alcohol and drug abuse treatment 
contributed to favorable outcomes in one study 
(Trepper et al. 2000), and a study by Fals-
Stewart and colleagues (2005) indicates that 
behavioral couples therapy was associated with 
abstinence and sustained recovery. Zlotnick 
and colleagues (1996) also found family therapy 
to be an effective component for women in an 
outpatient substance abuse treatment program. 
It appears that women who develop 
relationships in treatment are less likely 
to successfully complete treatment if their 
new partner discontinues treatment. In one 
qualitative study, all of the women who did not 
successfully complete treatment established a 
sexual relationship during the early phase of 
outpatient treatment (Ravndal and Vaglum 
1994). 
Age: Age appears to be a factor that infl uences 
retention. According to the Drug Abuse 
Treatment Outcome Study (DATOS), age has 
a significant positive effect on retention in 
residential treatment (Grella et al. 2000). In 
a study examining variables associated with 
retention in outpatient services, women younger 
than 21 were not as likely to successfully 
complete outpatient treatment (Scott-Lennox 
et al. 2000). Likewise, criminal justice research 
found that women who are older at their fi rst 
arrest were more likely to complete treatment 
(Pelissier 2004). 
Education: Women with a high school education 
are more likely to stay in treatment. According 
to two studies (Ashley et al. 2004; Knight 
et al. 2001), women who have a high school 
degree or equivalent are more likely to stay in 
treatment longer and complete treatment than 
women with less than a high school education. 
While education level is influential, it may be 
a reflection of other client characteristics or 
socioeconomic conditions. 
Women of color: Research typically refl ects 
lower retention rates among women of color. 
While more research is needed to pinpoint the 
specific factors that lead to lower retention rates 
among ethnically diverse women, a key variable 
appears to be economic resources. According 
to Jacobson, Robinson, and Bluthenthal 
(2007), limited economic resources may play a 
more significant role in retention than specifi c 
demographics or severity of substance use 
disorder. 
Substance Abuse Treatment for Women 138 
  
 
 
 
 
Criminal justice and child 
protective services referral and 
involvement 
It appears that either referral or involvement 
with the criminal justice system or child 
protective services is associated with longer 
lengths of treatment (Brady and Ashley 2005; 
Chen et al. 2004; Green et al. 2002). Specifi cally, 
Nishimoto and Roberts (2001) concluded that 
women who were mandated by the criminal 
justice system to enter treatment and who also 
had custody of their children were more likely 
to stay in treatment longer. While some studies 
reflect mixed results on the effect of women 
being mandated to treatment by the court, 
another study (generated from the sample of 
participants in the Substance Abuse and Mental 
Health Services Administration’s [SAMHSA’s] 
Women, Co-Occurring Disorders, and Violence 
Study) found that retention was higher among 
women who had been mandated to treatment 
(Amaro et al. 2007). 
Pregnancy 
Pregnancy status can signifi cantly infl uence 
treatment engagement and retention. Grella 
(1999) concluded that pregnant women were 
more likely to spend less time in treatment, and 
that pregnancy interrupted treatment. Yet, the 
length of stay may be more related to the stage 
of pregnancy. In another retention study among 
women, women who entered treatment late in 
their pregnancies had good retention whereas 
women who entered treatment in their fi rst 
trimester tended to leave treatment early (Chen 
et al. 2004). 
Pregnancy and co-occurring disorders: 
Pregnancy often adds to the challenge of 
retaining clients who have severe psychiatric 
disorders in treatment. In one study (Haller 
et al. 2002) that compared retention rates 
across three groups of women, the group 
characterized by severe addiction, psychiatric 
(DSM Axis 1 diagnosis) and personality (DSM 
Axis 2 diagnosis) disorders had rapid attrition 
(a 36 percent dropout rate), whereas the 
groups described as clinically benign or with 
less severity but with externalizing personality 
deficits were more likely to complete treatment. 
In a similar study conducted by Haller and Miles 
(2004), women with more severe pathology were 
twice as likely to leave treatment against medical 
advice. While these studies have limitations, 
they do shed light on the role of psychiatric 
issues in retention among women, particularly 
pregnant women, and the need to provide 
appropriate intervention earlier in the treatment 
process. The findings of a study examining the 
effects of trauma-integrated services suggest that 
women who receive these mental health services 
may engage in treatment longer (Amaro et al. 
2008). 
Treatment environment and 
theoretical approach 
Supportive therapy: The consensus panel’s 
clinical experience has shown that women who 
abuse substances benefit more from supportive 
therapies than from other types of therapeutic 
approaches. Review of the literature indicates 
that positive treatment outcomes for women 
are associated with variables related to the 
characteristics of the therapist (e.g., warmth, 
empathy, the ability to stay connected during 
treatment crises, and the ability to manage 
countertransference during therapy; Beutler et 
al. 1994; Cramer 2002; Crits-Christoph et al. 
1991). Women need a treatment environment 
that is supportive, safe, and nurturing 
(Cohen 2000; Grosenick and Hatmaker 2000; 
Finkelstein et al. 1997); the therapeutic 
relationship should be one of mutual respect, 
empathy, and compassion (Covington 2002b). 
The type of confrontation used in traditional 
programs tends to be ineffective for women 
unless a trusting, therapeutic relationship has 
been developed (Drabble 1996). Early research 
on women in treatment demonstrated that 
women entered treatment with lower self-esteem 
than their male counterparts (Beckman 1994). 
Hence, the traditional practice during recovery 
of “breaking down” a person who abuses 
substances and rebuilding her as a person is 
considered unduly harsh and not conducive 
to effecting change among women who abuse 
substances (Covington 2008a rev., 1999a; 
Drabble 1996; Kasl 1992). Although designed 
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to break through a client’s denial, these 
approaches can diminish a woman’s self-esteem 
further and, in some cases, retraumatize her. 
Approaches based on awareness, understanding, 
and trust are less aggressive and more likely to 
effect change (Miller and Rollnick 2002). An 
atmosphere of acceptance, hope, and support 
creates the foundation women need to work 
through challenges productively. 
Collaborative approach: Leading practitioners 
in the field of substance abuse treatment for 
women suggest that effective therapeutic styles 
are best characterized as active, constructive, 
collaboratively and productively challenging, 
supportive, and optimistic (Covington and 
Surrey 1997; Finkelstein 1993, 1996; Miller 
and Rollnick 1991). Effective therapeutic styles 
focus on treatment goals that are important to 
the client. This may mean addressing issues of 
food, housing, or transportation fi rst. Having 
her primary needs met builds a woman’s trust 
and allows her to address her substance use. A 
collaborative, supportive approach builds on 
the client’s strengths, encourages her to use her 
strengths, and increases her confidence in her 
ability to identify and resolve problems. 
Effective therapeutic styles facilitate the client’s 
awareness of the difference between the way her 
life is now and the way she wants it to be. The 
client and counselor agree to work together to 
identify the client’s distortions in thinking— 
discrepancies between what is important 
to her and how her behavior and coping 
mechanisms prevent her from reaching her 
goals. Approaching treatment as a collaboration 
between equal partners—where the therapist 
is the expert on what has helped other people 
and the client is the expert on what will work for 
herself—may reduce the client’s resistance to 
change. 
Type of treatment services 
Same-sex versus mix-gender groups: While 
literature (Grella 1999; Gutierres and Todd 
1997; Niv and Hser 2007; Roberts and 
Nishimoto 1996; Zilberman et al. 2003) generally 
supports same-sex groups as being more 
beneficial than mix-gender groups for women, 
most research surrounding this issue is either 
too small to generalize, fails to control for 
other factors that may influence results, or falls 
short in matching and evaluating same-sex and 
mix-gender groups using comparable services 
and program lengths. Inconsistent results are 
evident when comparing retention and outcome 
rates between both groups (Kaskutas et al. 
2005). Historically, research has not controlled 
for the confounding variable that female-only 
groups provide more gender-responsive services 
than mix-gender groups. These enhanced 
services may be more responsible for retention 
and outcome than the gender constellation of 
treatment. In one study comparing women in 
a female-only program to a mix-gender group, 
the author concluded that just placing women 
in a same-sex group without women-specifi c 
treatment services is not effective in improving 
retention or outcome (Bride 2001). 
More rigorous studies are needed to clarify 
factors. Several qualitative studies (Grosenick 
and Hatmaker 2000; Nelson-Zlupko et al. 1996; 
Ravndal and Vaglum 1994) have highlighted that 
women perceive same-sex or female-only groups 
as more beneficial than mix-gender groups 
Note to Clinicians 
While women may perceive female-only groups as beneficial, it is important for clinicians to 
prepare for and recognize that some women may express hostility toward other women in the 
group or treatment program. Women are as likely to impose the same societal gender stereotypes 
that they experience onto other women in the group (Cowan and Ullman 2006). Some women 
may see other women as a threat to their relationships and engage in competitive behavior in the 
group process, and other women may impose and project their internalized negative stereotypes 
onto other group members; e.g., blaming a woman who was victimized by violence or making 
assumptions about, calling attention to, or labeling another woman’s sexual behavior. 
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because they provide the women more freedom 
to talk about difficult topics such as abuse and 
relationship issues and to focus on themselves 
rather than on the men in the group. TIP 41 
Substance Abuse Treatment: Group Therapy 
(CSAT 2005d), provides more information 
on treatment issues and process using group 
therapy. 
Service delivery: Women who have access 
to various services in one location appear to 
have higher retention rates (McMurtrie et 
al. 1999; Volpicelli et al. 2000). In addition, 
studies support that women who are involved 
in or initially receive greater intensive care, 
specifically residential treatment, are more 
likely to remain in treatment and in continuing 
care (Coughey et al. 1998; Strantz and Welch 
1995). Retention is also heightened when 
treatment services also include individual 
counseling for women (Nelson-Zlupko et al. 
1996). 
Onsite child care and child services: In two 
randomized studies (Hughes et al. 1995; 
Stevens and Patton 1998) comparing women in 
residential programs whose children stayed with 
them versus women whose children did not stay 
with them, women whose children stayed with 
them had a longer length of stay (retention). 
Other less rigorous studies provide similar 
results (Ashley et al. 2004; Metsch et al. 2001; 
Nelson-Zlupko et al. 1996; Wobie et al. 1997). 
For more information on children in residential 
treatment programs, see chapter 5, “Treatment 
Engagement, Placement, and Planning.” 
Therapeutic alliance and counselor 
characteristics 
Although the relationship with the counselor is 
important to both men and women, each gender 
defines this connection differently. When women 
and men were asked what was important about 
the quality of their therapeutic relationships 
and their recovery from substance abuse, most 
women answered trust and warmth, and most 
men answered a utilitarian problemsolving 
approach (Fiorentine and Anglin 1997). Across 
studies, women have identified several counselor 
characteristics they believe contribute to 
treatment success: non-authoritarian attitudes 
and approach, confidence and faith in their 
abilities, and projection of acceptance and care 
(Sun 2006). Overall, the therapeutic alliance 
appears to play a paramount role in predicting 
posttreatment outcome (Gehart and Lyle 2001; 
Joe et al. 2001; Miller et al. 1997). 
Staff gender: Research on the impact of gender 
differences in client–counselor relationships is 
limited across mental health professions and 
is nearly non-existent in the substance abuse 
field. Although women show greater preference 
for female staff in addiction treatment, 
further research is needed in examining the 
role of gender in treatment retention and 
outcome among women in individual versus 
group counseling, same-sex versus mix-gender 
groups and treatment programs, and women at 
different levels of substance abuse treatment. In 
a study that examined how clients in inpatient 
substance abuse treatment would view their 
ideal male and female counselor, gender was 
not considered an important variable even 
Implications for the Male Counselor 
“Men may need to pay particular attention to certain issues when counseling women. The issues 
of anger, autonomy, power, and stereotypical roles have great impact on women clients and 
are extremely important issues for women in therapy. For some women, because of previous 
dependence on men, their emotional responses to anger are more likely to be repressed and 
viewed as unacceptable. For other women, autonomy and power are often seen as masculine 
traits and inappropriate for women. Men’s greater, or perhaps different, familiarity with anger, 
autonomy, and power can potentially provide therapeutic benefit for their women clients” (DeVoe 
1990, p. 33). 
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Improving Transitions and Retention Rates for Women 
Programs that maintain relationships or connections with women throughout their treatment and 
during step-down transitions from more intensive to less intensive treatment appear paramount 
in maintaining high levels of retention. Using supportive telephone calls between residential and 
outpatient addiction treatment is an effective strategy for women. Women are more likely than 
men to attend continuing care if a telephone intervention is implemented (Carter et al. 2008). In 
addition, women are more likely to stay in treatment during transitions to less intensive levels of 
care if it is the same treatment agency (Scott-Lennox et al. 2000). 
though the majority of clients preferred a 
female therapist (Jonker et al. 2000). Prior 
research on therapist preference in counseling 
highlighted that nearly 95 percent of women 
who expressed a preference specified a female 
counselor (Stamler et al. 1991). Grosenick and 
Hatmaker (2000) reported that 82 percent of 
the women and treatment staff in a residential 
program treating pregnant women and women 
with children believed it was important to have 
female staff, while 38 percent of the clients and 
46 percent of the staff sample asserted that male 
staff were important. For those who endorsed 
the importance of male staff, they indicated that 
men serve as male role models for children and 
provide a male perspective on various clinical 
issues, such as relationships. 
In a study that examined the influence of both 
client–counselor race and gender composition 
in treatment retention among African-American 
clients in intensive outpatient groups (Sterling 
et al. 1998), no significant gender differences 
were found. Nonetheless, several trends were 
evident. Female clients treated by female 
counselors stayed in treatment 5 days longer 
than mix-matched gender groups (mix-matched 
refers to clients being matched to counselors 
of the opposite sex), and women in gender-
matched groups at discharge were more likely to 
continue outpatient care. The authors suggested 
that different results may have transpired if 
they had examined the role of gender and race 
in client–counselor relationships in individual 
substance abuse counseling versus group 
therapy. Research focused specifi cally on 
client–counselor race and gender composition in 
women’s treatment is lacking. 
Client’s confidence in the process 
A woman’s successful experience in other 
life areas and her level of confidence in the 
treatment process appear important to staying 
in treatment. Kelly, Blacksin, and Mason (2001) 
compared two groups of women—a group that 
completed treatment and another group that 
did not—to ascertain factors affecting substance 
abuse treatment completion. They found that 
women who had prior successes were more apt 
to complete treatment. While self-effi cacy may 
play an important role, methodological issues 
and other factors may be as responsible for the 
study’s results, namely the limited economic 
resources in the group of non-completers. In 
addition, other general retention studies have 
highlighted the importance of the therapist’s 
prognosis of client retention; thus the 
counselor’s confidence may be as signifi cant to 
retention as the client’s confi dence (Cournoyer 
et al. 2007). Further gender-specifi c retention 
research is needed to address the role of self-
confidence and confidence in the treatment 
process. 
Theoretical Approaches 
for Women 
In a meta-analysis of studies on treatment 
approaches, Wampold (2001) attributed 
more than half of the effect of therapies to 
therapeutic alliance—a key element of all the 
theoretical approaches. Some approaches have 
significant clinical and empirical support in 
substance abuse treatment research literature 
(including motivational interviewing, cognitive– 
behavioral therapies, and some psychodynamic 
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approaches), however, research highlighting 
the role of gender differences is in its infancy, 
and limited research is available that delineates 
gender-specific factors that contribute to the 
effectiveness of these therapies. Data available 
at the time of publication is referenced 
throughout this TIP. For general information 
on counseling theories, refer to TIP 34 Brief 
Interventions and Brief Therapies for Substance 
Abuse (CSAT 1999a); TIP 35 Enhancing 
Motivation for Change in Substance Abuse 
Treatment (CSAT 1999b); and TIP 47 Substance 
Abuse: Clinical Issues in Intensive Outpatient 
Treatment (provides an overview of counseling 
theories; CSAT 2006c). 
Women’s Treatment Issues 
and Needs 
Relationships and the Need for 
Connection 
Relationships are central in women’s lives—as 
part of their identities, as sources of self-esteem, 
as the context for decisionmaking and choices, 
and as support for day-to-day living and growth 
(Covington and Surrey 1997; Finkelstein 
1993, 1996; Miller 1984). Connections are 
relationships that are healthy and supportive— 
mutual, empowering, and emotional resources. 
“Disconnections” involve relationships that 
are not mutual and empowering: one member 
is dominant, there is imbalance in the give 
and take, or a disparity exists in emotional 
supportiveness. Disconnections range from 
feeling “unheard” or “unknown” to extreme 
forms of disconnection, such as sexual abuse 
and violence. Disconnections create major 
difficulties for most women, such as lowered 
self-esteem, feelings of powerlessness, and lack 
of assertiveness. The experience of relationships 
as connections and disconnections is a central 
issue in personality development, with repeated 
severe disconnections potentially having serious 
psychological and behavioral consequences. 
The Influence of Family 
Treatment providers should be sensitive to the 
relational history women bring into treatment, 
both positive and negative. For instance, the 
extended family often functions as a safety net 
that provides women with child care, fi nancial 
support, and emotional and spiritual guidance 
(Balcazar and Qian 2000). However, few 
studies have examined the role of the extended 
family in the development of substance abuse 
and recovery. While research on the extended 
family tends to define its role as primarily 
protective, drinking and drug use in the family 
can contribute to the development of abuse. 
Many women who abuse substances were raised 
in families where there was chemical abuse, 
sexual abuse, violence, and other relational 
disconnections. These family relationships form 
a basic model for the relationships women later 
develop with others. 
Women with a substance-using family 
background may develop adult relationships 
that mimic these broken family dynamics. Thus 
many women who have family members who 
used substances also may have a partner or 
friend who abuses substances. Relationships 
that center on substance use, or include 
emotionally or physically negative, harmful 
behavior (whether past or present), can play a 
significant role in enabling a woman’s continuing 
substance use. 
To assess the impact of a client’s family 
relationships, treatment providers should 
explore the role of the extended family in her 
life and try to determine how her substance 
abuse has affected her relationships with family 
members. Counselors should also help a client 
to explore her current relationships outside 
her family in the light of her substance use. 
Counselors may need to work with some clients 
to help them understand the negative effects 
these relationships can have. 
In addition, skills related to improving the quality
of relationships—such as communication, stress
management, assertiveness, problemsolving,
and parenting—can be an important part of
treatment. To help clients learn these skills,
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treatment providers can model connection with
clients, provide support, help clients repair or
replace hurtful or damaging relationships, and
help clients “redefine” their families (Knight et
al. 2001b). Family therapy is a more essential
approach in substance abuse treatment for
women. For more guidance in employing family
therapy, refer to TIP 39 Substance Abuse
Treatment and Family Therapy (CSAT 2004b). 
If maintaining or reconnecting with extended 
family members is not an option, plans should 
be made to find alternatives in developing 
a support system or a “family of choice.” 
However, the grief associated with the loss of the 
original family needs to be addressed. Treatment 
programs can help women connect with natural 
supports in the community—friends, work 
colleagues, and significant others (Knight and 
Simpson 1996). Developing or maintaining 
Advice to Clinicians: 
Relational Model Approach 
Beginning in the 1970s, a number of theorists started to examine the importance 
of gender differences in psychological development. Jean Baker Miller’s Toward a 
New Psychology of Women (1976) offered a new perspective on the psychology of 
women that challenged the basic assumptions of traditional theories. Carol Gilligan, a 
developmental psychologist, gathered empirical data on fundamental gender differences 
in the psychological and moral development of women and men (Gilligan 1982). 
Drawing on Miller’s and Gilligan’s work, theorists have been developing a relational 
model of women’s psychology. The three major themes in relational theory are: 
• 	 Cultural context. Recognizes the powerful effect of the cultural context on women’s 
lives. 
• 	 Relationships. Stresses relationships as the central organizing feature in women’s 
development. Traditional developmental models of growth emphasize independence 
and autonomy. This model focuses on women’s connection with others. 
• 	 Pathways to growth. Acknowledges women’s relational qualities and activities as 
potential strengths that provide pathways to healthy growth and development. 
The relational-cultural theory affirms the power of connection and the pain of 
disconnection for women, with repeated disconnections having adverse consequences 
for mental health (Covington and Surrey 1997; Jordon and Hartling 2002). As a result, 
the approach requires a paradigm shift that has led to a reframing of key concepts in 
psychological development, theory, and practice. For example, instead of using the “self” 
as the sole focus, the model focuses on relational development. 
According to Miller, “Women’s sense of self becomes very much organized around being 
able to make and then to maintain affiliations and relationships” (Miller 1984, p. 83). 
More than men, women find an activity more satisfying and more pleasurable when 
others are involved. Therefore, for women, relationships directly affect their feelings of 
empowerment, self-worth, and self-esteem. 
Substance abuse treatment often provides a woman her first opportunity to establish 
new, healthy relationships—especially relationships with other women. Accordingly, 
counselors should help women to “examine past relationships, including issues of loss, 
violence, and incest; to validate and build upon [their] relational skills and needs; to 
learn how to parent successfully; …to let go of problematic, abusive relationships” 
(Finkelstein 1996, p. 28); and to confront the loss of a primary relationship with their 
drug of abuse (Cramer 2002). 
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positive relationships can improve women’s self-
esteem and increase their feelings of self-effi cacy 
(Finkelstein et al. 1997). Further, a high degree 
of social support is positively related to better 
treatment outcomes (Laudet et al. 1999). 
Partner Relationships 
Many women drink and use substances to 
maintain relationships and cope with the pain 
and trauma of lost relationships. Some women 
feel they are expected to maintain relationships 
at all costs, even if those relationships are 
undermining, abusive, or otherwise detrimental. 
Women may stay in harmful relationships 
because of economic or social dependence. 
Treatment providers sometimes unknowingly 
reinforce this expectation by focusing on the 
importance of relationships to the exclusion of 
helping their clients increase their feelings of 
autonomy, healthy solitude, and individuality— 
also important needs for women. 
Once a woman’s significant relationships have 
been examined relative to her substance use, the 
counselor and client can work together on a plan 
for reconnecting with significant others during 
recovery (if possible). Yet, engaging a partner 
in a woman’s treatment can be challenging, 
especially in balancing issues of the woman’s and 
her partner’s needs, safety concerns, and lack 
of funding for partner and family services. Few 
models within women’s treatment programs exist 
that include partners and other family members, 
and even fewer address lesbian partners. Price 
and Simmel (2002) provide an overview of the 
issues surrounding a partner’s influence on a 
woman’s addiction and recovery and examples 
of model programs. They recommend starting 
with a thorough assessment after a woman has 
identified her partner(s) and given permission to 
involve the partner in treatment. 
As women become healthy through participating 
in treatment and developing appropriate 
relationships, and as other supports (e.g., 
financial, housing) are put in place, it is hoped 
they will choose to reevaluate relationships 
that are detrimental to their well-being and 
recovery. When women decide to end signifi cant 
relationships, counselors should realize that 
ending these significant relationships is a 
real loss that must be mourned while new 
attachments are being created. However, some 
women often choose to continue to participate 
in, or may be unable to escape, destructive 
relationships. 
Tolerating or accepting a client’s relationships 
that the counselor finds objectionable is 
complicated because a woman’s substance abuse 
frequently is maintained in connection with 
her partner (Amaro and Hardy-Fanta 1995), 
and maintaining this relationship can increase 
her risk of relapse. Thus, any relationship that 
enables a woman to continue to abuse substances 
or threatens her safety becomes a therapeutic 
issue between a counselor and a female client. 
The counselor should acknowledge a woman’s 
feelings about that relationship, regardless of 
the counselor’s opinion about what is best for 
the client. However, if a client is in danger of 
being victimized, the counselor should primarily 
be focused on ensuring her safety. Initially, staff 
should take immediate measures to increase 
physical safety in the treatment environment— 
in both outpatient and inpatient settings. 
In addition to validating her experience, it 
is important to help facilitate a safety plan 
that may necessitate additional referrals to 
domestic violence hotlines and shelters. To
review a sample personalized safety plan for 
domestic violence, refer to Appendix D in TIP 
25 Substance Abuse Treatment and Domestic 
Violence (CSAT 1997b). 
Safety issues for the client or her children may 
preclude the partner’s involvement. If the client 
does not feel safe involving her partner, the 
emphasis should change to safety planning. 
Several curricula focus on a woman’s 
relationships in recovery and help her 
identify, assess, and evaluate both destructive 
and empowering relationships and support 
systems. Covington’s curriculum, Helping 
Women Recover (2008a, 1999a), allows women 
to examine their relationships and support 
systems. Najavits’ Seeking Safety (2002a) and 
Woman’s Addiction Workbook (2002) include 
information that assists women in understanding 
healthy and unhealthy boundaries, strategies 
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Advice to Clinicians: 
Considerations in Involving the Partner in Treatment 
In deciding whether or not to involve a woman’s partner in treatment, primary 
consideration should be given to her safety and to the partner’s willingness to 
participate in treatment. The following important issues should also be assessed 
to determine participation and level of treatment involvement and to establish an 
appropriate treatment plan: 
• 	 History of violence: Has there been a history of violence in the relationship, including 
threats and other emotional, physical, and/or sexual abuse; protection orders; police 
reports; or citations for domestic violence or assaults? Is there a history of impulsivity 
with client or partner? Has there been a history of violence outside the relationship, 
in previous relationships, or with children? Is there a recognizable progression of 
violence in the relationship? 
• 	 History of substance use in the relationship: How influential has this partner been 
regarding the client’s continued drug and alcohol use? Does the partner see the 
woman’s alcohol and/or drug use as a problem needing treatment? Has the history 
of the relationship been centered upon using or providing drugs and alcohol? 
How often are alcohol and other drugs used when engaged in activities with each 
other or during sexual intimacy? Is the client or partner worried about having sex 
without being under the influence of substances? Has the client left prior treatment 
experiences prematurely due to this relationship? Is the client worried that her 
partner is going to leave either as a result of her use or of her treatment? Does the 
client acknowledge that her use has impacted the relationship? Is she able to describe 
how her substance use has affected the relationship? 
• 	 Partner’s history of substance use: What is the partner’s attitude toward alcohol 
and drug use? Does he/she use as well? Is he/she in recovery? Has the partner been 
arrested, charged, or convicted of alcohol or drug related offenses? Does the client 
minimize the influence of her partner’s current drug and alcohol use? 
• 	 Accessibility: Does the partner have the financial resources and transportation to 
attend treatment? Are there potential barriers that limit physical attendance, such as 
distance from program, transportation, work schedule, financial resources, childcare 
responsibilities? 
• 	 History of mental illness: Are there any known mental health issues with the partner 
or client that have or will impact the relationship? 
• 	 Relationship support of the partner: Has the partner been emotionally supportive 
throughout the history of the relationship? Currently, how emotionally supportive 
is the partner regarding the client’s treatment and recovery? Does the partner play 
an essential role in childcare? Does the partner provide financial support? Has the 
partner ever threatened to leave, withdraw financial support, or threaten the custody 
of the children? 
• 	 Commitment to relationship: Is there a current commitment to maintaining the 
relationship? 
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for identifying persons who can be positive 
(supportive) or negative (destructive) infl uences 
on their recovery, tactics for enhancing or 
minimizing those infl uences, and activities to 
enhance support from other women. Cohen’s 
Counseling Addicted Women: A Practical 
Guide (2000) provides client and staff activities 
surrounding relationship issues.
Sexuality
Healthy sexuality is integral to one’s sense of 
self-worth. Sexuality represents the integration of 
biological, emotional, social, and spiritual aspects 
of who one is and how one relates to others. If 
healthy sexuality is defi ned as the integration 
of all these aspects of the self, it is apparent 
how substance abuse can have an impact on 
every area of a woman’s sexuality. In addition, 
sexuality is one of the primary areas that women 
say change the most between substance abuse or 
dependence and recovery and is a major trigger 
for relapse (Covington 2008a, 1999a, 2007).
Women and men are socialized into different 
gender roles. For example, many men are 
taught to seem knowledgeable about sex and 
be comfortable with their bodies. In contrast, 
women struggle more with body image and are 
socialized to be less assertive sexually or risk 
being labeled as promiscuous. This polarization 
of sex roles is mirrored in society’s belief about 
male and female substance use. Women who use 
substances are perceived as being more eager for 
sex and more vulnerable to seduction (George et 
al. 1988). This is refl ected in the stronger stigma 
against women with substance use disorders, 
which is often expressed in sexual terms and 
labels women as promiscuous or sexually loose. 
Sexual terms are rarely used to describe men 
with substance use disorders.
Recovery and healing goes beyond abstinence 
from alcohol or drugs to developing 
relationships with others. Many women will need 
to explore the connections between substance 
abuse and sexuality, body image, sexual identity, 
sexual abuse, and the fear of sex when they are 
alcohol and drug free. Therefore, the consensus 
panel believes that discussion of women’s 
sexual issues is an important part of substance 
abuse treatment. The following are some of the 
sexual concerns that women report during early 
recovery:
• Sexual identity. Counselors may need to 
help a woman determine her sexual identity 
as a heterosexual, lesbian, or bisexual 
person. Substance abuse during adolescence 
can interrupt the healthy development 
of sexual identity. Circumstances such as 
prostitution or incarceration may lead 
women to participate in sexual activity with 
other women. Some women use drugs to 
suppress their sexual feelings toward other 
women. Others use drugs to act on their 
erotic attachment to other women and may 
feel confused about their sexual identity 
when in recovery. Once the substance of 
abuse has been removed from a woman’s 
life, the counselor can help her discover 
whether her identity is heterosexual, lesbian, 
or bisexual (Covington 1997). For review of 
sexual identity stages of development and 
its relationship to substance abuse, see A 
Provider’s Introduction to Substance Abuse 
Treatment for Lesbian, Gay, Bisexual, and 
Transgender Individuals (CSAT 2001b, pp. 
61–67).
• Fear of sex while abstinent. Many women 
enter treatment with little or no experience 
of sexual relationships without being under 
the infl uence of substances. For women with 
a history of sexual trauma, using alcohol 
and drugs to manage emotions while having 
sex may have served as an important coping 
mechanism. Subsequently, women may 
become fearful of having sex without the 
assistance of substances (Covington 2000, 
Note to Clinicians
Safety issues for the client or her children may preclude the partner’s involvement. If the client 
does not feel safe involving her partner, the emphasis should change to safety planning.
  
 
 
 
 
 
 
 
 
 
 
 
Clinical Activity: 
Exploring the History and Influence of Relationships: Sociogram 
Using a simple diagram (referred to as a sociogram) that was pioneered by J. L. Moreno in the 
1940s, clients can highlight their most influential female and/or male relationships (including 
positive and negative attributes). Starting with this diagram, counselors can use this activity 
as a foundation to help women explore how these relationships influence current relationship 
patterns, preference for male or female friends, attitudes toward other women and/or men, and 
the development of support systems. 
Depending on your goal, you can have the client focus only on the men or women who have 
been most influential in their lives. Generally, the exercise provides more clarity for the client if 
you focus on only one gender at a time. Yet, your selection depends on your treatment goal, the 
client’s current struggles, and previous relationship history. If the woman is having a diffi cult time 
connecting with other women in treatment, it may be helpful to start with a history of her female 
relationships. Even though there are other ingredients that influence how a woman relates to 
and views other women (namely gender socialization), a sociogram that begins with the history of 
female relationships may enhance awareness of the issues that impede her ability to relate to other 
women. At other times, it may be more fruitful to focus on the history of male relationships with 
women due to clinical issues that involve men. Here are directions and a sample of a sociogram on 
female relationships: 
Provide the client with a piece of paper and a pencil, and ask her to list the most infl uential 
females throughout her life. The list should include women who have had the most signifi cant 
impact—both positive and negative. It should not be limited to family members, but instead 
include women throughout her lifespan up to the present day. The list should consist of women 
who have had a powerful influence even if the encounter was brief. You could ask her to limit the 
list to six to eight women for this exercise. She can always go back and add individuals later on. 
After compiling this list (it takes about 3 to 5 minutes), have the client turn the page over and draw 
a circle (about the size of a quarter) in the middle of the page and have her place her own name 
within the circle. Referring back to her list of influential women, ask the client to draw a circle for 
each influential woman on the piece of paper and to place the circles in reference to how infl uential 
they have been in her life—placing the most influential women closer to her circle and other 
women with less influence farther away on the page. The circle can be placed anywhere on the 
paper. For example, if you have a client with a physically abusive mother and the client feels that 
this history prevented her from trusting other women, she may place the circle, labeled “Mother” 
quite close to her circle. 
After instructing the client to draw and place the circles on the page so that the placement 
represents how influential or how much she believes this relationship affected her, ask the client 
to go back and list three things in each circle that she learned about other women based on each 
specific relationship. For example, you may say to the client, “What did you learn about women 
based on your relationship with your mother and how your mother was with you? Select three 
things and write them in the circle that is labeled ‘Mother.’” 
Upon completion, have the client present her sociogram. This exercise works quite well in a 
women’s group and in individual counseling. In group, it promotes a dynamic discussion on how 
women learn to relate to each other, and it creates an opportunity to understand how each client’s 
history of female relationships can influence current relationships in treatment and recovery. As a 
counselor, you can promote further discussion by asking the following questions: 
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Clinical Activity:
 
Exploring the History and Influence of Relationships: Sociogram
   
(continued)
 
Are there any themes or recurrent patterns in this sociogram? 
1. 	 How does this history influence your relationship with other women in treatment, in therapy  
groups, and in support groups? 
2. 	 Can you provide a specific and recent example of how your history of relationships affected or  
contributed to a specific situation in treatment?  
Sample Sociogram Exercise: “What have I learned from each 
relationship about other women?” 
High 
School 
friend: Lenore 
Kind, patient, 
undependable, 
will drop you 
for men 
Current 
Girlfriend: Cheryl 
Used drugs together, 
loyal, secretive, 
trustworthy 
Sponsor: 
Georgia 
Steadfast, 
dependable, 
patient 
Sister: 
Amy 
Competitive, will 
steal your men, 
angrySelf 
Mother: 
Competitive, not 
dependable, cold 
Sister: Tara 
Unavailable, 
secretive, angry 
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1997). Trauma survivors may view sex as 
taboo or hurtful and their sexual responses 
as bad. In addition, sexual relationships 
sometimes can trigger painful memories 
of past abuse that can create diffi culties 
for women, particularly in early recovery 
(Covington 1997; Finkelstein 1996). 
• 	 Sexual dysfunctions. Alcohol and drugs 
interfere with sexual sensitivity and 
enjoyment in many ways. They disrupt the 
delicate balance of a woman’s hormonal 
system, interfering with her body’s 
emotional, reproductive, and physiological 
functions (Greenfield and O’Leary 2002). 
Women with substance use disorders have the 
same kinds of sexual dysfunctions as those 
without the disorder (lack of orgasm, lack 
of lubrication, lack of sexual interest, etc.), 
but they have more problems more often 
(Covington 2000). 
• 	 Sexual and interpersonal violence. Sexuality 
often is associated with violence and 
abuse for female clients with histories of 
trauma. Consequently, they may be fearful, 
angry, and distrustful, and have diffi culty 
functioning sexually. Given the association 
between substance abuse and sexual abuse 
(Ullman et al. 2005), women who have been 
abused may use alcohol or drugs to numb 
the emotional pain of the abusive experience. 
This can create a spiraling relationship where 
many women use substances to alleviate the 
sexual difficulties they are experiencing. 
But the alcohol or drugs only exacerbate the 
problem. Women who are under the infl uence 
of drugs are at greater risk for sexual and 
physical aggression (Blume 1991; Testa et al. 
2003), and this remains true with pregnant 
women who have substance use disorders 
(Velez et al. 2006). 
• 	 Sexually transmitted diseases (STDs). 
The use of alcohol and drugs increases the 
likelihood of contracting STDs, including 
HIV/AIDS. There are three primary reasons 
for this increased risk. When drunk or high, 
many women neglect to protect themselves 
against STDs or to make sure they do not 
use contaminated needles (Evans et al. 2003; 
Pugatch et al. 2000). Often women with 
substance use disorders fi nd themselves 
in relationships with men who are also 
chemically dependent, thereby increasing 
the risk that their partner may have STDs 
or are HIV positive. In addition, rates of 
other infectious diseases among women 
with substance use disorders tend to be 
higher than among other female populations 
(CSAT 1993c; Grella et al. 1995). Notably, 
preliminary findings suggest that women who 
inject illicit drugs and have sex with other 
women exhibit increased HIV infection and 
risk behaviors in comparison to other people 
who use injection drugs (Young et al. 2005). 
In addition to research pertaining to prevalence, 
counselors need to address clinical issues 
associated with infectious diseases. Specifi cally, 
shame and stigma are highly associated with 
sexually transmitted diseases and HIV infection 
(Fortenberry et al. 2002), and, as a result, 
women who are addicted and infected with 
a sexually transmitted disease are likely to 
perceive and experience a more profound 
sense of shame and higher levels of stigma— 
potentially serving as a barrier to engaging in 
help-seeking behavior. 
Pregnancy 
Pregnancy creates stress for many women. 
Literature suggests that this stress can come 
from the woman’s physical discomfort; her 
anxiety about the health of her fetus and how 
she will care for her baby; or her shame from 
the social stigma of using drugs, alcohol, or 
tobacco while she is pregnant (Daley et al. 
1998). Providers can create an atmosphere that 
supports talking freely about pregnancy and 
recognize that ambivalence toward pregnancy 
is a normal reaction. Counselors should make 
a careful assessment of the woman’s existing 
parenting and other family responsibilities and 
of the social services and economic resources the 
mother needs. 
Some women experience feelings of ambivalence 
about their pregnancy that become apparent 
during treatment. Educational programs, 
particularly for young women, that review 
the effects of alcohol, drug, and tobacco use 
on pregnant women and their fetuses may 
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provide motivation to enter treatment, but this 
information will probably also generate concern 
over the status of their fetus. Counselors should 
be supportive of the client as she processes this 
emotionally difficult information. Counselors 
must understand a woman’s guilt, shame, 
and unspoken feelings about the effects of 
substance use on fetal health and development. 
Counselors can advocate for fetal well-being but 
must also give the mother information that is 
nonjudgmental. It is important for counselors to 
stress that “it is never too late to stop,” and that 
whenever pregnant women reduce or stop drug 
and alcohol use, benefits are obtained! 
Women should be encouraged to consult with 
an obstetrician or geneticist regarding their 
concerns of prenatal exposure on the fetus. 
However, caution should be exercised in 
evaluating pregnancy outcomes based on use 
of alcohol, drugs, or tobacco during pregnancy 
and their possible effects on the newborn. It is 
almost impossible to make accurate predictions 
on neonatal outcomes. Nevertheless, a woman 
should have support from her substance abuse 
counselor to meet with her prenatal care 
provider to discuss these issues. 
After detoxification and stabilization, 
counselors should offer the important message 
that abstinence, staying in substance abuse 
treatment, and prenatal care can reduce the 
impact of substance use on the fetus (Bolnick 
and Rayburn 2003). Research indicates that 
a positive environment is as enriching to 
a child’s early growth and development as 
prenatal exposure to substances is detrimental 
(Frank et al. 2001; Hurt et al. 2001). After the 
child is born, a mother can work to create a 
positive environment for her child’s healthy 
development. This approach emphasizes the 
recovering woman’s control and self-effi cacy; 
it is another element of empowerment for 
recovering women (Covington 2002a). 
Parenting 
A woman’s relationship with her children and 
her identity as a mother play a vital role in her 
sense of self. These relationships are important 
in recovery from substance use disorders. The 
consensus panel believes that substance abuse 
treatment programs should offer treatment that 
addresses the critical component of parenting 
connections to children, as well as a full range 
of children’s physical and mental health care, 
along with other services, whether within a 
treatment program itself, or by referral to a 
collaborating agency. Refer to chapter 5 for 
more specific information on programming 
across each level of care for women who are 
pregnant and/or have children. 
Most mothers who are in substance abuse 
treatment feel a strong connection with their 
children and want to be good mothers. Most 
want to maintain or regain custody of their 
children and become “caring and competent 
parents” (Brudenell 2000, p. 86). Women who 
believe they have not cared for their children 
adequately or who believe that they are 
perceived as having neglected their children 
carry enormous guilt (Sun 2000). Therefore, for 
many women, maintaining caring relationships 
with their children is sufficient motivation to 
keep them in treatment. Unfortunately they 
often have inadequate role models in their own 
lives or lack the information, skills, or economic 
resources that could make motherhood less 
difficult (Camp and Finkelstein 1997; Moore and 
Finkelstein 2001). They also have the challenge 
of balancing the work necessary for recovery 
with their tasks as mothers. Another challenge 
treatment providers may face is the mother who 
is developmentally disabled to the extent that 
her mothering is inadequate. Ensuring the safety 
of her children while respecting the mother’s 
choice to care for them requires careful case 
management to provide support for the mother. 
People take from their family relationships a 
basic sense of their own identity and an equally 
basic model for the relationships they later 
develop with others. Mother–child relationships 
are understood to be the model for the child’s 
future relationships. At the same time, because 
women tend to develop their sense of self 
through relationships, a woman’s identity is 
also deepened when she becomes a mother. 
Society places a high value on a woman’s ability 
to mother, and her own perceived success or 
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failure in this endeavor forms an important 
aspect of her self-concept. For a mother with 
a substance use disorder, this concept can be 
paramount (Feinberg 1995). 
Parenting programs 
Research findings are inconsistent in 
demonstrating the effectiveness of behavioral 
parenting programs for improving the parent– 
child relationship and children’s psychological 
adjustment among mothers who have substance 
use disorders (for review, see Suchman et al. 
2004; Suchman et al. 2007; Velez et al. 2004). 
More research is needed to evaluate the most 
effective parenting approaches and to address 
research methodological issues surrounding 
parenting program evaluations. In general, 
literature appears to support combining 
behavioral training with attachment-based 
parenting interventions (relational model). 
A strengths-based relational approach to 
parenting assumes maternal assets already 
exist that can be identified and built on, and 
that the emotional quality of the parent–child 
relationship is equally important in improving 
the parent–child relationship and psychological 
adjustment of the child. In essence, parenting is 
a relationship—not solely a set of skills. Some 
topics for parenting skills and relationship 
building include: 
• 	 Age- and developmentally appropriate 
behavioral expectations for children. 
• 	 Children’s emotional, physical, and 
developmental needs. 
• 	 Parenting styles and other childrearing 
practices, including attachment-oriented 
approaches (defined as enhancing the 
parent’s ability to accurately perceive and 
sensitively respond to the emotional needs 
reflected in their child’s behavior) (Slade and 
Cohen 1996; Suchman et al. 2006). 
• 	 Strategies to improve nurturing that begin 
with helping mothers find a way to nurture 
themselves as an important step in learning 
how to nurture their children. 
• 	 Constructive discipline strategies without 
corporal punishment. 
• 	 Anger management strategies to assist parents 
in learning how they can appropriately 
manage their strong feelings. 
• 	 Appropriate parent–child roles including 
modeling opportunities. 
• 	 Integration of culturally congruent parenting 
practices and expectations. 
Clients need time to practice these new 
parenting skills and change patterns of behavior 
to improve interactions with their children 
(CSAT 2000b). It is helpful to match parenting, 
coaching, or other support groups to the 
woman’s ability to cope with her children and 
the other problems she is facing. Substance 
abuse counselors must simultaneously help 
mothers address their other ongoing challenges 
while teaching them to be better parents (Camp 
and Finkelstein 1997). Programs that provide 
support and parent training to mothers can 
also help children by building their self-esteem, 
supporting them educationally and emotionally, 
and assisting them to achieve developmental 
milestones. 
Children affected by maternal alcohol and
drug dependence have increased vulnerability
for physical, social-emotional, and academic
problems (Conners et al. 2004; VanDeMark et
al. 2005). Moreover, analysis from SAMHSA’s
Women, Co-Occurring Disorders and Violence
Study (WCDVS) suggests that children are also at
an increased risk for physical child abuse when
the mother has a current history of mental health
symptoms, alcohol and drug use severity, and
trauma (Rinehart et al. 2005). Thus, children
need more than just adequate child care. 
The consensus panel recommends that an onsite 
child specialist or one available by referral 
should be a standard element of programs that 
include children. Assessment and screening 
for developmental and learning delays and 
social problems is necessary, as are play 
and expressive therapies that help children 
acknowledge and express feelings about their 
parents’ problems. Children should be provided 
with information regarding their mother’s 
substance use disorder in an age-appropriate 
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manner. Counselors can help the mother and 
children frankly discuss issues surrounding 
substance use and recovery. A staff member 
providing therapeutic services for children 
should conduct substance abuse prevention 
activities for children of all ages. 
While a woman is learning to parent, her 
children need assistance to overcome the effects 
of her substance abuse. It is likely their mother 
has been emotionally and physically unavailable 
at times. Counselors can help children realize 
that their mother’s behavior was unintentional 
and, as she regains control of her life, she will 
likely become more available. In addition, 
Alateen; psychoeducational curricula, such 
as the National Association for Children of 
Alcoholics “Celebrating Families™;” and onsite 
individual and group therapy can provide 
further support to children. 
Parenting issues for women with 
trauma histories 
A history of trauma can affect both how a 
woman experiences parenting and how effective 
she is as a parent. Factors that affect a woman’s 
parenting include the extent of trauma history, 
who the abuser was, and a woman’s parenting 
role models, as well as whether she has been 
involved with trauma work or has developed the 
skills to manage trauma memories and feelings 
(Melnick and Bassuk 2000). Several major 
parenting issues for trauma survivors can be 
identifi ed: 
• 	 Many women feel shame, guilt, and self-
blame, which can interfere with their 
emotional availability to their children. 
This includes a mother’s self-criticism 
or depression when evaluating current 
parenting as well as her belief that she 
deserves blame for inadequate parenting, 
or feeling that her children’s behavior is 
an attack because they had inadequate 
parenting. 
• 	 Interaction with a child can trigger a 
mother’s traumatic past. This includes 
experiencing a child’s misbehavior as a 
traumatic trigger, children’s distress or need 
for bonding reminding a mother of her own 
vulnerabilities, and having posttraumatic 
stress disorder (PTSD) symptoms triggered 
by normal developmental events such as 
breastfeeding, bathing a child, and providing 
sexual education to a child. Likewise, a 
mother may experience heightened anxiety 
and vigilance when one of her children 
reaches the same age that her own prior 
sexual abuse or trauma began or occurred. 
For example, if a client witnessed her 
younger brother getting shot when she was 
12, she may encounter more traumatic stress 
symptoms as her oldest child reaches the 
same age as her brother. 
• 	 A mother may internalize and reenact 
the role of both victim and perpetrator in 
response to trauma. This may cause her to 
worry that her children will be mistreated 
and lead to either overprotectiveness or 
helplessness, a reluctance to set limits out of 
fear of identifying with a perpetrator. 
• 	 Female clients will need to come to terms 
with having been inadequately nurturing 
parents at times and with the complexities 
of providing a better relationship with their 
children (Melnick and Bassuk 2000). 
Trauma-informed parent training assists 
mothers in identifying their triggers, learning 
appropriate boundaries and discipline, and 
learning nurturing behaviors so they can care 
for their children in healthy ways. As the 
mother becomes more stable, she will need to be 
prepared for the possibility that her children 
will feel safer in acting out their previous 
distress. Programs can prepare women in 
early recovery for this predictable event with 
information, coaching for effective parenting, 
and reframing the children’s behavior as a signal 
that they feel safer and can afford to express 
themselves. 
Children who are not in a 
mother’s care 
Regaining custody or re-establishing their role 
of primary caregiver can be a major motivating 
factor for women in treatment. Professionals at 
all levels of care are encouraged to support the 
relationship between mothers and children and 
to support and facilitate ongoing connections 
with their children in foster care or with 
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relative caregivers. Since parent–child visiting 
is an essential ingredient toward reunifi cation, 
substance abuse treatment providers may be 
able to provide supervised visits, offering an 
opportunity for therapeutic intervention and 
the mother’s attention to her relationship with 
children not in her custody. Yet, numerous 
factors inhibit visitation, including the mother’s 
health status, transportation needs, and 
support from others (Kovalesky 2001), and staff 
should be aware of these variables. Ultimately, 
counselors will need to help women recognize 
how their recovery needs can complicate meeting 
their children’s needs and determine the pacing 
of reunifi cation efforts. 
Occasionally, a mother in substance abuse 
treatment expresses a desire not to keep her 
children. The woman may feel unable to be a 
mother or has no support in doing so, or her 
children have been cared for by others for a 
long time. In other cases, it is possible that these 
children were the result of rape or prostitution. 
Sometimes it is in the best interest of both the 
mother and the child(ren) for the mother to 
relinquish care. Counselors must be careful to 
allow the decision to belong to the woman, to 
listen to her ambivalence, and to support her 
regardless of her decision (CSAT 2001b). 
Children with special needs 
Some mothers with substance use disorders 
have children with special needs, possibly as a 
result of alcohol or drug use during pregnancy, 
inadequate prenatal care, poor nutrition during 
pregnancy, or other factors. In addition to 
coping with the personal guilt, mothers will 
find that these children demand extra care 
and attention and create additional stresses 
during recovery. Careful assessment of these 
children by trained professionals is essential. An 
educational and/or treatment plan should result 
from an assessment that is integrated with the 
mother’s treatment plan. Because so many of 
the children who are included in treatment with 
their mothers have emotional or developmental 
problems, there is a real need for child 
specialists on staff (Conners et al. 2004; CSAT 
2000b). A linkage to programs for children 
with special needs and children with disabilities 
would be an asset in providing the services these 
children need. 
History of Trauma 
Trauma can result from numerous experiences, 
including emotional, physical, and sexual 
abuse, as well as assault, war, natural disasters, 
terrorism, and interpersonal violence that 
occurs between family members or with intimate 
partners. Women who experience or witness 
violence, particularly actions that threaten 
their lives and safety, can become traumatized 
by these events (Herman 1997). The Diagnostic 
and Statistical Manual of Mental Disorders, 
4th Edition, Text Revision (DSM-IV-TR) defi nes 
trauma as “involving direct personal experience 
of an event that involves actual or threatened 
death or serious injury, or other threat to 
one’s physical integrity; or witnessing an event 
that involves death, injury, or a threat to the 
physical integrity of another person; or learning 
about unexpected or violent death, serious 
harm, or threat of death or injury experienced 
by a family member or other close associate” 
(American Psychiatric Association [APA] 2000a, 
p. 463). 
Women respond to and are affected by trauma 
in a variety of ways. Based on their histories, 
circumstances, and other factors, some women 
experience traumatic stress symptoms that 
dissipate over time, while other women are 
resilient to the effects of trauma and recover 
from it quickly (Foa and Rothbaum 1998). 
Some women develop psychological disorders 
including PTSD and other anxiety and mood 
disorders, and other women may use alcohol, 
tobacco, and drugs to cope with the trauma and 
its symptoms. Still others may replicate their 
trauma by engaging in problematic parent–child 
interactions, including abuse and neglect 
(McMahon and Luthar 1998). A family history of 
anxiety, early traumatic violence, and repeated 
exposure to trauma can predispose an individual 
to develop severe problems. The Adverse 
Childhood Experiences Study (Felitti et al. 1998) 
reflected a strong association between health 
risk behavior and disease for both adult men 
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and women to exposure to emotional, physical, 
or sexual abuse, and household dysfunction 
during childhood. 
The relationship between trauma 
and substance abuse 
Substance abuse and victimization appear to be 
highly correlated; drug abuse increases the risk 
of violent assault, and victimization appears to 
increase the risk of substance abuse (El-Bassel 
et al. 2005; Kendler et al. 2000; Kilpatrick et 
al. 1997). Nevertheless, the connection between 
substance use and abuse and interpersonal 
violence often is complex, especially for women. 
Men who abuse substances are at high risk 
of committing violence against women and 
children. Women who use substances are more 
at risk for being abused because of relationships 
with others who abuse substances, impaired 
judgment while using alcohol or drugs, and 
being in risky and violence-prone situations 
(Testa et al. 2003). Survivors of abuse may 
become dependent on alcohol and drugs to 
manage trauma symptoms and reduce tension 
and stress from living in violent situations. 
Thus begins a cycle of “victimization, chemical 
use, retardation of emotional development, 
limited stress resolution, more chemical 
use, and heightened vulnerability to further 
victimization” (Dayton 2000; Steele 2000, p. 72). 
A history of trauma is common in the lives of 
women with substance use disorders. Female 
survivors of sexual trauma were found, in one 
study, to be dependent on more substances, to 
have had more hospital stays and emergency 
department visits, and to be less able to care for 
their children than women who had not been 
sexually abused (Young and Boyd 2000). Girls 
who suffer physical and sexual abuse by dating 
partners are more likely to engage in risky 
behaviors such as smoking, binge drinking, 
and cocaine use (Silverman et al. 2001). In 
another study, adverse childhood circumstances 
predicted binge drinking among adult women 
(Timko 2008). 
Alcohol and drug use by trauma survivors can 
be adaptive at first. Some victims use substances 
to numb psychological effects of the trauma. 
Some substances help survivors dissociate the 
trauma from their consciousness (Herman 
1997). Women who have histories of violence and 
trauma have a higher propensity for substance 
use disorders and are more likely to encounter a 
difficult recovery from substance use disorders. 
Their treatment is typically complicated because 
of the interrelationship between trauma and 
substance use, the role that substances play 
in managing traumatic stress symptoms, and 
sequelae from the experience of trauma such as 
depression and other psychological disorders. 
To obtain more specific information on the 
impact of trauma, traumatic stress disorders, 
symptoms of PTSD and associated symptoms, 
and treatment approaches, refer to TIP 42 
Substance Abuse Treatment for Persons With 
Co-Occurring Disorders (CSAT 2005e) and the 
planned TIP Substance Abuse and Trauma
(CSAT in development h). 
Interpersonal violence 
Violence dramatically affects the physical and 
emotional health of victims and witnesses. 
The United Nations defines violence against 
women as “any act of gender-based violence 
that results in, or is likely to result in, physical, 
sexual or psychological harm or suffering to 
women, including threats of such acts, coercion 
or arbitrary deprivation of liberty, whether 
occurring in public or in private life” (United 
Nations General Assembly 1993, p. 2). The 
National Violence Against Women Survey 
(Tjaden and Thoennes 1998; 2000; 2006), 
conducted in 1996, estimated that in the year 
before the survey, almost 2 million women were 
physically assaulted and more than 300,000 
women experienced a completed or attempted 
rape. Estimates of lifetime incidence increased 
to more than 50 million women who were 
physically assaulted and almost 20 million who 
experienced rape or attempted rape. Moreover, 
sociologists have commented that this level of 
violence has created a culture of fear for many 
women, observing that women feel they need 
to be alert and aware of their surroundings to 
protect themselves against assault and rape 
(Gordon and Riger 1989). 
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Women are more likely to become victims of 
intimate partner abuse (Catalano 2007), and 
men and women become victims of interpersonal 
violence under different circumstances. Women 
often experience violence in the privacy of their 
home (Catalano 2007; Covington 2002a; Tjaden 
and Thoennes 2006). Both boys and girls are at 
risk for physical and sexual abuse by parents 
and people they know, but this risk changes over 
the course of life. As girls move into adolescence 
and adulthood, they continue to be at risk for 
interpersonal violence. Often their abuser is 
someone with whom they have a relationship. 
For example, about one in five high school  
girls reportedly has suffered sexual or physical 
abuse from a boyfriend (Ackard and Neumark-
Sztainer 2003; Silverman et al. 2001, 2004). 
For an overview of violence and women, see 
Figure 7-1. 
Violence and abuse also occur in lesbian 
relationships. While research is limited, studies 
reviewed by Renzetti (1993) have indicated that 
lesbians experience partner violence at about 
the same rate as heterosexual women. As is the 
case with violence in heterosexual relationships, 
alcohol consumption often is part of the 
battering (Schilit et al. 1990). In comparing 
the prevalence of domestic violence between 
homosexual males and females, the National 
Coalition of Anti-Violence Programs (2007) 
reports there are no overall differences. 
Childhood sexual and physical 
abuse 
A history of childhood sexual or physical abuse 
(or both) is a significant risk factor for the  
development of a substance use disorder (Evans 
and Sullivan 1995). Two models help explain 
this—the distress coping model and the emotion 
regulation model. It is likely that substances 
not only serve as means of coping with negative 
emotions generated by childhood abuse, but 
Figure 7-1 
Violence and Women 
• 	 The strongest risk factor for being a victim of intimate partner violence is being female. 
• 	 One of every six women has been forcibly raped at some time in her life, and women are as 
likely to be raped as adults as they are as minors. 
• 	 While women are at a significantly greater risk in  comparison to men of being raped by all 
types of offenders, 43 percent of all female victims were raped by either a current or former 
intimate partner. 
• 	 Between 25 and 50 percent of women will be abused by male partners during their lifetime. 
• 	 Women are injured as a result of domestic violence about 13 times more frequently than men. 
• 	 Women with fewer resources or greater perceived vulnerability—girls and those experiencing 
physical or psychiatric disabilities or living below the poverty line—are at even greater risk 
for domestic violence and lifetime abuse. 
• 	 Interpersonal violence is characterized by a pattern of physical, sexual, or psychological 
abuse. The most common pattern in domestic violence is escalation in frequency and severity 
over time. 
• 	 When women are violent toward family members, it often is in self-defense. 
• 	 A history of intrafamilial violence may be the most influential risk factor for a woman’ s abuse 
of substances. 
• 	 Violence in the media significantly affects attitud es and behaviors related to violence. It 
increases fear and mistrust, desensitizes people to violence, and glamorizes risk-taking 
behaviors and violence. 
Source: American Psychological Association 1996; Brownridge 2006; Tjaden and Thoennes 2006 
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in regulating emotions by enhancing positive 
feelings (Grayson and Nolen-Hoeksema 2005; 
Simpson 2003; Ullman et al. 2005). 
A study of 1,411 women born between 1934 and 
1974 found that women who experienced any 
type of sexual abuse in childhood were more 
likely than those who were not abused to report 
drug or alcohol dependence as adults. In fact, 
childhood sexual abuse was associated more 
strongly with drug or alcohol dependence than 
with any other psychiatric disorder. This study 
is based on data from women in the general 
population, as opposed to clinical studies of 
women in treatment (Kendler et al. 2000). 
Clinical studies have documented that up to 75 
percent of women in substance abuse treatment 
have a history of physical and/or sexual abuse 
(Ouimette et al. 2000; Teusch 1997). Earlier 
studies have shown that women who abuse 
substances are estimated to have a 30- to 
59-percent rate of current PTSD (Najavits et 
al. 1998), which is higher than the rate in men 
who abuse substances (CSAT 2005a). A history 
of sexual and/or physical abuse puts women at 
risk for psychiatric hospitalization (Carmen 
1995), depression (Herman 1997; Ross-Durow 
and Boyd 2000), eating disorders (Curtis et 
al. 2005; Janes 1994; Miller 1994; Smolak and 
Murnen 2001), and self-inflicted injury (Dallam 
1997; Haswell and Graham 1996; Miller and 
Guidry 2001). See also TIP 36 Substance Abuse 
Treatment for Persons With Child Abuse and 
Neglect Issues (CSAT 2000b). 
Co-Occurring Disorders 
When working with women with co-occurring 
mental and substance use disorders, substance 
abuse treatment counselors need to apply 
the tools of the mental health professional, 
especially in knowing when and where to 
refer clients with co-occurring disorders. 
Substance abuse treatment providers do not 
necessarily have to be trained as mental health 
professionals, but making appropriate referrals 
and coordinating the services needed by these 
clients requires a solid grasp of the differences 
in treatments, role of medications, and available 
resources. The following section provides an 
overview of co-occurring issues and highlights 
three disorders that are prevalent in substance 
abuse treatment among women. For more in-
depth coverage of treatment for those with co­
occurring substance use and mental disorders, 
review TIP 42 Substance Abuse Treatment for 
Persons With Co-Occurring Disorders (CSAT 
2005e). 
An overview of issues 
Both the substance abuse and mental health 
care fields understand that clients can 
enter treatment with issues they perceive 
as interwoven, whether or not the services 
themselves are. To address the dilemmas facing 
the people they serve, mental health, substance 
abuse, and trauma services are opening a 
dialog with one another, paving the way toward 
providing an appropriate, integrated system of 
care for each client in every system. 
An integrated care framework provides 
assessment and treatment wherever the 
woman enters the treatment system, ensures 
necessary consultation for her issues when 
a given individual or program does not have 
the necessary expertise, and encourages all 
counselors and programs to develop competence 
in addressing co-occurring disorders. When 
women are assessed at a facility that does not 
have all the services they need, staff members 
at that facility are responsible for ensuring that 
the women are assessed at other appropriate 
facilities. Too often, services may over- or 
under-treat one of the disorders (Miller 1994a). 
Staff members also are responsible for following 
up with the cooperating facility to ensure that 
clients receive proper care. 
The need for ongoing evaluation of co-occurring 
disorders is critical because both substance 
abuse and substance withdrawal can mimic 
or mask co-occurring psychiatric disorders. 
The client’s internal turmoil can result in 
overwhelming affect and chaotic behavior that 
creates heavy demands for providers. Women 
with co-occurring substance use and mental 
disorders are likely to have PTSD, other anxiety 
disorders, depression, or eating disorders 
(particularly bulimia). While women are also 
more willing to identify social and psychiatric 
problems, they appear to have more diffi culty 
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in acknowledging problems with substance use 
(Mangrum et al. 2006). Treatment services 
that provide an integrated system of care 
can naturally assist women in exploring the 
interaction and impact of substances and mental 
health without supporting or reinforcing the 
polarization of each disorder that can arise 
when one disorder is easier to acknowledge by 
the client. 
Co-occurring mental and substance use 
disorders often result in poor psychosocial 
functioning, health problems, medication 
noncompliance, relapse, hospitalizations, 
homelessness, and suicidal behavior (Reed 
and Mowbray 1999). Co-occurring disorders 
are associated with poorer treatment outcomes 
for women with substance use disorders and 
contribute to high rates of treatment dropout 
(Bernstein 2000). Among women in the child 
welfare system, the prevalence of co-occurring 
disorders is high and the need for services is 
paramount. More often than not, mothers’ co­
occurring disorders interfere with the likelihood 
of family reunification—especially if there are 
numerous needs, such as vocational, housing, 
and mental health services (Choi and Ryan 
2007). Thus, appropriate referrals and case 
management are needed to retain these clients in 
substance abuse treatment and to afford the best 
possible outcome for women and their children. 
Pregnant women and co-occurring 
mental illness 
Pregnancy can aggravate the symptoms of co­
occurring mental illness. This can be a result of 
the hormonal changes and stresses that occur 
during pregnancy, some medications given 
during pregnancy or delivery, the stresses of 
labor and delivery, the challenges and hormonal 
changes with lactation, and adjusting to and 
bonding with a newborn (Grella 1997). Women 
with co-occurring disorders sometimes avoid 
early prenatal care, have diffi culty complying 
with healthcare providers’ instructions, and are 
unable to plan for their babies or care for them 
when they arrive. According to the literature, 
women with anxiety disorders or personality 
disorders have a greater risk of postpartum 
depression (Grella 1997), and mood disorders 
affect treatment outcome among pregnant 
women who are drug dependent (Fitzsimons 
et al. 2007). More outcome research is needed 
to evaluate the role of co-occurring disorders 
among pregnant women and the impact of 
treatment for co-occurring disorders on prenatal 
and postnatal care. 
It is important to remember that women can 
become depressed not only after childbirth but 
during pregnancy. According to the National 
Women’s Health Information Center (HHS 
Advice to Clinicians: 
Women With Co-Occurring Disorders 
Provide women who have co-occurring disorders with comprehensive coordinated• 
services using an integrated treatment model. 
Screen and assess for trauma as a standard practice for women in treatment for• 
substance use disorders. 
View services as long term, suggesting a range of continuing care services and peer • 
support, such as 12-Step programs, group therapy, or women’s support groups. 
Maintain regular contact with clients and advocate for them; adapt case management• 
models that promote regular contact with clients. 
Attend to a client’s reaction to medication and compliance, particularly when a • 
woman is treated for psychiatric illnesses. Learn about medications effective for 
anxiety, depression, and other mental disorders; their safety profile, side effects, and 
possibilities for cross-addiction; and length of time needed for symptoms to decrease. 
Offer encouragement to women with co-occurring disorders and reward them for • 
gains made in treatment to help them establish a stronger sense of self-worth. 
Source: DiNitto and Crisp 2002. 
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Postpartum Depression: An Under-Diagnosed Disorder 
According to the DSM-IV-TR (APA 2000a), postpartum depression begins within 4 weeks after 
delivery. Episodes occurring after this period are considered “ordinary” depression. Risk 
factors for postpartum depression include a history of depression, psychological distress or 
psychiatric diagnosis before or during pregnancy, or a family history of psychiatric disorders 
(Nielsen Forman et al. 2000; Steiner 2002; Webster et al. 2000). Prospects for recovery from 
postpartum depression are good with supportive psychological counseling accompanied as 
needed by pharmacological therapy (Chabrol et al. 2002; Cohen et al. 2001; O’Hara et al. 
2000). Antidepressants, anxiolytic medications, and even electroconvulsive therapy have all 
been successful in treating postpartum depression (Griffiths et al. 1989; Oates 1989; Varan et 
al. 1985). (Note that some medications pass into breast milk and can cause infant sedation.) 
Patients with postpartum depression need to be monitored for thoughts of suicide, infanticide, 
and progression of psychosis in addition to their response to treatment. 
The term “postpartum depression” encompasses at least three different entities: 
• 	 Postpartum or maternity “blues,” which affects up to 85 percent of new mothers 
• 	 Postpartum depression, which affects between 10 and 15 percent of new mothers 
• 	 Postpartum psychosis, which develops following about one per 500–1,000 births, according 
to some studies (Steiner 1998) 
Postpartum blues is temporary depression occurring most commonly within 3–10 days after 
delivery and may be caused by progesterone withdrawal (Harris et al. 1994), a woman’s 
emotional letdown that follows the excitement and fears of pregnancy and delivery, the 
discomforts of the period immediately after giving birth, fatigue from loss of sleep during 
labor and while hospitalized, energy expenditure at labor, anxieties about her ability to care 
for her child at home, and fears that she may be unattractive to her partner. Anticipation and 
preventive reassurance throughout pregnancy can prevent postpartum blues from becoming 
a problem. Women with sleep deprivation should be assisted in getting proper rest. Symptoms 
include weepiness, insomnia, depression, anxiety, poor concentration, moodiness, and 
irritability. These symptoms tend to be mild and fleeting, and women usually recover completely 
with rest and reassurance. Followup care should ensure that the woman is making suffi cient 
progress and not heading toward a relapse to substance abuse. 
Postpartum depression is a more severe case of the postpartum blues that does not go away 
after a few days. Beyond the temporary weepiness, irritability, and emotional letdown 
that follows delivery, postpartum depression involves a longer-term experience of despair, 
discouragement, guilt, self-reproach, and withdrawal from social contact. In many ways, 
postpartum depression resembles the grief and mourning that follows bereavement. Women 
may also lose their appetite and thus also lose weight, experience insomnia and severe mood 
swings, and have trouble coping with simple daily tasks, including the care of their newborns. 
Postpartum psychosis is a severe mental disorder. Women with this disorder lose touch with 
reality and may have delusions, hallucinations, and/or disorganized speech or behavior. Women 
most likely to be diagnosed with postpartum psychosis are those with previous diagnoses 
of bipolar disorder, schizophrenia, or schizoaffective disorder, or women who had a major 
depression in the year preceding birth (Kumar et al. 2003). Other studies reviewed by Marks 
and colleagues (1991) indicate that other risk factors for postpartum psychosis include previous 
depressive illness or postpartum psychosis, first pregnancy, and family history of mental illness. 
Recurrence of postpartum psychosis in the next pregnancy occurs in 30–50 percent of women 
(APA 2000a). Peak onset is 10–14 days after delivery but can occur any time within 6 months. 
In most cases, the severity of the symptoms mandates pharmacological treatment and sometimes 
hospitalization. The risk of self-harm and/or infanticide is widely reported and monitoring of 
mother–infant by trained personnel can limit these occurrences. 
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2009), several factors increase a woman’s chance 
of depression prior to delivery: minimal support 
from family and friends, a history of depression 
or substance abuse, a family history of mental 
illness; anxiety about the condition of the fetus, 
problems with previous pregnancies or birth(s), 
relational or financial problems, and age of 
mother (younger women). 
Many pregnant women with co-occurring 
disorders are distrustful of substance abuse 
and mental health treatment providers, yet 
they are in need of multiple services (Grella 
1997). One concern is whether the mother can 
care adequately for her newborn. For her to 
do so requires family-centered, coordinated 
efforts from such caregivers as social workers, 
child welfare professionals, and the foster care 
system. It is particularly important to make 
careful treatment plans for women with mental 
health problems that include planning for 
childbirth and infant care. Women are often 
concerned about the effect of their medications 
on their fetuses. The consensus panel believes 
that treatment programs should work to 
maintain a client’s medical and psychological 
stability during her pregnancy and collaborate 
with other healthcare providers to ensure that 
treatment is coordinated. Providers also need to 
allow for evaluation over time for women with 
co-occurring disorders. Re-assessments should 
occur as they progress through treatment. 
Anxiety Disorders 
Anxiety disorders encompass physiological 
sensations of nervousness and tension, 
psychological worry characterized often by 
apprehension and rumination, and behavioral 
patterns of avoidance linked to the perceived 
source of anxiety. Some anxiety disorders have 
stronger familial ties than others. Anxiety 
disorders can develop without an identifi ed 
stressor or event or by exposure to acute or 
prolonged stress, (such as a traumatic event or 
a chronic condition such as living with poverty, 
in a dysfunctional family system, or as a result 
of migration and acculturation). PTSD, panic 
disorders, agoraphobia without panic, simple 
phobia, and generalized anxiety disorder are 
more common among women than among men 
(APA 2000a; Kessler et al. 1994; NIMH 2007). 
Among individuals with substance use disorders, 
traumatic stress reactions and PTSD are quite 
prevalent among women. As a result, this section 
will primarily focus on PTSD starting with 
a brief overview of treatment considerations 
for women with anxiety disorders. For more 
detailed information regarding anxiety disorders 
and trauma, refer to TIP 42 Substance Abuse 
Treatment for Persons With Co-Occurring 
Disorders (CSAT 2005e) and the planned 
TIP Substance Abuse and Trauma (CSAT in 
development h). 
General treatment considerations 
for anxiety disorders 
Women with anxiety disorders often seek 
medical help for physical (somatic) complaints 
such as fatigue, trembling, palpitations, 
sweating, irritability, sleeping problems, eating 
problems, irritable bowel syndrome, chronic 
pain, or dizziness. The symptoms of substance 
use and anxiety disorders are easily confused; 
therefore, abstinence must be established 
before a woman in substance abuse treatment is 
diagnosed with anxiety disorder. However, this 
does not preclude providers from working with 
Note to Clinicians 
It is important to remember that women can become depressed not only after childbirth but 
during pregnancy. According to the National Women’s Health Information Center (HHS 2009), 
several factors increase a woman’s chance of depression prior to delivery: minimal support 
from family and friends, a history of depression or substance abuse, a family history of mental 
illness; anxiety about the condition of the fetus, problems with previous pregnancies or birth(s), 
relational or financial problems, and age of mother (younger women). 
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women to develop coping skills and strategies to 
manage the symptoms of anxiety. 
Cognitive–behavioral therapies (CBT) are 
effective treatments for anxiety disorders 
(Hofmann and Smits 2008) including, but 
not limited to, stress inoculation and other 
anxiety management strategies, desensitization 
processes, and imaginal and in-vivo (live 
reenactments) exposure therapies. Nonetheless, 
other types of therapy that address the 
underlying stress-producing events may be 
required (Frank et al. 1998). Clinical experience 
indicates that women with anxiety disorders 
and substance use problems may benefi t 
from alternative therapies as an adjunct to 
CBT, including acupuncture, exercise, and 
mindfulness meditation. One study indicated 
that socially phobic female outpatients 
being treated for alcohol dependence had 
better outcomes with CBT than with 12-Step 
facilitation therapy (Thevos et al. 2000). 
Benzodiazepines, which are commonly 
prescribed for anxiety disorders, can also be 
addictive and thus present a major problem for 
women with a substance use disorder. Providers 
may prescribe sedating antidepressants or 
selective serotonin reuptake inhibitors (SSRIs; 
Zweben 1996) instead. Newer nonaddicting 
medications, both SSRIs and non-SSRIs, are 
being prescribed as anti-anxiety agents (NIMH 
2007). Other options include anticonvulsants, 
antihypertensive agents, and newer neuroleptic 
medications. 
PTSD 
Although some type of trauma has been 
experienced by many women who use 
substances, not all women who have been 
traumatized will develop PTSD. An anxiety 
disorder, PTSD may involve other anxiety 
symptoms including panic attacks and avoidance 
(Brady et al. 2000). Refer to Appendix E for 
DSM-IV-TR criteria for PTSD. For those 
women who have PTSD, their symptoms will 
involve persistent re-experiencing of trauma-
related events, avoidance of trauma-related 
material, and arousal (APA 2000a; Refer to 
Figure 7-2, p. 162, for PTSD symptom clusters). 
In addition, they will present other associated 
symptoms, such as depression and sleep 
disturbance. Subsequent to a heightened state 
of arousal, many women report signifi cant sleep 
difficulties characterized by nightmares, trouble 
falling sleep, frequent awakenings or problems 
in staying asleep, and apprehension in going to 
sleep. Among women with a history of sexual 
assault and PTSD, sleep difficulties have been 
noted as a significant motive to drink (Nishith et 
al. 2001). 
Along with the physiological and psychological 
symptoms that so often characterize PTSD, 
the experience of trauma can impact core 
assumptions and beliefs about self, others, 
and life (for review, see Janoff-Bulman 1992). 
One study (Hall 2000) demonstrated that the 
severity of the effects of trauma is evident 
in two core beliefs identified by survivors of 
childhood abuse who are in recovery: “I am 
nothing” (feeling inconsequential) and “I am 
bad or wrong.” In addition to the abuse or 
trauma itself, experiences that lead to feeling 
inconsequential include being unprotected from 
danger, telling someone about the abuse but 
not being believed, being told lies to conceal the 
abuse, and being unprepared for life transitions. 
This can lead to shutting down emotions and 
social isolation (Boyd and Mackey 2000a; Hall 
2000). The perpetrator may have put the blame 
on them (“you asked for it”). 
Treatment of PTSD 
Unlike other memories, memories of traumatic 
events may seem to have vague cognitive content. 
Rather, they often are sensory fragments such as 
Note to Clinicians 
Anxiety in a client can increase a counselor’s anxiety. A tip for staff working with women who 
abuse substances with anxiety disorders is to “slow down,” that is, start with general and non-
provocative topics and proceed gradually as clients become more comfortable talking about 
issues. 
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Figure 7-2 
PTSD Symptoms 
Symptoms Client Experience Clinical Suggestions 
Reexperiencing • Feelings of being tossed from • Grounding techniques
• Flashbacks present and thrown into the • Develop support system
• Intrusive memories nightmare of the past • Education about trauma
• Nightmares • Feeling of being out-of-control and the symptoms of 
• Feeling of incompetence PTSD 
in managing symptoms or • Create sense of safety
triggers • Sleep hygiene strategies
• Imaginal rehearsal of
dreams 
• Cognitive and coping skills
to help separate past 
experiences from present 
moment 
Hyperarousal • All-or-none thinking • Normalize the symptoms
• Heightened startle • Fatigue • Ability to reassure
response • Feeling overwhelmed and • Containment strategies
• Irritability or heightened terror of being overwhelmed • Increasing coping and
aggression by feelings self-soothing capacities 
• Hypervigilance of •  Difficulty in managing anxiety • Anxiety management
environment and engaging in self-soothing training 
• Sleep disturbance skills • Cognitive restructuring
Numbing and Avoidance • Disconnection from others’ • Affect regulation skills
• Staying away from and own feelings • Cognitive–behavioral
persons, places, and • Mechanical experience of life; strategies to build coping 
things that remind client possible discussion of painful skills 
of trauma events with limited affect • Education regarding
• Dissociation (not knowing substance use disorders 
or remembering events or and opportunities 
periods or experiencing to draw connections 
oneself as separate from what between substance use 
one was experiencing) and distress 
• Repeated use of substances or • When appropriate and
engagement in behaviors to with adequate training, 
avoid distress use exposure strategies 
• Isolation; profound loneliness including desensitization, 
• Ineffective defense against eye movement 
overwhelming feelings desensitization and 
reprocessing, prolonged 
exposure therapies 
Sources: APA 2000a; Cramer 2000; Melnick and Bassuk 2000; and Najavits 2002b. 
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Figure 7-3 
Helpful Skills for Trauma Victims 
• 	 Self-knowledge, including attention to bodily cues 
• 	 Self-regulation, including recognizing triggers and expressing emotions appropriately 
• 	 Self-soothing; for example, using relaxation or guided imagery and keeping a journal 
• 	 Self-esteem and recognizing which behaviors to change 
• 	 Self-trust, including learning when to trust one’s own judgment and how to make decisions 
• 	 Limit setting and assertiveness, including recognizing personal limits and defending them 
• 	 Clear expression of needs and desires; for example, identifying a need, evaluating the need, 
and planning how to fi ll it 
• 	 Realization that the healthiest relationships have mutuality and reciprocity and learning to 
create them 
Source: Adapted from Harris and Fallot 2001a. 
sights, sounds, smells, or kinesthetic sensations 
and emotional states (van der Kolk 1996). 
Developing the ability to organize the traumatic 
events into coherent thoughts and narrative that 
can be expressed in some way can signifi cantly 
lessen somatic symptoms (see Figure 7-3; van 
der Kolk 1996). Some treatment methods 
support the premise that the trauma must be 
made conscious, effectively experienced, and 
integrated into present life (Volkman 1993). 
Some treatments suggest that coping strategies 
are the effective path in addressing PTSD, 
while other approaches heavily rely on the 
premise that repeated and prolonged exposure 
to anxiety-evoking material will gradually 
reduce PTSD symptoms through the process 
of extinction/habituation (Foa et al. 2007). A 
review of psychological treatments for PTSD is 
beyond the scope of this TIP. For a review of 
treatments, refer to the article, Psychosocial 
treatment of posttraumatic stress disorder: A 
practice-friendly review of outcome research 
(Solomon and Johnson 2002), along with the 
TIPs highlighted in the introduction to the 
Anxiety Disorders section earlier in this chapter. 
Women with substance use 
disorders and PTSD 
Substance abuse and the effects of trauma 
interact in complex ways in an individual. A 
treatment provider cannot assume that one is 
a primary problem and the other secondary. 
Nor is it always beneficial to delay working 
on trauma symptoms until the client has been 
abstinent for a predetermined minimum amount 
of time. The counselor should focus on the 
client’s current crisis and stabilizing her affect. 
Substance abuse can prevent full recovery 
from PTSD, and continuing PTSD symptoms 
may perpetuate use of substances and the 
development of substance use disorders. Two 
studies report double the lifetime prevalence 
of PTSD in women than in men: 11.3 percent 
versus 6 percent and 10.4 percent versus 5 
percent (Breslau et al. 1991; Kessler et al. 1995, 
respectively). These studies found that women 
were twice as likely as men to develop PTSD 
after exposure to a trauma, suggesting that
women are particularly vulnerable to PTSD or
that the particular type of trauma experienced
by women is more likely to result in PTSD. In
a study that sampled 558 cocaine-dependent
outpatient clients on current rates and symptoms
of PTSD, women were three times more likely to
meet diagnostic criteria for PTSD (Najavits et al.
2003). 
Najavits and colleagues (1997) cite studies
demonstrating that women with substance use
disorders have higher rates of PTSD (30 to 60
percent) in comparison to men, most often as the
result of physical or sexual assault. Women with
substance use disorders have also been found to
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have higher rates of repeated trauma by family
perpetrators than men who abuse substances
(Grice et al. 1995). Rape has been found to be the
most likely form of violence to lead to PTSD for
both women and men, and female rape victims
may be particularly vulnerable to developing
substance use disorders because of the traumatic
nature of rape (Kessler et al. 1997). 
More research is needed in evaluating outcome
and the role of PTSD and relapse. Women who
relapse often are labeled as “resistant” when, in
fact, victimizations that have not been addressed
could account for the difficulty in stopping
substance abuse (Root 1989). Trauma survivors
sometimes use alcohol and drugs to medicate the
pain of trauma and consequently are perceived
as “treatment failures” because their trauma
experience is misunderstood or not identifi ed
(Covington 2008a rev., 1999a). In an outcome
study comparing women with and without PTSD
in treatment for substance use disorders, the
authors found that individuals with both PTSD
and substance use disorders relapsed more
quickly and that PTSD was a predictor of relapse
(Brown et al. 1996). 
While women with PTSD appear to possess more
psychological risk factors associated with relapse
than men, another outcome study comparing
men and women in an outpatient treatment
setting highlighted that women are more likely to
engage in treatment, thereby offsetting the higher
risks for relapse (Gil-Rivas et al. 1996). Women
with PTSD may benefit from relapse prevention
therapy as an effective short-term treatment for
substance use disorders and PTSD. In a study
evaluating the efficacy of cognitive–behavioral
relapse prevention therapy for substance use
disorders (only), the “Seeking Safety” program
(manual-based treatment for substance abuse
and PTSD), versus “standard” community
care, women who were engaged in either relapse
prevention therapy or the “Seeking Safety”
program showed sustained improvement in
substance use and PTSD symptoms at 6- and
9-month followups in comparison to women in
standard care (Hien et al. 2004). 
Substance abuse treatment: 
Trauma-informed treatment 
approach 
When providing treatment, clinicians need to 
be aware that most female clients are trauma 
survivors, even if they do not meet criteria for 
PTSD. During the past 20 years, the treatment 
community responded to this treatment need in 
varying ways. Several years ago, most providers 
first treated the substance use disorder then 
addressed trauma-related issues later. As 
knowledge in the field grew, collateral services 
were offered that treated substance abuse 
and trauma issues concurrently. A “trauma­
informed” program has an awareness of the 
pervasiveness of traumatic events and translates 
that awareness into integrated services 
that support the coping capacity of clients. 
This capacity enables a woman to stay and 
participate in treatment, to engage in a positive 
therapeutic alliance, and to learn to cope with 
the aftermath or consequences of trauma. The 
text box below provides an example of a trauma-
informed approach to treatment. 
A trauma-informed approach adjusts services 
to meet the needs of women who have a history 
of trauma. In 6- and 12-month outcome studies 
evaluating program and person-level effects 
among women with co-occurring disorders and 
trauma (Morrissey et al. 2005; Morrissey et 
al. 2005a), programs that provided integrated 
services (mental health, substance abuse, and 
trauma) displayed increased positive effects 
on mental health and substance use outcomes. 
Programs can use Appendix F, Integration Self-
Assessment for Providers, to determine the 
extent to which their agency integrates treatment 
for substance abuse, mental illness, and trauma. 
To be trauma-informed means to know of past 
and current abuse in the life of a woman. But 
more importantly, it means to understand 
the roles that violence and victimization 
play in the lives of women seeking substance 
abuse and mental health services, to design 
integrated service systems that accommodate 
the vulnerabilities of a trauma survivor, and 
to deliver services that facilitate participation 
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in treatment (Harris and Fallott 2001b). Being 
trauma-informed does not mean that the 
program forces clients to reveal their trauma 
unwillingly. Nor does it mean that substance 
abuse treatment counselors need the level of 
expertise that is required to help women resolve 
all their problems related to trauma. However, 
knowledge about violence against women and the 
effects of trauma helps counselors to: 
• 	 Consider trauma when making assessments 
and treatment plans. 
• 	 Avoid triggering trauma reactions or 
retraumatizing women. 
• 	 Adjust staff behavior with clients and other 
staff members, and modify the organizational 
climate to support clients’ coping capacities 
and safety concerns. 
• 	 Allow survivors to manage their trauma 
symptoms successfully so that they can access 
and continue to benefit from treatment 
services. 
• 	 Emphasize skills and strengths, interactive 
education, growth, and change beyond 
stabilization. 
Clinical considerations in trauma-
informed services 
A history of trauma should alert counselors to 
the potential for co-occurring mental disorders, 
such as PTSD, depression, anxiety disorder, 
or personality disorders that can impede 
treatment unless addressed early. Once the 
trauma has been identified either during the 
assessment process or in early treatment, the 
The Women Embracing Life and Living (WELL) Project 
The aim of the SAMHSA-funded Women Enhancing Life and Living (WELL) Project was both 
to integrate treatment services and to encourage trauma-informed services for women with co­
occurring substance use and mental disorders who have histories of violence. The project used 
relational strategies to facilitate systems change across three systems levels: local treatment 
providers, community or regional agencies, and the State government. 
Substance abuse treatment clinicians in the study reported they tended to be insensitive to 
trauma/violence issues because they were unaware of the overlap between these two issues (there 
were notable exceptions among staff at programs that were gender-specific and evidence-based). 
Clinicians who were cross-trained or attempted to provide a broader range of services to clients 
often encountered restrictions embedded in existing procedures, forms, and documentation 
requirements that made integrated care more diffi cult. 
Clients in the study recounted their frustration at having to slant their histories depending on 
the agency or practitioner they were addressing, and at having to conceal part of their histories 
to receive certain services. Rather than promoting wholeness and recovery, the experience in 
the treatment program recreated the secrecy of abuse and fed the stigma associated with their 
illnesses. 
The WELL project worked within three communities to address this fragmentation and to 
increase awareness of the importance of integrating an understanding of trauma into services 
offered to women. It began by convening leadership councils at the State and the local levels. 
Project activities included cross-training for clinicians, convening a consumer advisory group 
to provide guidance, submission of recommendations from the local leadership councils to the 
State level, and visits by consultants to each agency to assist clinicians in putting their training 
into practice. These activities resulted in greater understanding of trauma-related issues by 
clinicians, stronger linkages to community services for women with histories of trauma, and 
more referrals to these services. 
Source: Markoff et al. 2005. 
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Note to Clinicians and Administrators 
Preliminary data support that integrated trauma-focused interventions for women in 
substance abuse treatment programs appear to be safe, thus presenting no differences in 
adverse psychiatric and substance abuse symptoms or events in comparison to standard care 
(Killeen et al. 2008). So often, clinicians and administrators fear and hold the misperception 
that addressing trauma-related issues is counterproductive and produces deleterious effects 
on women in substance abuse treatment. While the selection of services and the planning 
on how these services are delivered is important in maintaining the integrity of care for the 
client, integrated trauma-focused interventions are not only a viable option but an essential 
component of treatment for women with substance use disorders. 
counselor can begin to validate a woman’s 
experience and acknowledge that she is neither 
unique in her experience nor alone. If women 
are not questioned directly, the abuse may go 
unrecognized and untreated. Many women who 
are dependent on alcohol or drugs experience 
difficulty in recovery and relapse if violence and  
abuse issues are not addressed in treatment. 
Women may need help understanding the 
serious long-term effects of violence, sexual 
abuse, and incest on their functioning and on 
the risk of relapse (Covington 2003; Finkelstein 
1996; Najavits 2006). 
In many instances, counselors can address 
trauma and its relevance to substance abuse 
treatment effectively. In other cases, complex 
or severe problems related to trauma that 
exceed the counselor’s competence may be 
present initially or may arise during treatment. 
Clients with such problems should be referred 
to a specialist—typically a licensed mental 
health professional trained in trauma within 
the treatment program. Trauma-informed 
counselors can recognize when a therapeutic 
relationship is stretching their abilities, but the 
decision to refer a client requires understanding 
of the situation and supervisory consultation 
and agreement. 
Major trauma-related clinical issues that 
counselors need to address or attend to during 
the course of treatment include: 
• 	 Outreach. Efforts to engage women in 
treatment include flexible scheduling, ready  
availability, identification of client interest  
in and need for treatment, and ongoing 
evaluation. Outreach includes informing the 
community of services offered and initiating 
contact with agencies that should refer 
women for assessment and counseling (Elliott 
et al. 2005). 
• 	 Assessment and referral. A counselor needs 
to understand the nature of a woman’s 
exposure to trauma—the type of abuse, 
when it occurred, whether it was a one-time 
event or repeated over time, the relationship 
between the client and the perpetrator 
(family member, acquaintance, stranger), 
and what occurred if the woman previously 
disclosed the experience (Bernstein 2000). 
It requires treatment by a clinician who 
is trained in treating traumatic stress 
disorders. Women who score high on a 
posttraumatic stress assessment should be 
referred for treatment to address their PTSD 
concurrently with their substance abuse 
treatment. Counselors should be candid when 
they cannot provide the treatment the client 
needs and may need to make a referral. 
• 	 Psychoeducation. One of the counselor’s 
major functions in treating a woman in 
recovery who has a trauma history is 
to acknowledge the connection between 
substance abuse and trauma. This 
acknowledgment validates a woman’s 
experience and helps her feel that she is 
not alone and that her experience is not 
shameful. Sharing prevalence data can 
reduce her sense of isolation and shame 
(Finkelstein 1996). 
• 	 Normalizing the symptoms. In addition, 
it is important to educate and discuss the 
Substance Abuse Treatment for Women 166 
Advice to Clinicians: 
When Is a Woman Ready for Trauma Processing? 
Many counselors and clients assume that “working on trauma” means telling the story 
of what happened. Although exposure therapy is a widely known treatment method 
(Foa and Rothbaum 1998), it is controversial in the substance abuse treatment fi eld. 
Questions remain about whether it is a safe treatment to conduct with clients who 
are abusing substances or engaged in self-destructive behavior. A study on exposure 
therapy for people in substance abuse treatment showed that many clients could not 
tolerate the work, with 61.5 percent not completing the minimum dose of treatment. 
Those who engaged in the treatment did well in outcomes—including reducing 
substance use and employment problems—but more research is needed to determine 
client factors that would identify who would best benefit from this type of treatment  
(Brady et al. 2001). 
Some experts recommend not asking the client to tell her story until she has achieved 
some abstinence or safe functioning, whereas others assert that this is a case-by-case 
decision. Staff and clients should not be led to believe that the “real work” is telling 
the trauma story. CBT is equally effective and may be preferred for some. Najavits 
(1998) has identified signs to determine when a woman with substance abuse disorder  
is ready for trauma-exploration work: 
• She is able to use some coping skills.
• She has no major current crises or instability (e.g., homelessness, domestic violence).
• She wants to do this type of work.
• She can reach out for help when in danger. 
• She is not using substances to such a degree that emotionally upsetting work may
increase her use. 
• Her suicidality has been evaluated and taken into account.
• She is in a system of care that is stable and consistent, with no immediate planned
changes (e.g., discharge from inpatient unit or residential program). 
typical symptoms associated with PTSD 
to help normalize the client’s physiological 
and psychological experience. Similar to 
other anxiety disorders, clients are often 
overwhelmed by symptoms leading to the 
belief that they cannot manage them or that 
they are not going to survive them. Some 
relief arrives when a client knows that they 
are having a normal reaction to an abnormal 
event or set of circumstances. 
• Safety, support, and collaboration. Trauma 
often creates profound disconnection in 
two areas: interpersonal relationships 
and internal feelings. Some women who 
experience traumas become isolated, feeling 
that the only safety is in solitude; others 
compulsively reenact dangerous relationshi
(Najavits 2002b). Alternating between the 
ps 
experience of feeling overwhelmed and 
shutting down, women come to treatment 
profoundly discouraged about the value and 
safety of relationships. For a client, safety 
is psychological and physical, internal and 
external. A major goal of treatment is to 
develop a therapeutic alliance. Ideally this 
alliance creates a safe place within which 
the woman can learn to trust and have new, 
meaningful experiences. For a substance 
abuse treatment program, safety is an 
organizational or system issue that calls for 
counselor readiness, collaboration with the 
client, staff training and supervision, and 
continual self-assessment of strengths and 
limitations (Markoff et al. 2005). 
 Tracking level of distress. Counselors need •
to monitor their own and their clients’ level 
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of distress. Counselors must observe the 
client for signs of discomfort. For example, 
if a client is hyperventilating, the counselor 
needs to help the client gain mastery of her 
breathing before proceeding. Using a scale 
of 1 to 100 to measure the client’s subjective 
units of distress (SUD scale) can be a helpful 
tool in assessing the client’s perception 
of current distress and in comparing her 
levels of distress from one session to the 
next (Wolpe 1969). It also provides tangible 
feedback to both the counselor and client. 
• Regulation of level of closeness and distance. 
Carefully maintained boundaries between 
the counselor and the client maximize the 
effectiveness of the therapeutic relationship 
and ensure that treatment does not re-create 
the original trauma. For example, counselors 
should not physically intrude on a client who 
is “shut down”—does not want to be touched. 
• Timing and pacing. The counselor addresses 
trauma issues when the woman is ready 
and functioning at a level where it is safe 
for her to explore the trauma; timing is 
directed by the client. The counselor helps 
the client identify when she is beginning to 
feel overwhelmed and how she can slow the 
process down. Trauma treatment begins 
with the start of substance abuse treatment 
and needs to be conducted in a careful and 
clinically sensitive manner. It is not always 
clear when and under what conditions it is 
helpful to a client to tell her trauma story. 
Sometimes results of this work are positive, 
but the telling can be harmful when the client 
does not yet have coping resources to handle 
the intense telling. Recalling or talking about 
her traumatic experience can retraumatize a 
woman. Even if the client wishes to talk about 
her trauma, it may be unwise if she is in an 
unstable situation (Najavits 2002a) and does 
not have a support system or is in danger of 
decompensation. 
• Coping skills. A client’s knowledge of 
coping skills helps her manage symptoms 
and increases her self-sufficiency and self- 
efficacy . Counselors and programs need to 
incorporate skill development components— 
including problemsolving, assertiveness, 
anger management, communications, and 
anxiety management—along with stress 
inoculation and relaxation techniques. 
Clients need to focus on both disorders and 
their interactions. More insight-oriented 
therapeutic work occurs once clients have 
attained abstinence and control over PTSD 
symptoms (Najavits et al. 1996, 2002a). 
Therapy should help women learn to use 
more healthful methods of coping with 
negative feelings, interpersonal confl ict, and 
physical discomfort (Stewart et al. 2000). 
• Affect regulation. Counselors need to assist 
clients in learning how to increase their 
tolerance for affective distress. The feeling 
of jeopardy feels real for both the client 
and counselor. It is the challenge for the 
counselor to remain connected with the 
client during this crisis, neither becoming 
overwhelmed by the traumatic reenactment 
nor emotionally abandoning the client by 
withdrawing (Cramer 2002). Training to 
handle strong feelings is essential, as is 
clinical supervision. Like the client, the 
counselor may feel shame, incompetence, 
anxiety, and anger. Emotional support from 
colleagues and supervisors helps counselors 
avoid defensiveness, client blaming, 
detachment, secondary traumatic stress 
reactions, and burnout. 
• Listening skills. A critical part of therapy 
for addressing trauma in substance abuse 
treatment is to help the client gain support 
and establish safety. Counselors need 
to be nonjudgmental, empathetic, and 
encouraging; creating an environment that 
validates the client’s experience through 
listening and gentle guidance. 
• Acknowledgment of grief and mourning. The 
client needs time to grieve many losses. While 
this grieving process begins from the outset 
of treatment, the intensity of grief reactions 
often rises as anxiety symptoms dissipate. 
• Case management. Case managers or 
counselors can assist women with solving 
problems and crisis intervention, locating 
peer-support groups and afterhours support, 
and coordinating linkages with other 
agencies. 
• Triggering and retraumatization . During 
treatment, triggering is unavoidable. A 
trigger sets off a memory of the trauma. It 
can be a noise, a television show, another 
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person’s presence, or anything that is a 
reminder of the event. Therapist and client 
must be prepared for the difficult work of 
coping with triggers. The client is prepared 
by learning to identify the triggers and in 
either developing or enhancing coping and 
self-soothing skills. The difference between 
retraumatization and triggering is the 
therapist’s ability to stay connected to the 
affective experience of the client and the 
client’s knowledge that she will not be totally 
overwhelmed by her intense feelings (Najavits 
2002a; Russell 1998). Triggering is inevitable; 
retraumatization is not. Reenactments are 
inevitable, but if they occur under controlled 
conditions and the client feels supported and 
safe with her counselor, retraumatization 
does not have to occur. All programs need 
to be alert to the risk of triggering and 
retraumatization. 
Models of recovery 
Since the late 19th century, a number of experts 
have conceptualized recovery from trauma 
in stages, describing it in different terms but 
referring to the same process (Herman 1997). 
Most of the conceptualizations followed three 
stages. The first stage is stabilization, preventing 
further deterioration and ensuring symptom 
management. During the second stage trauma is 
remembered, reenacted, and worked through. 
Stage three is a return to normal, the time 
when the client can live with the memories 
of the trauma, and problems are controlled. 
In Trauma and Recovery, Herman (1997) 
describes trauma as a disease of disconnection 
and provides a three-stage model for recovery: 
safety, remembrance and mourning, and 
reconnection. During these stages, clients 
receive consistent support for recovery from 
their substance use disorders. 
Stage 1: Safety 
Female trauma survivors in early treatment 
for substance abuse typically need to be in an 
all-women group led by a female facilitator. 
“Survivors feel unsafe in their bodies. . . . They 
also feel unsafe in relation to other people” 
(Herman 1997, p. 160). Counselors can ensure 
that the environment is free of physical and 
sexual harassment and assess a woman’s risk 
of domestic violence. Counselors teach women 
to feel safe internally by using self-soothing 
techniques to alleviate depression and anxiety 
rather than turning to drugs (Najavits et al. 
1996). Women are helped to feel physically 
and emotionally safe in their relationships 
with their counselors. The counselor works to 
develop the client’s trust and to help her make 
the connection between substance abuse and 
victimization (Hiebert-Murphy and Woytkiw 
Advice to Clinicians: 
Retraumatization 
Some staff and agency issues that can result in retraumatization of the client include 
the following: 
Violating the client’s boundaries • 
Breaking trust with the client• 
Unclear expectations• 
Inconsistent enforcement of rules• 
Chaotic treatment environment• 
Rigid agency policies that do not allow a woman to have what she needs to feel safe• 
Disruption in routines• 
Disrespectfully challenging the client’s reports of abuse • 
Labeling intense rage and other feelings about the trauma as pathological• 
Minimizing, discrediting, or ignoring the client’s feelings or responses • 
Disrupting relationships because of shift changes and reassignments• 
Obtaining urine specimens in a nonprivate manner• 
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SAMHSA’s Women, Co-Occurring Disorders and Violence Study 
(WCDVS) 
In 1998, SAMHSA funded sites in the United States to develop integrated services for women 
who were the victims of violence and diagnosed with co-occurring mental and substance abuse 
disorders; services were also available for these women’s children. This 5-year study sought to 
compare more integrated treatment with non-integrated treatment for more than 2,000 women 
and yielded information on the effectiveness of the integrated services approach for women. 
WCDVS also addressed the interplay of substance use disorders, trauma, and mental illness 
and demonstrated the empowerment and healing that comes when female clients are involved 
directly in their care and recovery. Outcomes for women in the study improved more than the 
outcomes for those in the treatment-as-usual group when women had a voice in the planning, 
implementation, and delivery of their treatment and received counseling for all three conditions 
together. 
The study showed that to improve treatment, an increased recognition is needed of the effects 
that past and present traumas have on women in treatment. Women should be encouraged and 
helped to play an active role in their healing processes. Additional key findings include, but 
are not limited to, the following: the need for comprehensive assessment that incorporates the 
history of trauma, physical and mental health needs, and the impact of co-occurring disorders 
on child care; the need for systems change to incorporate services for women and children with 
co-occurring disorders; and that integrated services for mental health, substance abuse, and 
violence issues in a trauma-informed context appear to be more effective and not more costly 
than treatment-as-usual. 
For an overview of the study, including contact information regarding the involvement of specifi c 
programs, refer to http://www.wcdvs.com/pdfs/ProgramSummary.pdf. 
Source: Becker and Gatz 2005; Salasin 2005 
2000). The client learns to stop using unsafe 
coping mechanisms such as substance use and 
other self-destructive behaviors. An alliance 
between the counselor and the client, whose level 
of trust has been damaged by trauma, is the goal 
of this stage. 
Stage 2: Remembrance and mourning 
In this stage, women tell their stories of trauma. 
Women mourn the losses associated with their 
abuse and substance use (Hiebert-Murphy and 
Woytkiw 2000). More specifically, they mourn 
their old selves, which the trauma destroyed. 
Women stabilized in substance abuse treatment 
may be ready to begin Stage 2 trauma work. A 
counselor can address the high risk of relapse 
that exists in this phase through anticipation, 
planning, and self-soothing mechanisms 
(Najavits 2002b). Considerable clinical judgment 
is required in determining whether the client has 
adequate coping skills. 
Stage 3: Reconnection 
Once the woman has coped with past trauma, 
she can look to the future. She learns new 
coping skills, develops healthy relationships, 
and becomes oriented toward the future. Stage 
3 groups, traditionally unstructured, can be 
comprised of both women and men. This phase 
corresponds to the ongoing recovery phase of 
substance abuse treatment. For some women, 
reconnection can occur only after years of 
working through trauma issues. 
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Note to Clinicians 
It is important to emphasize that the majority of clinical work surrounding trauma in substance 
abuse treatment programs and in early stages of recovery from substance use disorders should 
focus on safety, client skills in establishing safe behaviors, and early trauma recovery skills— 
specifically coping skills such as grounding, emotional regulation, and stress management  
strategies. 
Treatment programs and curricula 
for substance use disorders and 
trauma 
The following trauma-specific curricula are  
designed to address treatment issues with women 
who have a history of trauma and trauma-
related symptoms and substance abuse. These 
programs are mainly focused on establishing 
safety and support, providing psychoeducation, 
and developing coping strategies and skills 
surrounding the sequelae of trauma and 
substance use disorders (for review of integrated 
trauma treatment models see Finkelstein et al. 
2004 and Moses et al. 2003). 
The Addiction and Trauma Recovery 
Integration Model (ATRIUM; Miller and Guidry 
2001): Based on Miller’s Trauma Reenactment 
Model, ATRIUM is a 12-week program that 
integrates psychoeducational and expressive 
activities for individuals with trauma-related 
and substance use problems. The ATRIUM 
model assesses and intervenes at the body, mind, 
and spiritual levels and addresses issues linked 
to trauma and substance abuse experiences 
such as anxiety, sexuality/touch, self-harm, 
depression, anger, physical complaints 
and ailments, sleep problems, relationship 
challenges, and spiritual disconnection. 
Beyond Trauma: A Healing Journey for 
Women and A Healing Journey: A Workbook 
for Women (Covington 2003a, b): The theme of 
this 11-session integrated program for trauma 
treatment is the connection between substance 
abuse and trauma in women’s lives. It includes 
a psychoeducational component for teaching 
women about trauma and its effects on the inner 
self (thoughts, feelings, and beliefs) and the 
outer self (behavior and relationships, including 
parenting). The program emphasizes coping 
skills, cognitive–behavioral techniques, and 
expressive arts, and is based on the principles 
of relational therapy. It includes a facilitator’s 
manual, participant’s workbook, and videos. 
Helping Women Recover: A Program for 
Treating Addiction (Covington 2008a, b rev., 
1999a, b): This 17-session step-by-step guide 
integrates the theoretical perspectives of 
substance abuse and dependence, women’s 
psychological development, and trauma in 
four modules (self, relationships, sexuality, 
and spirituality). The program includes a 
facilitator’s guide to work with such issues as 
self-esteem, sexism, family-of-origin, support 
system, mothering, and self-soothing issues. 
A Woman’s Journal provides self-tests and 
exercises to help clients with substance use 
disorders create personal guides to recovery. 
There is a separate version for women in the 
criminal justice system (Covington, 2008a, b 
rev., 1999a, b). 
Seeking Safety (Najavits 2000, 2002b, 
2004, 2007): This manual-based, cognitive, 
behavioral, and interpersonal therapy model for 
substance use disorders and PTSD focuses on 
client safety. It can be conducted in individual 
or group formats. The manual includes 25 topics 
and is based on fi ve principles: 
1. Safety as the priority of this “fi rst stage” 
treatment 
2. Integrated treatment of PTSD and substance 
use disorder 
3. A focus on ideals 
4. Four content areas: cognitive, behavioral, 
interpersonal, and case management 
5. Attention to therapist processes 
Several outcome studies have been completed 
on Seeking Safety, all showing positive results. 
The studies involve the following populations: 
women treated in an outpatient setting using a 
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Note to Clinicians 
Key issues in treatment for trauma-related mental disorders have been how, when, and 
whether to encourage clients to address trauma intensively during the course of substance 
abuse treatment. Most clinicians believe that a woman needs to achieve a basic level of safety 
before moving on to detailed trauma processing. The counselor should consider carefully the 
client’s level of readiness for this type of work; the client’s symptoms may worsen if she engages 
prematurely in such exploration (Herman 1997). In one study, interventions were adapted 
to combine exposure therapy with the “Seeking Safety” program; clients with substance use 
disorders were encouraged to move in and out of trauma processing, balancing it with training in 
coping skills and building in specific safety parameters (Najavits et al. 2005).  
group modality (Najavits et al. 1998); women in 
prison in a group modality (Zlotnick et al. 2003); 
low-income and mostly minority women in 
individual format (Hien et al. 2004); adolescent 
girls (Najavits et al. 2006); and women in a 
community mental health setting in group 
format (Holdcraft and Comtois 2002). In a study 
that targeted patient and counselor feedback 
(Brown et al. 2007), results show that clinicians 
and clients alike were satisfied and felt that the  
Seeking Safety program was relevant to the 
treatment program and clients’ needs. Seeking 
Safety has been implemented in a variety of 
clinical programs in addition to these research 
studies. 
Trauma Adaptive Recovery Group Education 
and Therapy (TARGET; Ford et al. 2000): 
TARGET assists clients in replacing their stress 
responses with a positive approach to personal 
and relational empowerment. The curriculum 
includes a one- to three-session orientation, a 
five- to nine-session core education and skills  
curriculum, and 26 sessions of applications of 
recovery principles. TARGET has been adapted 
for clients who are deaf and for those whose 
primary language is Spanish or Dutch. TARGET 
is being evaluated in several treatment settings. 
Trauma Recovery and Empowerment 
Model (TREM; Harris and The Community 
Connections Trauma Work Group 1998): This 
33-session group approach was developed by 
clinicians with considerable input from clients 
and includes survivor empowerment, power 
support, and techniques for self-soothing, 
boundary maintenance, and solving problems to 
be covered over 9 months. TREM assists women 
with the trauma recovery process and includes 
social skills training, psychoeducational and 
psychodynamic techniques, and peer support 
groups. Each section includes discussion 
questions, typical responses, and experiential 
exercises (Harris and The Community 
Connections Trauma Work Group 1998). TREM 
is being evaluated in several treatment settings. 
Preliminary studies showed symptom reduction 
and client satisfaction (Berley and Miller 2004). 
Treating Addicted Survivors of Trauma (Evans 
and Sullivan 1995): Combining therapeutic 
approaches with a 12-Step approach to the 
treatment of substance use disorders, this model 
for treatment of survivors of childhood abuse 
who have substance use disorders is based on 
a medical view of substance abuse as illness. It 
assumes clients accept the 12-Step approach, 
uses the principle of safety first to drive all  
interventions, and has five stages to organize the  
selection and timing of treatment tactics: crisis, 
skills building, education, integration, and 
maintenance (Sullivan and Evans 1994). 
Substance Dependent PTSD Therapy (SDPT; 
Triffleman 2000): This integrated approach  
showed positive outcomes in a small controlled 
pilot study that compared it with 12-Step 
facilitation therapy. SDPT is a 5-month, 
two-phased, individual CBT method using 
relapse prevention and coping skills training, 
psychoeducation, stress inoculation training, 
and exposure treatment for PTSD. Participants 
meet twice weekly. The use of the combined 
approaches for PTSD treatment techniques with 
clients with substance use disorders is notable. 
The first phase incorporates understanding and  
education about PTSD symptoms as part of 
the overall approach to abstinence. The second 
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phase continues work on substance-related 
abstinence, while primarily targeting PTSD 
symptoms. In clinical trials, this model showed 
equal success rates in women and men. 
Mood Disorders 
Depression 
Major depression is an intense, acute form of 
depression, often with physiological changes 
in such areas as sleep, appetite, energy level, 
and ability to think. Thought content includes 
feelings of worthlessness and suicidal ideation 
or plans, although older adults and people from 
some ethnic groups or cultures sometimes do 
not express this cognitive component. Major 
depression has severe, moderate, and mild 
variants. Even mild major depression is a 
serious mental disorder. 
Major depressive episodes and dysthymia are 
present in nearly twice as many women as men 
for both lifetime and 12-month prevalence. 
Research suggests that women experience more 
chronicity of depression in comparison to men 
characterized by earlier onset of symptoms, 
poorer quality of life, greater social impairment, 
and greater familial history of mood disorders 
(Kornstein et al. 2000). 
Although rates of depression among women of 
color in the general population are comparable 
with those for Caucasian women, the illness is 
more likely to be undiagnosed and untreated in 
the former group, according to the literature 
reviewed (Mazure et al. 2002). Depression may 
appear through somatic symptoms that are 
misinterpreted by providers. Of concern is the 
lack of compliance with treatment regimens 
using psychotropic medications by women of 
color, which is possibly related to side effects 
of the medication. In addition, the sense of loss 
associated with migration may contribute to 
high levels of depression among Hispanic/Latina 
and Asian and Pacifi c-Islander immigrant 
women. In a study examining the use of 
pediatric emergency services with a sample of 
Mexican- and Central-American immigrants in 
Los Angeles, the women reported high levels of 
mental distress (Zambrana et al. 1994). Somatic 
complaints are common among Hispanic/Latinas 
and can mask depression or other mental illness. 
Women with substance use 
disorders and depression 
Alcohol consumption and alcohol-related 
problems co-occur with depression more often 
in women than in men (Graham et al. 2007). 
Depression usually precedes alcohol abuse in 
women, whereas alcohol dependence usually 
comes first among men (Moscato et al. 1997). 
Two mechanisms have been suggested to explain 
the pattern among women: (1) alcohol is used to 
try to relieve the symptoms of depression, and 
(2) depression renders women less concerned 
about issues of health and safety, including 
alcohol consumption (Dixit and Crum 2000). For 
more in-depth information on depression, refer 
to the TIP 48 Managing Depressive Symptoms 
in Substance Abuse Clients During Early 
Recovery (CSAT 2008). 
One study indicates that the risk for heavy 
drinking is higher among women with a history 
of depressive disorder than among women 
with no history of depression, and the risk for 
heavy drinking rises with increasing reports of 
depressive symptoms (Dixit and Crum 2000). 
Research suggests that genetic factors contribute 
to women’s susceptibility to both disorders. 
Among treatment-seeking women, depression is 
positively correlated with craving (Zilberman 
et al. 2003). While craving is not consistently 
associated with relapse, clients who experience 
cravings express distress in managing and coping 
with them. 
Although it may be difficult to determine 
whether the depression or substance use 
disorder is primary, both need to be identifi ed 
and treated concurrently to minimize relapse 
and improve a client’s quality of life. If a 
woman’s depression is life threatening, the 
depression must be treated immediately. In 
general, the disorder with the higher crisis 
potential needs to be addressed fi rst—but 
neither should be neglected. Withdrawal 
symptoms sometimes include depression, 
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and withdrawal symptoms sometimes mask 
depression. Appropriate treatment requires a 
thorough history and monitoring of symptoms 
over time. 
Substance abuse treatment and 
depression 
Women with co-occurring substance use 
disorders and depression can be placed in a 
variety of treatment settings, depending on the 
severity of their disorders. Antidepressant and 
mood-regulating medications are appropriate 
for women in treatment for both disorders. 
Clients may require medication to overcome 
debilitating and incapacitating depressive 
symptoms so that they can participate in 
substance abuse treatment. In addition, relief 
from depression can be significant motivation in 
recovery. However, it may take time for a client 
to be stabilized on the appropriate medication 
and dosage. Women may need education and 
medication monitoring initially to ensure they 
are taking their medications as prescribed. Some 
women may increase their dose thinking that the 
larger dose provides more help or reduce their 
dose to prove they are improving. Still other 
women may have difficulty taking antidepressant 
medication based upon fear and misinformation 
that it is addictive. 
SSRIs and other new generation antidepressants 
often are used because their improved side effect 
profile increases the likelihood of compliance 
(Zweben 1996). Women with depression may 
respond to a combination of psychotherapy and 
medication. CBT and interpersonal therapies 
(IPT) are evidence-based approaches in treating 
depression (Butler et al. 2006; deMello et 
al. 2005; Kuyken et al. 2007), and they can 
be used as an adjunct to medication or as a 
principal intervention for mild or moderate 
depression. For clients who are hesitant to 
use medications or when the use of medication 
is contraindicated, CBT and IPT are viable 
options but appear far less effective when 
depression is severe (Luty et al. 2007; Markowitz 
2003). 
Eating Disorders 
Between 90 and 95 percent of those diagnosed 
with eating disorders are women (Hoek 1995), 
with as many as 5 percent of young women being 
affected (Frank et al. 1998). Studies have shown 
that bulimia affects between 2 and 5 percent of 
women, whereas anorexia is much less common 
(Frank et al. 1998). About 2 percent of the U.S. 
population has a binge eating disorder, and it 
occurs in 10 to 15 percent of mildly obese people 
(National Institute of Diabetes and Digestive 
and Kidney Diseases 2001). However, all 
measures of the prevalence of eating disorders 
are considered to be estimates by researchers 
because they represent only cases diagnosed in 
medical facilities. Women with eating disorders 
are skilled at concealing their disorders and 
many remain undiagnosed (Hoek and Van 
Hseken 2003). Common definitions of eating 
disorders and behaviors are defi ned in 
Figure 7-4. 
Substance abuse counselors and mental health 
professionals have difficulty detecting eating 
disorders because clients minimize or deny 
their symptoms and fail to seek treatment out 
of shame or fear of gaining weight. Counselors 
should be alert to symptoms of eating disorders 
that may be serious but do not meet full criteria 
for an eating disorder diagnosis. Disordered 
eating behaviors can pose serious health issues 
and lead to full-blown disorders. In addition, 
counselors should be aware that eating disorders 
occur in women from diverse backgrounds. 
Note to Clinicians 
Women receiving methadone maintenance treatment (MMT) require antidepressant medication 
that is compatible with methadone, but dosages of both need close monitoring. Although MMT 
can normalize mood in some women, it is a treatment for opioid dependence, not depression 
(Zweben 1996). TIP 43 Medication-Assisted Treatment for Opioid Addiction in Opioid Treatment 
Programs (CSAT 2005b), provides more information. 
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Figure 7-4 
Common Definitions of Eating Disorders and Behaviors 
Anorexia nervosa is self-starvation. Women with this disorder eat very little even though they 
are thin. They have an intense and overpowering fear of body fat and weight gain. 
Bulimia nervosa is characterized by cycles of binge eating and purging, by either vomiting or 
taking laxatives or diuretics (water pills). People with bulimia have a fear of body fat even 
though their size and weight may be normal. 
Overexercising is exercising compulsively for long periods to burn calories from food that has 
just been eaten. Women with anorexia or bulimia may overexercise. 
Binge eating means eating large amounts of food in short periods, usually when alone, without 
being able to stop when full. The overeating or bingeing often is accompanied by feeling out of 
control and is followed by feelings of depression, guilt, or disgust. 
Disordered eating refers to troublesome eating behaviors, such as restrictive dieting, bingeing, 
or purging, which occur less frequently or are less severe than those required to meet the full 
criteria for the eating disorder diagnosis. 
Source: Adapted from HHS, Office on Women’s Health 2000b. 
Although anorexia is seen most often in young 
heterosexual Caucasian women, girls and women 
from all ethnic and racial groups have eating 
disorders and disordered eating at increasing 
rates. Often these women receive treatment 
for the accompanying symptoms of an eating 
disorder, such as depression, rather than 
for the disorder itself. When they are fi nally 
diagnosed, the disorder tends to be more severe 
(HHS, Office on Women’s Health 2000). Overall, 
studies show that eating disorders are positively 
associated with all DSM-IV mood, anxiety, 
impulse-control, and substance use disorders 
regardless of age, gender, and race-ethnicity 
(Hudson et al. 2007). 
Women with substance use and 
eating disorders 
One study evaluating the role of eating disorder 
behaviors and its association with substance 
use (Piran and Robinson 2006) determined 
that as eating disorder behavior becomes more 
severe, the number of substance classes used 
increases as well. Specifically, severe bingeing 
was consistently associated with alcohol 
consumption, and dieting and purging was 
associated with stimulant and sleeping pills/ 
sedative use. Herzog and colleagues found that 
17 percent of women seeking treatment for 
either anorexia nervosa or bulimia nervosa had 
a lifetime drug use disorder (Herzog et al. 2006). 
Overall, research indicates that substance abuse 
is accompanied more often by bulimia and 
bulimic behaviors than by anorexia (Bulik et 
al. 2004; Holderness et al. 1994; Ross-Durow 
and Boyd 2000). Nearly one third of women 
with a history of bulimia also have a history of 
alcohol abuse, and 13 percent have a history 
of alcohol dependence. Alcohol abuse and 
dependence have been found to be related to 
PTSD and major depressive disorder, which in 
turn were associated with bulimia. One study 
demonstrated that alcohol use disorders are 
highly prevalent among women with bulimia 
and that the presence of PTSD and depression 
increases the risk of alcohol abuse occurring 
(Dansky et al. 2000). 
Attitudes toward dieting among young women 
may be related to increased susceptibility to 
alcohol and drug use (Zweben 1996). This is 
both a health issue and a relapse risk because 
some women may use cocaine or amphetamines 
(or both) to manage their weight. Additionally, 
the tendency to overeat affects many women in 
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early recovery. Compulsive or binge eating bears 
a similarity to abuse of substances other than 
food and is correlated with depression, thoughts 
of suicide, and childhood sexual abuse. Women 
engaging in binge eating sometimes use food as 
a substitute addiction; others may overeat to 
compensate for the stress they experience in 
early abstinence. Elements of the eating disorder 
take the place of relapsing to the drug of choice 
(Ross 1993). 
Eating disorders need to be viewed in a 
biopsychosocial context that addresses 
biological or organic factors, a social component 
(influence of media and other cultural images 
enforcing standards of slimness for women), 
and psychological issues. Eating disorders are 
correlated with growing up in dysfunctional 
families where substance abuse occurs (van 
Wormer and Askew 1997). A strong relationship 
exists between eating disorders and depression, 
self-inflicted violence, and suicidal tendencies 
(APA 2000a; Kuba and Hanchey 1991). Most 
women with eating disorders meet DSM-IV 
criteria for at least one personality disorder, 
such as borderline, histrionic, or obsessive– 
compulsive personality (Zerbe 1993). 
Eating disorders are sometimes present before 
the onset of alcohol and drug problems and 
can be obscured by active substance use, or 
they may be inactive during periods of active 
drinking or drug abuse. Eating disorders can 
precede the onset of substance use disorders 
chronologically, follow them, or develop 
simultaneously (Bulik and Sullivan 1998). A 
history of bulimia, anorexia, or compulsive 
overeating could become a barrier to the 
successful treatment of a client’s substance 
use disorder if the prior eating disorder goes 
undetected. Deprived of compulsive involvement 
with food, a woman may begin to abuse 
substances. During treatment for substance use, 
unbeknownst to the therapist, the disordered 
eating behavior may reappear. Because the 
eating disorder takes over the function of the 
substances by helping the client cope, a cycle 
can occur that never addresses the common 
and predisposing factors contributing to both 
problems. There may be success in that the 
substance use has stopped; however, this may 
be a result only of disordered eating or symptom 
substitution. This disordered use of food masks 
depression, anxiety, and other symptoms 
expected to surface during the treatment of 
substance use, leaving the therapist with no 
view of the woman’s coping abilities without any 
compulsive and disordered behavior. Eating 
disorders may coexist with alcohol and drug 
consumption in other ways (John et al. 2006). 
Diuretics, laxatives, emetics, stimulants, heroin, 
tobacco, and thyroid hormone may be attractive 
to a woman with anorexia or bulimia because 
of their weight-loss potential or their ability to 
facilitate vomiting (Bulik and Sullivan 1998). 
Substance abuse treatment and 
eating disorders 
Therapeutic modalities include individual, 
group, and family therapies. A cognitive– 
behavioral approach is used to address the 
irrational thoughts that lead to disordered 
eating behaviors (van Wormer and Askew 
1997). CBT has been effective for women with 
bulimia in reducing the frequency of binge/purge 
cycles and improving body image, mood, and 
social functioning. In some instances, the use of 
tricyclic antidepressants and selective serotonin 
reuptake inhibitors can improve short-term 
outcomes, but in all eating disorder cases, 
medical evaluation should be included (Carr and 
McNulty 2006; Raeburn 2002). 
Interpersonal therapy has been used 
successfully with women with bulimia, and 
dialectical behavior therapy recently has begun 
to be used with this population (Raeburn 
2002; Safer et al. 2001). Additional treatment 
approaches for women with eating disorders 
that can engage clients include psychoeducation, 
behavioral contracting, and nutrition 
monitoring (Frank et al. 1998). 
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Treating this condition requires specialized 
training, along with a thorough medical 
evaluation for problems typically associated 
with eating disorders. Clients require nutritional 
counseling to develop healthful eating patterns, 
medications (usually antidepressants), and 
discharge planning that addresses both eating 
and substance use disorders (Marcus and Katz 
1990). Eating disorders often surface or are 
exacerbated when women reduce substance 
use; in this situation, integrated care and 
management is the optimal choice. 
It is important for counselors to look beyond 
the earlier profiles of eating disorder cases 
and consider symptoms among women of color 
and in various social classes. The HHS Offi ce 
on Women’s Health provides educational 
materials on eating disorders on its Web site 
(www.4women.gov/BodyImage). 
Addressing Tobacco Use 
With Women in Treatment 
Cigarette smoking is a major cause of lung 
cancer among women. Approximately 90 percent 
of all lung cancer deaths are attributable to 
smoking. Since 1950, lung cancer mortality 
rates for American women have increased an 
estimated 600 percent. In 1987, lung cancer 
surpassed breast cancer to become the leading 
cause of cancer death among American women. 
In 2000, about 27,000 more women died of lung 
cancer (67,600) than breast cancer (40,800; 
CDC 2001). In 2004, diseases caused by cigarette 
smoking killed an estimated 178,000 women in 
the United States. The three leading diseases 
were lung cancer (45,000), chronic lung disease 
(42,000), and heart disease (40,000; CDC 2005). 
Although it is commonly accepted in the 
substance abuse treatment field that the use of 
one addictive drug frequently leads to relapse 
Advice to Clinicians: 
Women With Eating Disorders 
Substance abuse counselors may want to consider these steps in addressing eating 
disorders: 
Include an eating history as part of a comprehensive assessment of a client (refer to• 
chapter 4 on Screening and Assessment). 
Refer for medical evaluation.• 
Ask the client what happens as a result of the disordered eating behaviors. Does she• 
feel in control, more relaxed, or numb? Approach eating disorders as a response to 
emotional discomfort. 
Educate the client about eating behaviors as a legitimate health concern.• 
Develop integrated services, and coordinate necessary services and referrals (including• 
a referral to a provider that specializes in eating disorder treatment). 
Incorporate nutritional counseling and psychoeducation on eating disorders and• 
disordered eating. 
Institute routine observations at and between meals for disordered eating behaviors.• 
Recommend the use of support groups that are designed specifically for the given • 
eating disorder. 
Teach coping skills using cognitive–behavioral therapy and include anxiety • 
management training. 
Source: Bulik and Sullivan 1998; Rome 2003 
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to a person’s “drug of choice,” this has not 
been clarified in the issue of nicotine use and 
substance abuse (Burling et al. 2001). Many 
treatment professionals have thought it too 
difficult for clients to give up tobacco and still 
remain abstinent from other substances even 
after years of being drug or alcohol free. They 
believed that any attempt to stop smoking could 
put the recovering person at an increased risk 
for relapse. It also was assumed that people 
will quit naturally if they so desire (Bobo et al. 
1986). 
However, research and experience since the mid­
1980s has begun to challenge these assumptions 
(for review, see Prochaska et al. 2004; Sussman 
2002). Research shows that quitting smoking 
does not jeopardize substance abuse recovery; 
that nicotine cessation interventions in 
substance abuse treatment are associated with 
an increase in long-term abstinence of alcohol 
and illicit drugs. Prochaska and colleagues 
(2004) examined outcomes of smoking cessation 
interventions in 19 randomized controlled 
trials with individuals both in current addiction 
treatment and in recovery. The researchers 
found striking interactions between smoking 
cessation and success in treatment for other 
drug abuse. Their first observation was that 
among both men and women, those who stopped 
smoking while also quitting other drug use 
showed higher success rates in abstinence from 
alcohol and other drugs, even though their rates 
of relapse to cigarette use was high. 
Motivating women to stop smoking involves 
addressing their concerns about the diffi culties 
and negative consequences of smoking cessation 
and bolstering their confidence to stop (Miller 
and Rollnick 2002). Women’s motives for 
stopping smoking include their present health, 
their future health, and the effect of their 
smoking on the health of others. Women’s 
concerns about quitting include believing 
stopping will be difficult, feeling tense and 
irritable if they quit, enjoying smoking too much 
to stop, expecting difficulty concentrating after 
quitting, and anticipating gaining considerable 
weight after stopping (Lando et al. 1991; 
Pomerleau et al. 2001). Studies have not 
consistently shown differences in relapse rates 
between men and women, yet women appear to 
have higher rates of relapse when they fail to 
adhere to pre-established quit dates (Borrelli et 
al. 2004). Among women, relapse is signifi cantly 
related to weight gain, strong negative affect, 
history of depression, family history of smoking, 
unemployment, and a history of smoking 
cigarettes high in nicotine (Cooley et al. 2006; 
Hoffman et al. 2001; Swan and Denk 1987; 
Wetter et al. 1999). 
Akin to other services, smoking cessation 
programs should be integrated into substance 
abuse treatment for women. Providers are 
encouraged to include smoking cessation in their 
clients’ treatment plans, as this will help send 
a message to women that treatment providers 
care about their total health. Further, even 
temporary cessation from smoking (assisted 
with nicotine replacement therapy) may give 
women confidence about remaining abstinent 
from other substances, and there may be no 
other opportunity to help them quit smoking. 
In reviewing the common relapse risks among 
women, nicotine cessation programs should 
consider strategies (along with pharmacologic 
therapies), that address body image, nutritional 
counseling, and emotional regulation combined 
with CBTs that target cognitions, establish 
quit dates, and teach coping strategies to 
manage anticipated difficulties in maintaining 
abstinence. 
The consensus panel believes that smoking 
cessation programs should be offered in all 
substance abuse treatment programs. Clinics 
can meet a minimum standard of care by 
adopting some of the following guidelines: 
• 	 Require all treatment facilities to be smoke 
free, and provide nicotine cessation programs 
for employees as well. 
• 	 Provide onsite cessation services and include 
tobacco and nicotine issues as part of 
treatment planning. 
• 	 Train staff to address nicotine addiction. 
Substance abuse counseling skills already in 
place can be applied to help clients achieve 
and maintain smoking cessation. 
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• Base counseling sessions on professional 
guidelines for smoking cessation, such as 
those supported by the National Cancer 
Institute and the U.S. Public Health Service. 
• Provide all clients access to pharmacotherapy 
as an aid in quitting tobacco use; for 
example, nicotine patches and nasal sprays, 
bupropion (Zyban™), and varenicline 
(Chantix™), if medically appropriate. Note 
that few studies have examined the risks 
associated with nicotine replacement and 
other pharmacotherapies among pregnant 
women (for review, see Schnoll et al. 2007; 
Wise and Correia 2008). 
• Identify local resources for referrals for 
more intensive interventions, such as the 
American Cancer Society (www.cancer.org) 
and the American Heart Association (www. 
americanheart.org). 
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8 Recovery 
Management and 
Administrative 
Considerations 
Overview 
The first part of this chapter, aimed at the substance abuse 
treatment counselor, examines the most critical aspects of re­
covery management including continuing care services, outcome 
and relapse variables, and support services. The second part 
is directed toward substance abuse treatment program admin­
istrators and supervisors. This segment looks at the benefi ts of 
consumer participation in programming, the characteristics of 
a healing environment for treatment, and the main components 
of staff development including staffing, training, and clinical 
supervision specific to women’s programming. Organizational 
change strategies that focus on how an organization can become 
gender responsive follow. 
Continuing Care 
Continuing care services, often referred to as aftercare, are substance 
abuse services that occur after initial treatment. Continuing care is 
designed to provide less intensive services as the client progresses in 
treatment and establishes greater duration of abstinence. The dearth 
of research on continuing care is particularly evident surrounding 
gender differences. Several studies are available that show potential 
patterns, but caution is needed in interpreting the findings due to 
methodological issues and sample size. 
Although women appear more likely to attend aftercare, any 
transition from one service to the next can be challenging for the 
client and treatment provider (Carter et al. 2008). In general, clients 
are more likely to discontinue treatment during these periods. Women 
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often express feelings of disconnection with 
the new treatment provider and experience 
additional struggles in managing the added 
demands and expectations of child care while 
attending less intensive treatment. Relapse is 
more prevalent during these periods, especially 
when there is little compliance or support from 
family to follow aftercare plans. The initial risk 
factors that served as a direct or indirect path 
to substance use often are the same risk factors 
that reappear in early recovery and sabotage 
involvement in continuing care, recovery 
activities, and abstinence. As an example, 
women who have a history of substance use 
that involves a significant relationship appear 
more likely to leave care prematurely due to the 
influence of a boyfriend, spouse, or signifi cant 
other. 
In one study that gained information from 
program case managers, it was reported that 
the women who had prior inadequate drug 
treatment services were most likely to drop out 
of continuing services (Coughey et al. 1998). 
Those women who completed aftercare had two 
times the amount of prior residential alcohol/ 
drug treatment and longer sobriety time at 
admission. Equally important, women appear 
more likely to engage in continuing care if 
the primary treatment they received involved 
specialized programming for women (Claus et al. 
2007). 
Treatment Outcome 
Historically, researchers have used 
posttreatment abstinence rates as the focal 
point of measuring success. Debate has 
ensued regarding how to measure treatment 
outcome and whether or not posttreatment 
abstinence rates are myopic in that they fail 
to account for the physical, psychological, 
and social conditions that improve in the 
treatment process. Other commentaries have 
suggested that using abstinence rates as the 
only benchmark to measure outcome falls 
short of recognizing the chronic nature of 
substance dependence disorders––that relapse 
is not inevitable but a likely event that can 
provide a client with a learning opportunity 
to strengthen recovery skills. Overall, most 
outcome studies have targeted more immediate 
responses to treatment, often measuring and 
following outcome variables no longer than 12 
months beyond discharge (Grella et al. 2005). 
This section examines the many factors that 
contribute to treatment outcome and includes 
numerous studies that expand the defi nition 
of treatment outcome beyond abstinence 
rates, including quality of life and other 
biopsychosocial benefits. The segment ends 
with a discussion on relapse and prevention for 
women, and specifically for postpartum women. 
Gender is not a significant predictor of 
treatment outcome. Once in treatment, women 
are as likely as men to complete treatment 
and have good treatment outcomes, although 
outcome differences are noted when evaluating 
individual and program characteristics 
(for a comprehensive literature review, see 
Greenfield et al. 2007a). Women are also as 
likely to have similar abstinence rates and 
overall quality of life 1 year after discharge 
from treatment (Slaymaker and Owen 2006). 
As shown by previous research (Timko et al. 
2002), women show greater increases than 
men in employment, recovery-oriented social 
support systems, and participation in self-
help groups (Grella et al. 2005). Grella’s study 
found that women have greater reduction 
in levels of distress, although their levels of 
distress appear to remain consistently higher 
than those of their male counterparts at each 
period of outcome evaluation. For women 
with posttraumatic stress reactions, literature 
supports the relationship between the receipt 
of integrated trauma treatment services and 
positive treatment outcome (Cohen and Hien 
2006; Cocozza et al. 2005). In a posttreatment 
outcome study measuring factors that predicted 
5-year abstinence, 12-Step participation and 
involvement in social networks that support 
recovery were among the essential ingredients 
(Weisner et al. 2003a, b). 
Although further evaluation is needed, there 
appears to be a stronger association between 
treatment participation and posttreatment 
outcome among women (Fiorentine et al. 1997; 
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Hser et al. 2004). Literature suggests that 
treatment completion and length of stay in 
residential treatment are important factors in 
establishing positive posttreatment outcomes 
among women (Greenfield et al. 2004). Specifi  c 
posttreatment outcome analysis comparing 
length of treatment to posttreatment outcome in 
residential treatment for pregnant and parenting
women and their children shows an association 
between longer lengths of stay and abstinence, 
improvements in employment and income, 
decreases in arrests and depressive symptoms, 
and more positive attitudes toward parenting 
(Conners et al. 2006). Although studies have 
begun to shed light on gender differences in 
posttreatment outcome, future research should 
continue to examine the specifi c underlying 
factors that influence treatment outcomes  
and how these factors differ between men and 
women. 
Relapse 
Gender alone does not predict substance 
abuse treatment outcomes. Instead, client 
characteristics are more likely to predict 
relapse, and these characteristics often infl uence 
the risk of relapse differently in men and women 
(Greenfield et al. 2007 b). Women who complete 
treatment for substance use disorders show 
no significant differences in relapse rates or  
only slightly better outcomes compared with 
men (for review, see Walitzer and Dearing 
2006). However, gender 
differences do emerge 
across qualitative and 
quantitative studies that 
evaluate antecedents or 
risk factors associated 
with relapse and the 
 clients’ psychological 
and behavioral reactions 
to the relapse. Relapse 
characteristics and 
reactions specifi c to 
women are highlighted in 
Figure 8-1 (p. 184). 
Currently, many relapse 
prevention programs 
do not delineate 
specific strategies and  
therapeutic approaches 
for women. Thus, 
research is needed 
to develop and evaluate relapse prevention 
programs and intervention strategies for 
women. One randomized study is available that 
evaluates a manual-based, women-only, women-
oriented relapse prevention therapy group 
called Women’s Recovery Group (WRG). In this 
study, WRG produced better outcomes in the 6 
months following treatment than a mix-gender 
group using a standard manual-based program 
(Greenfield et al. 2007 b). A forthcoming book by 
Greenfield, to be published by Guildford Press,  
Women are as likely 
as men to experience
positive treatment
outcomes including
similar abstinence 
rates and overall 
improvement in
quality of life.
Note to Clinicians: 
Family Reunifi cation 
The ability to regain custody of children can significantly motivate mothers to not only enter and  
pursue treatment but also to maintain motivation for ongoing recovery after treatment. Mothers 
in early recovery can face numerous challenges and stressors associated with reunifi cation, 
including time pressures in establishing recovery to avoid termination of parental rights, the 
maintenance of recovery activities while assuming the parenting role, the management of affect 
associated with the impact of their past drug and alcohol use on their children’s physical and 
mental health, effective implementation of parenting skills, and others (for review, see Carlson et 
al. 2006). As a provider, it is important to not only acknowledge the mother’s initial enthusiasm 
and motivation for reunification, but also incorporate preparatory skills, including parenting,  
stress and anger management, and problemsolving to help fortify personal resources in 
anticipation of future parenting and childcare issues and challenges. 
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 will provide the protocol for this women-specifi c 
relapse prevention group. Figure 8-2 provides 
examples of topics discussed in WRG. 
Postpartum relapse prevention 
It is not uncommon for women who abstained 
from alcohol, drugs, and tobacco during 
pregnancy to return to use after childbirth 
(Mullen 2004). The stresses of parenting a 
newborn and the resumption of activities 
curtailed during pregnancy can involve a host 
of triggers. The postpartum period presents 
numerous triggers for relapse in recovering 
women who are drug dependent, including: 
• 	 Pain and other common discomforts of the 
postpartum period. 
• 	 Fatigue and sleep deprivation. 
• 	 Other chronic health problems. 
• 	 The stress of role adaptation and caring for a 
newborn (along with other children for some 
women). 
• 	 Shifts in relationships with partners and 
family members. 
• 	 Interactions with child welfare agencies, 
courts, and criminal justice agencies. 
• 	 Ambivalence about parenting. 
• 	 Temporary or permanent loss of custody, 
whether voluntary or involuntary. 
• 	 Reunification after temporary loss of infant 
custody. 
• 	 Guilt and grief related to infant illness or 
death. 
• 	 Other stressors of daily living. 
Figure 8-1 
Women-Specific Predictors of Relapse and Reactions to Relapse  
Relapse Risks Unique to Women 
Women are more likely to relapse if they report or display: 
• 	 Interpersonal problems and confl icts. 
• 	 Low self-worth that is connected to intimate relationships. 
• 	 Severe untreated childhood trauma. 
• 	 Strong negative affect. 
• 	 More symptoms of depression. 
• 	 Greater difficulty in severing ties with other people who use.  
• 	 Failure to establish a new network of friends. 
• 	 Lack of relapse prevention coping skills. 
Women’s Reactions to Relapse 
Women are more likely than men to exhibit the following behaviors during or after relapse: 
• 	 Relapsing in the company of others and particularly with female friends or a signifi cant other. 
• 	 Escalating use after initial relapse that is positively associated with severity of childhood 
trauma. 
• 	 Seeking help. 
• 	 Experiencing slightly shorter relapse episodes. 
• 	 Reporting depressed mood. 
Women are less likely than men to be affected by the same relapse risks across multiple relapse 
episodes. 
Source: Coyne et al. 2006; Hyman et al. 2007; McKay et al. 1996; Project MATCH 1997; Rubin et 
al. 1996; Sun 2007; Zywiak et al. 2006. 
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Relapse prevention education with emphasis on 
postpartum triggers will help women anticipate 
and plan for such triggers. Relapse prevention 
techniques are often taught in groups using 
structured curricula that include strategies for 
maintenance of abstinence and recovery, such 
as identifying high risk situations; learning 
refusal skills that can be practiced with peers 
and staff in advance of “real life” challenges; 
and recognizing triggers that lead to relapse 
thinking, drug craving, and eventual use. 
Although there are multiple new demands placed 
on recovering postpartum women, using the 
tools for relapse prevention in the context of a 
full program of recovery activities is essential 
for continued abstinence. 
During treatment, triggers for drug use should 
be identified and explored with recovering  
women prior to program discharge in concert 
with individualized treatment planning. Many 
of the services and resources used by the 
client prenatally should be continued, if not 
intensified, in the postpartum period. Alumnae  
groups and in-home visitation programs 
have assisted women with relapse prevention 
and family preservation (French et al. 2007; 
Gruber et al. 2001). Drug-specific research on  
postpartum women and relapse has primarily 
examined relapse to smoking after childbirth. 
In one study, correlates of postpartum relapse 
to smoking included high maternal weight 
gain, late or no prenatal care, and stressful 
Figure 8-2 
Women’s Recovery Group: Manual-Based Relapse Prevention 
Group Format: 90-minute sessions 
• Brief check-in 
• Review of past week’s skill practice 
• Presentation on session topic 
• Open discussion of topic and other recovery-related issues 
• Review of session’s “take-home message” and upcoming week’s skill practice 
• Check-out 
Content Areas: 
• The effect of drugs and alcohol on women’s health 
• What are the obstacles to seeking treatment and getting into recovery? 
• Managing mood, anxiety, and eating problems without using substances 
• Violence and abuse: Getting help 
• Women and their partners: The effect on the recovery process 
• Women as caretakers: Can you care for yourself while taking care of others? 
• Women’s use of substances through the life cycle 
• Substance use and women’s reproductive health 
• The issue of disclosure: To tell or not to tell 
• How to manage triggers and high risk situations 
• Using self-help groups to help yourself 
• Can I have fun and not use drugs or alcohol? 
• Coping with stress 
• Achieving balance in your life 
Source: Greenfield et al. 2007 b 
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Advice to Clinicians: 
Postpartum Relapse Prevention 
• 
• 
• 
Pregnancy issues must always be fully addressed within a set of comprehensive 
treatment plans, including postpartum relapse prevention. 
Relapse prevention following delivery is especially critical as many clients “quit for the 
baby” and not themselves and thus are susceptible to resume use. 
The postpartum period is saturated with stresses and triggers for relapse, and each 
must be addressed in the client’s relapse prevention plan. 
life events (Carmichael and Ahluwalia 2000). 
Other research suggests that postpartum 
women relapsed to smoking in order to manage 
emotions, stress, and weight, and because they 
did not initially quit for themselves (Bottorff 
et al. 2000; Levine and Marcus 2004). Relapse 
prevention programs for postpartum women 
who smoke can decrease future smoking in some 
of these women (Ratner et al. 2000). 
For many perinatal women who are monitored 
by drug courts, probation, parole, and child 
welfare agencies, the consequences of relapse 
can be devastating in terms of the potential for 
loss of child custody. Perinatal programs, in 
acknowledgment of the importance of parenting 
roles and relationships to women, recognize the 
possibility of relapse and acknowledge that this 
is the time when assistance to the client and her 
child should be intensified, not eliminated. 
Support Systems for 
Women 
Twelve-Step recovery groups have been a 
vital resource for over 50 years, and as time 
has evolved, more women have participated 
in these recovery support groups. Originally, 
the Alcoholics Anonymous (AA) program was 
written by men and primarily for men, and 
the content and language reflected this bias—a 
bias that was steeped in the culture of the time 
period in which it was written. The AA literature 
has since been revised and updated, yet issues 
regarding sensitivity to language and the limited 
focus on cultural and social issues pertinent to 
women’s dependence and recovery remain a 
potential roadblock for some women (Covington 
1994). Nonetheless, 12-Step support groups 
have been the most steadfast peer-facilitated 
program, providing women a viable avenue of 
support in establishing abstinence, in developing 
recovery skills, and in maintaining recovery. 
Most research on the effectiveness of 12-Step 
groups has been conducted with men, but some 
studies have examined gender differences. To
date, research results refl ect inconsistencies 
regarding differences in attendance and 
abstinence rates between men and women. 
Moos, Moos, and Timko (2006) found that 
women appeared to gain even greater benefi ts 
from AA than men, and women were more likely 
to attend AA and to attend more frequently. 
Compared with men, women showed less 
avoidance coping and greater reduction in 
depression with continued AA participation. 
Another study reported no gender differences 
in 12-Step attendance over a 24-month period, 
including frequency of participation and drop­
out rates (Hillhouse and Fiorentine 2001). For 
women, availability of support and sponsorship 
appear to be the main ingredients in perceived 
social support in 12-Step recovery groups (Rush 
2002). 
Like men, women have other options for support 
group involvement. Women for Sobriety is the 
only self-help program designed specifi cally for 
women who are alcohol-dependent. Although 
women can benefit from participation in groups 
and from the supporting women-centered 
literature, availability of support groups is 
limited. To date, gender-specifi c outcome 
research on recovery groups outside of 12-Step 
programs is minimal. 
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Consumer Direction, Participation, 
and Empowerment 
The field of substance abuse treatment has a 
tradition of integrating consumers into service 
delivery as counselors and case managers, 
particularly at the direct service level. However, 
the field is only beginning to learn about and 
apply the enormous benefits received when 
these individuals are integrated into the entire 
fabric of service delivery, from program design 
to implementation and evaluation. For example, 
the SAMHSA-funded Women, Co-Occurring 
Disorders and Violence Study demonstrated a 
priority on including consumers in all aspects of 
study design and implementation throughout the 
5 years of the study. 
Prescott (2001) identifies the important 
contributions made to service systems and 
research when consumers are actively involved. 
When hiring people in recovery as mentors, case 
managers, counselors, and board members, 
characteristics to consider include signifi cant 
time in recovery, ability to handle the expected 
range of tasks, and considerable training 
in issues related to recovery in the specifi c 
treatment areas (Moses et al. 2004). 
Service system benefi ts include: 
• 	 Improving quality of services and systems. 
• 	 Contributing to systems knowledge. 
• 	 Improving customer orientation. 
• 	 Positively affecting policy development. 
• 	 Adding diversity. 
• 	 Reducing stigma. 
• 	 Providing positive role models. 
• 	 Promoting increased awareness and 
education among coworkers. 
• 	 Providing knowledge about and linkages to 
community and alternative resources. 
• 	 Increasing client engagement and retention. 
Research benefi ts include: 
• 	 Enhancing research design. 
• 	 Promoting engagement of research subjects. 
• 	 Broadening interpretations and perspectives 
of research fi ndings. 
• 	 Increasing research relevance (Prescott 2001, 
p. 6). 
Active involvement of consumers in all aspects 
of treatment planning signifi cantly contributes 
to both recovery and empowerment, and 
is essential if meaningful, effective services 
for women and children are to be developed 
(Schauer et al. 2007). The consensus panel 
believes consumers should have input into 
program design as well as management and 
research evaluation protocols. In addition, 
training in leadership and advocacy for 
consumers contributes to their feeling of being 
part of a group, effecting changes in their lives 
and communities, learning skills, changing 
others’ perception of their competencies, 
increasing their positive self-images, and 
overcoming stigma. These elements are critical 
components of empowerment (Chamberlin and 
Schene 1997). 
Prescott (2001) lists the benefits to recovering 
women involved in programs: 
• 	 Positive role model. Consumers are positive
role models when they serve in capacities
ranging from chief executive officer to support
staff. Women who volunteer at the treatment
program or in the community can be positive
role models for clients new to treatment. 
• 	 Promotion of specifi c skills . As staff members
in a treatment program, consumers learn
skills to help themselves communicate with
community agencies and social service groups
and learn how organizations change and ideas
are implemented, thereby gaining a sense of
control over the environment. 
• 	 Promotion of recovery and well-being. 
Being a part of the treatment milieu, having
responsibility for an aspect of the program,
and working with colleagues whose mission
is to promote wellness can help a woman
focus her life on maintaining her health and
recovery. 
• 	 Increased sense of hope. The increased
security of having employment and perhaps
income helps consumers envision their future
in a more promising light. 
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• 	 Cultivation of self-effi cacy . As consumers
acquire the skills they need to make positive
contributions to the work of the treatment
program, their belief grows in their abilities to
handle problems on a broad scale. 
• 	 Decreased stigma. When consumers play
a role in a treatment program, they give
evidence that substance abuse is not a
character flaw or moral defect but an illness
that can be overcome. Their presence sends
that message to others and mitigates any
internalized stigma of consumers. 
Consumer-centered programs incorporate
the views of women in recovery in all stages of
program design, management, and evaluation.
In this way, the quality of services and systems
integration improves, coworkers become better
educated about the process of recovery, and the
stigma of substance abuse is reduced. 
Creating a Healing Environment 
The primary characteristic of a healing
environment is safety. The environment should
also be holistic, seamless, and centered on
a woman’s needs. To promote healing, the
therapeutic environment must be inviting
and welcoming, with culturally appropriate
decorations and pictures. Surroundings should
be multicultural, highlighting heroines from
many cultures. A connection to women’s history
and female heroes plays an important role in
bolstering women’s self-effi cacy. 
In both residential and outpatient programs,
the physical layout must provide privacy and
space where women can be quiet and meditative.
Private time is needed in their schedules;
treatment programs can offer an array of services
that pack a daily schedule, but women need
time for contemplation and to pursue personal
interests. Music and recreational activities should
be available. Space dedicated to child care and
equipment for children’s activities is essential if
children are included in the program. 
In women’s treatment programs, sensitivity to
trauma-related issues is critical to a healing
environment. A calm atmosphere that respects
privacy and maximizes client choices promotes
healing. Staff should be trained to recognize the
effects of trauma, and women should have a clear
understanding of the rules and policies of the
residence. A trauma-informed environment must
consider: 
• 	 Attention to safety. 
• 	 Attention to boundaries between staff and
participants, among participants, and between
participants and visitors (e.g., giving women
permission to say no to hugging; hugging can
be a common expression of positive emotion
for some women, but for those who have been
traumatized it could represent an undesired
intrusion into their personal space). 
• 	 Mutuality in staff–staff and staff–client
relationships. 
• 	 A nonpunitive atmosphere in which confl ict
is addressed by negotiation to the extent
possible. 
• 	 An organizational structure that allows 
participants access to several layers of staff 
and administrators. 
• 	 Encouragement of assertiveness and 
leadership. 
• 	 Self-care. 
Staffi ng 
A woman-centered staff member is an active 
participant in treatment and considers the 
specific needs of women in general and of each 
particular client and how they can be addressed. 
She weighs the realities and complexities of 
women’s lives and their social and gender 
roles with a nonjudgmental attitude. Although 
programs are not always able to hire a woman 
for each staff position, a program still can 
adhere to a woman-centered philosophy. A 
key rationale for having female staff work with 
female clients is role modeling; people watch 
more than they listen. A woman-run program 
shows clients how women can exercise power 
effectively. Women need to be seen in leadership 
roles in the program. 
This goal does not, however, exclude men as 
treatment providers for female clients; men 
who are respectful of women’s experiences 
can help women. They must have a woman-
centered perspective and be knowledgeable 
about women’s issues, particularly trauma 
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and domestic violence. In residential programs 
or other programs with children’s services, 
male staff members can play a valuable role 
by being healthy male role models for women 
and their children. Women report that working 
with a male counselor who is compassionate 
and respectful can be a healing experience, 
particularly if they endured negative 
relationships with men. Ideally, a woman should 
have the option to choose either a man or a 
woman as her primary counselor. 
Men can serve in a variety of roles in
nonresidential programs, including case manager,
housing coordinator, couples’ or children’s
counselor, and general equivalency diploma
teacher. They can provide a male point of view
about parenting and assist in exploring the
attitudes and behavior of the clients’ partners. 
Training 
Treatment providers and staff members at 
all entry points in systems that serve women 
need to be able to screen, triage, and refer for 
substance abuse treatment using an approach 
that supports and encourages women to receive 
treatment. Because of a lack of knowledge 
about substance use generally and about women 
particularly, as well as the tremendous stigma 
attached to women who abuse substances, it 
is important that all staff training include a 
process that identifies, acknowledges, and brings 
to awareness the biases, judgments, and anger 
toward women who use and abuse substances. 
The pervasiveness of substance use and abuse 
and the negative effect it has on the lives of 
so many people make it difficult to remain 
objective as a helping professional. If women 
are to be identified and referred when in need 
of treatment for their substance use, those in 
a position to help must be able to interact in a 
manner that assists and causes no harm. 
Training for point-of-entry 
providers 
Point-of-entry providers see women with a 
variety of complaints and have the potential 
to identify and refer women for assessment 
and treatment. These point-of-entry providers 
include those in healthcare, domestic violence, 
social service, child protection, mental health 
systems; schools and daycare centers; the 
criminal justice system; TANF (Temporary 
Assistance for Needy Families) workers, 
judges, and clergy. The consensus panel 
recommends that because these providers 
are in the position to identify women in need 
of substance abuse treatment, a minimum 
standard of cross-training among systems and 
within interdisciplinary groups is needed. With 
a heightened focus on cultural and linguistic 
competency, along with substance abuse 
education, training can help practitioners avoid 
creating barriers to treatment when clients are 
from cultures, ethnicities, or sexual orientations 
different from their own (Goode et al. 2006). 
Figure 8-3 defines the attitudes, skills, and 
knowledge that should be the goals for training 
an audience of point-of-entry staff. 
Training for substance abuse 
treatment counselors 
Although it is widely assumed that clinical 
staff members who provide substance abuse 
treatment are prepared to serve both men and 
women, the training received by clinicians does 
not always specifically include women-centered 
treatment. The consensus panel believes 
that training for clinicians should include 
information on the psychological growth and 
development of women, cultural competence, 
sexual orientation and gender identity issues, 
the role of relationships in women’s development 
of a sense of self, the importance of children in 
the treatment process, children’s importance in 
the lives of mothers, and the sense of adequacy 
in parenting that is vital to self-esteem. Training 
should include information on the etiology of 
use and abuse of substances in women and the 
physiological effects that are unique to women. 
Counselors also need to be able to disseminate 
accurate information about the bodily changes 
and potential effects of substance use on both a 
pregnant woman and her fetus. 
In addition, social roles and status in society 
strongly influence the patterns, consequences, 
and context of use, as well as the treatment 
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Figure 8-3 
Goals and Training Guidelines for Point-of-Entry Staff 
(Non–Substance-Abuse Treatment Providers) 
Goals Guidelines 
Attitudes • To be nonjudgmental, supportive, and respectful 
• To be culturally responsive and appropriate
Skills • To actively listen and express concern 
• To treat all women with respect and dignity 
• To engage women in nonthreatening discussions 
• To routinely screen for alcohol and substance use and abuse (e.g., 
complete a behavioral checklist, identify behavioral signs) 
• To recognize signs of intoxication and symptoms of mental disorders 
• To facilitate appropriate referrals for women who abuse substances 
Knowledge • To understand women’s lives in sociocultural, psychological, 
economic, and political contexts 
• To learn about the etiology, symptoms, consequences, and course of 
substance use disorders among women 
• To know the available treatment and support resources for women 
who abuse substances and how to make a referral 
• To continue to learn drug language and culture 
• To understand the diverse experiences of women from different 
cultural groups, sexual orientations, and gender identities 
experience. Some clients need to feel empowered 
to assume new roles, make decisions and a new 
life, and remain substance free. Treatment staff 
can help clients find acceptance, understand 
their conflicts, and reach comfortable roles. 
Figure 8-4 defines the attitudes, skills, and 
knowledge that training should instill in 
an audience of substance abuse treatment 
counselors. 
Supervision 
The consensus panel recommends that staff 
supervision be built into an agency’s procedures 
on two levels: administrative supervision 
(timesheets, policies, etc.) and clinical 
supervision. Clinical supervision provides a 
method to address countertransference issues 
or other problems when a staff member’s 
values, attitudes, and/or expectations might 
interfere with the therapeutic process. 
Clinical supervisors can help counselors foster 
therapeutic alliances and help providers 
learn to use the therapeutic relationship to 
model and foster mutuality, respect, and 
connection for women (Finkelstein 1996; 
Finkelstein et al. 1997). Literature from cross-
cultural psychology and social work shows 
that therapeutic relationships with those who 
have substance use problems are stronger and 
more effective if the counselor understands 
the client’s historical, cultural, and economic 
background (Pedersen et al. 1989; Sue and 
Sue 2003). Research in psychology shows that 
counselors’ gender and ethnicity can affect the 
diagnoses they assign (Loring and Powell 1988). 
This speaks to the need for ongoing clinical 
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Figure 8-4 
Goals and Training Guidelines for Substance Abuse Treatment 
Counselors 
Goals Guidelines 
Attitudes To main tain a nonjudgmental, supportive, and respectful manner • 
To understand the diverse experience of women from different cultural • 
groups, abilities, sexual orientations, and gender identities (e.g., be aware of 
attitudes toward race, sex, and disability) 
To be committed to women’s issues • 
To uphold a sense of hope • 
To demonstrate unconditional acceptance of and positive regard for the client • 
Skills To engage women with empathy, warmth, and sincerity • 
To develop a treatment alliance with female clients that is mutual and • 
collaborative, individualized, and continually negotiated 
To have clear professional boundaries (neither distant nor abandoning) and • 
maintain confi dentiality 
To remain consistent in caring and availability and possess the ability to set • 
limits in a calm and supportive manner 
To conduct assessments that are thorough and trauma informed • 
To develop individually focused and outcome-oriented treatment plans • 
To work with multidisciplinary teams • 
To perform crisis intervention • 
To apply trauma coping skills • 
To tolerate one’s own distress in hearing trauma information • 
To deliver client-led treatment (e.g., help the client learn how to manage her • 
distress without shutting down or becoming overwhelmed—a central focus of 
treatment) 
To maintain and ensure self-care • 
To support clients’ cultural and racial identities and sexual orientations • 
To ask for and participate in supervision, in part to explore personal biases in • 
ongoing processes, and to be invested in ongoing training 
To be a visible advocate for women who use/abuse substances for stigma • 
reduction and for treatment (within treatment teams, the community, and the 
system) 
To be an appropriate role model for women, including on the topic of • 
parenting 
To develop professional, respectful, mutually supportive, and collaborative • 
relationships with coworkers 
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Figure 8-4 
Goals and Training Guidelines for Substance Abuse Treatment 
Counselors (continued) 
Knowledge • 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
• 
To be culturally informed and knowledgeable 
To be trauma informed, including awareness of the prevalence and impact of 
trauma on women’s lives 
To understand the psychological growth and development of women 
To recognize the centrality of relationships for women, particularly parenting 
and social roles and the socialization process 
To be knowledgeable about the physiology of women as it relates to substance 
use and abuse 
To understand the etiology of substance abuse in women 
To be familiar with the co-occurring disorders that commonly occur in women 
To understand the context of abuse and patterns of use for women 
To identify the consequences of substance abuse (e.g., legal, general health, 
infectious diseases, family and relationships, psychological) 
To understand the treatment and recovery experience of women 
To identify family dynamics (e.g., family of origin, parenting, child 
development) 
To be familiar with a woman’s process of recovery 
To be knowledgeable about relapse prevention for women; relapse triggers 
such as family reunification; recovery resources; maintaining a safe place for 
the client; and loss, grief, and mourning 
To understand issues related to sexuality, sexual orientation, and gender 
identity for women and their relationship to substance abuse 
To know confidentiality rules and guidelines 
supervision of counselors and to the need for 
training individuals to be effective supervisors 
(Cramer 2002). Supervisors also can support 
staff members who are in recovery and working 
as volunteers or mentors. 
Clinical supervision for trauma 
The management of the powerful effect 
associated with trauma presents challenges for 
counselors. As a result of their intense daily 
contact with trauma survivors, counselors are 
vulnerable to many symptoms and conditions 
including: 
Vicarious traumatization. The experiences of 
trauma frequently are overwhelming for clients. 
As counselors listen to the life experiences of 
their clients, they too are at risk of becoming 
overwhelmed. Counselors can develop symptoms 
of depression, such as sleep disturbance, loss of 
appetite, or loss of pleasure in usually enjoyable 
activities. Programs can take various steps to 
lessen the effect of vicarious traumatization: 
• 	 Training. Staff training on trauma issues 
(including vicarious traumatization) and on 
the connections between trauma, substance 
abuse, and mental illness, help staff address 
trauma experiences. 
• 	 Supervision. Regular clinical supervision 
helps counselors unburden themselves. The 
sooner a counselor’s distress is addressed, 
the easier it is to manage. Understanding the 
counselor’s emotional vulnerabilities when 
she works with women who were traumatized 
is essential to providing effective treatment 
and allowing staff to work well, safely, and 
consistently. 
• 	 Debriefi ng . Managers and supervisors need to 
ensure that counselors debrief after hearing 
painful and intense histories from their 
clients and to watch for signs of counselors 
becoming overwhelmed. 
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• Self-care. Agency support should include 
awareness and education about signs of 
burnout, breaks from work, vacations, and 
varied schedules (i.e., with periods of less 
exposure to trauma histories). 
• 	 Employee services. Through peer support 
groups, an agency can acknowledge that 
vicarious traumatization is taking place and 
that its employees’ ability to do their jobs 
well is important. 
• 	 Staff appreciation. Program managers 
and supervisors should be aware that staff 
members perform an important function as 
role models; they need to let staff members 
know they are valued. Counselors need to 
be examples of assertive, appropriate, high-
functioning adults. 
Supervision for counselors can be understood 
in a rock-climbing metaphor. The client has 
survived a terrible experience; it is as if she were 
on a high and windy ledge, still alive, but unable 
to find her way back to safety . To help her, the 
counselor must go out on the ledge; calling to 
her from safe ground will not do. To manage the 
task, the counselor must be tied to a supervisor, 
much as a rock climber is tied to another 
climber, to keep from falling (Cramer 2002). 
Strategies for Organizational 
Change 
A program seeking to become woman-centered 
cannot limit the transformation process to 
simply adopting superficial elements of the  
treatment culture (Markoff et al. 2005), such 
as creating a female-only program without 
changing program structure, integrating 
services, or building collaborative relationships 
across community agencies. Rather, it must 
use numerous strategies and endorse a change 
model to ensure organizational change is deep, 
pervasive, and across systems. The consensus 
panel recommends the following: 
• 	 Training and education . Staff members 
need help in identifying their biases and 
assumptions. Such training does not have to 
be intensive or expensive to be effective. For 
example, agencies can trade speakers. 
• Policies and procedures. It is critical that 

programs have clear policies and procedures, 
and that women are informed of these 
policies and procedures at the beginning 
of their treatment. Programs must be 
consistent in how they implement policies 
and procedures. This is important from both 
a program management perspective and a 
clinical treatment perspective. Having clear, 
reasonable standards that are implemented 
uniformly creates a safe and predictable 
environment for clients. 
 Drug and alcohol testing and searches for 
contraband must be done respectfully, 
letting the client know it is part of 
treatment and seeking her cooperation. 
It is necessary to spend time building a 
relationship with the client and to give her 
an opportunity to admit to a relapse or to 
remove items that are not permitted in a 
residential community. 
 Staff must reinforce policies and rules 
uniformly and without preferential 
treatment. Fairness and justice are critical 
for women in treatment, and they must be 
modeled by the staff. 
 Rules and punitive restrictions must 
be germane to treatment. For example, 
some programs do not allow women to 
talk to their children for the fi rst 30 
days of treatment. Such a blanket rule 
is inappropriate for children and shows 
disrespect for the importance of the 
mother–child relationship. Arbitrary rules 
are disempowering for women and not 
part of a collaborative relationship. The 
treatment milieu is a model for parent– 
child relationships, in which the use of 
arbitrary rules is discouraged. Following 
rules and procedures should not result 
in acts that retraumatize women. For 
example, it could be frightening for some 
women to have counselors check rooms at 
night while the women are sleeping. 
• 	 Top-down support for change . Advocacy 
for the program’s philosophy of treatment is 
essential. It must be top down and explicit. 
• 	 Hiring, retention, and promotion. Programs 
must reflect women’ s needs, possibly 
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including onsite daycare for staff, sick-
child care, support (both fi nancial and 
technical) for staff to become certifi ed as 
addiction counselors, onsite training, and a 
good health benefits package. The programs 
should consider ways in which male staff 
members can contribute to woman-centered 
programming. Staff members are more likely 
to support staffing policies and procedures 
when they are involved in their development. 
• 	 Consumer input. The development of 
consumer advisory boards allows clients to 
share their input and lets them know their 
opinions are valued and respected. 
• 	 Relationships. Positive relationships are of 
immeasurable value to women. How staff 
members relate to one another is part of the 
treatment milieu. Administrators need to 
model respectful relationships with clients 
and staff and incorporate support services 
for staff issues, such as mediation for 
staff conflicts and peer support groups for 
handling job stress. 
• 	 The environment is a message. Women 
recover best in a homelike atmosphere that 
is warm and welcoming for them and their 
children. The program environment needs 
to reflect the diverse cultures of the staff 
and clients; all groups can participate in 
designing, arranging, and furnishing the 
facility. 
• 	 Adopt a change model. Administrators and 
supervisors need to develop a change plan to 
maintain a steadfast course in adopting new 
policies and procedures and in integrating 
services. Anticipation of roadblocks, methods 
for creating buy-in with staff, and strategies 
for building interagency relationships are a 
few issues that need consideration. Relevant 
resources to help support and guide change 
include the Relational Systems Change Model 
(Markoff et al. 2005a) and The Change 
Book: A Blueprint of Technology Transfer
(Addiction Technology Transfer Center 
[ATTC] 2004). 
• 	 Collaborative relationships. Establishing 
a collaborative relationship with the client 
provides the woman with an experience 
of mutuality and shared power in a 
relationship, which in itself is part of healing. 
At all times, staff members should work 
respectfully and in partnership with the 
client, and should: 
Set a positive tone for the treatment 
relationship. Counselors get a good 
start by showing respect for the clients’ 
personal needs and comfort. For example, 
one treatment agency keeps a book that 
highlights the stories of women who have 
successfully completed treatment. Another 
offers clients food and drink. During a 
long client-assessment session, a counselor 
can offer a client a break instead of 
waiting for the client to ask for one. If 
possible, during the break the counselor 
should interact with the client so that 
she does not feel alone. However, if she 
requests it, the client should have private 
time. 
Treat substance abuse as a health issue, 
not a moral one. A client who feels judged 
is more likely to leave treatment. Let 
clients know how they can be involved in 
their treatment, explain the process to 
them, explain the roles of the treatment 
staff members, and explain when clients 
will make decisions with staff about their 
treatment (i.e., during treatment planning, 
reassessments, discharge). 
Allow time to hear the client’s stories. Too 
often, a client’s low self-esteem is made 
even lower by cues that there is not enough 
time to listen to her. 
Do what is necessary to ensure that 
the client understands the assessment 
and treatment processes. For a client 
with cognitive impairment, this can 
involve breaking down the process into 
short sessions, repeating or explaining 
questions, proceeding more slowly, using 
less abstract language, or presenting 
information in an alternative format. 
Seek feedback from the client on how 
her treatment plan is working. Inquire 
where she is in relation to her goals for 
treatment, her life, and her feelings about 
her progress. Implement formal strategies 
to obtain client feedback on a regular 
basis instead of gathering this data at the 
termination of treatment. 
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When addressing noncompliance with 
clients, involve them in identifying the 
problem and its solution. Use policies that 
are educational rather than punitive. For 
example, encourage clients to examine the 
behaviors they need to change, how staff 
can help them in this process, an agreeable 
timeframe for doing so, and so on. 
State substance abuse treatment 
standards for women 
To provide general guidance in establishing and 
providing services for women, administrators 
and clinical staff benefit from reviewing 
available State standards or protocols for 
women, pregnant women, and women and 
children programs for substance abuse 
treatment (for review, see CSAT 2007). Figure 
8-5 provides examples of State standards of 
gender-specific treatment across the continuum 
of care. 
Figure 8-5 
State Standard Examples of Gender-Specifi c Treatment 
Gender-Specifi c 
Women Services 
State Standard Examples 
Treatment A relational or cultural approach that focuses on the relevance and• 
Approach centrality of relationships for women must be a vital ingredient in 
treatment 
Selected treatment approaches shall be grounded in evidence-based or• 
best practices for women 
Screening/ Screening and assessments shall involve the use of tools, including the• 
Assessment Addiction Severity Index and Stages of Change/Readiness Assessment 
Assessments shall evaluate barriers to treatment and related services• 
Assessment and documentation of a client’s need for prenatal care shall • 
be included in the assessment process 
History and assessment of interpersonal violence shall be evaluated• 
Sensitivity to retraumatization must be taken into consideration in the• 
assessment process 
Assessment shall be a collaborative process across agencies• 
Treatment Planning Planning shall include participation of significant others and other • 
agencies; i.e., child welfare, correction, and other social service 
agencies 
Treatment Programs Emotional and physical safety of women shall take precedence over all• 
other considerations in the delivery of services 
Women-only therapeutic environments shall be made available • 
Treatment shall include psychoeducation on the impact of gender on • 
development and functioning in society 
Treatment must be strength-based • 
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Figure 8-5 
State Standar  d Examples of Gender-Specific Treatment (continued) 
Treatment Services • Services must provide prenatal and childcare services
• Treatment shall include smoking cessation strategies and programs 
• Services shall include child safety, parenting, and nutrition services 
• Wrap-around and integrated interagency and intra-agency services 
must be an integral part of treatment delivery services 
Trauma-Informed 
and Integrated 
Trauma Services 
• Treatment considerations shall incorporate an understanding of the 
way symptoms of trauma affect treatment, progress in treatment, and 
the relationship among counselor, program, and client 
Co-Occurring 
Disorders 
• Treatment must include symptom management strategies 
• Services for mental health and substance abuse treatment shall be
integrated and coordinated 
 Staffing • The program must provide gender-specifi c staff 
• Treatment services shall involve a majority of women as staff members 
Support Systems • The program shall make use of peer supports
• Referrals shall be made to female-dominated support groups where
available 
Staff Training • Formal staff training in women’s treatment needs must include family 
counseling, trauma-informed services, prenatal education, etc. 
Program Evaluation • Program must measure short- and long-term impact of interventions,
including educational attainment, employment, housing, parenting and 
 reunification with children, and physical and mental health 
Source: Adapted from Connecticut Treatment Guidelines 2007; Colorado Alcohol and Drug Abuse Division Substance 
Use Disorder Treatment Rules 2006; Oklahoma Department of Mental Health and Substance Abuse Services Standards 
and Criteria for Alcohol and Drug Treatment Programs 2008; and Oregon Department of Human Services Standards 
for Outpatient and Residential Alcohol and Drug Treatment Programs 2008. 
Guidance to States: Treatment Standards for Women with Substance 
Use Disorders 
This document serves as a comprehensive guide to assist States in creating their own treatment 
standards for women with substance use disorders. It provides a summary of existing State 
standards and incorporates other relevant resources pertinent to women’s treatment needs 
across multiple service systems. Specific concerns for special populations are addressed, such as  
pregnant women, women with children, and women involved in the criminal justice system (The 
National Association of State Alcohol and Drug Abuse Directors 2008; see http://www.nasadad. 
org/resource.php?base_id=1482). 
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Appendix B: CSAT’s 
Comprehensive 
Substance Abuse 
Treatment Model for 
Women and Their 
Children 
By the CSAT Women, Youth and Families Task Force 
Background 
In the early 1990s, Congress appropriated funds to the newly 
created Substance Abuse and Mental Health Services Administration 
(SAMHSA), Center for Substance Abuse Treatment (CSAT) to support 
long-term residential substance abuse treatment programs for women 
with children. Two separate demonstration programs were funded, 
including the Residential Women and Children’s (RWC) program, and 
the Pregnant and Postpartum Women and Children’s (PPW) program. 
Based in part on the experiences of the RWC and PPW programs, 
CSAT published a “Comprehensive Treatment Model for Alcohol and 
Other Drug-Abusing Women and Their Children” in order to help 
substance abuse treatment providers develop program services to meet 
the comprehensive needs of the women and children served by these and 
other programs. The model was included in a 1994 CSAT publication, 
Practical Approaches in the Treatment of Women Who Abuse Alcohol 
and Other Drugs. 
This model recognized that there was an important difference between 
“treatment that addresses alcohol and other drug abuse only” and 
“treatment that addresses the full range of women’s needs.” As stated in 
the model 
Treatment that addresses the full range of a woman’s needs 
is associated with increasing abstinence and improvement in 
other measures of recovery, including parenting skills and 
overall emotional health. Treatment that addresses alcohol 
and other drug abuse only may well fail and contribute to a 
higher potential for relapse (CSAT 1994f). 
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CSAT’s model remains an important 
contribution toward describing an approach 
to working with women that recognizes the 
importance of gender in the design and delivery 
of services for women and their families. 
Since 1994, the field has gained additional 
insights about critical needs of women and 
children and the role that partners and fathers 
play regarding these needs. The knowledge 
gained in the past decade should drive the 
delivery of services to women. These insights 
include the following: 
• 	 Psychological differences between men 
and women and, in particular, the 
heightened importance that women place on 
relationships have a great impact on both 
women’s gateways into addiction and relapse 
once in recovery. A woman’s focus within 
relationships is often to serve as “caretaker,” 
a role that can result in a woman not 
attending to her own needs. Positive, 
therapeutic relationships, on the other hand, 
can also act as powerful tools for supporting 
a woman’s recovery. 
• 	 Women self-medicate with addictive 
substances to mask pain associated with 
underlying trauma, including past and 
ongoing domestic violence as well as 
childhood abuse and neglect. The high 
prevalence of a history of trauma among 
women receiving substance abuse treatment 
heightens the need for substance abuse 
treatment to recognize the critical impact of
trauma on the woman’s recovery.
• 	 The prevalence of co-occurring mental health
disorders among women receiving substance
abuse treatment has also come to light over
the past decade and raises the need for
providing coordinated services to address both
substance use and mental health disorders. 
• 	 Women appear to be significantly affected by 
the service systems they depend on, including 
welfare agencies and child welfare agencies, 
which tend to operate independently, with 
different timetables and perspectives on the 
purposes of recovery. 
• 	 A new understanding has arisen about the 
benefits of women’s economic self-suffi ciency 
in the process of long-term recovery. This 
is partly a result of the pressures of society, 
exemplified by welfare reform and data 
indicating that gainful employment can be a 
protective influence for preventing relapse. 
• 	 The field has also come to appreciate that 
children of women in treatment have many 
of their own needs that cannot simply be 
addressed by the provision of child care 
and residential living space. These needs 
are addressed when children are provided 
services directly, as well as when the needs of 
their parents are met. 
• 	 Both mothers and fathers should receive the 
education and support necessary to prepare 
them for the responsibility of parenthood, 
understanding that the roles fathers play in 
families are diverse and related to cultural 
and community norms, the health and well­
being of the father, and the viability of the 
parents’ relationship to one another. 
• 	 Changes in family composition play a role in 
supporting women and recovery. In 1960, 
fewer than 10 million children did not live 
with their fathers (U.S. Bureau of Labor 
Statistics n.d.). By the turn of the century, 
the number had risen to nearly 25 million. 
More than one-third of these children will not 
see their fathers at all during the course of a 
year. Studies show that children who grow up 
without responsible fathers are signifi cantly 
more likely to experience poverty, perform 
poorly in school, engage in criminal 
activity, and abuse drugs and alcohol (U.S. 
Department of Health and Human Services 
2000a). 
This update to the model considers the needs of 
women, their children, and their families in the 
context of their community and culture. 
An Evolving Paradigm 
As was the case with the earlier version, the 
purpose of this model is to 
Foster the development of state-of-the­
art recovery for women with alcohol and 
other drug dependence and to foster the 
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healthy development of the children of 
substance abusing women. The model is 
a guide that can be adapted by commu­
nities and used to build comprehensive 
programs over time (CSAT 1994f, p. 
267). 
CSAT’s Comprehensive Treatment Model 
continues to reinforce that confi dentiality and 
informed consent, as well as the establishment 
of universal precautions against the spread 
of sexually transmitted and other infectious 
diseases, are essential throughout all aspects of 
treatment (CSAT 1994e, 2000d). 
In addition to incorporating the new knowledge 
about the common histories and service needs of 
women and their children, this model goes a step 
further by delineating the relational elements of 
the service continuum that have an impact on 
treatment for women. These elements shown in 
Figure B-1 below and are categorized as 
• 	 Clinical treatment services: those services 
necessary to address the medical and 
biopsychosocial issues of addiction 
• 	 Clinical support services: services that assist 
clients in their recovery 
• 	 Community support services: those services 
and community resources outside of 
treatment but within a community that serve 
as an underpinning or support system for the 
recovering individual 
In parallel, the model also describes clinical 
treatment and clinical support services for 
children of women in treatment. 
Research has established that there are many 
paths to recovery from alcohol and drug 
problems. Some women resolve their alcohol 
and drug problems with individual and family 
supports and without any outside intervention. 
Others recover with support from self-help 
groups such as Alcoholics Anonymous and/ 
or the faith community. Still others have 
found recovery through formal treatment 
interventions. A variety of factors can infl uence 
which of these paths is successful, including 
the severity of the problems and the support 
systems available to women with substance use 
disorders. 
To achieve the best outcomes at the lowest cost, 
SAMHSA encourages the establishment of a 
comprehensive continuum of recovery. The full 
complement of these services is appropriate 
for many women who meet the Diagnostic 
and Statistical Manual of Mental Disorders, 
Fourth Edition (DSM-IV) diagnostic criteria 
for substance use disorders. However, not 
all services and/or interventions are needed 
by every woman in treatment or recovery for 
substance dependence, and those who meet the 
diagnostic criteria for substance abuse may 
require a less comprehensive range of services 
than those who are substance dependent. 
Similarly, women with a range of family, social, 
and economic supports may not require a full 
complement of services while those who have 
fewer naturally occurring supports may require 
more services from the formal health, social, 
and economic supportive systems. 
The array of services described below does not 
need to be provided by a single entity, but in 
most instances will be provided by a consortium 
of addiction treatment, health, and human 
service providers. The continuum is not specifi c 
to philosophies of treatment and recovery, 
modality, or setting. It is a generic framework 
within which providers can conceptualize service 
arrays, service capabilities, and appropriate 
managerial and administrative processes. 
Methods of implementing each service, the 
manner and setting in which different services 
are delivered, and other ingredients of the 
model should be based upon an assessment and 
patient placement determination that considers 
(1) the needs of the individual, and (2) the extent 
to which the continuum of services is available in 
the community. 
To better understand the model, it is helpful 
to view services as a series of interwoven and 
interdependent circles of care that are necessary 
to support the recovery process for women. 
In the Navajo Nation, the woven basket 
is actually a series of concentric rings, 
one lying within the other, expanding 
outward and upward until the entire 
basket is shaped. By itself, one ring can 
hold nothing and bear no load. When 
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 Figure B-1 
Interrelated Elements in the Comprehensive Treatment Model 
bound together, the circles join, gain 
strength, and what before could hold 
nothing now holds stones for building 
nations and water for building bodies. 
The concept of interdependence is critical 
to understanding the model. Each circle 
requires the existence of the other two and yet 
they are depicted as dotted lines to illustrate 
their permeability. The three circles together 
comprise comprehensive treatment, and any 
provider seeking to emulate the model must 
also ensure that there is an interdependent 
relationship among the three systems. 
Borrowing again from the basket metaphor, 
the circles are also three-dimensional as a 
basket must be and, as such, have binders 
that interweave and hold the circles together. 
Likewise, in treatment, there are activities 
that weave through each circle, helping to bind 
the service continuum together. Housing is a 
good example. Some people with substance 
use disorders are functionally homeless and, 
thus, the issue of housing permeates clinical 
treatment, clinical support, and community 
support. 
A final and critical aspect of how the circles 
are interrelated requires the inclusion of two 
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 concepts that provide the foundational support 
to the network of comprehensive care: cultural 
competence and gender competence. These 
concepts are graphically displayed as the 
handles to pick up and use the basket. For a 
system of care to be comprehensive in nature, 
it must have cultural and gender competence at 
all levels of treatment and support. The terms 
cultural competence and gender competence 
mean more than knowledge about culture or 
gender. The terms require practitioners to be 
knowledgeable, understanding, and sensitive 
to the milieu from which the woman comes 
regarding the issues and concerns she may bring 
to treatment. These include the socioeconomic 
context of her background; her sexual identity; 
the sources of potential anger, hurt, and fear; 
and disconnection from family, friends, and 
community. Both cultural competence and 
gender competence require recognition of the 
biases that may exist within the programs and 
practitioner that will impact treatment and 
relationships with clients. 
Clinical Treatment Services
 
As shown in Figure B-2, the fabric of the basket 
is interwoven with a range of clinical treatment 
services. These services include the following 
elements: outreach and engagement, screening, 
detoxification, crisis intervention, assessment, 
treatment planning, case management, 
substance abuse counseling and education, 
Figure B-2 
Elements of Clinical Treatment Services 
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trauma-informed and trauma-specifi c services 
and psychoeducational therapies, medical care 
(including treatment for infectious diseases, 
women’s health, and health education), 
pharmacotherapies, mental health services, 
drug monitoring, and continuing care (these 
services are defined and further explained in the 
last section of this appendix). While arguments 
could be made to support the addition of other 
core services to this continuum, experience has 
shown that these elements of service are typical 
of those that are under the core umbrella of 
treatment programs. 
For most women in treatment, particularly those 
burdened with issues such as intergenerational 
poverty, violence, and homelessness, time-
limited clinical treatment services alone will 
not likely result in sustained recovery. Women 
with multiple needs will need support from 
other systems, designated clinical support, 
and community support to achieve success in 
recovery. 
Addiction affects women’s connections and 
relationships, causing them to leave or abandon 
many of the relational systems upon which they 
formerly depended—family, friends, and roots 
in the community. Thus, for a woman to succeed 
in treatment, deliberate steps must connect her 
with the support structures that allow her to 
reverse the isolation and fragmentation often 
synonymous with addiction and reconnect 
with these important relationships. While 
some of that occurs within the context of 
clinical treatment itself, other aspects of the 
reconnection process occur as a result of clinical 
support and community support services. 
Clinical Support Services 
Within this circle is an array of services that, 
by themselves, are not necessarily part of the 
treatment modality but, like ball bearings to 
machinery, make the treatment modality work. 
These support services (shown in Figure B-3) 
include primary healthcare services, life skills, 
parenting and child development education, 
family programs, educational remediation 
and support, employment readiness services, 
linkages with the legal and child welfare systems, 
housing support, advocacy, and recovery 
support services. Elsewhere in this appendix, 
similar circles are identified that relate to the 
special needs of children. While introduced 
separately, they are inextricably intertwined 
with those of the parenting woman. 
Clinical support services are not ancillary 
services, they are a critical part of treatment 
designed to prevent relapse. This model suggests 
that these services are not enhancements of 
treatment but, rather, critical elements of 
treatment designed to promote overall well-being 
and prevent relapse. 
Community Support 
Services 
Community support services are those that 
must be available in the community to ensure 
long-term recovery. These services, as shown 
in Figure B-4, include recovery management, 
recovery community support services, housing 
services, family strengthening, child care, 
transportation, Temporary Assistance for Needy 
Families (TANF) linkages, employer support 
services, vocational and academic education 
services, and faith-based organization support. 
This ring represents some areas that are not 
typically included in the service array for 
women, but women’s treatment program staff 
and policy analysts increasingly view these 
elements as critical to long-term recovery. 
Over the last decade, the concept of relapse 
prevention and aftercare evolved into the 
approach known as continuing care. This 
approach recognizes both the need to provide 
continuing support to a person in recovery 
and that treatment providers share some of the 
responsibility for providing this support. The 
concept of community support operationalizes 
continuing care by recognizing the systems and 
services that must exist in the community in 
order to make continuing care a meaningful 
reality. 
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Figure B-3 
Elements of Clinical Support Services 
Taken together, as shown in Figure B-4, clinical 
treatment, clinical supports, and community 
supports complete the basket and provide the 
comprehensive services needed by many women 
in substance abuse treatment. Implicit in the 
model is the responsibility of providers to look 
inward to their own resources as well as outward 
to community partners’ resources to ensure that 
the elements of comprehensive services are made 
available in the community. 
The Next Generation: 
Services for Children of 
Women in Substance 
Abuse Treatment 
While it is important to provide the 
comprehensive array of services and supports 
to all women, women who are also mothers 
demand increased attention to their unique roles 
as parents and their children require additional 
services and supports. Treatment agencies 
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have come to understand that, for women who 
are mothers, their children are a major factor 
influencing why they enter, complete, and/ 
or leave treatment. Mothers in treatment are, 
in most instances, the custodial parent who 
carries out the tasks of parenting and child-
rearing. In some cases, the mother in treatment 
may not currently have custody and the daily 
responsibility for the care of her children. 
Those cases require special considerations by 
treatment providers to assist the woman in her 
efforts to regain custody if appropriate, and, 
when regaining custody is not an option, assist 
the mother as she transitions in the loss of her 
children. 
Among mothers in treatment with custody of 
their children, the experience of the RWC and 
PPW programs is clear: Providing child care 
alone is an insufficient response to the needs of 
children whose mothers abuse alcohol and/or 
drugs. In many cases, the children themselves 
need services ranging from interventions for 
fetal alcohol spectrum disorders, to intervention 
services for childhood mental health disorders 
and developmental delays. Treatment programs 
have responded to the needs of children and 
have reported that treatment for women 
and their children requires a whole-family 
perspective in service delivery and in clinical 
practice. 
Figure B-5 
Clinical Treatment Services for Children 
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Children’s clinical treatment needs are depicted 
in Figure B-5. Their clinical needs include 
intake; screening and assessment of the full 
range of medical, developmental, emotional-
related factors; care planning; residential 
care; case management; therapeutic child care; 
substance abuse education and prevention; 
medical care and services; developmental 
services; and mental health and trauma services. 
In addition, children need supports that 
reinforce their individual needs. These clinical 
support services are shown in Figure B-6 and 
include the concepts of cultural competence 
and developmentally appropriate services. As 
with the women’s model, cultural competence is 
a critical aspect and is depicted as the handles 
for using the service array in the model. Needs 
and services for young children must be tailored 
to their developmental status and cognition. 
Clinical support services include primary health 
care, onsite or nearby child care, mental health 
and remediation services, prevention services, 
recreational opportunities, educational services 
and advocacy, advocacy in other service arenas 
and with legal issues, and peer supports for 
recovery such as self-help and mutual support 
groups. 
Regardless of the child’s current custody status,
services to address children’s needs should be
coordinated, and when appropriate, should
be integrated with their primary caregivers’
treatment and case plans to ensure that the whole
Figure B-6 
Clinical Support Services for Children 
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family’s needs are met. Ensuring that parents’
and children’s case plans are in harmony in
terms of timing and strategies is imperative for
family recovery. While children can be signifi cant
motivators for women to seek treatment, without
proper planning, caring for children can also
produce stress that may contribute to relapse.
Taken together, providing comprehensive 
services for women and their children (as shown 
in Figure B-7) requires treatment agencies 
to provide an array of direct services and to 
establish linkages to a wide range of supports 
and community resources. This is no easy feat. 
The need for coordination and collaborative 
relationships among agencies and service 
systems can tax scarce resources in staff time 
and expertise to establish those bonds. While it 
may seem overwhelming to consider all of the 
various linkages needed, treatment agencies 
can prioritize their most immediate need for 
collaboration by understanding the most 
immediate needs of their clients. 
Putting the Elements 
Together 
The elements of treatment for women, including 
those who are mothers, are described below. 
Together the elements make up the continuum 
of services that women and women who are 
mothers need to succeed in substance abuse 
treatment. The intensity, duration, and type 
of treatment will vary depending upon the 
assessment and diagnosis of the woman and 
the needs of her child or children. The manner 
in which services are delivered will also vary, 
depending on factors specific to the woman and 
the child, including culture, race, ethnicity, 
social class, age, and sexual orientation. 
Treatment intensity, philosophy, and methods 
will vary depending on the needs of the client, 
reimbursement policies, and treatment methods 
used by providers. 
Clinical Treatment Services 
Clinical treatment services are generally 
provided directly by the substance abuse 
treatment provider. As such, they are 
considered core services. Providers recognize 
that providing core services without support 
services is likely to result in less than optimum 
outcomes for women and children over the 
longer term; thus, support services are pivotal to 
the successful treatment of women and children. 
Clinical treatment services for 
women 
• 	 Outreach, engagement, and pretreatment. 
Activities designed to assist clients in engaging 
in treatment are essential elements of service, 
falling into the broad category of outreach, 
engagement, and pretreatment services. For 
many women, these services break the ice and 
help them overcome the shame and denial 
that often serve as obstacles to treatment. 
Same-day services, visits to programs, and 
familiarization with program staff should be 
facilitated whenever possible. Identifi cation 
of and attention to women’s immediate needs 
(e.g., legal, health, safety) are important 
aspects of engagement, even if those problems 
cannot be resolved immediately. When a 
program slot is not immediately available, 
services should be offered to keep women 
connected to the treatment organization. 
Outreach for women must address barriers 
that keep women from treatment, such as 
fear of reprisal from significant others and 
family members, fear of not being able to 
care for children or the loss of custody, as 
well as language and/or cultural barriers. 
Outreach must also address systemic barriers 
such as lack of money or insurance, waiting 
lists, lack of treatment for pregnant women, 
absence of child care, lack of transportation, 
inability to find sustaining employment, and 
need for time to address demands of other 
systems, such as child welfare and TANF 
stipulations. 
• 	 Screening. Intake screening is part of the 
admissions process and can be an important 
strategy that assists in engaging a woman 
in treatment. As such, the interview should 
be relevant and sensitive to the woman’s 
immediate needs, including the needs of 
her children. Intake screening should be 
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conducted by a staff person, preferably a 
female, who is respectful of the complex 
needs of women, who is nonjudgmental, 
and who can determine critical immediate 
needs, including medical, prenatal care, 
detoxifi cation, housing, safety, food, clothing, 
urgent dental needs, and transportation. 
Screening is a good opportunity to provide a 
complete explanation of confi dentiality and 
represents the beginning of the treatment 
engagement and case management process. 
• Detoxifi cation . Detoxifi cation services 
are generally provided in an inpatient or 
residential setting and generally include 
close medical supervision. Although some 
treatment providers consider detoxifi cation 
to be part of the continuum of care, others 
consider it a pretreatment activity. When 
needed, these services are critical to the 
comprehensive care model and offer another 
opportunity for a provider to engage a 
woman in longer-term treatment. 
• Crisis intervention. Women coming into 
treatment are often victims of violence and 
may be experiencing crises warranting 
emergency intervention. Ideally, programs 
would have crisis intervention specialists 
available or they may have established 
strong linkages for immediate access to crisis 
services. While some crises may be evident at 
intake, others may arise during the course of 
the treatment and may affect the woman and 
her children. 
• Assessment. Full assessment for women 
encompasses a wide range of concerns 
and includes a focus on her strengths; 
a comprehensive view of health-related 
needs; risks for HIV/AIDS and other 
infectious diseases; psychological status and 
screening and/or assessment for disorders 
that commonly co-occur in women with 
substance use disorders (e.g., depression 
and posttraumatic stress disorder [PTSD]); 
personal and community safety issues; 
understanding her signifi cant current 
relationships and family-of-origin factors that 
may predispose her to abuse substances (such 
as sexual, emotional, and physical abuse, 
neglect, parental addiction, and parental 
mental illness); her current parenting and 
caregiving roles; responsibility and issues 
such as custody of children, special needs 
of children living with the mother; options 
for care of children if the mother is to enter 
residential treatment without her children; 
her housing status and the safety of her 
housing; financial resources; vocational/  
educational/employment issues; legal issues; 
and involvement with other health, social, 
and/or criminal justice service systems. Using 
the information garnered in the assessment 
process, a recommendation on the level of 
care and treatment placement should be 
made. The placement decisions should follow 
those promulgated by the American Society 
for Addiction Medicine (ASAM). Known as 
Patient Placement Criteria, ASAM’s criteria 
are increasingly the standard for determining 
the needed level of care. 
• Treatment planning. Treatment planning is a 
collaborative process that should be done in 
the context of the unique needs and informed 
choices of women, and should be based 
on their individual strengths. Treatment 
planning should include any immediately 
needed services to help stabilize the family 
and assist the woman as she prepares for 
treatment. It needs to build on the internal 
and external resources available to the 
agency and should integrate the assistance 
offered and stipulations required by other 
health and social service systems. Treatment 
planning with women and their children 
requires attention to re-entry and continuing 
care planning as well. 
• Case management. Case management 
addresses coordination of the myriad service 
elements that are needed by women and their 
families. Case management can occur as a 
pretreatment activity, during treatment, and 
posttreatment. Among services requiring 
coordination are medical, housing, child 
care, transportation, employment/vocational 
preparation, educational, and legal. 
Coordination with child protective services, 
welfare, and probation and parole offi ces 
must also be managed. 
• Substance abuse counseling and education. 
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Substance abuse counseling and education 
for women needs to address the dynamics 
associated with addiction in women, as 
well as current behavioral issues in her 
addiction and the interrelationship between 
addiction and other co-occurring disorders. 
These include issues stemming from family-
of-origin dynamics and the importance of 
relationships in the lives of women. It also 
needs to address the physical and social 
consequences of substance use disorders. 
Programs should ensure that all counseling 
activities are conducted in a respectful and 
caring manner and should not use counseling 
approaches that are contraindicated for 
trauma survivors, such as shaming, harsh 
confrontation, and intrusive monitoring. 
Staff should work with women in a manner 
that builds self-esteem, using nonaggressive 
and nonthreatening techniques so as not 
to revictimize clients. In addition, relapse 
prevention and recovery management are 
important components of substance abuse 
counseling and education. 
• Trauma-informed and trauma-specifi c 
services. Given the high prevalence of 
histories of violence among women with 
substance use disorders, providing treatment 
in a trauma-informed environment is 
especially important. Staff should be trained 
to understand the multiple and complex links 
between violence, trauma, and addiction; 
to understand trauma-related symptoms 
as attempts to cope; to understand that 
violence and victimization play large and 
complex roles within the lives of most 
consumers in substance abuse and mental 
health services; and to behave in ways that 
are not retraumatizing to women. Trauma-
specific services include individual and group  
services that directly address the impact of 
trauma and facilitate recovery and healing. 
A woman should not have to disclose her 
trauma history to receive trauma-specifi c 
services. The best practice is to enter into 
every treatment relationship as if the woman 
has experienced trauma, whether disclosed 
or not. 
• Medical care, including treatment for 
infectious diseases, women’s health, and 
health education. Medical assessments and 
subsequent care should be provided onsite 
or by referral by care providers who are 
sensitive to gender, addiction, mental health, 
and trauma issues. The types of services 
that may be needed include primary care; 
prenatal and postnatal care; emergency and 
hospital care; chronic diseases care (arthritis, 
diabetes, etc.) and testing, treatment, and 
counseling for HIV/AIDS, tuberculosis, 
and sexually transmitted diseases; and 
gynecological care. During pregnancy, special 
consideration should be given to the medical 
management of the pregnancy. Maternal 
education about and preparation for delivery 
and postpartum needs, including postpartum 
relapse prevention, should be included. 
Methadone maintenance and medication 
management of opioid dependence is 
particularly important during pregnancy. 
For women with a history of mood disorder, 
the postpartum period should include close 
monitoring for psychiatric symptoms. 
• Pharmacotherapies. The use of methadone 
for treatment of opioid dependence is 
an accepted standard of care. Although 
usually provided on an outpatient basis, 
it should be available at all levels of care. 
Special attention may be needed when 
integrating patients on methadone and other 
phamacotherapies into treatment milieus 
with other clients who may not understand 
the utility of pharmacotherapies or who may 
have a negative attitude toward their use. 
• Mental health services. Provision of or 
linkage to psychiatric and psychological 
care providers is often needed, given the 
high prevalence of co-occurring psychiatric 
disorders among female substance abuse 
treatment clients. It is not unusual for women 
to need services for affective disorders, 
anxiety disorders (including PTSD), and 
somatization disorders. Services for other 
mental illnesses (including severe mental 
illnesses such as bipolar disorder or major 
depression) are not as common but are also 
needed. Pharmacotherapy is sometimes 
part of mental health care, and onsite staff 
can provide medication education and 
monitoring. 
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• 	 Drug use monitoring. Drug use monitoring, 
as part of ongoing assessment of the client’s 
progress, is a component of treatment and 
can be used as a deterrent to relapse. 
• 	 Continuing care. Continuing care is a critical 
element of clinical treatment services for 
women. Trusting relationships formed among 
women, their peers, and their counselors 
continue to provide support to women once 
they have completed the formal treatment 
period. Planning for discharge is often 
anxiety-provoking and counselors should 
be prepared for a recurrence of presenting 
problems and possible resistance and 
procrastination by the client. Continuing care 
takes place, ideally, in all three domains— 
clinical treatment, clinical supports, and 
community supportive services. It addresses 
individual needs identified in a woman’s 
relapse prevention plan, and builds a 
supportive network for the woman and 
her family to encourage and reinforce her 
recovery. When possible, a mother’s schedule 
of continuing care services and her child’s 
prevention services should be coordinated 
in order to encourage maximum attendance 
by both mother and child. A variety of self-
help support programs can also promote the 
integration of the woman and her family into 
the community. 
Clinical treatment services for 
children 
• 	 Intake. Substance abuse treatment agencies 
able to serve children should establish 
criteria that encourage enrollment of children 
in the program. In providing children with 
developmentally appropriate services, the 
agency’s criteria might consider the child’s 
age, as well as the number of children who 
may be involved for each mother. The child’s 
safety and well-being, including bonding 
and attachment issues, are paramount and 
any threats to these must be evaluated and 
considered in the intake criteria. 
• 	 Screening. Screening of children is an 
important part of providing family-centered 
and family-supportive treatment. Screening 
of children should be done in a supportive 
and friendly environment conducive to open 
dialog. There are advantages to having the 
same person conduct the screening who might 
later perform an assessment. 
• 	 Assessment. Medical, developmental, 
psychological, and trauma history should 
be assessed for all children participating in 
treatment with their mothers. Particular 
attention should be paid to issues that 
require immediate attention, such as 
methamphetamine lab exposure and physical 
abuse or severe neglect. As with screening, 
the assessment environment should be 
supportive, friendly, and conducive to open 
dialog. Determinations must be made as 
early as possible and should be continuously 
reviewed as to whether the child needs 
education, prevention services, intervention, 
treatment, or a combination of these. 
The child’s own support system should be 
assessed, including the role that the child’s 
father and extended family plays (or could 
play) in the child’s life. 
• 	 Care planning. For children, care planning 
includes planning for education, prevention, 
and intervention services. Care planning 
should be conducted by professionals with 
particular experience in addressing the 
physical, psychological, and developmental 
needs of children whose mothers abuse 
alcohol and/or drugs. When age appropriate, 
it should include education about the 
treatment process that the mother will 
undergo and concerns about the transition 
that may be associated with that process. 
• 	 Residential care in residential settings. 
Providing safe and appropriate living space 
and adequate services for children whose 
mothers are in residential care is a powerful 
motivating factor for women to enter and 
continue in treatment. It enables children 
to either avoid separation or be reunited 
with the mother when treatment is made a 
condition of reunification by the courts. 
• 	 Case management. In addressing the 
service needs of children of mothers with 
substance use disorders, special attention 
should be paid to coordinating the child’s 
services with those of the mother. Active 
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involvement of the mother will aid in the 
transition from treatment program to home. 
Of critical importance to care for children 
are the dual concepts of personal safety 
and environmental stability. When children 
are not in their birth mothers’ custody, 
engagement of the foster or kin caregiver in 
care management is critical. 
• 	 Therapeutic child care. Children born to 
mothers who use substances are at high risk 
for poor developmental outcomes including 
neurological effects and alcohol-related 
spectrum disorders as well as consequences 
stemming from preterm delivery. Living with 
a parent with an addiction may also result 
in mental health issues for the children, 
particularly those associated with witnessing 
violence or separation from primary 
caregivers. Children with medical and mental 
health disabilities may need specialized 
child care provided by professionals with 
advanced training and in a setting where 
accommodations can be made to the physical 
environment that are responsive to these 
disabilities. 
• 	 Substance abuse education and prevention. 
Children whose mothers have substance use 
disorders need substance abuse education 
and prevention support at an early age, in 
part to correct their misconceptions of what 
is normal adult behavior. These programs 
should present information about the role 
of substances in the mother’s role in caring 
for her children and to put the mother’s 
treatment in the context of the child’s view of 
reality. 
• 	 Medical care and services. In addition to 
a need for primary health care, attention 
must be given to the possibility of organic 
damage resulting from prenatal or early 
childhood substance exposure. This includes 
the physiological damage of alcohol-related 
spectrum disorders and exposure to drug 
production such as methamphetamine. 
Medical assessments and subsequent care 
should be provided onsite when possible or 
by referral when necessary. The types of 
services that may be needed include neonatal 
and perinatal care; pediatric care; emergency 
and hospital care; and testing, treatment, 
and counseling for pediatric HIV/AIDS. 
• 	 Developmental services. Children who have 
been exposed to alcohol or drugs in utero or 
within their family environment may be at 
risk for physical and cognitive developmental 
delays. Physical, occupational, and speech 
therapy may be indicated for these children. 
Children experiencing developmental delays 
may also require behavior modifi cation 
support, tutoring, and medication that will 
need to be managed. 
• 	 Mental health and trauma services. 
Children who grow up in the care of adults 
with substance use disorders can suffer 
psychological distress resulting from the 
experience of neglect as well as emotional, 
physical, or sexual abuse. Some children 
have witnessed domestic or other acts of 
violence. Children of mothers with substance 
use disorders often benefit from psychological 
counseling and therapy and from having 
their own trauma issues addressed through 
individual and group modalities. 
Clinical Support Services 
Clinical support services assist women in making 
the transition to independent and healthy 
alcohol- and drug-free living. They introduce 
or stabilize the woman’s ability to care for 
herself and her family and to fulfill her role as 
a community and family member. For children, 
these services support healthy development and 
increase their capacity to reach their potential. 
Clinical support services for 
women 
• 	 Primary health care services. Primary 
health care services, which are often 
provided at the beginning of the treatment 
episode, are clinical support services (as 
opposed to medical interventions such as 
detoxification and related triage services 
considered clinical treatment services). These 
clinical support medical services include 
obstetric and gynecologic services, HIV/AIDS 
Appendix B: CSAT’s Comprehensive Substance Abuse Treatment Model 288 
counseling, general medical and dental care, 
nutrition counseling, eating behavior issues, 
family planning, reproductive health, health 
education, and physical and exercise therapy. 
Also critical to primary health care for 
women are medical self-awareness, personal 
hygiene, and self-advocacy for wellness. 
• Life skills. Life skills include all of the 
activities that support independent, healthy 
lifestyles. They include budgeting and 
banking; negotiating access to services such 
as housing, English as a second language, 
income support including access to TANF, 
food stamps, and Medicaid; navigating legal 
services and commitments; setting up and 
running a household; grooming and clothing; 
recreation and leisure; nutrition; using 
public transportation; and arranging for 
child care. 
• Parenting and child development education. 
Treatment for women with children is 
optimized and interaction between the 
mother and child is improved when the 
women’s role as a mother is acknowledged 
and incorporated throughout treatment. 
Parenting skills are improved through 
education about child development and 
caretaking, skill building, and addressing 
shame and guilt over past parenting 
activities. Mothers who are being reunited 
with children will need support in 
preparation for and after the reunion. 
Fathers can also be important contributors 
to the well-being of their children, and when 
possible, should receive the education and 
support necessary to prepare them for the 
responsibility of parenthood. 
• Family programs. The more psychologically 
and emotionally healthy a woman’s 
significant others are, the more likely they  
are to help her remain engaged in treatment 
and recovery. Significant others should be  
involved in understanding family members’ 
roles in the family and how those roles may 
have become maladaptive coping strategies 
while the woman was in active addiction. 
When significant others are directly involved  
in relapse prevention planning, they are 
more likely to become productively involved 
in supporting positive efforts at recovery 
and intervening on relapse warning signs. 
Family-centered programs address all 
members in the family and include efforts 
to improve relationships with signifi cant 
others, including partners, parents, siblings, 
children, and caretakers. These family 
interventions can be an important part of the 
woman’s preparation for long-term recovery. 
• Educational remediation and support. 
Educational deficiencies may be a  
consequence of a woman’s addiction or may 
be a significant contributor to her addiction.  
A lack of education is reflected in poor  
reading skills, conduct issues, illiteracy, 
special education needs, low family income, 
and psychological barriers associated with 
poor performance and low self-esteem. 
Cognitive impairments due to alcohol-related 
spectrum disorders and other congenital or 
biological origins may require signifi cant 
educational supports. Establishing linkages 
and/or services to address these educational 
issues may be signifi cant motivators 
for women to remain in treatment and 
provide hope for her to establish economic 
independence. 
• Employment readiness services. Given the 
relationship of meaningful employment to 
recovery success and societal pressures to 
move the unemployed to the workforce, 
employment readiness services are an 
essential element of treatment. These 
services include reading and numeric skills 
testing, literacy tutoring, GED classes, 
vocational assessments, pre-employment 
readiness training (soft skills), job referral, 
job retention services, and transitional 
employment placement. Treatment programs 
should establish as one of their goals the 
self-sufficiency of the client, seeking effective  
linkages with TANF and child welfare 
agencies. 
• Linkages with the legal and child welfare 
systems. Many women in treatment have 
conditions set by the child welfare system 
to maintain their parenting role or for 
reunification with children who may have  
been removed from the mother’s custody. 
These requirements often include reports 
that progress is being made toward treatment 
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goals, completion of parenting and anger 
management programs, supervised visits, 
drug testing, and court appearances. 
Communication among treatment providers, 
child welfare workers, the mother’s legal 
advocate, and the dependency court helps 
women move toward these goals. When 
mothers are also involved in the criminal 
justice system, linkages and communication 
with probation and parole staff are also 
critical. Criminal justice requirements may 
include drug testing, court appearances, and 
documentation regarding treatment progress 
toward goals. Often these communications 
require access to the community’s legal aid 
services. 
• 	 Housing support services. For women, 
particularly women with children, housing 
represents more than just shelter. It is a 
crucial support for recovery. It represents 
safety both for her and for her children. 
Thus, a comprehensive care provider must 
address the issue of where the woman will 
reside when she completes treatment and 
make the provision for adequate housing a 
part of the program’s continuum of care. 
Given the time involved in arranging for 
affordable, safe, drug-free housing, this 
service needs to be part of early planning. 
• 	 Advocacy. Women entering treatment 
often require advocates to assist them in 
negotiating the various systems they may 
need to interact with. Although direct 
advocacy services provide immediate access 
to remediation, the goal of this process is to 
transform women into empowered individuals 
who can effectively advocate for themselves 
and their families. 
• 	 Recovery community support services. 
Regardless of the treatment model or 
modality, women need to appreciate that they 
are not alone and that others have traveled 
the same road. It is critical for women to be 
supported in developing relationships with 
other women and persons in recovery who 
can be role models and provide support, 
friendships, and companionship in pursuing 
safe and sober leisure activities. Thus, early 
in the treatment process, providers must help 
women develop a gender-sensitive support 
network within the recovery community. 
• 	 Clinical support services for children 
• 	 Primary health care services. Primary 
health care services are an ongoing need 
for children of mothers with substance use 
disorders. Monitoring medical conditions 
should include screening for a range of 
potential medical complications including 
effects resulting from prenatal substance 
exposure and risks of HIV/AIDS and other 
communicable diseases. Primary health care 
services should also focus on wellness and 
prevention, including immunizations and 
regular medical examinations. 
• 	 Onsite or nearby child care. Developmentally 
appropriate, quality child care is needed 
for children whose mothers participate in 
treatment. Child care should be onsite or 
proximate to the program and should include 
a full range of services, from therapeutic 
child care to developmentally appropriate 
interventions and recreational play. 
• 	 Mental health and remediation services. 
Children whose mothers abuse alcohol and/ 
or drugs often have developmental delays 
that require specific interventions. These 
children may experience higher rates of 
attention deficit disorder, attention defi cit/ 
hyperactivity disorder, conduct disorder, 
speech and language delays, and learning 
disabilities. 
• 	 Prevention services. Children whose mothers 
have substance use disorders are at higher 
risk of developing a substance use disorder 
of their own as they enter preadolescence 
and adolescence. Evidence-based prevention 
services tailored to these children may be 
most appropriate when offered in the context 
of the parent’s own history and recovery. 
Prevention programs that have demonstrated 
their effectiveness with a range of child and 
adolescent populations can be found at http:// 
modelprograms.samhsa.gov. 
• 	 Recreational services. Participation in 
pleasurable recreational activities helps 
children socialize, express themselves, 
relax, experience new activities, and become 
knowledgeable about healthful alcohol- and 
drug-free leisure activities. Participation in 
developmentally appropriate recreational 
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activities is a critical learning experience for 
children. Participation in sports, hobbies, 
and creative outlets can also provide vehicles 
for enhanced self-image and self-esteem. 
• 	 Educational services. The needs of school-
age children, including attention to academic 
progress, are a necessary part of each child’s 
service plan. Often, children in treatment 
with their mothers experience disruption 
in their academic experience because of 
frequent moves or other family crises. 
Children who were prenatally exposed 
to substances may have ongoing learning 
disabilities that require advocacy to ensure 
special education services are available and 
to ensure children’s academic success. When 
regular reviews of individual education plans 
are needed, the treatment agencies must 
recognize the critical role that the mother 
may play in attending such sessions. 
• 	 Advocacy. Mothers with substance use 
disorders may not be effective advocates 
for their children. Programs may need to 
provide direct advocacy services as well as 
assist mothers in developing appropriate 
advocacy skills to ensure that they are able 
to negotiate for the needs of their children. 
Children, as well, should be introduced 
to advocacy skills when developmentally 
appropriate. 
• 	 Recovery community support services. 
Because of the significant impact of peers 
and role modeling on the development of 
children, there is a marked need for age-
appropriate recovery support activities. By 
building their own community of support, 
children can identify with peers and learn 
from those who have coped with similar 
experiences. 
Community Support 
Services 
Community support services are those services 
that extend beyond the treatment program and 
are found within the community. These services 
help to ensure that short-term treatment success 
can be sustained in long-term recovery. While 
there are additional services that women, 
children, and other family members may 
need in order to support the recovery of the 
family, those included below represent the 
more common services used by families as they 
progress in their recovery. 
• 	 Recovery management and recovery 
community support services. Community-
based recovery management services include 
activities that provide relapse prevention 
and continuing care. While these services 
may begin during treatment, they are part of 
the community-based network that supports 
recovery. Consistent with the importance of 
women’s personal relationships, women will 
benefit from the availability of peer-driven 
recovery mutual support services, which can 
include Alcoholics Anonymous, Narcotics 
Anonymous, and Women for Sobriety. 
• 	 Housing services. Adequate housing is 
essential both for safety and for security. 
While housing services are often placed 
within clinical support services, in the 
context used here, housing services are also 
a community infrastructure issue. In this 
context, housing which encourages alcohol-
and drug-free living can be a vital component 
for sustaining recovery. 
• 	 Family strengthening. Recognizing the family 
disruption that is common to addiction, 
women (particularly those who are heads of 
their households), need services that support 
the re-establishment of important family ties, 
including ongoing family therapy and family 
support services. 
• 	 Child care. This is both an immediate and 
short-term treatment support service as 
well as a broader community service. As a 
community support, quality preschool, child 
care, and after-school care programs are 
longer-term needs that enable mothers to 
work outside the home. 
• 	 Transportation . Accessible and reliable 
transportation is important given 
the complicated schedules of women 
caretakers who often have to balance the 
transportation needs of their children with 
the transportation needs of employment and 
ongoing participation in continuing care. 
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• 	 TANF linkages . With some exceptions, 
women from lower socioeconomic strata 
who progress through treatment are either 
TANF eligible or may become TANF eligible. 
TANF agencies have a role to play in 
providing support for recovery by serving 
as a bridge between the three circles of 
clinical treatment, with an emphasis on work 
preparation and sustaining employment for 
women going through the recovery process. 
• 	 Employer support services. Communities 
need to create systems within employment 
settings that support recovery and combat 
workplace substance abuse. Larger 
employers may offer employee assistance 
programs and smaller employers may be 
able to coordinate needed job support 
services with treatment providers from their 
communities. 
• 	 Vocational and academic education 
services. Critical to recovery success is the 
continuation of educational and vocational 
services that are begun during treatment. 
• 	 Faith-based organization support . 
Recognizing that spirituality plays a crucial 
role in the recovery process, it is important 
that connections are established by treatment 
providers with faith-based institutions 
that can serve as appropriate resources 
for addressing the spiritual issues related 
to addiction and recovery. Faith-based 
organizations can play an important role in 
the community and can connect families in a 
supportive community network. 
Funding Issues 
Finally, in response to the needs of providers 
to understand funding options for this array 
of services, this revision to the model allows 
providers to identify discrete elements of the 
comprehensive model and to make their own 
assessments of how to finance the elements 
through available funding streams. For some 
elements, funding will be readily available 
and sufficient to cover the full cost of services 
delivery. Other elements, such as continuing 
care and many of the services for children, are 
not as easily supported; providers will have to 
use more flexible funding to cover these services 
while they continue to communicate to funders 
that unfunded and underfunded components are 
critical elements in the comprehensive model of 
care. 
Providing comprehensive services through 
the separate agencies serving women and their 
children involves connecting the multiple 
funding streams that flow into the various 
health, human service, and educational agencies 
serving families. The more comprehensively 
a continuum of care is defined, the wider the 
array of funding streams that is needed. The 
more committed an agency is to family-centered 
services, the more mastery is needed of all the 
different funding streams that can support 
families. No single agency has adequate funding 
sources by itself to achieve comprehensive 
outcomes; interagency funding streams are 
therefore critical to converting hopes for new 
linkages into reality. 
Fiscal context always matters, and in tight fi scal 
climates, tapping new sources of funding is both 
desired and resisted. It is desired for the obvious 
reason that hard-pressed agencies are anxious 
to find alternative funding streams to support 
their programs; it is resisted for the equally 
obvious reason that agencies seek to protect 
their own funding streams even more when 
funding is tight. The descriptions of funding 
and suggestions that follow are made in full 
awareness that in most States, fi scal constraints 
are very significant factors at present. 
Several issues affect the ability of programs 
to provide the comprehensive services needed 
by women and children affected by substance 
use disorders. Some of these issues are based 
on the nature of the collaborative relationship 
between the agencies, some flow from categorical 
funding constraints, and some are based on 
other Federal or State policies. Understanding 
which of these barriers are affecting a State’s or 
community’s ability to provide comprehensive 
services is a critical first step in developing 
its response. These concerns may include the 
following: 
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• 	 Existing categorical definitions of funding 
streams and eligibility restrictions can create 
barriers to interagency efforts, with agency 
officials sometimes resistant to what seems 
like “one more earmark” on funding streams. 
• 	 Decisions by agencies to provide services 
directly or to negotiate for services with 
outside agencies are critical choices, but at 
times they may be made based on limited 
understanding of other agencies’ funding 
streams. 
• 	 Each system sees the other’s funding streams 
as mysterious and difficult to access, and 
each sees its own as overcommitted and 
possibly threatened, leading to a debate over 
“your money, our money, or their money.” 
• 	 A sustained, time-consuming effort is 
required to achieve new Federal, State, and 
local collaboration, which is needed to create 
financing responsive to the multiple needs of 
children and families. 
• 	 As the majority of funding fl ows through 
State-level government, State systems 
may need specific legislation to overcome 
categorical requirements. 
• 	 There are signifi cant fi nancial incentives 
to maintain the status quo in fragmented 
funding streams. 
• 	 Categorically funded programs that do not 
apply adequate “dosage” to ensure treatment 
effectiveness may require additional layers 
of funding from additional sources to get 
to scale and provide an adequate dosage of 
services. For example, programs that do not 
provide aftercare services to parents may be 
unable to respond to relapse issues, resulting 
in readmission to treatment that was 
underfunded but that ends up with a higher 
overall cost due to clients’ readmission. 
Unified Fiscal Planning 
The concept of unifi ed fiscal planning has 
been introduced recently. This approach 
includes a variety of strategies used by States 
and communities to create and sustain an 
integrated and flexible continuum of care for 
children and families (Crocker 2003). Some 
of the more commonly used strategies include 
decategorization, pooled funding, blended 
funding, braided funding, wraparound services, 
and refinancing. Often the terms are used 
interchangeably or without clear defi nition; 
however, the following are common defi nitions 
used for these concepts: 
• 	 Decategorization refers to State-level 
efforts to reduce or eliminate categorical 
requirements on how funds are spent. This 
reduction in requirements is often created in 
exchange for greater accountability for a set 
of negotiated outcomes. 
• 	 Pooled or blended funding is generally a 
local-level effort that is implemented among 
a group of agencies that formally integrates 
a set of funding streams into a single source 
of dollars. A new funding structure is often 
developed that administers and allocates the 
funds to the participating agencies based on 
negotiated contracts. 
• 	 Braided funding is generally implemented 
by an individual agency or program and 
refers to administrative efforts to obtain 
multiple funding sources to create more 
comprehensive services. This strategy 
typically works within the categorical 
system and administrative responsibilities 
for maintaining the various categorical 
requirements remain. 
• 	 Wraparound services. The term 
“wraparound” came into use in 1986, in an 
article by Lenore Behar, who defined it as a 
way to “surround multi-problem youngsters 
and families with services rather than with 
institutional walls, and to customize these 
services” (Behar 1986). The wraparound 
approach is more a process than a service, in 
which a child’s or family’s individual needs 
are addressed by the full range of services 
they need, with maximum fl exibility in 
funding. 
• 	 Refi nancing . “Refi nancing entails 
aggressively pursuing monies from uncapped 
Federal appropriations such as entitlement 
funds, using these new Federal funds to pay 
for standard services, and then applying 
the freed-up local and State funds to pay 
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 for alternative programs, including… 
comprehensive service initiatives” (Orland 
1995). 
Specifi c Treatment-Related 
Funding Streams 
While the Substance Abuse Prevention and 
Treatment Block Grant is still the largest source 
of publicly supported substance abuse treatment 
(approximately 40 percent), treatment providers 
should become familiar with the Medicaid-
reimbursable services in their States and learn 
how to bill for these services. Medicaid is a 
joint Federal–State entitlement program and 
the third largest source of health insurance in 
the country. It makes up approximately one 
quarter of public funds available for treatment. 
Medicaid coverage varies from State to State. 
Nearly all States restrict services when paying 
for alcohol and drug abuse treatment. The 
types of restrictions include low payment rates 
for treatment providers, restrictions on the 
settings for treatment, low limits on the days of 
inpatient treatment, low limits on the number 
of outpatient visits, and restrictions on types of 
providers that can be reimbursed (Legal Action 
Center 2002). 
The Medicaid codes published by the Centers 
for Medicare and Medicaid Services (CMS) are 
also known as the HCPCS codes (Health Care 
Financing Administration Common Procedure 
Coding System). With few exceptions, all of the 
services described here as clinical treatment 
services for women have applicable HCPCS 
codes. There are fewer applicable HCPCS codes 
for the clinical support services for women, 
and HCPCS codes do not apply to community 
support services. As noted earlier, the existence 
of a code does not necessarily mean that a State 
reimburses for a service (at any level). States are 
only responsible for a short list of mandatory 
services, whereas most services are optional 
reimbursable services. The CMS updates the 
HCPCS codes on an annual basis. Information 
on applicable alcohol, drug, and behavioral 
health HCPCS codes can be found on the Web 
site of the National Association of State Alcohol 
and Drug Abuse Directors (www.nasadad.org). 
In addition to the mandatory and optional 
Medicaid alcohol and drug benefi ts, Medicaid 
includes a benefit known as Early and Periodic 
Screening, Diagnostic, and Treatment (EPSDT) 
to cover both prevention and treatment services 
for children and adolescents under age 21. All 
children enrolled in Medicaid are entitled to 
EPSDT. “Under EPSDT, States must screen and 
then furnish appropriate medically necessary 
treatment to ‘correct or ameliorate defects 
and physical and mental illness and conditions 
discovered by the screening services’” (Legal 
Action Center 2002, p. 10). In practice, use of 
this resource has been limited by States’ ability 
to pay for the services. An additional source of 
funding for uninsured, low-income children is 
the State Children’s Health Insurance Program, 
which is allocated by block grant formula to the 
States. 
TANF can fund a range of nonmedical clinical 
treatment services as well as clinical and 
community support services for both women and 
children. The extent to which this is used varies 
greatly from State to State. Other additional 
valuable funding sources are available for 
many of the services described, although many 
are time-limited and/or specialized, increasing 
the time demands on the provider to seek and 
manage multiple funding streams. 
Closing Considerations 
In designing a comprehensive substance abuse 
treatment model for women and their children, 
CSAT is not attempting to articulate every 
element of treatment for this population. 
Rather, CSAT wishes to provide a standard 
or goal to which programs should aspire as 
they design and plan services that will be 
characterized as holistic, wraparound, and/or 
comprehensive. Additionally, it is not CSAT’s 
intention to see this model adopted without 
reference to the context of the community in 
which it is used. Thus, for the model to be truly 
comprehensive, it should be more than adopted; 
it should be adapted to its community and its 
consumers. 
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In adapting this model, different communities 
will emphasize different aspects. For example, 
the American Indian and Alaska Native 
communities have demonstrated the special role 
that spirituality, culture, and historical trauma 
play in treatment, and for these communities, 
a worthwhile adaptation requires an increased 
emphasis on these issues. For a community of 
older women, an emphasis on medication abuse 
may also be appropriate. 
This model embodies the best practices known 
to CSAT, as well as the agency’s experience in 
addressing this issue on a nationwide basis. 
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 Appendix C: Screening 
and Assessment 
Instruments 
Addiction Severity Index (ASI) 
Purpose: The ASI is most useful as a general intake screening tool. It 
effectively assesses a client’s status in several areas, and the composite 
score measures how a client’s need for treatment changes over time. 
Clinical utility: The ASI has been used extensively for treatment 
planning and outcome evaluation. Outcome evaluation packages for 
individual programs or for treatment systems are available. 
Groups with whom this instrument has been used: Designed for 
adults of both sexes who are not intoxicated (drugs or alcohol) when 
interviewed. 
Norms: The ASI has been used with males and females with drug and 
alcohol disorders in both inpatient and outpatient settings. Female 
version: ASI-F. 
Format: Structured interview 
Administration time: 50 minutes to 1 hour 
Scoring time: 5 minutes for severity rating 
Computer scoring? Yes 
Administrator training and qualifi cations: A self-training packet is 
available as is onsite training by experienced trainers. 
Available from:
A. Thomas McLellan, Ph.D. 
Building 7 
PVAMC 
University Avenue 
Philadelphia, PA 19104 
Ph: (800) 238-2433 
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Clinical Institute 
Withdrawal Assessment 
(CIWA-Ar) 
Purpose: To track severity of withdrawal and 
measure severity of alcohol withdrawal. 
Clinical utility: Aid to adjustment of care 
related to withdrawal severity. 
Groups with whom this instrument has been 
used: Adults 
Norms: N/A 
Format: A 10-item scale for clinical 
quantification of the severity of the alcohol 
withdrawal syndrome. 
Administration time: 2 minutes 
Scoring time: 4 to 5 minutes 
Computer scoring? No 
Administrator training and qualifi cations: 
Training is required, and the CIWA is 
administered by nurses, doctors, research 
associates/detoxification unit workers. 
Fee for use: No 
Available from:
Dr. E.M. Sellers 
Ventana Clinical Research Corporation 
340 College Street, Suite 400 
Toronto, Canada 
M5T 3A9 
Phone: 416-963-9338 
Fax: 416-963-9732 
www.ventana-crc.com/ 
Level of Care Utilization 
System (LOCUS) 
Purpose: To assess immediate service needs 
(e.g., for clients in crisis); to plan resource needs 
over time, as in assessing service requirements 
for defined populations; to monitor changes in 
status or placement at different points in time. 
Clinical utility: LOCUS is divided into three 
sections. The fi rst defines six evaluation 
parameters or dimensions: (1) Risk of Harm, 
(2) Functional Status, (3) Medical, Addictive, 
and Psychiatric Co-Morbidity, (4) Recovery 
Environment, (5) Treatment and Recovery 
History, and (6) Engagement. A fi ve-point scale 
is constructed for each dimension, and the 
criteria for assigning a given rating or score in 
that dimension are elaborated. In dimension 
IV, two subscales are defined, whereas all other 
dimensions contain only one scale. 
Groups with whom this instrument has been 
used: Adults 
Norms: N/A 
Format: A document that is divided into three 
sections. 
Administration time: 15 to 30 minutes 
Scoring time: 20 minutes 
Computer scoring? No 
Administrator training and qualifi cations: N/A 
Fee for use: No 
Available from: American Association of 
Community Psychiatrists 
www.wpic.pitt.edu/aacp/fi nd.html 
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Eating Attitudes Test (EAT-26) 
The following screening questionnaire is designed to help you determine if your eating behaviors and attitudes warrent further 
evaluation. The questionnaire is not intended to provide a diagnosis. Rather, it identifi es the presence of symptoms that are 
consistent with either a possible eating disorder. 
Answer thes as honestly as you can, and then score questions using the instructions at the end. 
Please mark a check to the right of each of 
the following statements: Always Usually Often 
Some­
times Rarely Never Score 
1. Am terrifi ed about being overweight.        
2. Avoid eating when I am hungry.        
3. Find myself preoccupied with food.        
4. Have gone on eating binges where I feel 
that I may not be able to stop. 
       
5 Cut my food into small pieces.        
6. Aware of the calorie content of foods that I 
eat. 
       
7. Particularly avoid food with a high        
carbohydrate content (i.e. bread, rice, 
potatoes, etc.) 
8. Feel that others would prefer If I ate more.        
9. Vomit after I have eaten.        
10. Feel extremely guilty after eating.        
11. Am preoccupied with a desire to be 
thinner. 
       
12. Think about burning up calories when I 
exercise. 
       
13. Other people think that I am too thin.        
14. Am preoccupied with the thought of 
having fat on my body. 
       
15. Take longer than others to eat my meals.        
16. Avoid foods with sugar in them.        
17. Eat diet foods        
18. Feel that food controls my life.        
19. Display self-control around food.        
20. Feel that others pressure me to eat.        
21. Give too much time and thought to food.        
22. Feel uncomfortable after eating  sweets.        
23. Engage in dieting behavior.        
24. Like my stomach to be empty.        
25. Have the impulse to vomit after meals.        
26. Enjoy trying new rich foods.       
Total Score = 
 
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Eating Attitudes Test (EAT-26) (continued)
 
A) Have you gone on eating binges where you feel that you may not be able to stop? __ No    Yes __    How many times in the last 
6 months? _______ 
B) Have you ever made yourself sick (vomited) to control your weight or shape? __ No    Yes __    How many times in the last 6 
months? _______ 
C) Have you ever used laxatives, diet pills or diuretics (water pills) to control your weight or shape? __ No   Yes __    How many 
times in the last 6 months? _______ 
D) Have you ever been treated for an eating disorder?   __ No   Yes __    When? _______ 
EAT-26’ David M. Garner (1982) Note: The EAT-26 has been made available with permission of the authors. 
Step 1: 
EAT-26 ITEM SCORING 
Score each item as indicated below and put score in box 
to the right of each item 
Items # 1-25: Item # 26 only: 
Always = 3 = 0 
Usually = 2 = 0 
Often = 1 = 0 
Sometimes = 0 = 1 
Step 2: Total EAT-26 Score 
Total = 
Add item scores together for a Total 
EAT-26 score: 
Step 3: Behavioral Questions 
Total = 
Did you score Yes on Questions A, B, 
C or D? 
Step 4: Underweight 
Determine if you are signifi cantly underweight according 
to the table to the right 
Step 5: Referral No Yes 
If your EAT-26 score is 20 or more 
or if you answered YES to any questions A-D 
or if your weight is below the number on 
the weight chart to the right 
Please discuss your results with your physician or 
therapist 
Signifi cantly Underweight According 
to Height 
(Body Mass Index of 18)* 
Height 
(inches) 
Weight 
(pounds) 
Height 
(inches) 
Weight 
(pounds) 
58 86 68 118 
58 88 68 120 
59 89 69 121 
59 90 69 124 
60 91 70 125 
60 93 70 127 
61 95 71 128 
61 96 71 131 
62 99 72 132 
62 100 72 134 
63 101 73 135 
63 103 73 138 
64 105 74 140 
64 106 74 141 
65 108 75 144 
65 109 75 146 
66 112 76 147 
66 113 76 149 
67 114 77 152 
67 117 77 154 
× 
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*Note: The table on the previous page indicates the body weights for heights considered to be “sig­
nificantly underweight” according to a Body Mass Index (BMI) of 18.  BMI is a simple method of 
evaluating body weight taking height into consideration. It applies to both men and women. There 
is some controversy regarding whether or not BMI is the best method of determining relative body 
weight and it is important to recognize that it is possible for someone to be quite malnourished 
even though they are above the weight listed in the table. In order to determine if you are “signifi ­
cantly underweight”, locate your height (without shoes) on the table and see if the corresponding 
body weight (in light indoor clothing) is below that listed. If so, you are considered “signifi cantly 
underweight” and should speak to your physician or therapist about your weight. To Calculate 
Body Mass Index (BMI) exactly; Weight (pounds) Divided by Height in Inches; Divide this again 
by Height in Inches and Multiply by 703 
BMI = (lbs) ÷ (inches) ÷ (inches) × 703 
Spiritual Well-Being Scale 
(SWBS) 
Purpose: A general indicator of well-being 
that may be used for the assessment of both 
individual and group spiritual well-being. It 
provides an overall measure of the perception 
of spiritual quality of life, as well as subscale 
scores for Religious and Existential Well-Being. 
The Religious Well-Being subscale provides a 
self-assessment of one’s relationship with God, 
while the Existential Well-Being Subscale gives a 
self-assessment of one’s sense of life purpose and 
life satisfaction. 
Clinical utility: The SWBS is composed of 20 
items, 10 of which assess religious well-being 
specifically, and 10 of which assess existential 
well-being. 
Groups with whom this instrument has been 
used: Adults and children 
Norms: Yes 
Format: The SWBS is a paper-pencil instrument 
currently available in English and Spanish. 
Administration time: 10-15 minutes 
Scoring time: Information not available 
Computer scoring?  Information not available 
Administrator training and qualifi cations: 
Information not available 
Fee for use: Yes 
Available from: 
Life Advance, Inc. 
81 Front Street 
Nyak, NY 10960 
Lifeadvance.com 
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 Drinker Inventory of Consequences (DrInC-2L) 
Instructions: Here are a number of events that drinkers sometimes experience. Read each one 
carefully, and circle the number that indicates whether this has EVER happened to you (0 = No, 1 = 
Yes). If an item does not apply to you, circle zero (0). 
Has this EVER happened to you? No Yes 
1. I have had a hangover or felt bad after drinking. 0 1 
2. I have felt bad about myself because of my drinking. 0 1 
3. I have missed days of work or school because of my drinking. 0 1 
4. My family or friends have worried or complained about my drinking. 0 1 
5. I have enjoyed the taste of beer, wine, or liquor. 0 1 
6. The quality of my work has suffered because of my drinking. 0 1 
7. My ability to be a good parent has been harmed by my drinking. 0 1 
8. After drinking, I have had trouble with sleeping, staying asleep, or
 nightmares. 
0 1 
9. I have driven a motor vehicle after having three or more drinks. 0 1 
10. My drinking has caused me to use other drugs more. 0 1 
11. I have been sick and vomited after drinking. 0 1 
12. I have been unhappy because of my drinking. 0 1 
13. Because of my drinking, I have not eaten properly. 0 1 
14. I have failed to do what is expected of me because of my drinking. 0 1 
15. Drinking has helped me to relax. 0 1 
16. I have felt guilty or ashamed because of my drinking. 0 1 
Has this EVER happened to you? No Yes 
17. While drinking I have said or done embarrassing things. 0 1 
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18. When drinking, my personality has changed for the worse. 0 1 
19. I have taken foolish risks when I have been drinking. 0 1 
20. I have gotten into trouble because of drinking. 0 1 
21. While drinking or using drugs, I have said harsh or cruel things to 
someone. 
0 1 
22. When drinking, I have done impulsive things that I regretted later. 0 1 
23. I have gotten into a physical fight while drinking. 0 1 
24. My physical health has been harmed by my drinking. 0 1 
25. Drinking has helped me to have a more positive outlook on life. 0 1 
26. I have had money problems because of my drinking. 0 1 
27. My marriage or love relationship has been harmed by my drinking. 0 1 
28. I have smoked tobacco more when I am drinking. 0 1 
29. My physical appearance has been harmed by my drinking. 0 1 
30. My family has been hurt by my drinking. 0 1 
31. A friendship or close relationship has been damaged by my drink­
ing. 
0 1 
32. I have been overweight because of my drinking. 0 1 
33. My sex life has suffered because of my drinking. 0 1 
34. I have lost interest in activities and hobbies because of my drinking. 0 1 
35. When drinking, my social life has been more enjoyable. 0 1 
36. My spiritual or moral life has been harmed by my drinking. 0 1 
37. Because of my drinking, I have not had the kind of life that I want. 0 1 
Has this EVER happened to you? No Yes 
38. My drinking has gotten in the way of my growth as a person. 0 1 
39. My drinking has damaged my social life, popularity, or reputation. 0 1 
40. I have spent too much or lost a lot of money because of my drink­
ing. 
0 1 
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41. I have been arrested for driving under the influence of alcohol. 0 1 
42. I have had trouble with the law (other than driving while intoxi­
cated) because of my drinking. 
0 1 
43. I have lost a marriage or a close love relationship because of my 
drinking. 
0 1 
44. I have been suspended/fired from or left a job or school because of 
my drinking. 
0 1 
45. I drank alcohol normally, without any problems. 0 1 
46. I have lost a friend because of my drinking. 0 1 
47. I have had an accident while drinking or intoxicated. 0 1 
48. While drinking or intoxicated, I have been physically hurt, injured, 
or burned. 
0 1 
49. While drinking or intoxicated, I have injured someone else. 0 1 
50. I have broken things while drinking or intoxicated. 0 1 
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Appendix E: 
DSM-IV-TR Criteria for 
Posttraumatic Stress 
Disorder 
A. 	 The person has been exposed to a traumatic event in which both of 
the following were present: 
(1) 	 The person experienced, witnessed, or was confronted with 
an event or events that involved actual or threatened death or 
serious injury, or a threat to the physical integrity of self or 
others. 
(2) 	 The person’s response involved intense fear, helplessness, or 
horror. Note: In children, this may be expressed instead by 
disorganized or agitated behavior. 
B. 	 The traumatic event is persistently reexperienced in one (or more) 
of the following ways: 
(3) 	 Recurrent and intrusive distressing recollections of the event, 
including images, thoughts, or perceptions. Note: In young 
children, repetitive play may occur in which themes or aspects 
of the trauma are expressed. 
(4) 	 Recurrent distressing dreams of the event. Note: In children, 
there may be frightening dreams without recognizable content. 
(5) 	 Acting or feeling as if the traumatic event were recurring 
(includes a sense of reliving the experience; illusions, 
hallucinations, and dissociative flashback episodes, including 
those that occur on awakening or when intoxicated). Note: In 
young children, trauma-specific reenactment may occur. 
(6) 	 Intense psychological distress at exposure to internal or 
external cues that symbolize or resemble an aspect of the 
traumatic event. 
(7) 	 Physiological reactivity on exposure to internal or external 
cues that symbolize or resemble an aspect of the traumatic 
event. 
C. 	 Persistent avoidance of stimuli associated with the trauma and 
numbing of general responsiveness (not present before the trauma), 
as indicated by three (or more) of the following: 
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(8) 	 Efforts to avoid thoughts, feelings, 
or conversations associated with the 
trauma 
(9) 	 Efforts to avoid activities, places, or 
people that arouse recollections of the 
trauma 
(10) Inability to recall an important aspect 
of the trauma 
(11) Markedly diminished interest or 
participation in signifi cant activities 
(12) Feeling of detachment or estrangement 
from others 
(13) Restricted range of affect (e.g., unable 
to have loving feelings) 
(14) Sense of a foreshortened future (e.g., 
does not expect to have a career, 
marriage, children, or a normal 
lifespan) 
D. 	 Persistent symptoms of increased arousal 
(not present before the trauma), as 
indicated by two (or more) of the following: 
(1) Difficulty falling or staying asleep 
((2) Irritability or outbursts of anger 
(3) 	Diffi culty concentrating 
(4) 	Hypervigilance 
(5) 	 Exaggerated startle response 
E. 	 Duration of the disturbance (symptoms in 
Criteria B, C, and D) is more than 1 month. 
F.	 The disturbance causes clinically 
significant distress or impairment in social, 
occupational, or other important areas of 
functioning. 
Specify if: 
Acute: if duration of symptoms is less than 3 
months 
Chronic: if duration of symptoms is 3 months or 
more 
Specify if: 
With Delayed Onset: if onset of symptoms is at 
least 6 months after the stressor. 
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 Appendix F: Integration 
Self-Assessment for 
Providers 
The Women Embracing Life and Living (WELL) Toolkit is designed to 
help organizations develop plans to improve the quality of care offered to 
women with co-occurring substance abuse and mental health diffi culties 
and histories of experiencing violence. The toolkit includes 
• 	 Instructions for using the WELL Toolkit 
• 	 Principles for the Trauma-Informed Treatment of Women with Co­
occurring Mental Health and Substance Abuse Disorders (WELL 
Project 1999) 
• 	 Self-Assessment for Providers 
• 	 Organizational Self-Assessment 
• 	 WELL Planning Tool 
• 	 Example of the use of the WELL Planning Tool 
The assessment instruments can be used to take an initial measure 
of an organization’s strengths and weaknesses, and to track progress 
in moving in the desired direction. Organizations that provide direct 
services to families should use the Self-Assessment for Providers, 
while State agencies and funding or regulatory agencies should use the 
Organizational/Agency Self-Assessment. The information from the Self-
Assessment can be used in conjunction with the Planning Tool to develop 
concrete plans to strengthen quality of service in particular areas. 
There are many ways of using the Self-Assessment for Providers, 
depending on the priorities of the organization. The general approach is 
to 
1. Look at one subscale at a time. 
2. List the items on which you are not satisfied with your scores. 
3. Prioritize them in terms of importance to your agency. 
4. Choose a certain target number of items. 
5. Develop remedies, steps, and timelines for those items. 
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An organization can prioritize the subscales and 
work on only one at a time, or can select items 
from a number of subscales and then prioritize 
the items, without reference to subscale. It is a 
good idea to re-administer the assessment tool 
on a yearly basis in order to track progress. This 
assessment should be done for each program 
administered by your organization. Following is 
the Self-Assessment for Providers. 
Items to be scored on the following Likert Scale: 
1. Rarely 2. Occasionally 3. Sometimes 
4. Often 5. Consistently 
Integration—General 
1. 	 ___ Staff is knowledgeable about the way 
trauma, substance abuse, and mental illness 
interact. 
2. 	 ___ Consumers are provided with psycho-
education about the ways in which trauma, 
substance abuse, and mental illness interact. 
3. 	 ___ Service plans address substance abuse, 
mental illness, and trauma when appropri­
ate. 
4. 	 ___ Case management is available which 
integrates substance abuse, mental health, 
and violence/trauma services. 
5. 	 ___ Multidisciplinary teams can be consulted 
to address service plan diffi culties. 
6. 	 ___ Policies and procedures encourage 
direct care providers to have regular contact 
(with consent of the consumer) with other 
service providers who serve the same client. 
6. 	 ___ Aftercare plans address substance 
abuse, mental illness, and trauma. 
7. 	 ___ The program appropriately supports 
direct care staff in participating in supervi­
sion and obtaining training. 
            ___Total 
Trauma Integrated Into 
Other Services 
7. 	 ___ Staff is knowledgeable about symptoms 
of trauma. 
8. 	 ___ Staff is knowledgeable about domestic 
violence. 
9. 	 ___ Staff is knowledgeable about the risk for 
retraumatization of victims of violence by 
staff and peers. 
10. ___ Staff is knowledgeable about vicarious 
traumatization and self-care. 
11. ___ Staff is knowledgeable of nonviolent de-
escalation techniques. 
12. ___ Consumers are assessed regarding their 
history of experiencing violence. 
13. ___ Consumers are assessed regarding their 
current safety from perpetrators. 
14. ___ Consumers are assessed regarding the 
safety of their current living situation. 
15. ___ Psychoeducation is provided for con­
sumers about domestic violence. 
16. ___ Psychoeducation is provided for con­
sumers about the symptoms of trauma. 
17. ___ Psychoeducation is provided for con­
sumers regarding skills for dealing with 
trauma symptoms such as grounding and 
self-soothing. 
18. ___ Consumers have access to services for 
healing from trauma. 
19. ___ Consumers have access to safety plan­
ning. 
20. ___ Consumers have access to legal services. 
21. ___ Crisis Prevention Plans are developed 
in which consumers and providers agree 
regarding what to do if the behavior of the 
consumer begins to escalate. 
22. ___ Advanced Directives are developed 
regarding what consumers would like pro­
viders to do in the event of a crisis (i.e., 
who should be notified, where she might be 
transferred if necessary). 
23. ___ Physical restraints are used only as an 
extreme exception and last resort in ac­
cordance with the recommendations of the 
report of the Massachusetts Department of 
Mental Health task force on the restraint 
and seclusion of persons who have been 
physically or sexually abused. 
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24. ___ Consumers are instructed in procedures 
for maintaining each other’s confi dentiality 
in order to maintain safety. 
25. ___ Procedures are in place to protect both 
staff and clients if a perpetrator attempts to 
enter. 
26. ___ A “quick response” agreement is in 
place with local law enforcement should a 
perpetrator attempt to enter the program. 
27. ___ Procedures are in place (which protect 
the confidentiality of current consumers) 
for screening new admissions to determine 
whether they are victimizers of current con­
sumers. 
28. ___ A policy is in place to deny admission to 
the victimizers of a current consumer and 
refer elsewhere (including certifi ed batterers 
intervention). 
29. ___ Procedures are in place to assist a con­
sumer in accessing a corresponding level of 
care in another community if it is not safe 
for her to use the services in her local area. 
30. ___ Consumers are helped to grieve the loss 
of family when it is necessary in order to 
maintain safety. 
31. ___ There is no arbitrary exclusion based on 
domestic violence. 
32. ___ Linkages exist with domestic violence 
providers for referral purposes. 
33. ___ Linkages exist with domestic violence 
providers for consultation purposes.
 ___Total 
Substance Abuse 
Treatment Integrated Into 
Other Services 
34.___ Staff has basic knowledge about sub­
stance abuse. 
35.___ Psychoeducation is provided for consum­
ers about substance abuse. 
36.___ Consumers are assessed for substance 
abuse. 
37.___ Linkages exist with substance abuse pro­
viders for referral purposes. 
38.___ Linkages exist with methadone providers 
for referral purposes. 
39.___ Linkages exist with substance abuse pro­
viders for consultation purposes. 
40.___ Consumers can participate in the pro­
gram if they are on methadone. 
41.___ There is no arbitrary exclusion based on 
substance abuse. ___Total 
Mental Health Integrated 
Into Other Services 
42.___ Staff has basic knowledge about mental 
disorders. 
43.___ Consumers are assessed for mental 
health problems. 
44.___ Linkages exist with mental health provid­
ers for referral purposes. 
45.___ Linkages exist with mental health provid­
ers for consultation purposes. 
46.___ Staff has basic knowledge about common 
side effects of psychotropic medications. 
47.___ Psychoeducation is provided for consum­
ers regarding mental disorders. 
48.___ Policies are in place and provided for 
consumers regarding what to do if a consum­
er decompensates psychiatrically. 
49.___ Referrals are made for psychotropic 
medication evaluation and monitoring. 
50.___ Consumers can participate in the pro­
gram if they are taking psychotropic medica­
tion. 
51.___ There is no arbitrary exclusion based on 
mental health diagnosis or symptoms.
 ___Total 
Empowerment 
52.___ Staff is knowledgeable about informed 
consent and confi dentiality. 
53.___ Staff is knowledgeable about stigmas. 
54.___ Staff has received training in empower­
ment-based treatment. 
55.___ Intake assessments include the strengths 
of consumers. 
56.___ Consumers are given choices regarding 
which services they access. 
57.___ Consumers may change individual pro­
viders of services if they are not satisfi ed. 
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58.___ Service plans are individualized. 
59.___ Advanced Directives are developed in 
which consumers indicate what they would 
like providers to do in the event of a crisis 
(i.e., whom to notify, where she would like to 
be transferred to). 
60.___ The program meets the Federal guide­
lines for confidentiality that apply to sub­
stance abuse. 
61.___ The program meets State confi dential­
ity statutes regarding domestic violence and 
substance abuse counselors. 
62.___ Limits on confidentiality, how records 
are kept, who has access to information, and 
how information could be used to the con­
sumer’s detriment are carefully explained to 
consumers before information is collected. 
63.___ All discussions of consumer information 
are done in private settings. 
64.___ Policies and procedures are in place for 
collecting information from diverse groups 
of consumers about quality of services and 
for incorporating that feedback into service 
planning. 
65.___ Staff and Board members across the 
hierarchy of positions include signifi cant 
numbers of diverse consumers. 
66.___ There is appropriate support for con­
sumers moving into a professional role, such 
as peer leadership training, mentoring, and 
opportunities to function in an advocacy 
role. 
67.___ All consumers have access to peer sup­
port.
 ___Total 
Gender Specifi c 
68.___ Staff is knowledgeable about the specifi c 
needs of women. 
69.___ Gender-specific services are provided. 
70.___ Female consumers can work with female 
providers if that is their preference. 
71.___ Female role models in positions of leader­
ship are available.
 ___Total 
Family Focus 
72.___ Psychoeducation is provided for consum­
ers on the intergenerational transmission of 
substance abuse, mental illness, and vio­
lence. 
73.___ When a consumer requests services, 
information is collected regarding her chil­
dren. 
74.___ When a consumer requests services, 
information is collected regarding her chil­
dren’s need for services. 
75.___ There is a means in place for screening 
children of consumers regarding their need 
for services. 
76.___ Linkages are in place for helping a con­
sumer obtain appropriate services for her 
children. 
77.___ Linkages are in place for helping a con­
sumer obtain appropriate services for other 
family members. 
78.___ In a residential program, there is some­
one who can assist a consumer in arrang­
ing for education of children while she is a 
resident. 
79.___ The program provides a level of parent­
ing education that is appropriate to the level 
of care (a minimal level being assistance and 
education regarding communication with 
children about substance abuse, mental ill­
ness, and violence). 
80.___ Child care is provided or there is some­
one who can help a consumer arrange child 
care that may be necessary for a consumer 
to receive services. 
81.___ Education is provided for a consumer’s 
family (as defined by the consumer) or sup­
port system (excluding unsafe relationships). 
Appendix F: Integration Self- Assessment for Providers 316 
  
  
82.___ Providers work with consumers in 
advance to develop plans for their children 
that would be followed in the event that the 
consumer must be transferred to a more 
acute level of care.
 ___Total 
Cultural Competence 
83.___ Staff is knowledgeable about cultural 
competence. 
84.___ Staff is knowledgeable about the cultures 
represented by the consumers served. 
85.___ Information is collected regarding a con­
sumer’s primary language at intake. 
86.___ Information is collected regarding a 
consumer’s sexual orientation and identity 
at intake. 
87.___ When a consumer requests services, in­
formation is collected regarding her cultural/ 
ethnic/racial identity. 
88.___ Differences, including those attributable 
to class, income, culture, race, ethnicity, 
disability, language, sexual orientation, re­
ligion, and age are incorporated into service 
planning. 
89.___ Language in all intake and training mate­
rials is gender neutral and nonviolent. 
90.___ Services are available in all languages 
that are the first language of a large number 
of the population served. 
91.___ Professional translators are provided 
when necessary, rather than using persons 
with a personal relationship with the con­
sumer. 
92.___ Policies and resources are in place for re­
ferring to or obtaining services for consum­
ers who speak languages other than those in 
which the program provides services. 
93.___ There are staff members with the same 
cultural, racial, and ethnic backgrounds as 
the consumers being served. 
94.___ Policies are in place that state that rac­
ism, sexism, homophobia, ageism, and other 
forms of hatred will not be tolerated.
 ___Total 
Holistic 
95.___ Information is collected regarding a con­
sumer’s current support system at intake. 
96.___ Information is collected regarding a con­
sumer’s medical status at intake. 
97.___ Information is collected regarding a con­
sumer’s legal status at intake. 
98.___ Information is collected regarding a con­
sumer’s housing status at intake. 
99.___ Information is collected regarding a con­
sumer’s financial status at intake. 
100.___ Psychoeducation is provided for con­
sumers regarding sexually transmitted diseases/ 
HIV/AIDS/Hepatitis C. 
___Total 
Total scores: 
# of 1s—Rarely ___ 
# of 2s—Occasionally ___ 
# of 3s—Sometimes ___ 
# of 4s—Often ___ 
# of 5s—Consistently ___ 
Source: WELL Project, Institute for Health and 
Recovery 2002. For more information about 
the toolkit contact The Institute for Health and 
Recovery, (617) 661-3991, or 
http://www.healthrecovery.org. 
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CSAT TIPs and Publications Based on TIPs 
What Is a TIP? 
Treatment Improvement Protocols (TIPs) are the products of a systematic and innovative process that brings together clinicians, research­
ers, program managers, policymakers, and other Federal and non-Federal experts to reach consensus on state-of-the-art treatment practic­
es. TIPs are developed under CSAT’s Knowledge Application Program to improve the treatment capabilities of the Nation’s alcohol and drug 
abuse treatment service system. 
What Is a Quick Guide? 
A Quick Guide clearly and concisely presents the primary information from a TIP in a pocket-sized booklet. Each Quick Guide is divided 
into sections to help readers quickly locate relevant material. Some contain glossaries of terms or lists of resources. Page numbers from the 
original TIP are referenced so providers can refer back to the source document for more information. 
What Are KAP Keys? 
Also based on TIPs, KAP Keys are handy, durable tools. Keys may include assessment or screening instruments, checklists, and summaries 
of treatment phases. Printed on coated paper, each KAP Keys set is fastened together with a key ring and can be kept within a treatment 
provider’s reach and consulted frequently. The Keys allow you—the busy clinician or program administrator—to locate information easily 
and to use this information to enhance treatment services. 
TIP 1 	 State Methadone Treatment Guidelines—Replaced by 
TIP 43 
TIP 2* Pregnant, Substance-Using Women— BKD107 
Quick Guide for Clinicians QGCT02 
KAP Keys for Clinicians KAPT02 
TIP 3 	 Screening and Assessment of Alcohol- and Other Drug-
Abusing Adolescents—Replaced by TIP 31 
TIP 4 	 Guidelines for the Treatment of Alcohol- and Other 
Drug-Abusing Adolescents—Replaced by TIP 32 
TIP 5 	 Improving Treatment for Drug-Exposed Infants— 
BKD110 
TIP 6* Screening for Infectious Diseases Among Substance 
Abusers—BKD131 
Quick Guide for Clinicians QGCT06 
 KAP Keys for Clinicians KAPT06 
TIP 7 	 Screening and Assessment for Alcohol and Other Drug 
Abuse Among Adults in the Criminal Justice System— 
Replaced by TIP 44 
TIP 8 	 Intensive Outpatient Treatment for Alcohol and Other 
Drug Abuse—Replaced by TIPs 46 and 47 
TIP 9 	 Assessment and Treatment of Patients With Coexisting 
Mental Illness and Alcohol and Other Drug Abuse— 
Replaced by TIP 42 
TIP 10 Assessment and Treatment of Cocaine-Abusing Metha­
done-Maintained Patients—Replaced by TIP 43 
TIP 11* Simple Screening Instruments for Outreach for 
Alcohol and Other Drug Abuse and Infectious 
Diseases— BKD143 
Quick Guide for Clinicians QGCT11
 
KAP Keys for Clinicians KAPT11
 
TIP 12 Combining Substance Abuse Treatment With Inter­
mediate Sanctions for Adults in the Criminal Justice 
System—Replaced by TIP 44 
TIP 13 Role and Current Status of Patient Placement Criteria 
in the Treatment of Substance Use Disorders—BKD161 
Quick Guide for Clinicians QGCT13 
Quick Guide for Administrators QGAT13 
KAP Keys for Clinicians KAPT13 
TIP 14 Developing State Outcomes Monitoring Systems for 
Alcohol and Other Drug Abuse Treatment—BKD162 
TIP 15 Treatment for HIV-Infected Alcohol and Other Drug 
Abusers—Replaced by TIP 37 
TIP 16 Alcohol and Other Drug Screening of Hospitalized 
Trauma Patients—BKD164 
Quick Guide for Clinicians QGCT16 
KAP Keys for Clinicians KAPT16 
TIP 17 Planning for Alcohol and Other Drug Abuse Treatment 
for Adults in the Criminal Justice System—Replaced by 
TIP 44 
TIP 18 The Tuberculosis Epidemic: Legal and Ethical Issues for 
Alcohol and Other Drug Abuse Treatment Providers— 
BKD173
 
Quick Guide for Clinicians QGCT18
 
KAP Keys for Clinicians KAPT18
 
TIP 19 Detoxification From Alcohol and Other Drugs—Re­
placed by TIP 45 
TIP 20 Matching Treatment to Patient Needs in Opioid Substi­
tution Therapy—Replaced by TIP 43 
*Under revision 
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TIP 21 	Combining Alcohol and Other Drug Abuse Treatment 
With Diversion for Juveniles in the Justice System— 
(SMA) 08-4073 
Quick Guide for Clinicians and Administrators 
QGCA21 
TIP 22 LAAM in the Treatment of Opiate Addiction—Replaced 
by TIP 43 
TIP 23 Treatment Drug Courts: Integrating Substance Abuse 
Treatment With Legal Case Processing— 
(SMA) 08-3917 
Quick Guide for Administrators QGAT23 
TIP 24 A Guide to Substance Abuse Services for Primary Care 
Clinicians—(SMA) 08-4075 
Concise Desk Reference Guide BKD123 
Quick Guide for Clinicians QGCT24 
KAP Keys for Clinicians KAPT24 
TIP 25 Substance Abuse Treatment and Domestic Violence— 
(SMA) 08-4076 
Linking Substance Abuse Treatment and Domestic Vio­
lence Services: A Guide for Treatment Providers MS668 
Linking Substance Abuse Treatment and Domestic Vio­
lence Services: A Guide for Administrators MS667 
Quick Guide for Clinicians QGCT25
 
KAP Keys for Clinicians KAPT25
 
TIP 26 Substance Abuse Among Older Adults—(SMA) 08-3918 
Substance Abuse Among Older Adults: A Guide for 
Treatment Providers MS669 
Substance Abuse Among Older Adults: A Guide for 
Social Service Providers MS670 
Substance Abuse Among Older Adults: Physician’s Guide 
MS671
 
Quick Guide for Clinicians QGCT26
 
KAP Keys for Clinicians KAPT26
 
TIP 27 Comprehensive Case Management for Substance Abuse 
Treatment—(SMA) 08-4215 
Case Management for Substance Abuse Treatment: A 
Guide for Treatment Providers MS673 
Case Management for Substance Abuse Treatment: A 
Guide for Administrators MS672 
Quick Guide for Clinicians QGCT27 
Quick Guide for Administrators QGAT27 
TIP 28* Naltrexone and Alcoholism Treatment—(SMA) 05-4077 
Naltrexone and Alcoholism Treatment: Physician’s 
Guide MS674 
Quick Guide for Clinicians QGCT28 
KAP Keys for Clinicians KAPT28 
TIP 29 Substance Use Disorder Treatment for People With 
Physical and Cognitive Disabilities—(SMA) 08-4078 
Quick Guide for Clinicians QGCT29 
Quick Guide for Administrators (SMA) 08-3592 
KAP Keys for Clinicians KAPT29 
TIP 30 Continuity of Offender Treatment for Substance Use 
Disorders From Institution to Community— 
(SMA) 08-3920 
Quick Guide for Clinicians QGCT30
 
KAP Keys for Clinicians KAPT30
 
TIP 31 Screening and Assessing Adolescents for Substance Use 
Disorders—(SMA) 08-4079 
See companion products for TIP 32. 
TIP 32 Treatment of Adolescents With Substance Use Disor­
ders—(SMA) 08-4080 
Quick Guide for Clinicians QGC312 
KAP Keys for Clinicians KAP312 
TIP 33 Treatment for Stimulant Use Disorders—(SMA) 06-4209 
Quick Guide for Clinicians QGCT33 
KAP Keys for Clinicians KAPT33 
TIP 34 Brief Interventions and Brief Therapies for Substance 
Abuse—(SMA) 07-3952 
Quick Guide for Clinicians QGCT34 
KAP Keys for Clinicians KAPT34 
TIP 35 Enhancing Motivation for Change in Substance Abuse 
Treatment—(SMA) 08-4212 
Quick Guide for Clinicians QGCT35 
KAP Keys for Clinicians KAPT35 
TIP 36 Substance Abuse Treatment for Persons With Child 
Abuse and Neglect Issues—(SMA) 08-3923 
Quick Guide for Clinicians QGCT36 
KAP Keys for Clinicians KAPT36 
Helping Yourself Heal: A Recovering Woman’s Guide to 
Coping With Childhood Abuse Issues—(SMA) 08-4132 
Available in Spanish: PHD981S 
Helping Yourself Heal: A Recovering Man’s Guide to 
Coping With the Effects of Childhood Abuse— 
(SMA) 08-4134 
Available in Spanish: PHD1059S 
TIP 37 Substance Abuse Treatment for Persons With HIV/ 
AIDS—(SMA) 08-4137 
Quick Guide for Clinicians MS678 
KAP Keys for Clinicians KAPT37 
Drugs, Alcohol, and HIV/AIDS: A Consumer Guide— 
(SMA) 08-4127 
Drugs, Alcohol, and HIV/AIDS: A Consumer Guide for 
African Americans—(SMA) 07-4248 
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TIP 38 Integrating Substance Abuse Treatment and Vocational 

Services—(SMA) 06-4216
 
Quick Guide for Clinicians QGCT38
 
Quick Guide for Administrators QGAT38
 
KAP Keys for Clinicians KAPT38
 
TIP 39 Substance Abuse Treatment and Family Therapy— 
(SMA) 08-4219
 
Quick Guide for Clinicians QGCT39
 
Quick Guide for Administrators QGAT39
 
TIP 40 Clinical Guidelines for the Use of Buprenorphine in the 

Treatment of Opioid Addiction—(SMA) 07-3939
 
Quick Guide for Physicians QGPT40
 
KAP Keys for Physicians KAPT40
 
TIP 41 Substance Abuse Treatment: Group Therapy—(SMA) 

05-3991
 
Quick Guide for Clinicians QGCT41
 
TIP 42 Substance Abuse Treatment for Persons With Co-Occur­
ring Disorders—(SMA) 08-3992
 
Quick Guide for Clinicians (SMA) 07-4034
 
Quick Guide for Administrators QGAT42
 
KAP Keys for Clinicians (SMA) 08-4036
 
TIP 43 Medication-Assisted Treatment for Opioid Addiction in 

Opioid Treatment Programs—(SMA) 08-4214
 
Quick Guide for Clinicians QGCT43

KAP Keys for Clinicians (SMA) 07-4108
 
TIP 44 Substance Abuse Treatment for Adults in the Criminal 

Justice System—(SMA) 05-4056
 
Quick Guide for Clinicians QGCT44

KAP Keys for Clinicians (SMA) 07-4150
 
TIP 45 Detoxification and Substance Abuse Treatment—(SMA) 

08-4131
 
Quick Guide for Clinicians (SMA) 06-4225

KAP Keys for Clinicians (SMA) 06-4224
 
Quick Guide for Administrators (SMA) 06-4226
 
TIP 46 Substance Abuse: Administrative Issues in Outpatient 

Treatment—(SMA) 06-4157
 
Quick Guide for Administrators—(SMA) 07-4232
 
TIP 47 Substance Abuse: Clinical Issues in Outpatient Treat­
ment—(SMA) 06-4182
 
Quick Guide for Clinicians—(SMA) 07-4233
 
KAP Keys for Clinicians—(SMA) 07-4251
 
TIP 48 Managing Depressive Symptoms in Substance Abuse 

Clients During Early Recovery—(SMA) 08-4353
 
TIP 49 Incorporating Alcohol Pharmacotherapies Into Medical 

Practice—(SMA) 09-4380

 TIP 50 Addressing Suicidal Thoughts and Behaviors in Sub­
stance Abuse Treatment—(SMA) 09-4381
 
TIP 51 Substance Abuse Treatment: Addressing the Specifi c 

Needs of Women—(SMA) 09-4426
 
TIP 52 Clinical Supervision and Professional Development of 

the Substance Abuse Counselor—(SMA) 09-4435
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Substance Abuse Treatment:
 
Addressing the Specifi c
 
Needs of Women
 
The primary goal of this TIP, Substance Abuse Treatment: Addressing the Specific Needs of Women, 
is to assist substance abuse treatment providers in offering effective, up-to-date treatment to adult 
women with substance use disorders. This TIP reviews gender-specific research and best practices 
beginning with the common patterns of initiation of substance use among women and extending to 
specific treatment issues and strategies across substance abuse treatment services. In the last 15 
years, women-specific substance abuse research and gender-responsive treatment strategies have 
dramatically increased, thus providing this TIP with a wealth of women-specific resources to guide 
its development. This TIP provides clinical and administrative information to assist counselors, 
clinical supervisors, program administrators, and others working with female clients with substance 
use disorders on how they can best respond to the specific treatment needs of women. The TIP will 
provide researchers and clinicians with a guide to sources of information and topics for further 
inquiry. 
Using a biopsychosocial framework and incorporating gender-responsive principles, this TIP 
emphasizes the importance of women’s unique developmental milestones, physiological makeup, and 
the sociocultural influences that can play a significant role in treatment needs and in determining 
effective treatment planning, counseling strategies, and services. To enhance its practical 
application for substance abuse treatment providers, this TIP features “Clinical Notes” that 
highlight relevant issues for counselors, “Clinical Activities” that provide counselors with clinical 
tools to use with clients, and “Advice to Counselors and Administrators” that present an overview of 
the main clinical and programmatic issues pertinent to a particular treatment issue for women. 
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